Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81110487-81166221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 184.7"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 243.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 60.1;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	3.3	4.2	35.4	3.1	79.2	3.7	2.3	43.4	82.0	2.8	0.0	7.7	30.9	0.9	0.5	1.8	2.8	2.7	3.9	30.6	30.8	1.0	0.9	9.5	0.9	99.2	67.9	0.9	20.6	3.0	17.3	2.0	63.4	5.2	0.5	2.1	5.9	3.3	0.6	4.5	23.7	0.8	38.8	9.7	5.8	0.7	78.4	0.1	2.9	1.0	0.2	2.8	4.2	184.7	0.3	0.5	0.7	4.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	60.1	0.2	0.0	0.3	0.0	0.0	1.2	0.6	0.0	0.0	0.0	2.0	2.2	3.2	2.8	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	6.6	0.0	0.2	0.7	0.6	0.3	2.1	4.1	0.6	0.0	0.2	4.5	17.1	0.2	0.4	2.3	0.2	1.1	2.2	2.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	0.2	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	35.4	79.2	43.4	82.0	30.6	30.8	99.2	67.9	63.4	38.8	78.4	184.7	6.3	32.1	20.3	17.0	0.3	0.3	1.0	1.9	0.6	43.0	1.3	5.1	2.2	2.8	0.1	0.0	4.2	0.1	0.5	6.8	0.0	0.6	0.0	0.4	0.2	1.8	1.8	0.0	34.6	1.8	0.1	0.5	7.1	0.6	6.3	2.0	1.1	0.1	2.1	21.9	36.0	4.6	0.0	2.8	0.4	0.0	1.5	8.2	5.4	2.8	1.5	9.6	4.1	21.1	243.2	1.1	4.2	2.6	0.1	0.9	34.1	0.9	0.0	4.4	0.0	4.3	0.8	0.4	0.5	0.0	0.3	2.3	1.4	0.4	7.0	0.2
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.5;intestine: 242.2;kidney: 87.6"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	8.9	0.5	0.1	1.4	0.1	0.6	4.3	0.4	0.3	0.6	1.9	9.9	183.3	0.5	0.5	1.8	1.5	65.5	42.7	0.2	0.2	87.6	5.7	0.8	0.4	0.2	0.2	1.8	2.5	1.5	0.1	1.2	0.2	0.4	5.9	0.3	1.4	4.1	0.7	0.3	242.2	0.5	0.1	0.1	2.6	49.7	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM11	MDC	ENSG00000073670	"ADAM metallopeptidase domain 11"	O75078	17	44758988-44781846	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 36.6;heart muscle: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 11.8;Cardiomyocytes: 18.0;Excitatory neurons: 47.1;Horizontal cells: 23.5;Inhibitory neurons: 23.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEK 293: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074550	Enhanced					NA	NA		23000		"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074550: AB_2732259"	"unprognostic (1.79e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.46e-3)"	"unprognostic (7.16e-2)"	"unprognostic (9.99e-16)"	"unprognostic (1.39e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-1)"	0.5	0.2	11.9	0.0	16.6	0.2	0.6	23.9	36.6	1.6	0.0	2.5	0.1	3.2	0.2	0.5	1.6	0.4	11.1	18.4	3.5	0.3	0.2	0.3	0.1	9.4	6.0	1.4	0.2	0.0	1.8	0.0	10.2	1.4	0.0	2.7	0.3	0.8	0.2	1.0	0.6	1.0	0.3	0.2	0.8	4.1	14.0	0.3	0.3	0.0	0.0	0.9	0.9	17.8	0.0	1.3	0.5	4.4	0.2	0.0	0.3	0.1	0.0	1.2	0.3	0.7	0.2	0.1	0.3	0.0	1.9	0.0	3.3	0.0	0.4	1.4	19.7	0.1	0.4	0.3	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.3	0.1	4.2	0.0	2.3	0.7	1.5	1.2	2.7	0.0	0.3	0.0	0.1	3.2	1.7	0.0	0.1	1.0	0.3	1.3	0.7	0.0	0.5	1.4	1.5	0.4	0.7	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.9	16.6	23.9	36.6	18.4	3.5	9.4	6.0	10.2	0.3	14.0	17.8	0.2	0.0	0.0	10.7	0.1	0.0	0.2	0.2	0.0	11.8	0.3	0.3	18.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.2	1.4	0.4	0.0	0.0	47.1	0.0	0.0	1.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	23.5	23.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.7	0.0	2.2	1.0	3.0	4.2	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.1	3.5	0.0	0.3	1.3	0.7	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.0
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 166.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"MAIT T-cell: 6.1"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	11.4	0.1	2.0	6.0	4.0	0.1	4.6	1.6	2.1	18.2	3.5	0.4	0.2	6.3	0.0	0.4	0.2	11.8	0.7	1.0	2.5	1.0	0.2	1.3	3.2	6.0	2.7	8.8	0.5	0.1	1.1	166.5	3.1	0.3	0.6	0.3	1.1	0.0	0.1	0.4	0.5	4.3	1.8	1.6	0.5	0.9	10.4	1.8	0.3	0.0	3.5	11.6	0.5	3.0	16.8	2.5	6.5	0.1	18.7	38.3	0.0	42.7	3.5	14.2	35.5	0.0	0.0	0.0	0.0	154.2	30.0	0.0	0.2	1.4	15.5	1.9	0.6	0.2	25.1	0.0	2.9	0.0	33.2	47.0	0.0	94.3	2.9	27.1	0.0	0.0	0.0	0.2	11.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	4.8	4.4	0.4	44.1	0.5	28.4	5.0	0.0	0.7	2.5	0.1	0.1	0.0	50.9	16.9	93.2	86.2	0.0	0.5	0.0	70.7	0.1	32.3	0.0	0.0	0.0	0.3	0.0	6.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	2.0	4.0	1.6	2.1	1.0	2.5	6.0	2.7	3.1	1.8	10.4	3.0	0.5	0.0	1.9	22.5	0.3	1.5	0.4	3.0	0.0	2.1	1.7	3.6	2.3	0.0	0.5	0.0	102.2	14.0	0.5	0.7	0.0	8.0	10.9	10.7	16.6	1.6	0.0	0.0	7.4	1.1	400.8	34.5	0.5	1.8	49.5	7.8	2.5	0.2	15.5	6.7	19.0	1.0	4.1	0.6	3.1	1.7	16.8	0.8	1.8	14.0	9.0	3.3	1.0	99.0	52.2	2.2	0.1	0.7	0.3	1.0	0.7	0.4	6.5	30.5	0.0	5.1	13.4	6.0	5.0	0.0	0.6	129.2	4.7	28.1	0.9	0.5
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.8;OE19: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.2	2.2	5.9	24.7	4.6	9.3	3.9	7.1	5.0	16.1	4.0	14.3	8.8	6.9	357.5	2.8	12.3	40.2	1.0	5.8	8.8	5.1	1.2	3.9	26.7	12.0	9.3	2.3	3.5	1.1	18.5	3.7	11.7	5.3	12.1	1.3	15.9	5.7	0.3	3.3	24.7	2.9	9.8	19.9	110.3	0.7	10.1	5.1	1.9	0.4	32.3	11.3	1.7	18.6	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.1	27.8	0.3	0.8	0.0	0.9	0.1	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.7	0.7	8.8	0.1	0.1	0.0	0.4	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.2	2.5	0.1	2.1	1.0	0.2	42.4	2.5	18.5	0.0	0.6	0.0	71.6	0.1	0.0	21.0	87.0	0.1	0.0	4.3	2.7	0.2	1.1	0.1	2.5	5.9	4.6	7.1	5.0	5.8	8.8	12.0	9.3	11.7	9.8	10.1	18.6	1.5	3.2	6.0	0.7	240.9	0.9	3.0	36.9	0.0	0.1	2.3	2.2	2.0	28.6	62.9	3.7	0.0	0.4	9.9	0.7	0.0	7.9	1.3	7.6	1.0	3.7	0.0	8.2	4.3	3.5	8.7	3.9	141.7	18.4	2.5	0.0	0.0	0.0	9.4	0.0	2.7	0.4	28.5	12.3	30.9	1.8	0.6	46.4	5.4	233.3	7.8	0.1	23.7	3.5	1.6	55.7	0.1	0.4	43.3	1.5	0.6	4.4	13.1	0.1	6.6	0.0	1.1	0.4	0.2	0.7	0.6	0.5	9.0	6.4	1.3	7.6
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"adipose tissue: 898.8;breast: 248.9"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	672	"ASC diff: 312.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	910000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			898.8	8.9	0.1	2.4	0.1	0.2	248.9	0.2	0.1	0.0	0.0	7.7	0.1	0.1	0.0	1.2	0.1	7.6	6.5	0.0	0.0	0.8	0.1	0.1	1.3	0.1	0.0	0.0	6.2	0.1	0.1	0.0	0.1	0.3	6.1	0.1	18.8	0.0	2.3	6.6	8.5	1.2	0.0	0.0	3.9	0.1	0.1	2.2	2.9	20.2	0.0	2.4	0.9	0.3	0.0	0.0	0.0	0.1	312.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984765-110023742	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 328.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA		160000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	68.0	66.1	222.3	33.5	271.0	14.7	51.4	244.2	238.0	66.5	175.2	52.1	126.8	54.3	91.8	47.9	72.9	65.2	38.2	183.8	300.2	102.1	69.2	44.6	31.5	337.1	292.5	53.0	73.3	178.5	51.4	56.3	271.6	44.2	51.6	68.8	50.9	64.1	91.8	38.5	64.1	57.3	310.0	34.6	56.3	28.3	299.6	32.2	75.3	44.6	37.5	49.3	39.9	295.6	100.9	83.4	77.3	80.5	182.8	106.8	127.2	78.1	87.7	72.2	70.7	65.3	56.4	42.5	64.9	115.5	55.0	63.0	69.2	89.1	95.0	355.3	59.8	70.8	106.5	69.5	188.4	61.1	47.7	109.7	55.2	90.0	131.0	175.5	92.2	70.7	51.8	84.1	75.7	80.1	51.3	30.2	91.5	140.6	64.1	54.9	161.1	47.7	157.7	99.8	75.4	49.1	121.1	142.9	165.2	116.8	76.5	60.3	80.3	69.3	67.3	82.8	70.4	68.8	30.5	36.0	142.2	65.7	145.1	3.9	5.0	4.6	2.2	5.4	2.3	3.9	2.3	3.1	3.5	4.4	2.4	2.3	4.7	2.5	3.8	3.2	5.0	2.2	222.3	271.0	244.2	238.0	183.8	300.2	337.1	292.5	271.6	310.0	299.6	295.6	67.3	35.3	74.8	328.1	30.1	89.2	100.1	61.7	47.8	62.3	105.9	71.2	49.8	85.8	68.0	117.7	223.1	80.7	29.4	72.0	125.2	142.2	41.6	226.2	69.1	59.0	85.5	42.0	48.7	110.5	50.4	107.4	69.8	181.1	31.7	81.1	61.8	158.2	42.8	63.9	50.4	71.1	65.1	75.8	67.7	29.6	93.5	62.2	62.2	53.4	57.2	99.9	19.6	60.8	53.2	100.8	38.5	81.6	27.0	108.1	134.3	143.6	83.5	105.7	46.0	87.9	105.7	31.6	13.1	75.6	108.4	100.3	26.8	61.4	78.9	134.2
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469472	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 345.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	70.9	99.1	134.7	51.8	136.1	51.0	55.4	142.0	345.7	63.9	135.3	82.4	44.8	80.1	72.3	72.6	120.9	39.4	116.7	134.9	139.1	73.2	71.8	60.8	71.6	141.8	139.3	69.8	50.3	65.5	66.7	76.5	144.0	64.4	71.8	39.1	56.7	70.3	140.2	59.8	54.9	85.0	139.4	55.7	61.9	99.4	142.5	65.2	47.1	118.3	91.4	76.9	61.1	156.2	185.0	356.7	103.1	131.9	159.1	110.3	175.1	131.2	111.6	223.0	165.3	277.0	163.4	361.3	103.0	145.1	258.4	204.7	386.2	186.5	231.8	131.8	207.5	156.1	181.6	343.3	113.7	102.6	230.8	98.3	244.9	150.7	72.2	133.1	209.9	225.3	205.5	115.6	138.5	522.6	278.6	207.8	170.6	347.7	372.9	210.2	110.3	178.1	178.2	187.1	155.0	161.4	119.2	302.9	115.8	154.4	174.4	152.6	100.3	115.3	162.1	126.2	198.7	103.7	241.6	273.8	169.1	211.3	131.1	82.7	51.5	67.9	66.4	74.0	76.9	81.0	59.8	68.0	67.2	63.7	69.0	70.6	39.8	88.7	92.5	66.4	77.2	52.2	134.7	136.1	142.0	345.7	134.9	139.1	141.8	139.3	144.0	139.4	142.5	156.2	46.6	35.3	21.6	10.1	59.4	156.0	208.2	82.8	74.0	36.0	49.9	46.6	92.2	42.9	57.0	27.6	85.5	153.4	66.8	60.0	74.3	74.2	40.6	112.6	60.8	54.9	78.3	55.8	14.6	48.8	113.3	68.3	25.5	59.6	76.2	55.2	28.9	41.0	93.5	18.5	14.7	70.5	65.1	26.7	117.5	34.2	67.7	52.6	90.7	12.2	58.5	46.6	61.8	10.1	23.6	67.8	65.6	66.5	54.1	145.4	56.4	87.0	132.2	54.1	98.6	46.9	135.0	92.0	57.3	67.7	140.1	136.7	92.3	86.0	85.2	120.1
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;intestine: 3.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"amygdala: 5.3;basal ganglia: 13.5;cerebral cortex: 8.5;hippocampal formation: 7.7"	"Immune cell enriched"	"Detected in single"	8	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9"	"Group enriched"	"Detected in all"	5	"amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8"	"Group enriched"	"Detected in all"	5	"amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.3	0.3	5.3	1.4	13.5	0.6	0.5	0.0	8.5	0.4	0.0	3.7	0.5	1.3	0.1	0.5	0.5	0.9	0.2	7.7	0.0	1.3	0.8	1.8	1.9	0.0	0.1	0.4	0.2	0.4	1.0	1.1	0.0	0.4	3.8	0.6	0.3	0.4	0.2	0.5	1.4	1.3	0.0	1.2	0.5	0.3	0.0	0.9	0.5	0.0	1.6	0.6	0.3	0.3	1.3	1.0	1.3	0.8	0.4	0.1	4.2	0.9	0.4	1.2	1.5	10.9	3.3	1.0	2.0	0.7	0.1	0.4	2.8	0.2	1.1	2.0	2.4	3.3	2.0	0.9	0.1	0.4	0.4	0.4	0.1	0.8	0.0	2.1	0.4	2.4	0.4	0.7	0.7	0.8	2.7	0.2	1.0	0.1	0.5	3.3	0.5	0.2	1.9	1.2	3.3	1.4	1.1	0.1	0.2	3.8	1.0	0.2	0.6	1.4	4.2	0.1	1.7	2.2	2.6	2.4	0.9	0.4	0.2	3.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	5.3	13.5	0.0	8.5	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	6.4	2.4	1.6	2.8	0.9	1.3	0.5	1.2	7.4	1.8	1.4	1.6	1.5	0.2	0.0	8.4	0.6	15.6	5.1	0.0	0.6	2.6	0.5	1.4	1.9	0.0	2.7	17.2	0.2	1.9	2.1	0.5	1.0	67.6	0.9	0.4	0.7	0.5	8.4	5.5	28.7	0.0	0.3	2.9	0.9	0.0	1.2	1.8	0.0	0.3	0.9	16.5	3.0	1.6	0.8	2.2	0.0	6.4	1.2	0.8	1.4	0.2	7.7	0.0	2.2	0.8	0.5	4.9	0.1	0.9	0.7	12.4	0.3	6.2	0.9
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504178-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.6;Excitatory neurons: 9.6;Inhibitory neurons: 15.9;Rod photoreceptor cells: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	3.8	10.7	12.7	2.7	13.8	0.4	3.2	11.7	20.0	3.6	8.2	6.9	2.1	4.3	11.7	2.8	3.3	2.8	8.6	14.3	12.6	5.2	2.8	4.6	4.1	11.5	10.7	8.8	6.8	12.4	7.4	1.9	12.5	6.3	2.4	23.4	7.6	7.7	19.3	2.4	3.8	4.5	7.9	3.3	4.6	2.9	12.6	2.7	6.5	11.9	3.3	3.9	2.8	11.8	2.3	1.1	2.4	8.3	3.0	1.3	2.9	3.6	2.0	4.4	2.1	0.5	0.1	0.1	1.0	2.5	1.0	1.2	6.5	0.2	3.7	0.9	0.5	0.0	1.6	0.7	2.5	1.9	4.6	0.6	2.8	1.5	0.0	0.4	1.1	1.3	1.9	0.0	0.1	4.1	0.4	3.9	1.3	2.0	2.5	0.6	0.0	0.3	5.1	1.1	8.1	2.7	0.9	11.0	3.2	1.0	3.2	2.8	1.0	0.1	4.8	3.0	1.5	0.2	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.9	1.1	0.0	0.0	2.3	1.7	0.0	0.9	0.0	0.0	0.7	0.4	12.7	13.8	11.7	20.0	14.3	12.6	11.5	10.7	12.5	7.9	12.6	11.8	0.6	3.2	2.0	5.9	0.2	0.6	0.4	0.3	0.6	33.6	2.4	1.4	8.9	1.5	0.3	3.7	4.2	1.3	0.6	1.5	0.0	1.2	0.0	0.4	0.4	1.6	4.8	0.0	9.6	0.9	0.2	1.9	0.0	0.7	0.0	1.4	1.1	1.0	0.2	5.0	15.9	1.0	2.0	0.6	0.0	0.1	2.1	0.2	0.0	2.8	0.8	6.7	0.0	3.0	2.1	0.8	1.6	5.7	0.1	1.1	2.3	0.8	0.1	9.4	0.0	4.3	1.5	1.2	1.4	0.2	0.4	0.3	1.8	0.9	1.5	0.3
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APBA1	"D9S411E, MINT1, X11"	ENSG00000107282	"Amyloid beta precursor protein binding family A member 1"	Q02410	9	69427532-69672371	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5"	"Group enriched"	"Detected in many"	7	"Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061287			Supported	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA061287: AB_2684467"	"unprognostic (4.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.21e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.66e-3)"	2.9	1.2	14.1	0.7	13.1	0.0	2.5	0.0	16.5	3.6	0.0	2.9	0.6	4.1	0.1	1.8	2.5	1.3	3.0	16.0	9.5	2.2	11.9	1.4	0.6	15.1	13.8	5.3	1.9	6.8	6.3	1.4	16.1	1.9	1.9	3.2	2.9	1.1	2.0	3.9	1.8	0.8	0.0	3.8	2.0	2.8	7.9	0.2	2.0	0.6	0.3	2.8	3.6	0.9	0.0	0.0	0.6	0.0	3.1	2.2	0.1	7.2	6.0	0.1	0.1	0.0	0.0	0.0	3.2	3.0	0.0	0.1	17.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	2.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	2.5	6.5	4.2	0.4	0.9	0.1	0.2	0.0	0.0	7.8	6.9	0.8	0.0	0.5	7.1	3.3	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.1	0.0	16.5	16.0	9.5	15.1	13.8	16.1	0.0	7.9	0.9	1.0	0.0	0.0	53.5	0.0	1.8	1.2	0.2	0.0	15.4	2.0	2.2	4.9	0.0	0.2	0.0	4.2	0.8	0.0	3.7	0.0	0.1	0.3	0.9	1.7	1.4	4.2	0.0	130.3	0.0	0.6	1.7	0.0	1.0	0.0	1.3	3.3	5.8	3.1	69.0	181.6	1.6	0.0	3.7	1.4	0.6	2.5	1.4	0.0	78.7	1.0	3.2	0.0	141.3	106.2	0.2	0.4	10.9	0.0	0.6	0.0	0.4	0.1	9.1	0.0	1.6	2.3	1.1	1.3	0.5	2.4	0.4	0.5	6.0	1.2	0.4
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.0	1.6	4.3	0.7	4.4	0.7	0.9	8.7	8.4	2.9	0.0	1.3	0.4	1.2	0.4	1.7	1.6	0.3	0.4	8.0	2.5	0.9	0.9	3.3	0.6	3.3	2.4	1.1	5.9	0.0	7.6	0.1	2.4	2.5	0.2	1.1	0.4	0.1	0.1	1.0	4.9	0.0	2.2	10.7	1.4	5.7	3.0	1.4	2.7	0.0	0.7	1.3	1.5	4.9	0.0	1.6	0.7	3.7	0.0	0.0	0.0	0.9	1.4	0.1	0.5	0.0	0.0	0.0	3.5	0.0	2.3	0.0	0.5	0.0	0.0	0.0	3.1	8.4	0.0	0.1	3.1	0.0	0.2	0.4	2.5	0.4	0.0	0.4	4.4	1.8	5.0	0.2	0.0	0.5	0.2	2.4	1.1	0.0	3.3	0.0	0.4	0.2	0.0	0.0	5.4	20.0	0.0	0.0	0.2	0.1	0.0	1.0	4.4	0.0	4.4	0.0	0.9	0.0	0.1	0.0	0.1	14.9	1.7	0.0	0.0	0.0	0.9	0.0	0.2	0.0	1.5	3.3	0.0	0.0	5.4	5.6	0.1	1.3	0.0	0.0	0.0	2.0	4.3	4.4	8.7	8.4	8.0	2.5	3.3	2.4	2.4	2.2	3.0	4.9	0.5	0.0	0.6	53.2	1.8	0.4	0.2	0.0	0.0	21.5	1.9	2.3	1.4	0.0	0.1	0.0	0.0	0.1	36.5	0.1	1.9	1.8	18.9	2.9	6.4	1.2	0.0	2.1	142.7	5.8	0.2	2.2	0.0	2.1	0.0	1.9	3.6	0.5	1.2	89.2	106.1	0.3	0.0	1.6	0.4	10.4	1.8	0.8	3.6	33.7	1.9	1.3	63.8	97.0	74.1	3.3	0.0	3.8	12.3	0.1	0.0	0.3	0.2	4.5	0.0	0.4	2.1	1.6	14.5	0.4	0.3	0.1	30.7	10.6	0.0	0.1
APOO	"FAM121B, MGC4825, Mic23, MIC26, MICOS26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907938	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	9.0	23.7	55.8	9.0	58.0	7.9	13.3	58.1	76.3	13.1	67.8	17.3	14.4	10.6	19.6	12.6	20.8	9.3	65.1	57.9	58.4	46.5	18.2	8.6	11.7	58.8	57.0	9.4	14.2	62.0	29.2	10.9	57.3	13.7	18.8	52.8	19.7	15.0	45.9	7.7	12.0	12.0	57.0	8.4	17.7	16.8	56.8	14.0	20.3	73.2	11.6	11.2	8.1	57.1	36.5	32.7	53.9	37.8	8.8	19.9	8.3	17.9	21.9	37.4	38.8	19.3	17.0	31.5	21.9	16.5	48.5	29.3	68.5	35.7	41.2	33.4	48.7	15.9	28.6	31.1	20.8	40.9	17.1	22.2	20.7	41.2	30.4	20.1	26.6	38.8	22.9	33.2	35.1	34.6	41.2	43.0	49.2	47.5	52.7	31.5	26.6	75.6	74.1	18.4	36.4	26.5	39.0	36.7	39.7	52.4	63.6	17.9	6.5	23.9	14.6	86.6	27.9	26.3	50.5	28.7	38.5	19.8	35.8	14.8	4.8	1.4	12.6	15.9	16.6	10.8	13.7	12.5	14.0	10.2	10.9	10.7	3.0	10.3	16.0	16.6	14.0	7.7	55.8	58.0	58.1	76.3	57.9	58.4	58.8	57.0	57.3	57.0	56.8	57.1	7.4	16.0	11.5	61.7	11.8	14.0	17.0	74.3	11.4	20.4	14.3	17.0	61.8	21.5	28.3	23.9	14.6	17.2	11.3	12.8	180.0	28.4	25.9	56.0	13.0	10.1	7.2	20.8	61.4	16.0	8.9	11.7	13.3	24.4	3.8	14.2	7.9	13.9	22.7	20.2	76.5	17.0	44.7	14.6	12.0	15.7	11.5	9.9	28.4	74.0	34.2	50.0	8.2	43.7	76.5	10.2	20.0	15.8	14.8	14.1	24.0	80.6	106.9	32.4	6.6	10.8	22.3	26.1	53.2	18.9	7.0	12.4	9.5	17.0	22.3	16.8
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75260122-75351705	"Predicted intracellular proteins, Transporters"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 136.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8"	"Cell line enhanced"	"Detected in many"		"HEL: 168.9;RH-30: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm		NA	NA		1500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151"	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	30.7	7.1	49.7	21.9	49.4	15.7	24.1	28.3	49.5	10.0	0.0	26.4	21.9	10.2	6.1	19.0	15.9	12.9	17.6	54.3	43.6	14.2	10.1	53.0	15.3	41.1	55.6	16.2	24.5	3.8	4.1	25.1	49.4	16.3	22.5	5.3	12.7	9.7	11.4	16.8	27.2	21.8	23.2	40.1	33.9	4.3	49.9	9.9	8.8	10.9	10.3	16.5	11.0	36.7	5.1	23.6	24.2	12.0	20.2	17.6	48.8	5.0	17.2	6.2	4.3	34.5	23.9	2.0	58.9	4.5	4.7	1.1	9.5	0.1	2.4	0.2	5.5	168.9	3.3	20.6	5.5	5.1	63.9	8.9	1.2	10.3	0.0	7.4	70.4	6.1	83.5	0.2	12.2	14.1	3.1	58.4	17.8	76.9	7.1	18.8	114.4	6.8	26.8	20.4	12.5	13.5	8.7	61.7	15.0	49.3	44.8	27.6	61.0	4.7	5.9	19.3	0.6	0.1	0.1	0.1	3.5	78.0	5.8	33.7	65.7	45.9	11.6	106.5	4.3	0.4	5.5	6.6	42.5	0.2	5.0	6.6	49.5	14.8	136.8	0.9	5.7	41.1	49.7	49.4	28.3	49.5	54.3	43.6	41.1	55.6	49.4	23.2	49.9	36.7	24.2	28.9	14.8	52.2	1.9	1.9	2.0	1.9	2.8	3.1	9.0	14.7	4.6	8.6	5.8	3.7	6.2	41.7	10.7	38.5	1.9	5.0	2.6	0.8	4.3	19.4	5.4	10.3	35.6	8.4	4.1	9.1	17.3	0.9	23.5	2.3	25.7	2.1	39.6	0.0	48.9	11.1	8.2	55.2	17.9	21.4	15.8	31.2	3.6	55.3	42.1	0.2	29.9	8.0	23.9	9.2	19.1	16.6	1.0	3.6	29.9	0.2	4.7	1.1	13.1	4.5	7.7	0.2	0.8	1.0	3.0	33.7	5.9	9.4	20.0	2.8
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710596-4721499	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 263.6;lymphoid tissue: 168.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	48.6	39.7	54.4	110.0	53.8	263.6	26.1	48.2	62.2	19.3	49.1	29.5	50.5	17.4	10.8	15.1	29.0	31.4	25.0	63.8	67.7	25.2	35.6	94.8	59.4	61.6	58.3	17.5	19.4	16.4	24.9	35.5	59.5	19.5	27.6	16.9	20.9	11.7	12.7	14.6	51.1	29.6	55.4	168.3	35.0	7.2	59.5	45.2	15.8	18.1	38.0	41.6	17.6	66.5	17.3	88.7	34.7	32.9	6.8	9.5	18.6	13.7	18.0	38.4	48.0	31.0	14.2	49.1	12.2	10.3	18.3	28.5	58.0	18.4	39.4	116.6	85.0	195.8	46.8	55.6	10.2	89.2	315.9	8.8	23.5	47.9	18.7	24.9	29.6	89.1	13.5	46.4	8.9	30.5	87.9	199.2	18.9	44.9	18.4	104.3	31.0	53.8	13.2	9.2	36.0	49.2	30.8	50.8	23.6	14.2	24.6	40.0	26.1	14.3	29.1	25.1	51.5	19.8	28.6	27.6	37.9	279.4	21.6	116.2	145.5	269.7	49.1	151.1	35.1	10.1	31.1	51.3	84.9	9.0	29.3	38.7	250.6	29.9	168.6	20.7	28.8	93.5	54.4	53.8	48.2	62.2	63.8	67.7	61.6	58.3	59.5	55.4	59.5	66.5	7.7	22.4	32.3	5.5	26.4	11.5	7.7	16.6	3.4	20.5	9.6	12.3	8.3	14.3	47.9	3.7	2.1	7.5	83.8	7.4	15.6	11.2	0.6	1.5	3.6	10.1	8.4	33.9	20.4	7.3	12.0	8.7	19.4	1.8	94.9	7.8	19.2	12.4	262.0	21.9	18.2	17.0	50.8	242.5	164.2	3.5	5.0	226.4	10.6	42.2	311.3	5.8	89.6	7.1	8.4	6.3	22.0	4.9	23.4	4.4	35.5	17.5	24.4	8.7	19.7	10.9	8.5	1.1	13.1	6.8	8.4	6.0	77.2	3.5	11.4	11.7
ARRDC3	"KIAA1376, TLIMP"	ENSG00000113369	"Arrestin domain containing 3"	Q96B67	5	91368631-91383317	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 394.2;Syncytiotrophoblasts: 339.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 115.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.28e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.25e-8)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.15e-1)"	36.8	80.1	16.9	26.8	22.6	167.4	94.6	23.7	32.5	44.8	24.0	19.9	9.9	40.5	27.1	38.7	24.9	39.0	24.7	16.3	20.1	52.7	75.9	44.5	29.3	27.8	20.2	93.2	20.8	54.3	21.5	76.8	22.3	30.3	27.5	75.1	63.9	24.3	34.2	41.3	16.8	33.0	23.8	37.1	25.7	16.6	18.1	28.0	84.0	44.9	28.2	57.0	42.0	41.9	6.6	10.7	12.1	16.6	18.4	31.0	40.2	15.8	14.7	9.3	16.2	5.2	26.9	7.9	13.0	16.2	26.1	14.6	13.4	13.3	8.5	8.2	1.4	3.9	43.3	8.5	14.3	27.9	1.6	13.3	21.2	8.1	20.9	56.4	26.1	7.6	11.5	37.7	14.4	3.7	29.9	4.1	4.3	2.8	11.3	24.8	15.2	41.5	60.4	11.9	21.1	14.0	48.2	3.7	2.9	30.2	17.9	13.1	28.3	7.7	11.2	12.4	9.6	28.6	40.9	16.1	45.8	16.4	8.7	28.7	15.2	20.4	29.1	13.1	21.1	12.3	18.3	22.8	9.3	9.4	24.0	37.7	115.3	14.9	22.2	2.2	21.9	19.9	16.9	22.6	23.7	32.5	16.3	20.1	27.8	20.2	22.3	23.8	18.1	41.9	53.8	51.3	166.5	6.5	47.0	112.0	17.6	51.2	9.1	30.9	89.5	48.5	34.5	20.0	72.4	97.5	31.3	89.9	110.2	21.2	154.6	72.6	27.1	28.9	43.1	143.3	73.0	37.1	10.5	79.5	81.6	95.7	38.7	51.4	37.3	36.4	37.5	155.1	48.7	32.0	15.5	32.4	10.2	106.9	394.2	22.3	21.1	100.3	120.9	14.0	56.6	97.0	50.4	13.6	28.3	41.2	16.1	15.1	58.8	31.2	9.3	57.3	28.5	67.2	19.7	32.1	54.9	8.1	9.6	55.6	118.3	339.4	66.3	23.4	20.2	22.7
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	13.4	7.4	3.5	9.0	4.2	6.1	10.4	3.6	4.6	11.8	10.3	10.0	5.6	11.9	9.3	5.1	10.7	8.4	5.4	3.1	4.5	11.8	49.8	7.2	14.8	4.9	4.7	12.7	4.9	5.7	3.7	5.3	5.2	9.8	7.1	2.8	6.0	14.6	3.5	6.0	8.6	10.6	3.9	12.2	7.6	9.7	4.8	11.1	6.1	4.3	8.8	13.6	9.3	4.5	16.9	7.1	14.2	23.3	20.7	27.9	18.0	19.7	26.4	15.6	21.5	6.3	13.4	24.0	43.3	28.2	10.3	13.7	34.6	9.0	24.4	22.1	20.2	12.1	15.2	12.3	23.0	21.4	7.4	18.6	5.9	16.9	14.4	17.3	27.3	18.3	14.0	17.9	20.8	9.1	19.7	14.5	24.1	0.1	13.3	19.5	15.3	20.1	13.1	27.6	11.0	18.3	7.8	0.8	10.6	13.3	5.8	11.7	31.0	21.2	6.9	25.9	27.1	5.1	5.4	18.7	9.7	26.3	10.8	2.4	0.4	0.1	0.4	0.3	0.8	0.9	0.4	0.3	0.4	0.9	0.4	0.7	0.9	1.2	0.6	0.7	0.3	0.2	3.5	4.2	3.6	4.6	3.1	4.5	4.9	4.7	5.2	3.9	4.8	4.5	27.4	16.0	8.4	22.5	14.6	14.5	16.7	6.5	5.7	1.9	8.0	8.9	4.4	2.8	9.2	11.0	0.0	2.3	11.6	7.0	1.9	4.8	13.6	11.5	22.7	32.4	9.1	15.3	1.3	10.1	12.6	17.2	10.7	13.7	9.5	23.6	34.6	46.6	9.4	0.0	26.1	6.4	8.2	37.2	14.4	11.9	14.3	15.3	10.6	45.9	33.9	3.1	7.2	29.1	27.8	7.8	7.2	15.4	13.2	15.8	4.7	7.7	6.8	3.1	0.0	19.3	19.2	67.9	53.1	5.9	13.5	6.7	12.7	11.5	5.2	14.6
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428633-154436516	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	56.3	93.5	108.3	43.1	109.2	59.1	56.7	99.6	118.0	59.6	123.6	61.5	48.4	54.2	145.1	85.2	60.0	46.0	92.7	116.2	115.4	104.3	51.4	96.8	46.9	114.0	96.8	63.3	86.6	176.0	110.4	77.9	121.6	85.1	57.0	74.0	87.4	54.8	53.8	83.6	57.4	49.0	104.6	94.7	70.4	47.5	104.2	40.9	81.9	54.4	42.5	63.7	60.9	121.6	110.1	101.6	88.2	146.2	145.7	77.4	162.2	78.5	116.6	122.5	176.1	93.4	135.1	64.7	337.8	177.1	216.5	112.3	133.8	71.9	76.6	58.6	135.1	37.5	113.7	100.0	170.6	60.9	260.2	98.1	126.7	112.4	68.2	139.5	177.0	47.8	45.6	176.4	84.7	158.1	43.6	96.8	32.1	171.0	100.8	66.6	59.1	170.7	139.9	87.3	84.6	89.7	72.6	289.7	159.3	87.3	123.1	157.8	135.5	87.4	79.0	151.1	135.6	256.3	311.8	77.0	104.4	132.8	90.2	246.6	295.1	363.9	147.3	313.8	148.6	91.7	118.4	127.8	376.7	113.6	107.1	117.8	326.9	140.3	255.6	215.9	155.2	216.9	108.3	109.2	99.6	118.0	116.2	115.4	114.0	96.8	121.6	104.6	104.2	121.6	39.4	38.5	57.5	17.0	32.3	30.2	42.7	122.4	25.6	105.8	58.5	42.2	37.7	54.3	102.1	97.5	47.9	145.1	40.1	84.3	19.6	65.4	3.1	52.5	33.7	50.1	89.0	35.8	17.0	52.5	104.5	48.8	36.7	57.4	77.3	51.8	54.3	46.6	246.3	129.5	24.2	59.0	160.7	143.6	88.2	5.5	41.3	130.3	72.9	15.0	79.9	68.4	27.8	22.1	26.4	42.4	67.5	42.5	61.7	34.1	63.7	49.1	112.5	69.2	65.7	35.7	45.5	64.4	10.7	31.6	32.8	196.5	36.3	74.1	54.6	47.2
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 765.1"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 702.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved					NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	81.2	71.5	85.6	60.6	86.5	124.4	95.1	76.4	116.9	106.1	72.4	82.9	32.1	86.6	91.3	70.1	75.6	79.7	55.1	90.8	90.2	165.6	96.8	87.3	67.4	80.4	79.8	68.9	53.3	765.1	30.7	106.9	83.4	86.6	89.0	99.3	39.4	97.9	18.4	71.9	47.8	124.7	84.6	69.0	49.1	40.4	87.6	72.0	177.1	40.1	72.5	97.7	41.4	98.7	83.9	117.5	78.7	106.7	472.6	312.4	47.9	182.4	274.1	127.0	152.9	68.0	142.6	48.4	88.1	257.0	141.3	86.6	114.0	136.0	168.2	92.7	97.7	57.5	100.2	66.5	172.0	104.6	111.6	259.6	175.2	154.2	121.4	200.3	168.1	46.1	63.8	130.7	201.7	109.8	45.5	93.7	73.4	140.8	112.7	43.8	132.6	161.6	182.8	96.8	55.2	51.9	185.8	111.7	118.4	284.2	147.8	97.1	172.5	175.0	91.3	207.7	62.8	38.0	70.7	46.2	139.1	93.0	138.5	269.0	511.1	404.8	156.1	364.9	164.3	106.7	157.3	161.9	341.3	110.3	174.8	159.3	255.9	141.2	378.6	124.2	167.2	692.9	85.6	86.5	76.4	116.9	90.8	90.2	80.4	79.8	83.4	84.6	87.6	98.7	102.3	57.7	65.6	36.2	65.4	97.3	135.4	254.3	46.1	155.8	74.1	61.2	30.4	94.4	175.4	138.0	54.2	173.4	109.6	70.3	62.6	146.6	3.6	97.2	115.5	94.7	57.1	62.3	44.8	59.1	106.3	156.5	34.7	124.5	87.5	63.7	96.0	64.0	702.2	188.4	56.3	54.6	349.9	279.5	263.3	9.5	117.4	222.0	149.4	28.1	185.4	193.0	72.1	40.2	40.6	64.0	58.9	151.2	74.8	97.9	61.0	106.4	127.4	93.3	105.2	116.7	138.7	106.7	43.1	60.0	99.9	174.4	100.3	188.2	63.6	121.1
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-secretase 2"	Q9Y5Z0	21	41167801-41282530	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 290.4;Syncytiotrophoblasts: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 73.8;SK-BR-3: 53.3;SK-MEL-30: 52.6;WM-115: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	10.0	1.6	2.1	4.3	3.1	0.6	7.7	4.4	2.6	6.1	9.4	7.3	3.5	8.7	1.9	9.4	6.3	8.3	6.2	2.0	4.1	9.8	1.7	4.3	3.1	6.7	3.8	2.7	13.1	2.3	1.5	2.9	5.1	8.3	4.5	0.3	26.8	2.6	2.2	5.0	4.5	4.7	5.5	4.7	22.9	1.0	4.1	1.1	4.6	2.2	3.6	6.7	5.6	8.7	27.4	2.1	12.6	0.0	2.5	2.1	0.1	6.3	0.0	3.9	3.8	0.0	9.6	0.1	12.2	7.1	7.2	8.1	0.0	13.6	1.4	0.0	12.6	6.2	3.3	0.0	1.0	0.0	14.4	5.5	2.8	0.5	2.7	20.9	12.1	6.4	0.0	0.1	6.0	6.1	3.4	0.0	8.5	73.8	12.1	1.0	0.0	9.8	11.5	2.5	0.4	0.1	0.5	53.3	52.6	1.0	12.0	0.1	15.8	7.3	5.3	6.5	10.9	0.1	0.1	0.0	17.8	0.0	46.2	2.9	0.0	5.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	3.1	4.4	2.6	2.0	4.1	6.7	3.8	5.1	5.5	4.1	8.7	55.0	12.8	15.9	11.8	28.6	18.5	91.6	25.6	42.7	0.8	40.3	33.8	9.7	123.0	72.5	20.2	2.1	127.6	0.5	40.5	93.9	146.3	24.3	65.4	19.8	90.2	18.5	22.1	11.7	105.2	64.2	34.0	186.6	115.8	90.7	6.7	35.3	1.0	28.0	0.0	7.5	86.2	44.7	17.0	8.2	16.0	14.3	3.6	179.7	20.6	2.9	3.1	0.0	9.5	46.0	86.6	23.9	18.8	3.2	290.4	7.3	1.4	76.5	0.8	0.0	15.9	23.6	0.6	1.4	43.5	11.8	514.7	6.2	8.7	56.6	134.2
BCL2L11	"BIM, BimEL, BimL, BimS, BOD"	ENSG00000153094	"BCL2 like 11"	O43521	2	111119378-111168445	"Predicted intracellular proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.3;Plasma cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026332, CAB079899"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"CAB026332: AB_566386, CAB079899: AB_10981505"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.86e-2)"	8.1	7.4	4.2	16.4	5.0	38.8	12.5	3.7	3.7	7.2	4.6	11.0	7.2	6.5	4.9	9.8	7.0	8.8	5.7	3.0	3.9	10.7	14.3	8.5	24.2	4.3	4.0	10.3	10.3	18.8	9.4	6.0	4.5	7.8	11.9	12.1	10.1	7.1	12.3	5.8	11.7	4.8	3.9	16.3	7.0	8.1	4.4	18.9	16.6	7.3	23.0	8.9	8.2	6.7	8.0	2.4	10.8	10.4	9.1	4.7	29.1	1.2	2.3	3.3	3.3	6.6	24.9	32.0	6.5	1.2	18.9	9.5	10.0	3.9	2.0	24.9	18.2	39.7	8.1	10.5	3.9	14.6	8.8	4.8	10.5	3.7	3.8	7.0	4.6	14.2	20.8	46.6	0.7	5.2	15.3	14.7	13.2	6.3	7.5	19.5	10.3	40.7	4.5	13.0	9.3	24.0	11.0	14.5	8.3	7.1	5.0	31.2	1.9	1.7	11.4	3.7	4.3	91.2	19.5	45.3	2.7	10.1	1.5	5.2	3.7	1.8	1.7	2.6	1.8	3.3	2.3	1.9	1.9	1.9	1.5	1.5	5.2	1.7	5.7	0.4	5.9	1.5	4.2	5.0	3.7	3.7	3.0	3.9	4.3	4.0	4.5	3.9	4.4	6.7	33.9	3.2	9.9	2.9	61.3	17.5	18.2	7.0	34.7	7.4	19.5	29.2	19.3	12.8	10.3	9.2	10.4	4.6	43.9	37.6	13.7	9.7	118.3	36.6	10.8	18.0	21.5	26.5	2.2	6.5	7.8	11.6	8.6	54.7	11.4	5.9	14.6	11.3	10.9	0.0	4.8	15.2	12.2	26.8	52.6	39.2	5.9	34.8	23.2	6.5	41.0	12.1	5.2	3.0	5.3	8.8	16.4	3.8	137.9	15.9	16.6	6.4	15.2	21.1	0.0	11.8	11.9	7.3	17.7	66.1	10.9	5.7	41.0	2.5	12.3	16.0
BSG	"CD147, EMMPRIN, EMPRIN, OK"	ENSG00000172270	"Basigin (Ok blood group)"	P35613	19	571277-583494	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1535.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1408.0;Syncytiotrophoblasts: 1654.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002427, HPA036048, HPA074870"	Enhanced		Approved	Vesicles		NA	NA		340000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719"	"unprognostic (1.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.53e-3)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.61e-2)"	"prognostic favorable (1.95e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-1)"	378.6	518.8	652.6	154.5	615.4	431.3	313.8	575.6	847.5	320.6	975.8	543.5	231.3	413.3	259.5	245.1	323.1	176.2	1535.0	629.0	606.0	469.7	186.0	253.6	101.9	578.5	611.2	300.7	301.6	255.3	331.2	320.2	599.8	228.8	155.9	189.6	274.8	194.4	472.3	226.6	239.7	164.1	551.0	200.0	455.8	486.0	724.3	92.8	302.1	292.2	74.2	366.9	233.0	581.2	622.6	739.3	339.5	852.3	975.0	426.0	800.4	499.2	507.6	506.1	437.9	607.1	569.4	208.4	564.3	383.5	148.7	967.8	341.0	575.0	129.6	468.1	840.3	150.0	545.5	812.3	683.6	361.6	679.0	455.5	578.5	302.4	304.5	613.1	383.3	198.3	722.9	992.5	298.6	1015.8	261.6	706.6	901.9	353.7	408.3	522.8	301.2	745.2	655.9	412.1	561.0	539.1	984.4	408.1	769.7	257.9	432.3	1118.9	478.7	557.5	353.4	940.1	751.5	639.7	701.8	201.1	1066.9	510.2	712.8	189.0	324.7	348.9	226.4	245.9	200.5	115.0	150.7	218.4	209.6	93.2	114.0	144.7	474.8	173.5	284.2	235.2	192.0	434.0	652.6	615.4	575.6	847.5	629.0	606.0	578.5	611.2	599.8	551.0	724.3	581.2	313.5	22.4	31.5	75.1	101.5	208.6	176.8	668.0	91.0	157.7	202.8	187.6	80.6	128.7	253.4	286.9	204.3	1408.0	156.5	1140.1	146.8	580.9	261.6	156.6	296.6	246.7	255.1	1091.4	35.4	371.4	1095.5	279.8	192.1	190.1	116.2	181.1	132.1	96.9	416.7	139.7	31.4	337.2	510.6	137.8	179.6	600.2	300.4	139.8	506.9	122.7	264.5	495.5	221.4	20.6	30.7	458.0	929.1	336.7	192.4	172.8	450.7	306.7	178.8	269.2	203.8	74.3	235.6	347.9	604.4	127.7	156.7	1654.9	130.9	223.5	478.2	181.4
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory subunit beta"	Q8WZ55	1	54998933-55017172	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 9.4"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 25.4;Ionocytes: 87.5"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"RPMI-8226: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 8.4"	"Group enriched"	"Detected in some"	10	"Adipocytes: 34.9;Endothelial cells: 12.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"	NA	NA	210000000			"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	3.1	0.2	0.3	0.1	0.2	0.2	1.5	0.4	0.3	0.3	0.0	1.6	0.6	0.3	0.4	0.4	0.3	0.8	3.8	1.9	0.5	0.3	0.5	0.2	0.2	0.1	0.1	0.1	0.6	0.1	0.1	1.3	0.2	0.6	0.3	0.4	0.4	0.1	8.4	2.1	0.6	0.6	0.0	0.3	0.5	0.9	0.2	0.2	0.2	3.3	0.1	0.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.3	1.9	0.5	0.1	0.1	0.2	0.0	0.2	0.2	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.3	2.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.5	0.1	12.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.9	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.1
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011044, HPA075369"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA011044: AB_2668414, HPA075369: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	6.6	8.2	26.9	6.5	27.6	13.6	5.8	15.5	28.9	6.4	15.3	11.1	16.1	6.2	4.8	10.8	8.8	5.3	10.2	26.8	19.6	11.6	13.1	10.3	8.1	18.0	18.4	6.0	11.0	5.7	23.9	3.9	18.4	7.1	7.3	14.1	9.6	5.3	15.3	15.3	17.1	5.1	15.2	14.9	8.1	4.3	21.4	8.5	6.7	7.3	5.7	7.0	6.6	23.7	6.1	4.5	6.0	12.5	7.7	3.2	3.9	9.0	7.8	8.7	7.2	7.3	6.3	9.1	23.1	6.3	9.1	13.4	7.6	3.9	3.4	14.3	6.2	35.7	5.9	5.3	10.2	10.5	50.5	3.7	7.9	16.4	6.1	9.8	5.4	13.5	15.1	16.1	8.3	16.2	11.9	24.9	2.2	15.0	11.8	7.4	5.3	10.5	8.7	3.8	18.7	10.5	3.8	20.1	5.9	2.3	35.3	13.9	6.7	8.1	2.8	9.9	16.1	6.8	4.5	3.5	4.9	17.6	9.1	0.5	1.3	2.7	0.2	1.4	0.4	0.1	0.6	0.6	0.5	0.0	0.6	0.3	0.4	0.8	2.0	0.3	0.6	0.5	26.9	27.6	15.5	28.9	26.8	19.6	18.0	18.4	18.4	15.2	21.4	23.7	5.1	6.4	4.2	9.4	3.7	10.7	1.6	2.3	10.2	15.6	6.8	5.0	2.4	2.8	4.3	1.8	37.5	0.9	7.4	40.6	3.9	3.4	5.4	12.1	2.6	5.7	1.2	7.0	15.1	2.8	1.7	2.5	3.6	4.6	2.5	2.2	11.4	5.4	9.4	21.9	15.0	8.0	0.0	13.9	16.1	1.3	2.1	11.4	7.2	5.6	15.3	5.9	7.2	4.5	8.4	5.1	10.4	1.5	7.2	3.2	33.0	4.0	21.9	29.9	6.6	2.1	3.6	3.7	2.0	10.3	10.9	1.1	8.6	3.6	5.5	1.9
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673918-35681159	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"stomach 1: 289.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 275.3;Cholangiocytes: 62.9;Early spermatids: 205.8;Gastric mucus-secreting cells: 259.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 85.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A-431: 189.3;HDLM-2: 98.1;hTERT-RPE1: 113.1;U-87 MG: 374.4"	"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	3.8	0.4	0.0	0.2	0.0	0.0	0.1	5.6	0.6	0.5	0.0	0.6	14.5	0.2	0.1	0.8	0.4	24.4	2.0	0.2	0.1	0.2	1.3	0.2	0.0	0.0	0.1	0.7	6.6	0.0	0.5	0.0	0.2	0.5	0.0	1.0	0.1	0.1	0.1	8.2	13.6	0.1	0.0	0.0	289.3	5.5	0.5	0.0	0.0	0.0	0.0	0.7	0.7	0.0	189.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.3	2.5	0.0	0.1	0.0	0.1	0.0	0.5	5.7	0.0	0.9	1.5	98.1	0.0	0.0	0.7	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	113.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.5	0.0	0.0	10.6	0.0	0.6	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	18.9	0.4	0.0	4.7	0.0	0.4	0.1	374.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.2	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	4.5	0.7	275.3	0.0	0.4	0.1	0.0	0.4	62.9	28.1	0.0	0.0	0.0	0.0	0.1	0.0	49.1	205.8	0.0	0.1	0.2	0.0	0.0	0.1	50.9	0.6	1.2	259.5	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.6	4.0	18.3	0.0	0.0	19.6	1.5	0.1	0.0	0.0	0.6	1.3	0.0	0.0	0.0	26.6	0.0	0.7	0.3	0.8	0.7	0.1	5.5	0.0	0.0	0.0	1.5	0.9	4.0	0.0	3.1	0.3	0.1	0.7	5.3	0.4
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.1	13.1	17.5	2.0	18.7	0.1	11.8	6.4	11.3	11.9	22.8	2.9	1.5	10.8	9.1	3.7	14.4	4.5	4.0	14.9	12.9	6.3	1.8	9.0	1.9	12.0	18.1	22.6	7.3	6.9	9.1	10.2	10.9	8.2	2.7	6.4	8.2	7.6	2.9	7.7	3.5	9.6	8.6	4.5	6.7	2.3	18.9	5.1	6.4	5.4	1.6	6.0	10.6	5.7	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.5	18.7	6.4	11.3	14.9	12.9	12.0	18.1	10.9	8.6	18.9	5.7	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443777	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.7;tongue: 98.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 543.1;Inhibitory neurons: 383.3;Oligodendrocyte precursor cells: 357.9;Oligodendrocytes: 662.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 127.4;HUVEC TERT2: 54.9;SH-SY5Y: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		390000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	11.6	14.5	9.8	4.3	11.9	0.0	4.1	1.2	15.4	5.3	0.0	13.0	5.1	7.4	2.4	5.3	3.9	6.4	31.3	18.8	13.3	8.4	1.3	3.4	1.9	4.6	26.0	7.9	1.5	1.2	6.3	4.2	9.5	13.7	5.1	8.3	2.6	6.4	78.7	4.7	3.4	12.2	8.1	4.4	5.6	3.7	34.2	3.9	18.9	98.5	3.1	7.1	3.4	12.8	0.0	12.7	10.6	0.0	18.2	22.9	0.0	23.4	15.0	11.4	11.1	0.0	3.5	0.0	0.0	20.4	14.1	0.0	11.2	0.0	14.8	0.0	15.0	0.7	14.4	0.0	11.9	5.3	0.0	13.6	0.1	39.6	0.1	127.4	54.9	0.0	0.0	0.2	25.7	0.1	0.0	0.0	12.6	0.0	5.0	2.3	2.1	0.0	0.9	0.9	21.1	62.3	4.6	0.1	0.0	11.1	0.1	0.0	39.6	20.1	15.0	20.1	0.0	0.1	0.0	0.0	16.9	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.9	1.2	15.4	18.8	13.3	4.6	26.0	9.5	8.1	34.2	12.8	6.3	0.0	1.7	137.1	0.0	5.7	4.5	0.1	8.0	47.7	6.6	3.9	88.0	0.0	1.3	7.3	18.8	0.1	0.1	0.0	0.0	0.0	64.2	0.5	20.7	6.8	38.8	0.0	543.1	0.0	0.0	20.6	14.3	0.4	25.3	29.9	1.4	0.4	0.2	25.2	383.3	2.6	16.2	0.0	2.9	42.4	10.2	0.4	1.8	87.1	0.6	5.6	0.0	357.9	662.8	0.8	0.0	6.0	0.2	11.2	0.0	9.5	0.7	6.1	6.6	17.6	21.5	1.5	1.9	1.9	6.5	0.1	0.4	32.7	0.2	1.4
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.6	4.7	1.3	5.2	1.2	1.2	9.9	6.9	1.4	0.3	1.6	1.2	1.6	0.9	0.6	1.1	0.7	8.4	0.7	13.9	2.3	0.3	49.1	1.2	8.3	8.4	2.1	4.3	2.5	7.1	1.8	14.0	3.0	1.9	8.6	1.3	1.1	1.8	2.6	1.6	1.2	4.8	1.4	4.1	6.5	11.4	1.0	2.2	1.5	0.5	0.5	0.7	2.1	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	4.7	5.2	9.9	6.9	0.7	13.9	8.3	8.4	14.0	4.8	11.4	2.1	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CACNA2D3	HSA272268	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;skeletal muscle: 9.9;tongue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 828.3;Inhibitory neurons: 456.4;Oligodendrocyte precursor cells: 317.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.1;HAP1: 1.9;HeLa: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030849			Uncertain	Nucleoplasm		NA	NA		69000		"Cluster 47: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA030849: "	"unprognostic (6.92e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-5)"	"unprognostic (5.53e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.22e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.95e-2)"	0.2	4.1	8.8	0.1	11.6	0.0	0.2	0.0	15.8	0.3	0.0	0.7	0.1	0.1	1.3	0.5	0.4	0.2	2.6	9.4	8.4	1.3	0.0	0.5	0.5	2.1	10.2	2.5	0.0	0.3	0.8	0.5	1.3	1.0	0.3	2.9	0.4	1.5	9.9	0.1	0.3	0.6	0.0	0.2	0.4	1.4	3.5	0.1	0.4	10.7	0.5	0.1	0.4	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	9.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	11.6	0.0	15.8	9.4	8.4	2.1	10.2	1.3	0.0	3.5	9.9	0.5	0.0	0.0	160.9	0.6	0.3	0.4	0.2	7.4	10.8	0.2	0.5	30.2	0.0	0.7	0.0	8.4	9.9	5.5	0.1	7.9	0.0	83.4	0.9	0.8	0.6	0.0	1.3	828.3	0.6	3.2	3.4	1.5	1.8	0.0	1.1	0.4	0.0	5.9	0.0	456.4	0.0	2.0	8.9	2.7	56.1	2.8	11.0	0.0	97.4	22.2	5.0	0.0	317.7	11.3	1.2	0.0	1.5	0.1	0.4	0.0	0.2	0.8	1.4	6.6	1.7	1.9	5.7	2.9	3.4	0.1	68.0	0.7	0.8	0.0	0.4
CACNA2D4		ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791963-1918666	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"retina: 20.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cone photoreceptor cells: 156.4;Early spermatids: 56.3;Late spermatids: 117.6;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;HL-60: 2.8;HMC-1: 14.0;NB-4: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA031952	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA031952: AB_10600798"	"unprognostic (5.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-1)"	0.3	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	20.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.7	0.2	2.8	14.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	4.4	0.0	2.1	1.7	4.2	0.0	1.0	1.5	2.9	0.0	0.5	0.3	0.1	0.4	0.5	0.1	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	1.9	0.7	2.4	0.9	0.4	0.1	1.2	56.3	0.7	1.0	0.9	2.8	0.8	0.0	156.4	0.1	5.5	2.4	0.0	0.8	56.3	0.2	1.2	1.5	1.2	0.4	0.8	0.4	0.2	1.8	1.1	0.2	15.2	0.8	1.4	1.2	23.7	0.0	0.4	2.1	0.0	29.2	5.7	117.6	0.9	23.2	3.6	0.0	17.3	6.9	18.6	0.0	1.8	0.3	3.4	0.4	0.8	0.2	12.2	1.3	1.1	98.5	0.0	0.3	2.3	9.0	4.9	0.4	0.6	0.1	8.6	0.6	3.4	0.3
CACNB2	"CACNLB2, MYSB"	ENSG00000165995	"Calcium voltage-gated channel auxiliary subunit beta 2"	Q08289	10	18140424-18543557	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 863.5;Excitatory neurons: 545.7;Inhibitory neurons: 357.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.4;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035326	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035326: AB_10669903"	"unprognostic (3.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.67e-4)"	"unprognostic (8.03e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.16e-2)"	2.8	9.4	1.3	2.1	3.9	1.3	3.8	5.4	12.9	7.4	0.1	17.6	1.1	12.8	2.7	5.0	10.1	2.2	17.8	5.4	7.4	3.2	10.7	3.9	0.9	0.0	0.1	13.6	7.5	0.6	19.3	0.5	0.0	8.5	3.2	35.1	3.9	8.8	1.1	4.2	11.4	5.3	0.0	1.5	7.7	2.1	2.2	0.7	2.5	0.7	0.2	16.8	4.6	1.5	0.2	1.0	0.7	0.5	0.3	0.3	0.5	0.3	0.0	0.0	0.3	0.4	0.5	0.9	0.2	0.2	0.3	0.7	6.4	0.0	0.0	0.3	2.4	0.8	1.7	1.5	1.6	0.5	1.5	8.1	0.0	0.0	0.0	0.3	0.0	1.4	0.9	1.6	0.0	0.7	0.8	1.0	2.4	0.0	0.0	0.7	0.7	0.8	0.0	0.8	2.9	0.8	0.1	0.0	0.4	0.8	0.1	0.9	0.0	0.6	1.5	0.3	0.6	1.6	1.8	1.7	0.2	1.2	0.3	1.4	0.1	0.2	0.2	0.2	0.4	0.4	0.3	0.1	0.0	0.5	0.5	0.8	0.1	0.3	0.2	0.2	1.1	0.0	1.3	3.9	5.4	12.9	5.4	7.4	0.0	0.1	0.0	0.0	2.2	1.5	2.1	0.0	0.6	863.5	0.1	3.3	1.3	0.0	1.8	31.9	1.1	1.3	22.4	0.0	0.0	0.0	108.4	0.4	0.7	2.8	1.9	0.4	0.9	1.1	13.9	1.5	37.1	0.8	545.7	0.2	0.0	3.0	0.0	2.6	0.0	3.8	0.0	0.9	0.1	8.4	357.8	9.4	0.0	0.0	1.1	0.8	0.9	0.5	1.8	96.5	0.0	15.9	0.0	95.5	13.7	0.2	2.4	4.5	0.3	2.1	5.9	0.8	0.0	75.7	6.6	2.6	14.2	0.1	0.1	0.0	4.1	0.3	1.0	5.3	5.7	1.3
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.9;U-937: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	10.1	3.9	67.9	2.8	69.9	1.3	9.0	56.8	84.2	33.7	44.1	18.1	4.1	31.1	8.5	21.5	19.6	7.2	8.4	72.6	56.7	12.4	1.9	11.8	1.8	50.2	56.2	43.7	4.5	5.1	12.3	5.8	53.4	13.7	8.2	4.7	13.0	9.1	2.8	11.5	10.8	23.1	49.9	6.1	9.2	8.6	59.6	7.6	9.6	5.9	4.1	14.5	20.2	58.7	17.3	13.2	21.1	46.1	26.8	18.0	12.9	16.8	39.4	25.6	14.5	4.5	13.4	2.2	21.5	30.7	4.4	17.2	21.6	19.5	10.1	18.4	5.9	8.5	11.7	0.6	11.0	1.7	9.1	11.7	10.6	10.2	5.5	75.9	31.1	18.6	1.2	7.2	16.9	42.6	22.1	2.2	13.3	18.1	10.9	24.0	5.0	6.6	19.9	31.6	32.9	31.8	5.5	37.1	12.0	18.6	25.2	7.7	27.3	15.5	21.7	7.7	9.5	7.1	3.5	0.7	12.9	109.9	5.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.6	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	67.9	69.9	56.8	84.2	72.6	56.7	50.2	56.2	53.4	49.9	59.6	58.7	5.6	3.2	4.3	1.0	0.5	2.9	3.2	5.9	4.0	3.2	8.7	5.7	2.8	1.5	5.1	1.8	4.2	0.8	2.1	12.6	1.9	9.5	1.0	10.0	22.0	5.9	10.2	0.8	15.1	4.3	10.4	7.9	6.1	7.1	1.3	12.0	3.6	0.2	1.6	0.0	4.5	9.5	16.2	0.6	2.9	2.7	13.4	2.4	1.8	3.7	3.7	1.0	2.1	2.0	1.1	10.4	4.6	10.9	1.3	2.9	8.7	0.7	9.4	1.0	0.0	1.5	12.2	1.6	8.1	9.6	5.1	1.1	3.5	6.1	14.4	1.9
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 16.4;skin 1: 7.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	0.7	0.7	4.6	0.4	12.0	0.7	1.5	15.2	16.4	0.4	1.3	0.3	0.4	0.4	0.6	1.4	0.3	0.9	0.3	6.2	2.3	1.4	0.1	2.0	0.3	0.2	5.6	0.3	0.4	0.4	1.8	0.9	0.3	2.0	0.5	1.8	1.7	1.9	0.1	7.3	0.3	0.5	0.3	0.4	0.6	2.3	6.8	1.1	1.4	0.2	1.0	2.0	0.5	6.8	0.0	0.0	0.7	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.9	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.2	4.1	0.0	0.2	20.2	0.2	0.1	0.4	0.0	1.7	0.0	0.8	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.6	2.0	0.2	0.6	1.1	0.5	1.3	0.7	0.0	0.0	0.0	0.1	3.3	0.8	0.0	1.8	2.0	0.6	0.4	0.3	0.0	0.0	0.4	5.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.1	4.6	12.0	15.2	16.4	6.2	2.3	0.2	5.6	0.3	0.3	6.8	6.8	1.1	12.8	53.3	80.6	0.8	12.4	16.3	3.5	30.7	9.9	6.8	7.2	1.3	0.0	3.8	3.7	4.2	0.1	0.3	0.3	3.9	0.5	0.9	3.0	3.0	1.3	0.0	0.0	495.6	1.5	0.0	7.9	1.1	5.4	0.0	84.1	0.7	0.0	3.4	20.2	470.7	0.0	0.0	1.2	7.5	2.1	3.4	2.4	1.8	136.8	1.2	2.3	1.0	155.3	31.2	1.0	0.1	4.5	2.0	29.0	0.1	0.9	1.2	3.4	0.0	0.6	1.2	0.7	4.1	3.2	8.2	0.0	1.1	6.6	0.1	16.3
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044554-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"skeletal muscle: 327.7;tongue: 121.8"	"Cell type enriched"	"Detected in single"	27	"Skeletal myocytes: 8.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6;head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 2.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"									NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	0.0	1.6	0.6	0.0	0.7	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	3.3	0.0	327.7	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.6	0.0	121.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG2	"MGC138502, MGC138504, stargazin"	ENSG00000166862	"Calcium voltage-gated channel auxiliary subunit gamma 2"	Q9Y698	22	36560857-36703752	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 20.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 87.5;Horizontal cells: 26.9;Inhibitory neurons: 119.7;Oligodendrocyte precursor cells: 43.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"								"unprognostic (7.54e-2)"					"unprognostic (3.06e-1)"	"unprognostic (8.80e-3)"			"unprognostic (2.34e-2)"	"unprognostic (3.07e-2)"			0.0	0.7	5.7	0.0	7.1	0.0	0.0	13.8	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	6.0	0.0	0.0	0.0	0.0	5.9	3.8	0.0	0.0	0.0	1.2	0.0	6.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	7.1	13.8	20.7	6.0	6.0	5.9	3.8	6.5	2.6	6.2	11.0	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	119.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.5	0.0	0.2	0.0	43.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24256335-24362412	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 53.4;retina: 17.7"	"Group enriched"	"Detected in some"	24	"Excitatory neurons: 157.1;Horizontal cells: 176.7;Inhibitory neurons: 107.6"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.0	1.8	22.1	0.0	32.0	0.0	0.0	2.9	53.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	7.1	0.0	0.0	0.0	0.0	6.1	15.5	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	7.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	32.0	2.9	53.4	36.2	7.1	6.1	15.5	11.9	5.8	7.3	26.9	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	176.7	107.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.6	0.0	0.4	0.0	6.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.1;prostate: 11.7"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.5	0.8	26.5	0.1	35.1	0.0	5.3	6.9	26.8	0.4	4.2	0.8	0.2	0.5	0.1	0.2	4.2	0.4	0.2	14.5	17.9	0.2	0.0	5.7	0.0	11.7	16.7	0.1	0.4	1.2	0.3	0.7	15.0	11.7	0.1	0.7	1.7	1.3	0.1	0.5	0.1	1.1	14.3	0.0	1.5	0.2	29.6	0.0	0.1	0.0	0.0	0.4	0.7	9.5	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	35.1	6.9	26.8	14.5	17.9	11.7	16.7	15.0	14.3	29.6	9.5	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53991637-54012666	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 90.7;tongue: 29.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	107	"basophil: 13.3;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in some"		"A549: 12.7;EFO-21: 23.6;HHSteC: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.1	0.9	0.3	0.2	0.1	0.2	0.2	0.0	0.3	8.8	0.0	0.0	0.6	0.6	0.0	0.0	2.2	0.0	1.0	2.0	0.0	0.0	2.9	1.9	0.0	0.8	0.4	0.0	0.1	1.0	0.0	90.7	0.0	0.2	0.0	1.0	0.1	0.3	2.3	0.4	0.0	0.0	29.9	0.1	0.0	0.0	0.5	0.0	12.7	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	23.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.6	0.0	0.1	0.1	0.0	0.0	0.0	1.9	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.1	1.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.2	0.0	2.8	0.0	0.0	0.0	3.5	0.1	0.2	0.0	0.0	13.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.9	0.6	0.6	1.0	2.0	0.8	1.0	0.4	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.1	0.0	0.0	2.3	0.1	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909278-53943950	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 56.6;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 32.0;Horizontal cells: 134.6;Inhibitory neurons: 43.3;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.3"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 52.8;GAMG: 14.6;HMC-1: 40.8;hTERT-RPE1: 51.4;SH-SY5Y: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"							"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			0.0	0.4	44.2	0.0	38.8	0.0	0.0	37.5	56.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	38.9	0.0	0.0	0.0	0.0	39.9	41.2	0.0	0.1	0.1	6.6	0.0	38.9	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	0.0	31.9	0.0	0.1	0.5	50.5	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	7.0	52.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	40.8	0.4	0.0	0.1	0.0	51.4	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.9	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	38.8	37.5	56.6	43.9	38.9	39.9	41.2	38.9	31.9	50.5	45.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	32.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	134.6	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.2	0.0	23.1	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53962937-53990215	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"brain: 33.9"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 61.9;Horizontal cells: 50.5;Inhibitory neurons: 66.0;Oligodendrocyte precursor cells: 29.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;HMC-1: 23.7;hTERT-RPE1: 8.4;TIME: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.0	0.0	9.6	0.1	9.3	0.2	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	32.6	3.7	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.4	0.2	0.1	0.1	1.8	0.1	0.2	0.6	6.4	0.0	0.1	0.2	0.0	0.0	0.0	9.4	0.0	2.4	7.2	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.5	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	2.7	0.7	0.1	1.1	0.0	23.7	0.3	0.0	0.1	0.3	8.4	2.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	1.5	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.1	0.1	0.0	0.2	0.2	0.0	14.9	0.1	1.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.1	5.5	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	9.6	9.3	0.0	33.9	32.6	3.7	0.7	1.2	0.4	1.8	6.4	9.4	3.6	0.0	0.0	5.9	0.4	1.7	1.5	0.0	0.0	6.9	0.1	1.5	3.3	0.0	0.7	1.8	0.0	0.0	0.0	0.4	0.0	1.9	2.3	0.7	1.0	6.4	0.0	2.7	61.9	0.0	0.0	0.6	0.0	1.0	0.0	0.0	5.7	0.0	0.1	50.5	66.0	0.3	0.0	0.8	2.1	1.7	0.0	0.5	0.0	0.0	0.3	1.1	1.0	29.7	4.3	0.2	0.1	0.4	0.0	1.5	0.1	0.2	2.6	1.7	0.0	3.8	1.0	6.2	7.1	0.0	1.1	0.1	0.6	0.5	0.9	1.3
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190575-160201886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	64	"skeletal muscle: 4442.6;tongue: 1892.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		270000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	0.9	0.4	5.1	0.8	6.0	1.5	1.4	4.9	10.0	0.5	3.3	3.3	0.5	1.7	0.3	43.1	1.9	1.2	44.9	6.5	3.1	0.3	0.4	0.7	3.0	3.7	3.9	0.4	0.3	0.2	1.0	6.2	3.2	16.2	0.5	49.7	16.7	5.0	4442.6	1.0	1.9	7.4	3.1	1.3	0.8	5.7	3.6	0.5	0.6	1892.7	1.0	5.7	0.9	6.2	0.0	0.0	0.5	0.0	0.2	0.0	19.3	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	38.5	0.4	0.1	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.7	0.4	0.1	0.0	0.2	0.3	0.2	0.0	67.4	0.0	0.1	0.3	0.2	0.0	3.5	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.7	0.8	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	6.0	4.9	10.0	6.5	3.1	3.7	3.9	3.2	3.1	3.6	6.2	0.1	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	1.9	0.7	0.9	17.6	0.0	0.0	0.0	2.1	3.0	0.1	0.0	0.0	0.1	3.0	0.1	0.1	0.2	0.0	0.0	2.0	0.0	4.9	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.3	0.6	0.6	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	25.2	0.0	20.6	0.6	1.2	1.9	0.0	0.0	4.5	0.1	0.1	0.0	0.3
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 403.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	134.5	151.3	15.9	236.1	16.0	68.8	50.5	14.7	33.1	27.9	26.8	55.9	31.4	23.5	21.0	23.9	40.5	79.8	35.6	14.5	23.2	41.6	403.4	91.6	107.9	33.6	26.4	21.4	27.0	16.7	35.5	183.0	29.6	18.3	47.6	4.0	121.8	30.4	10.6	13.5	38.0	111.7	25.4	87.6	33.9	26.6	30.3	20.9	23.0	17.5	23.0	102.5	12.6	42.1	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	15.9	16.0	14.7	33.1	14.5	23.2	33.6	26.4	29.6	25.4	30.3	42.1	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832887-839831	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (5.58e-4)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favorable (6.92e-4)"	"unprognostic (7.83e-2)"	332.4	159.5	54.0	79.7	53.5	25.0	277.8	52.5	67.6	181.6	66.1	219.7	140.6	264.6	103.0	97.5	184.3	132.4	345.8	54.2	65.3	194.3	145.3	240.1	35.4	64.5	57.4	116.2	278.3	85.9	81.1	110.1	60.5	182.9	99.8	9.6	243.5	194.2	113.1	107.0	149.4	255.2	58.3	94.8	187.3	44.8	58.6	15.0	133.5	77.0	30.6	203.1	151.3	58.0	380.0	475.3	71.8	256.3	1088.7	422.8	110.4	587.1	400.4	285.0	241.2	252.6	677.2	0.2	224.0	943.5	388.4	358.4	71.1	498.4	96.1	135.0	236.6	112.8	139.1	193.4	366.7	90.2	157.4	388.6	328.2	164.5	367.8	1089.2	348.8	16.4	135.1	56.3	485.9	196.1	1.9	99.5	48.0	232.9	569.4	20.0	173.7	106.4	642.8	102.1	99.5	111.8	578.9	371.5	121.5	81.6	145.8	102.4	600.0	462.6	209.3	147.5	352.9	62.0	66.5	4.5	437.5	89.7	265.8	24.6	19.1	15.2	5.7	19.3	6.8	3.0	4.7	5.0	11.9	2.0	1.9	3.0	7.3	8.2	24.1	1.8	2.9	10.8	54.0	53.5	52.5	67.6	54.2	65.3	64.5	57.4	60.5	58.3	58.6	58.0	294.4	208.3	79.1	13.1	12.8	70.6	143.2	328.2	60.9	16.6	180.9	203.7	180.0	133.0	159.8	248.3	4.2	222.6	15.6	542.3	19.6	716.2	2.6	60.8	114.6	214.8	127.6	28.6	10.0	636.7	423.8	173.8	236.5	143.7	81.3	103.7	265.2	54.0	130.0	37.0	5.5	388.5	138.4	59.3	70.4	11.3	123.6	81.8	128.1	15.9	75.6	94.8	23.7	3.5	0.7	736.6	477.9	283.2	26.6	307.1	440.6	124.6	52.2	17.0	210.4	96.6	310.3	5.6	13.6	73.4	54.4	185.7	29.7	61.1	289.8	199.6
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 49.0;lymphoid tissue: 179.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 492.1;NK-cells: 727.1;T-cells: 247.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5"	"Group enriched"	"Detected in all"	32	"NK-cells: 225.3;T-cells: 376.4"	"Group enriched"	"Detected in some"	25	"HDLM-2: 155.9;JURKAT: 113.1;MOLT-4: 167.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	3.2	1.7	2.3	25.3	2.3	49.0	1.9	2.2	2.5	1.9	1.9	4.3	7.1	2.3	3.1	2.1	1.8	5.5	1.3	2.3	2.3	2.0	5.4	10.9	57.7	2.3	2.2	0.8	0.8	0.5	0.8	1.4	2.2	1.8	4.6	0.2	2.4	1.6	1.4	1.1	14.3	1.5	2.1	40.2	7.0	0.4	2.9	179.4	2.5	0.9	36.4	7.3	1.9	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	155.9	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.1	0.0	0.0	167.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	8.3	1.0	0.4	376.4	1.4	208.9	9.3	190.0	219.7	1.5	4.9	237.8	195.1	8.7	225.3	1.2	2.8	254.5	231.2	2.3	2.3	2.2	2.5	2.3	2.3	2.3	2.2	2.2	2.1	2.9	2.5	3.4	3.2	16.0	3.3	8.2	1.5	0.1	0.0	0.6	0.4	3.5	3.2	0.6	1.5	1.3	0.0	0.0	0.1	492.1	0.4	0.0	0.5	0.2	0.7	0.8	1.8	0.0	14.7	8.8	0.0	0.1	2.2	6.1	1.1	6.3	0.4	7.1	1.4	0.3	3.3	9.4	0.5	0.0	7.8	1.4	0.2	0.0	5.9	3.6	14.0	7.6	0.1	727.1	0.5	3.7	0.0	1.2	0.0	51.9	0.1	0.2	1.3	2.2	0.2	0.0	0.9	1.2	0.1	2.5	1.4	0.6	0.1	247.2	0.0	0.1	0.1
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.9;lymphoid tissue: 219.3;parathyroid gland: 173.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5"	"Group enriched"	"Detected in many"	20	"dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5"	"Group enriched"	"Detected in some"	6	"HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	45.5	16.2	15.0	82.1	15.4	26.5	14.7	15.5	17.4	20.4	15.8	26.0	18.7	7.9	7.0	15.1	21.3	35.3	10.0	15.1	16.7	10.1	152.9	72.1	119.0	22.9	20.2	8.6	7.6	173.8	6.1	47.4	21.0	7.3	31.0	10.5	8.5	10.3	2.9	12.6	27.4	26.5	19.6	164.4	21.0	7.5	19.6	219.3	8.8	5.7	75.7	41.0	5.8	25.7	0.0	0.0	3.6	0.1	0.1	0.2	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	103.2	0.0	0.6	10.5	42.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.4	60.0	1.0	0.0	0.0	0.0	0.2	12.8	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.1	116.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	109.7	0.0	0.8	247.3	1.9	2.0	241.4	6.3	0.5	153.4	0.8	166.3	0.5	128.1	0.7	11.1	2.0	204.2	263.8	154.5	240.6	15.0	15.4	15.5	17.4	15.1	16.7	22.9	20.2	21.0	19.6	19.6	25.7	4.5	0.0	5.2	1.6	5.2	3.4	0.3	0.4	0.0	1.5	2.9	5.8	2.1	8.6	2.1	3.7	0.0	0.9	61.9	0.0	5.9	0.0	0.1	3.5	8.7	9.6	0.0	7.8	0.9	0.4	1.2	3.7	0.0	0.4	7.6	0.4	278.8	34.3	139.3	5.0	0.7	0.0	0.0	247.1	80.1	0.5	16.8	109.0	5.4	29.0	104.5	22.0	6.2	0.5	0.2	0.0	0.0	15.1	2.5	0.2	0.0	3.3	20.3	0.2	13.1	0.7	13.5	0.0	0.2	0.4	2.3	1.2	34.0	0.0	0.0	0.4
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110871188-110899922	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 448.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 310.0;dendritic cells: 375.0;Hofbauer cells: 365.7;Kupffer cells: 324.3;Macrophages: 294.8;NK-cells: 383.1;T-cells: 297.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 473.5;HDLM-2: 214.8;HMC-1: 298.4;Karpas-707: 188.1;U-266/70: 251.2;U-698: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	63.4	30.8	10.1	284.4	11.1	126.6	27.0	12.6	16.3	20.8	12.3	41.5	37.9	17.3	10.5	20.0	22.8	58.5	12.2	9.7	13.4	15.1	46.8	114.9	397.9	18.9	16.0	9.2	11.9	6.6	6.2	58.5	18.9	12.8	54.8	2.0	19.3	12.8	4.5	6.7	103.4	55.8	18.3	269.4	44.3	5.7	17.5	144.9	11.3	10.6	448.3	85.1	9.0	31.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	473.5	0.2	0.0	0.2	0.5	0.0	0.0	0.0	214.8	0.0	26.4	0.1	0.0	0.0	60.4	298.4	0.0	0.0	0.0	0.0	0.0	0.0	139.2	11.2	188.1	0.0	0.0	103.1	71.1	0.4	0.0	0.0	98.0	0.7	104.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	88.4	17.2	0.2	0.4	0.1	0.5	251.2	123.2	149.2	1.5	68.7	3.4	1483.0	779.5	479.0	732.4	808.6	658.1	794.0	527.8	649.2	631.9	745.1	377.9	552.5	1144.2	526.6	882.9	517.5	740.3	1621.0	10.1	11.1	12.6	16.3	9.7	13.4	18.9	16.0	18.9	18.3	17.5	31.9	4.2	16.0	24.4	0.7	310.0	7.0	0.6	0.0	0.6	0.0	2.3	5.1	1.0	5.7	8.6	1.8	0.0	2.1	375.0	0.2	0.0	0.5	0.4	0.4	0.5	13.0	0.0	42.9	5.8	0.2	5.4	6.7	7.1	0.6	162.2	0.0	16.4	6.7	365.7	0.0	1.4	0.3	0.0	324.3	161.5	1.9	2.1	294.8	39.2	69.3	156.3	0.1	383.1	1.0	0.6	0.3	0.1	0.4	134.0	0.3	0.0	1.6	4.4	0.6	6.6	1.9	1.8	0.1	0.6	1.1	5.5	4.1	297.0	0.0	0.2	0.3
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1857.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 4897.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	954.0	882.1	509.4	457.9	526.5	747.2	769.6	532.6	717.1	715.6	611.8	809.3	394.5	854.6	1492.1	396.1	647.3	607.0	1152.2	508.5	565.7	625.3	565.1	882.2	325.0	564.7	539.9	645.9	830.1	524.7	486.6	588.0	544.3	520.0	736.0	269.1	871.6	547.4	919.3	410.0	559.3	744.5	534.9	597.7	790.8	224.3	583.6	193.3	657.7	587.4	284.9	835.3	539.7	561.7	481.0	669.0	432.6	430.8	4897.7	2932.4	577.5	1914.8	3104.6	979.2	1048.9	750.3	939.2	120.5	581.2	2608.7	787.7	436.3	301.7	732.6	1197.9	372.5	248.7	760.9	542.8	443.3	2006.7	338.5	1699.0	2315.1	639.7	1164.8	979.2	2305.1	1052.2	64.6	386.8	936.3	3062.5	626.3	64.1	439.5	395.7	1062.7	880.7	146.0	949.3	345.7	1699.3	1433.6	170.1	425.8	528.3	392.5	3348.6	630.4	546.4	1089.6	948.0	710.1	514.8	984.9	649.8	377.3	239.3	92.5	2023.9	208.1	1326.3	1279.9	610.3	1857.5	323.2	458.8	235.2	111.0	126.9	260.0	473.0	73.9	55.9	186.0	656.0	733.0	320.4	309.8	121.6	850.4	509.4	526.5	532.6	717.1	508.5	565.7	564.7	539.9	544.3	534.9	583.6	561.7	798.7	512.8	689.0	28.1	147.6	567.2	1382.5	3135.4	155.4	190.3	606.5	601.1	820.9	836.4	1789.7	875.4	152.2	608.3	322.0	1083.4	232.8	2621.2	16.7	446.7	766.7	916.3	581.1	97.0	8.8	3429.0	2756.5	1538.0	371.1	727.3	1030.0	531.6	739.6	423.9	3372.5	33.7	9.3	1251.6	1715.1	854.6	1698.3	65.5	1727.3	1146.7	1993.9	11.2	575.7	893.8	487.1	21.1	26.5	3437.4	1394.0	1157.0	326.9	2039.2	878.1	794.2	1012.6	258.8	1255.6	1845.2	1278.7	43.8	68.9	137.1	400.5	2708.1	310.4	645.8	761.6	1868.9
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397397	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 148.9;naive B-cell: 137.2"	"Lineage enriched"	"Detected in all"	4	"B-cells: 148.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 2960.6;fHDF/TERT166: 1752.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	892.1	299.1	560.6	270.7	598.4	77.8	773.6	614.8	590.2	952.7	498.9	992.0	150.7	1384.0	960.5	364.3	853.1	534.5	937.9	511.1	615.8	636.6	1175.7	768.4	429.0	665.7	640.8	656.8	449.5	258.3	409.1	441.0	651.1	634.0	234.4	75.9	531.1	1602.0	214.3	511.1	423.1	978.5	694.1	631.3	494.3	316.9	655.1	158.9	564.6	227.6	278.6	749.2	763.4	734.4	337.0	342.0	268.5	413.4	2960.6	1668.4	224.8	621.0	1361.6	490.3	492.2	322.8	1.8	285.4	218.3	1752.6	312.5	430.5	167.3	442.2	199.9	135.6	517.8	43.7	117.1	0.3	976.4	188.2	359.8	1222.3	619.9	201.1	302.1	757.9	476.6	204.0	198.7	484.9	696.4	257.2	160.7	239.1	324.4	304.7	274.2	324.7	135.5	183.3	529.1	223.3	288.8	319.2	198.4	514.4	383.8	214.3	171.0	337.8	641.3	249.0	181.6	471.2	216.6	356.9	88.1	529.1	361.3	111.0	435.0	0.9	3.3	22.9	21.1	5.8	34.4	148.9	14.9	33.0	2.6	137.2	9.2	16.9	1.0	14.7	7.3	7.7	12.0	10.7	560.6	598.4	614.8	590.2	511.1	615.8	665.7	640.8	651.1	694.1	655.1	734.4	1003.1	243.6	270.0	95.0	88.2	179.8	391.8	89.7	26.2	82.7	325.6	452.0	277.4	167.3	102.3	207.8	27.1	21.8	267.1	20.0	35.2	105.7	15.9	365.4	1050.9	344.5	71.9	30.7	19.0	55.1	31.7	560.4	21.4	462.7	81.7	204.0	293.4	603.9	251.5	148.0	32.4	48.2	50.8	232.7	179.7	50.2	389.2	277.6	151.2	60.0	23.0	809.2	45.3	145.8	93.6	61.3	14.7	251.3	50.7	147.6	5.0	29.9	85.8	76.1	118.3	356.9	423.6	15.6	19.4	30.6	164.9	20.1	136.8	379.0	41.5	298.1
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"basophil: 1957.3;eosinophil: 1156.4"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1957.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	204.4	287.8	116.9	96.5	162.9	17.3	298.9	139.8	193.3	399.5	157.3	496.9	127.2	242.4	270.9	1000.2	242.3	102.4	267.5	124.3	132.3	294.2	79.4	403.0	37.4	165.8	141.0	69.0	93.4	881.8	98.1	85.4	160.2	488.5	466.2	32.6	614.5	456.4	74.4	455.3	211.2	197.0	139.2	69.5	178.2	26.4	146.5	66.1	338.0	116.6	289.4	373.1	566.4	207.1	417.6	173.7	3.5	108.7	167.7	170.8	150.1	241.1	477.8	80.8	121.9	128.5	1521.6	1.4	59.2	51.4	239.0	885.6	92.7	475.5	62.7	21.5	63.1	2.0	117.1	26.6	71.3	1.1	497.0	0.6	347.0	147.3	126.0	225.3	976.3	28.9	19.3	1.7	51.5	578.6	1.8	45.4	136.0	504.3	175.7	4.1	290.1	529.7	802.1	1126.8	0.5	34.0	240.9	195.8	215.8	789.0	91.1	42.1	2266.0	8.6	214.6	8.8	29.5	1.7	1.3	63.2	137.2	1.0	221.7	1957.3	61.1	1156.4	1.3	23.6	2.2	5.5	1.4	1.6	10.2	20.5	4.2	11.5	30.9	2.6	0.6	3.7	0.4	71.7	116.9	162.9	139.8	193.3	124.3	132.3	165.8	141.0	160.2	139.2	146.5	207.1	250.0	794.9	403.1	35.6	27.8	1037.8	1864.4	2822.0	804.1	4.9	433.5	379.5	20.9	84.4	1403.7	1075.9	0.0	21.5	8.7	929.9	137.0	599.1	3.0	457.8	66.8	496.5	172.9	10.5	0.4	178.2	271.0	356.9	60.6	722.6	653.4	42.3	522.6	43.1	618.0	0.0	0.6	744.8	4461.6	35.2	685.3	13.1	32.0	253.4	940.9	11.2	151.7	375.1	2.1	56.3	169.5	352.9	896.4	70.7	59.3	1576.4	330.0	21.7	1409.8	14.7	664.0	322.6	397.5	7.3	74.1	1214.3	1279.8	54.0	77.8	838.5	761.1	2594.9
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37, HSP90 cochaperone"	Q16543	19	10391133-10420121	"Cancer-related genes, Predicted intracellular proteins, Transporters"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol		NA	NA		610000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	149.9	93.6	82.2	81.3	84.6	89.5	130.6	75.0	104.2	111.4	72.1	109.9	58.1	110.0	34.2	125.7	98.5	39.8	186.0	86.3	85.8	123.2	102.2	129.9	66.5	85.9	85.8	105.9	100.3	59.3	74.6	62.7	88.1	105.0	48.2	34.6	96.6	52.2	313.2	100.9	96.3	50.2	75.7	137.5	102.8	77.5	82.5	69.3	100.8	222.6	52.4	110.3	103.0	87.8	279.2	181.2	95.5	137.5	128.8	111.8	122.9	322.8	144.6	198.3	168.8	209.1	106.7	165.3	254.7	198.3	117.2	169.9	130.6	208.7	136.4	133.6	387.2	313.9	147.2	300.9	202.5	183.9	137.9	136.9	112.5	231.8	104.0	113.5	258.1	142.2	248.2	193.8	156.1	265.3	184.3	450.2	234.6	175.5	317.8	181.0	128.3	190.3	185.1	178.2	111.5	161.9	151.5	158.1	143.1	72.7	108.4	195.7	290.0	230.8	133.9	319.9	262.2	261.3	276.5	204.4	181.4	294.1	191.2	77.2	110.8	97.1	114.4	107.9	103.1	73.2	91.8	103.5	105.2	62.9	70.0	81.8	60.2	101.1	112.6	89.4	106.8	145.6	82.2	84.6	75.0	104.2	86.3	85.8	85.9	85.8	88.1	75.7	82.5	87.8	420.1	54.5	95.5	51.6	163.7	148.6	119.3	149.0	127.5	78.0	85.0	75.8	71.3	75.8	114.8	64.4	39.6	188.9	166.1	192.3	101.8	199.8	119.0	88.2	120.5	267.5	81.3	89.8	35.0	199.0	430.2	108.3	226.8	126.4	134.3	90.8	172.1	45.3	210.2	89.2	24.6	181.3	105.8	83.9	313.8	253.8	106.2	165.6	138.7	29.0	165.1	75.8	135.9	21.1	32.5	297.6	183.5	103.4	170.5	120.1	117.9	89.7	78.2	84.4	78.9	94.4	138.6	72.4	73.5	138.1	133.7	242.4	164.2	123.0	186.1	156.1
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281887	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	66.9	55.3	22.1	28.0	24.4	58.4	32.8	26.0	26.5	34.0	24.7	113.8	85.4	21.8	34.1	74.5	20.8	48.1	53.2	30.3	32.9	76.1	185.1	52.7	18.6	32.9	31.0	19.1	42.2	54.1	21.6	26.3	35.8	34.3	81.9	20.5	49.9	27.5	81.0	45.5	70.0	27.6	26.9	20.2	112.7	10.7	33.3	20.1	49.8	86.5	41.1	44.8	41.3	28.4	72.4	72.7	28.3	109.0	120.4	113.8	41.0	56.2	69.1	44.8	48.0	66.6	140.4	12.6	59.8	77.7	47.7	89.0	56.0	83.9	51.5	44.8	20.0	50.8	58.1	103.6	93.5	66.5	73.7	116.7	98.8	51.9	53.3	68.0	82.1	37.9	81.2	79.5	52.5	43.5	27.7	72.5	29.0	118.4	35.9	35.9	46.2	34.0	92.5	144.1	17.4	44.3	96.4	178.2	48.7	49.9	101.0	66.3	108.3	47.5	50.3	76.9	36.7	45.0	131.6	59.4	84.9	42.2	44.1	255.5	227.6	274.8	49.5	204.4	51.5	40.2	46.2	50.0	152.1	33.0	29.1	41.4	173.3	56.5	207.4	95.1	60.7	116.5	22.1	24.4	26.0	26.5	30.3	32.9	32.9	31.0	35.8	26.9	33.3	28.4	28.3	44.8	117.3	20.9	26.8	72.3	62.4	48.1	20.5	11.0	101.6	39.2	80.5	243.1	50.7	103.0	10.4	33.3	38.3	434.4	389.4	96.7	52.5	68.0	48.8	39.5	55.6	58.5	24.8	150.6	62.4	38.2	112.7	114.4	37.4	18.9	78.1	353.6	68.5	11.8	21.0	136.2	34.6	170.1	134.8	122.6	29.5	77.1	129.9	19.7	113.4	32.7	36.0	9.5	23.6	173.9	206.4	29.3	24.0	80.1	425.0	231.1	33.7	10.3	26.3	46.6	41.4	13.7	19.3	50.6	108.5	66.9	32.9	65.7	161.4	130.8
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237881-106304279	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 106.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 106.8"	"Cell line enhanced"	"Detected in many"		"BJ: 549.7;BJ hTERT+: 687.6;fHDF/TERT166: 834.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792"	Enhanced					NA	NA		560000	"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA000278: AB_1078527, HPA000792: AB_1078526"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (6.61e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	26.6	40.0	14.7	34.7	16.1	100.5	21.8	14.2	15.4	49.5	27.9	42.9	19.3	40.6	59.2	71.3	31.2	26.3	40.0	14.2	17.4	21.3	30.4	33.5	10.5	18.1	16.1	30.6	41.1	26.1	20.2	51.8	17.2	37.6	45.8	18.8	57.5	36.9	14.5	39.4	19.0	46.7	15.6	25.1	52.3	9.9	19.6	7.8	19.8	13.5	22.8	51.4	40.5	18.4	86.8	106.7	126.5	138.3	240.6	212.5	73.2	549.7	687.6	262.7	300.1	45.6	19.4	5.6	98.0	834.0	89.3	153.1	93.5	83.5	187.5	3.0	54.1	0.1	56.5	89.9	179.2	0.4	1.7	205.5	111.9	223.5	159.9	331.9	311.7	6.5	0.6	11.0	253.0	29.1	4.4	3.1	73.8	45.6	127.9	40.1	91.0	7.5	80.5	76.9	41.5	46.0	98.0	65.9	54.4	112.9	73.9	39.3	268.9	205.8	112.2	86.3	157.9	29.0	0.3	60.2	148.5	10.9	184.5	106.8	18.8	22.5	1.1	6.8	1.6	9.5	1.7	1.0	5.8	4.1	2.2	2.0	30.1	0.2	11.3	0.2	0.5	7.1	14.7	16.1	14.2	15.4	14.2	17.4	18.1	16.1	17.2	15.6	19.6	18.4	17.7	22.4	26.5	9.1	26.3	54.8	37.9	63.2	56.3	11.8	37.6	34.4	43.2	35.8	33.4	23.9	10.4	26.9	2.8	43.0	5.9	37.8	1.1	38.6	103.1	33.8	41.4	1.3	5.8	87.7	107.0	92.9	51.5	139.9	19.1	62.8	43.2	52.3	20.1	47.1	11.2	198.7	16.2	31.8	16.8	2.7	68.3	33.1	33.8	8.4	59.9	23.4	2.1	7.5	1.6	52.4	22.9	61.3	144.5	92.0	3.9	9.2	13.3	23.3	13.1	45.1	52.3	4.9	12.6	122.3	71.9	26.4	6.7	73.3	69.0	46.7
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 1093.8;choroid plexus: 316.7"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 575.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	53.6	42.6	477.0	40.7	757.5	49.1	48.8	696.1	804.5	59.0	316.7	58.3	36.5	58.8	43.1	77.8	46.7	50.6	57.6	483.5	577.6	39.2	50.0	46.9	54.7	851.3	670.8	63.9	23.6	32.6	28.2	73.8	837.8	49.5	46.9	46.5	29.8	51.9	43.6	64.8	42.2	63.5	643.7	44.0	37.4	106.6	638.3	44.7	40.5	68.9	54.9	64.0	65.8	1093.8	67.3	26.2	83.2	50.7	96.0	75.0	44.6	52.0	69.8	71.0	97.8	52.7	66.9	33.7	69.1	49.4	134.3	90.4	61.6	39.9	124.3	79.3	27.5	68.3	18.6	48.1	76.2	62.7	67.3	88.4	207.6	54.0	58.7	77.6	79.1	64.7	35.4	100.6	102.9	33.4	47.8	42.8	75.1	28.7	55.9	31.9	110.6	43.4	67.7	30.0	30.1	82.6	74.6	24.4	108.5	110.5	24.5	52.8	75.1	94.6	86.2	65.3	69.3	130.8	59.8	53.9	154.9	61.0	125.2	179.8	91.0	103.9	102.1	55.4	193.5	101.5	190.3	187.1	98.9	99.3	76.6	78.1	70.2	274.0	56.7	63.9	399.7	155.1	477.0	757.5	696.1	804.5	483.5	577.6	851.3	670.8	837.8	643.7	638.3	1093.8	83.3	35.3	36.6	17.9	72.1	144.0	131.7	122.3	87.0	20.1	43.6	45.3	53.8	17.2	71.4	27.6	25.0	52.0	72.8	16.9	29.4	21.2	105.3	21.1	47.7	70.8	28.7	65.4	25.1	16.2	160.6	86.6	30.1	41.7	36.8	25.2	61.4	19.4	35.6	15.2	23.6	19.6	89.5	29.2	168.1	76.7	51.6	46.9	113.8	20.6	42.3	28.1	38.1	30.7	575.2	30.3	16.8	46.6	131.7	98.1	34.6	23.3	27.5	35.0	52.6	53.2	128.4	182.4	55.3	90.1	196.5	95.8	147.1	22.8	17.5	121.9
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLPTM1		ENSG00000104853	"CLPTM1 regulator of GABA type A receptor forward trafficking"	O96005	19	44954585-44993341	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068767	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA068767: "	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.59e-1)"	69.1	152.8	54.7	34.3	56.9	27.3	62.7	40.1	103.3	56.7	36.4	63.6	50.6	58.5	36.0	70.2	51.6	27.4	106.5	54.4	50.1	92.9	130.7	54.6	33.4	56.3	58.4	63.5	86.6	78.0	60.2	38.8	50.9	63.4	32.9	35.1	66.6	43.1	109.0	87.4	66.0	37.0	34.8	64.8	81.0	76.2	60.0	25.4	63.2	51.3	43.4	55.0	57.6	55.5	88.5	213.8	48.6	96.9	158.3	63.4	52.5	90.8	102.0	107.5	114.9	93.3	95.0	96.1	93.1	124.2	79.0	112.0	87.2	84.4	72.3	72.4	126.8	74.5	74.7	79.3	111.6	59.9	83.2	99.8	87.8	102.9	66.1	76.3	75.9	54.7	78.7	129.3	96.2	86.9	58.1	35.0	43.9	139.3	73.6	60.4	52.8	93.1	100.1	132.7	57.4	59.5	115.6	169.1	51.4	43.0	92.7	47.1	72.4	119.9	73.7	60.4	116.0	82.4	180.2	65.5	98.9	58.3	112.7	17.7	28.4	43.5	25.8	38.4	21.4	27.1	27.9	37.3	24.9	27.4	21.7	18.7	24.6	21.4	49.5	38.8	26.3	22.9	54.7	56.9	40.1	103.3	54.4	50.1	56.3	58.4	50.9	34.8	60.0	55.5	33.9	6.4	7.8	25.5	31.9	36.7	36.1	68.4	25.0	40.3	36.6	26.8	12.3	41.5	42.1	36.8	39.6	94.0	27.7	82.7	13.7	77.3	53.0	23.5	27.5	32.7	40.7	21.5	20.7	74.1	83.7	35.7	30.1	36.0	10.8	31.7	31.4	46.6	75.2	43.7	22.9	47.1	65.1	29.3	29.9	51.1	30.1	31.2	33.8	9.4	87.8	57.2	23.7	24.6	19.1	68.4	64.7	30.1	58.3	40.3	106.0	62.7	17.7	36.3	26.3	30.3	32.5	33.5	29.6	31.5	44.0	120.0	26.0	67.3	49.4	35.6
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	172.8	174.2	131.6	80.8	139.1	67.2	165.6	144.7	165.1	170.9	137.5	163.3	107.9	165.6	100.7	207.1	158.9	64.4	98.1	133.3	143.8	236.0	146.8	146.2	84.1	145.1	138.5	205.6	164.3	104.3	139.3	124.4	151.4	145.0	108.6	84.8	162.8	71.2	87.7	163.2	136.0	84.9	141.6	153.0	161.4	108.5	141.7	85.2	160.1	51.5	93.4	150.9	158.4	151.5	326.3	257.2	188.4	146.3	270.0	269.8	302.6	328.5	248.2	258.1	301.5	194.2	143.9	243.8	177.0	220.9	460.7	136.2	238.8	228.2	238.4	166.0	193.1	187.5	255.0	199.8	359.4	201.0	166.5	297.3	250.5	297.4	234.3	241.0	329.6	129.3	166.0	126.4	399.0	113.3	182.2	254.8	301.8	218.8	360.3	173.3	124.8	142.1	353.7	229.1	146.1	245.3	137.3	160.0	289.4	220.2	146.9	244.2	418.4	209.4	234.0	240.3	347.9	83.0	208.9	259.5	256.9	278.0	188.9	142.2	221.7	115.4	97.1	239.6	101.9	121.0	104.9	100.2	222.6	119.6	92.9	82.0	86.7	96.2	191.8	192.2	162.9	209.4	131.6	139.1	144.7	165.1	133.3	143.8	145.1	138.5	151.4	141.6	141.7	151.5	291.5	128.2	143.9	14.4	105.9	197.3	274.3	374.3	169.0	139.4	274.0	315.0	51.5	217.3	247.4	180.3	60.5	958.0	140.1	349.3	463.7	480.5	51.9	241.5	174.3	244.0	183.8	154.8	28.5	335.6	469.1	187.5	142.2	182.7	73.5	198.4	312.7	170.6	903.7	92.5	30.4	350.5	248.2	391.7	172.0	97.6	262.9	249.3	195.7	20.6	343.5	282.8	117.4	16.1	49.0	465.2	426.4	215.5	97.7	320.5	411.5	651.7	304.7	127.3	177.5	170.0	310.4	288.0	216.8	210.9	193.2	1299.5	103.7	281.6	380.0	360.4
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392501-176416539	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 1839.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 704.2;MCF7: 641.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	102.9	133.6	125.8	50.1	125.1	40.6	82.9	117.8	176.7	180.4	125.3	133.9	92.3	85.9	23.2	473.7	82.4	34.1	320.8	130.8	129.6	90.4	82.5	96.5	32.9	136.9	122.8	107.2	68.2	70.1	112.8	57.5	138.1	88.1	45.5	37.9	128.6	44.4	322.5	453.1	99.7	41.2	114.5	68.7	123.3	38.9	127.9	43.7	69.5	120.8	58.5	106.2	300.8	133.6	229.1	107.6	29.9	128.2	65.7	49.2	244.4	286.3	110.9	178.6	127.0	140.3	103.9	49.6	165.0	130.2	71.8	213.3	51.4	704.2	69.7	341.7	95.3	33.6	163.3	87.7	102.9	53.2	85.6	52.6	241.5	98.1	114.7	36.0	84.7	39.2	65.2	123.4	100.3	641.9	84.5	81.1	24.4	189.5	158.2	91.3	52.9	165.2	95.6	92.0	127.7	43.7	136.6	148.0	103.6	34.7	61.4	101.9	185.2	64.0	96.3	117.5	165.1	96.5	73.3	68.5	51.4	112.7	74.4	6.6	19.7	61.7	13.6	15.8	7.0	5.9	11.9	13.2	20.0	10.1	10.0	10.0	36.6	15.0	20.8	16.1	24.9	8.1	125.8	125.1	117.8	176.7	130.8	129.6	136.9	122.8	138.1	114.5	127.9	133.6	113.7	57.7	19.8	8.5	54.7	634.0	238.7	155.7	180.4	310.5	105.5	124.6	208.5	72.9	93.4	82.8	64.6	141.1	82.3	794.5	135.0	324.7	9.5	58.4	72.7	102.2	151.8	43.6	25.4	453.1	586.9	136.7	193.2	85.2	48.2	40.8	70.3	96.3	111.9	336.5	24.1	348.5	114.0	80.7	226.1	13.7	122.1	88.4	220.5	6.5	85.7	136.1	107.1	8.0	15.2	1839.9	786.9	129.8	76.4	391.4	545.7	269.7	49.6	64.3	78.9	79.6	161.4	15.9	29.1	415.6	803.0	386.5	81.3	151.2	289.7	436.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291719	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 187.4;testis: 47.2;tongue: 61.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;neutrophil: 5.2"	"Group enriched"	"Detected in many"	20	"granulocytes: 5.2;monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.8;K-562: 31.8"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles		NA	NA		2300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	6.8	16.0	5.4	0.8	6.1	15.6	4.8	6.2	6.5	5.0	5.0	2.4	0.5	3.1	1.6	3.6	3.8	1.2	14.8	5.2	7.8	3.2	6.5	3.0	0.7	7.4	8.6	3.6	2.5	2.1	13.4	1.5	8.5	5.2	1.0	2.0	3.9	0.8	187.4	4.1	1.8	1.7	5.7	3.5	2.8	47.2	9.1	3.9	8.0	61.3	0.5	2.8	3.7	6.9	4.5	4.6	3.0	4.9	10.8	5.9	1.4	3.1	3.3	4.2	6.3	1.7	1.4	1.9	0.4	7.0	3.3	1.5	4.7	8.5	3.5	0.3	4.6	0.2	4.4	5.3	5.5	6.5	64.8	25.0	7.0	7.8	10.9	12.5	2.7	2.4	31.8	1.7	10.0	3.6	0.6	22.4	3.8	18.1	2.8	2.4	24.2	0.1	3.4	1.8	6.9	1.2	6.6	4.1	0.4	3.6	8.9	27.1	0.8	7.6	15.5	4.2	5.2	3.1	8.4	0.8	4.5	17.4	1.6	0.0	2.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.4	5.4	6.1	6.2	6.5	5.2	7.8	7.4	8.6	8.5	5.7	9.1	6.9	1.4	3.2	0.5	9.4	0.1	0.6	0.5	1.0	1.2	2.4	0.7	0.3	11.3	1.5	1.8	0.0	14.6	0.4	0.2	1.2	0.0	0.8	19.3	1.2	1.9	0.9	0.0	0.8	4.5	0.0	0.2	1.4	1.5	1.4	0.0	3.5	1.1	2.4	0.3	0.0	8.9	1.3	6.1	1.0	0.7	17.0	2.5	0.5	0.0	4.7	1.3	1.5	0.0	12.5	12.5	1.2	0.8	4.1	0.1	1.3	0.2	1.3	1.0	2.0	0.0	2.6	4.5	14.5	4.7	1.0	0.9	1.1	0.1	6.2	0.9	0.0
CNIH1	"CNIH, CNIL, TGAM77"	ENSG00000100528	"Cornichon family AMPA receptor auxiliary protein 1"	O95406	14	54423561-54441391	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002544	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA002544: AB_2081856"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.09e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (8.95e-4)"	73.2	61.7	40.2	50.9	42.1	37.2	73.6	45.2	49.5	59.8	58.5	86.9	99.4	49.6	50.8	72.5	67.0	74.4	84.6	42.8	47.2	79.9	232.9	46.7	61.2	44.3	43.4	44.0	41.8	59.8	41.2	58.4	44.8	57.2	95.1	60.3	49.7	57.1	58.9	36.0	85.4	68.2	49.1	33.8	45.4	37.1	41.3	56.2	65.0	95.5	79.0	95.1	39.4	50.7	233.4	141.3	113.8	129.2	301.0	380.9	107.8	276.8	348.6	232.0	264.4	86.5	316.4	289.7	180.2	209.2	141.6	226.5	208.3	200.3	287.5	111.9	124.5	112.1	80.9	152.8	303.6	136.5	90.2	314.4	244.3	217.1	304.0	236.8	221.3	117.7	111.5	95.5	262.4	138.4	151.5	102.9	84.2	266.3	281.3	114.8	191.8	97.3	264.2	171.4	95.5	106.3	163.4	127.8	316.7	104.8	197.5	144.9	143.7	194.7	192.9	165.4	167.8	59.7	138.8	141.2	235.9	115.3	176.5	5.3	84.6	10.7	32.5	66.8	54.8	64.3	57.3	47.0	86.0	55.2	75.1	52.1	20.9	44.0	53.7	48.4	65.1	96.6	40.2	42.1	45.2	49.5	42.8	47.2	44.3	43.4	44.8	49.1	41.3	50.7	41.1	35.3	60.6	14.7	64.9	105.7	86.2	186.1	141.7	41.9	69.2	64.0	85.6	50.1	79.8	46.0	20.9	95.7	48.1	98.8	90.1	89.3	44.4	54.8	57.9	72.3	104.4	65.0	26.9	62.3	123.4	90.3	52.5	32.8	197.3	32.4	70.3	140.0	115.5	67.3	34.8	91.5	99.7	102.8	80.0	17.0	60.0	73.5	83.6	9.4	110.3	59.9	35.0	17.6	22.5	65.6	96.6	65.8	84.0	92.0	149.9	164.7	79.9	45.1	46.0	60.5	68.1	68.7	64.1	144.9	110.0	70.9	69.3	68.4	123.0	91.4
CNIH2	"CNIH-2, Cnil, MGC50896"	ENSG00000174871	"Cornichon family AMPA receptor auxiliary protein 2"	Q6PI25	11	66278175-66285301	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 270.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 75.7;Enteroendocrine cells: 49.6;Excitatory neurons: 17.7;Horizontal cells: 16.8;Late spermatids: 28.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.8;AN3-CA: 13.9;MCF7: 13.9;NTERA-2: 15.1;SCLC-21H: 61.5;SH-SY5Y: 28.5;T-47d: 13.3"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.84e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.95e-8)"	"unprognostic (3.53e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.55e-2)"	0.4	3.3	88.4	0.2	74.6	1.6	0.3	28.8	270.1	0.6	11.0	1.0	0.6	0.4	0.0	0.8	0.6	0.2	0.3	234.9	61.3	0.5	0.4	0.7	0.1	28.3	37.1	0.4	3.4	0.1	45.9	0.5	34.5	0.5	0.2	1.1	0.3	0.0	0.1	1.4	0.6	0.2	30.3	0.6	1.0	5.1	53.4	1.3	0.4	0.0	0.0	0.3	0.5	47.5	0.4	0.8	15.8	13.9	0.2	0.3	2.0	1.0	1.1	2.0	0.1	0.4	0.0	0.1	0.3	0.2	0.9	0.2	3.6	0.0	0.3	1.5	1.4	0.0	0.5	0.0	0.0	0.1	1.1	0.0	0.3	0.1	0.0	0.3	0.0	1.6	0.2	2.1	0.9	13.9	2.1	0.3	15.1	0.0	1.0	6.8	0.0	0.1	0.1	0.8	61.5	28.5	0.1	7.6	0.6	0.7	13.3	0.2	0.0	1.8	0.7	0.5	0.6	0.3	0.4	0.6	4.2	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	74.6	28.8	270.1	234.9	61.3	28.3	37.1	34.5	30.3	53.4	47.5	0.8	0.0	0.5	2.9	0.2	0.6	0.3	1.4	0.6	2.3	1.6	1.3	0.7	1.5	0.8	0.0	0.0	1.4	0.7	0.1	0.0	0.2	75.7	5.7	0.6	0.4	49.6	0.0	17.7	0.2	1.6	0.7	2.0	0.6	0.0	0.5	0.4	0.1	0.2	16.8	11.7	1.5	0.0	0.0	0.3	28.1	0.6	0.4	0.0	1.9	0.1	0.7	0.0	1.5	2.7	0.6	0.1	0.4	0.9	0.3	0.2	0.2	6.8	2.6	0.0	0.9	0.7	6.0	0.9	0.6	0.4	1.2	1.4	0.1	0.4	0.3
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740554	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;pancreas: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 65.3;Distal tubular cells: 31.3;Excitatory neurons: 61.1;Inhibitory neurons: 47.5;Late spermatids: 38.0;Oligodendrocyte precursor cells: 68.3"	"Group enriched"	"Detected in many"	4	"glioma: 6.0;melanoma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.7;hTEC/SVTERT24-B: 47.0;hTERT-RPE1: 26.4;NTERA-2: 17.3;U-266/70: 25.1;U-87 MG: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	0.9	0.3	6.9	0.2	7.2	0.0	0.9	1.8	11.0	1.1	1.8	0.5	0.3	0.7	0.4	0.2	0.9	0.6	0.3	11.9	13.5	0.7	0.3	0.4	0.4	6.7	6.7	1.9	8.0	0.1	1.0	0.1	2.7	0.5	0.2	1.2	0.6	0.5	0.4	0.4	0.2	0.4	3.2	0.2	1.0	2.2	5.0	0.2	0.5	0.4	0.4	0.8	0.9	5.4	0.5	0.3	0.6	0.6	0.5	0.9	0.2	3.5	18.7	0.5	1.0	0.1	4.3	0.1	1.8	8.2	1.4	0.0	0.0	0.0	3.1	0.1	1.0	0.0	0.0	0.0	0.3	1.7	1.4	0.6	0.0	47.0	0.5	26.4	0.0	0.2	0.0	0.1	2.8	0.1	0.1	6.0	17.3	0.2	2.2	0.1	0.9	0.0	3.0	1.7	0.6	0.4	0.0	0.0	12.1	1.8	0.1	0.4	0.1	0.1	4.2	0.1	0.5	25.1	1.1	0.0	55.3	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	7.2	1.8	11.0	11.9	13.5	6.7	6.7	2.7	3.2	5.0	5.4	2.7	0.0	2.0	65.3	1.8	2.8	2.1	3.6	2.8	2.8	5.3	7.7	2.4	1.5	2.9	1.8	0.0	2.3	1.0	1.4	31.3	0.9	16.0	3.0	3.3	2.9	1.2	4.0	61.1	3.0	0.6	3.9	0.5	1.9	2.5	6.9	3.3	2.6	6.2	0.0	47.5	2.7	0.0	0.6	2.5	38.0	2.8	1.9	0.0	19.7	1.1	15.1	2.1	68.3	25.3	0.6	0.8	1.2	0.8	1.9	0.4	17.3	28.8	0.7	0.0	5.0	2.5	2.3	8.6	3.2	2.3	5.1	2.5	5.3	1.5	2.7
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078289	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 248.9"	"Cell type enriched"	"Detected in some"	11	"Oligodendrocytes: 335.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.9;SCLC-21H: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		58000		"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	0.3	0.5	82.6	0.4	145.4	0.0	0.1	125.7	112.4	0.6	32.4	2.1	0.1	0.0	0.0	0.2	0.1	0.1	0.7	85.2	96.6	0.1	0.0	0.0	0.0	161.6	128.1	0.0	0.1	0.0	8.0	0.0	139.8	0.3	0.5	1.2	0.4	0.6	0.0	0.5	0.9	0.2	110.1	0.1	0.5	6.1	125.7	0.1	0.1	0.0	0.3	0.2	0.7	248.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.6	145.4	125.7	112.4	85.2	96.6	161.6	128.1	139.8	110.1	125.7	248.9	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	2.4	0.9	1.3	3.7	0.0	0.6	1.8	0.0	0.0	1.2	0.0	0.0	0.6	13.7	0.6	0.5	0.5	0.0	0.0	18.4	0.6	0.0	0.4	0.0	1.2	0.0	2.6	0.0	0.0	0.0	3.3	16.0	0.0	0.0	0.0	0.0	29.0	0.6	0.5	0.0	4.7	0.0	0.2	0.0	9.5	335.5	0.6	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.8	0.0	0.0	0.3	3.2	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.2
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1871.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"EFO-21: 318.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	13.0	2.3	17.9	2.2	18.1	0.9	20.8	18.7	29.8	70.2	129.2	13.0	9.8	14.8	0.0	5.6	8.3	1.1	39.2	17.5	33.0	9.5	1871.4	13.4	18.9	28.1	20.3	0.8	6.5	3.9	28.6	3.4	24.9	7.9	16.4	246.5	39.9	0.9	2.6	13.0	20.8	2.4	19.2	23.1	3.0	1.5	20.1	0.5	16.1	8.3	20.0	23.9	2.3	29.0	0.2	18.8	15.6	0.0	3.3	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	318.8	0.0	29.4	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.4	32.7	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.5	5.4	0.0	0.0	0.0	0.4	6.7	16.2	0.0	0.2	0.3	1.0	0.1	0.4	0.0	0.4	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.1	18.7	29.8	17.5	33.0	28.1	20.3	24.9	19.2	20.1	29.0	2.3	19.2	76.6	3.3	10.6	3.3	8.3	28.6	0.6	6.9	14.0	0.6	0.6	65.8	558.1	9.2	6.2	0.1	0.3	0.1	0.0	83.4	0.9	190.5	51.0	12.6	0.0	34.7	1.5	21.4	0.2	16.3	0.0	406.0	2.5	0.1	34.6	1687.2	0.6	5.0	1.4	0.2	8.2	44.6	6.9	1.2	0.3	4.0	0.0	6.5	1.6	720.5	1.0	0.5	2.0	69.3	0.0	0.4	0.3	19.5	0.0	0.3	318.4	24.8	0.0	0.8	15.3	0.0	0.1	0.8	2.6	0.3	4.9	0.1	0.1	79.0
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"		"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045910: AB_10960409"	"unprognostic (1.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.47e-2)"	25.1	20.9	25.6	17.1	30.2	44.0	33.8	32.7	41.6	22.9	42.0	21.4	21.8	26.2	23.9	20.6	21.7	21.0	30.9	29.2	28.5	31.0	35.4	24.4	28.6	33.7	26.8	32.1	21.9	29.9	11.1	29.5	35.5	23.5	22.9	26.8	36.3	23.6	41.8	24.8	22.8	24.8	22.9	30.6	22.9	48.2	29.1	23.5	31.9	38.5	21.6	20.0	14.6	48.1	12.9	10.5	32.5	14.4	38.8	37.3	13.6	14.3	23.9	18.4	24.6	15.6	18.7	13.9	19.4	17.8	22.3	12.2	19.9	24.1	20.0	24.0	30.9	35.9	20.1	19.4	26.0	32.5	22.4	28.7	31.1	19.9	15.1	36.1	25.2	29.9	21.5	29.4	16.1	18.7	28.6	32.5	27.3	17.8	24.8	25.9	19.5	30.5	21.8	20.0	16.3	23.7	15.9	21.6	35.7	24.1	28.9	24.0	16.3	18.8	9.8	30.0	18.6	33.2	55.8	35.2	29.2	29.5	23.5	314.2	44.3	99.3	61.6	53.6	65.2	46.4	82.6	66.8	39.8	36.9	84.3	72.4	28.1	103.6	58.1	21.4	63.0	96.1	25.6	30.2	32.7	41.6	29.2	28.5	33.7	26.8	35.5	22.9	29.1	48.1	89.7	44.8	39.1	30.3	46.5	36.1	35.5	70.9	33.0	61.5	30.6	43.4	73.5	38.6	45.2	38.6	27.1	52.6	81.2	21.4	72.4	33.3	184.2	23.9	31.7	72.0	15.6	54.5	72.6	21.2	35.3	47.9	17.3	22.3	140.4	50.2	68.6	35.0	36.0	43.7	74.1	24.6	54.9	52.7	33.4	56.6	62.7	54.8	33.8	28.1	68.8	66.4	121.5	42.7	74.0	20.4	33.5	66.5	34.1	26.0	53.4	73.2	36.4	64.5	59.2	58.0	46.2	206.2	96.2	19.2	38.5	50.2	70.9	49.4	30.5	24.7
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6"	"Group enriched"	"Detected in many"	19	"dendritic cells: 6.3;monocytes: 9.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	72.6	48.8	29.6	34.8	28.1	5.9	83.3	28.2	33.0	86.0	50.0	107.9	97.8	70.8	49.3	209.7	58.4	56.3	49.0	26.6	26.8	77.9	82.6	83.9	19.0	34.8	30.6	49.3	120.0	76.1	57.7	106.0	32.5	78.9	102.0	23.5	121.8	57.1	26.8	129.4	104.9	54.8	32.3	51.5	105.4	44.3	38.0	24.4	98.6	19.9	48.4	83.5	111.9	33.5	156.6	106.4	70.2	63.3	46.1	71.6	141.7	65.1	78.8	58.5	55.6	88.5	163.9	1.0	113.2	72.5	50.9	201.7	58.8	97.4	71.1	1.0	21.9	32.0	35.8	109.9	52.6	5.0	52.7	70.0	133.5	67.1	73.5	103.8	197.2	1.7	55.1	0.4	55.1	48.0	1.7	13.9	54.7	101.2	56.5	0.7	67.4	1.3	90.2	171.0	4.9	40.1	91.5	133.6	113.1	176.3	138.9	6.1	166.0	59.6	50.3	53.2	34.6	1.2	0.9	2.3	53.2	3.4	111.5	0.0	4.9	0.1	0.0	9.5	0.2	0.2	0.0	0.1	6.3	0.3	0.0	0.0	0.2	0.4	5.6	1.4	0.1	1.1	29.6	28.1	28.2	33.0	26.6	26.8	34.8	30.6	32.5	32.3	38.0	33.5	116.2	147.4	84.0	0.0	8.8	117.1	96.9	82.9	126.9	21.0	101.5	70.5	17.5	125.8	96.6	141.6	39.6	94.0	2.3	305.5	13.7	106.7	14.1	91.1	58.5	98.6	86.2	21.3	0.0	97.2	85.6	34.5	165.1	139.4	32.4	61.1	91.8	127.6	44.4	15.2	0.0	160.7	52.9	64.3	55.5	10.5	28.3	46.4	48.0	0.0	28.5	30.2	2.1	0.0	0.0	141.8	169.3	38.4	5.0	116.9	179.6	57.6	88.2	26.4	26.3	32.3	38.1	37.0	21.1	285.1	200.5	90.8	6.2	39.9	127.0	194.6
CXADR	CAR	ENSG00000154639	"CXADR Ig-like cell adhesion molecule"	P78310	21	17513043-17593579	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4"					"Low region specificity"	"Detected in all"			"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted - unknown location"	NA	NA		18000	"Cluster 17: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	3.6	2.9	7.0	2.8	8.7	2.6	9.8	6.6	10.8	7.7	22.8	22.5	42.3	5.3	15.2	14.5	10.6	18.3	9.3	8.9	7.1	8.3	49.3	13.6	0.7	10.4	6.8	0.4	15.8	6.8	4.7	0.3	9.3	15.1	25.6	4.9	15.4	14.2	0.4	53.4	42.6	3.3	9.7	2.4	30.9	12.5	7.3	1.5	22.1	0.0	4.1	25.6	10.9	17.7	16.8	9.0	44.6	0.1	0.0	0.0	26.7	0.2	0.2	0.7	2.7	93.4	14.6	6.2	19.7	0.0	13.3	28.1	22.8	6.2	1.0	9.3	19.0	0.1	24.1	63.0	2.9	1.8	0.1	0.0	24.6	1.3	0.4	10.8	9.0	5.5	0.3	0.4	0.0	1.1	3.7	0.1	109.1	15.2	0.0	0.1	15.2	12.5	38.7	104.4	18.5	12.3	10.9	12.6	6.7	45.8	25.4	0.3	0.5	0.2	25.8	0.4	6.6	4.5	7.7	0.4	3.6	0.1	0.6	1.0	0.1	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.6	0.2	0.3	0.2	0.0	0.0	0.1	0.2	7.0	8.7	6.6	10.8	8.9	7.1	10.4	6.8	9.3	9.7	7.3	17.7	0.2	141.1	79.0	2.6	1.0	323.4	172.7	110.6	132.6	16.9	58.6	28.2	29.8	161.5	106.6	103.0	27.1	0.8	0.3	238.4	5.9	130.0	5.3	118.9	8.3	4.8	80.8	9.9	60.4	93.7	0.2	8.6	94.3	128.9	5.7	1.1	47.8	127.7	0.6	0.0	43.0	107.5	81.4	22.9	13.1	7.7	2.1	3.3	23.2	40.3	0.7	13.4	0.0	78.9	161.4	93.4	155.3	0.0	1.6	125.1	263.0	4.0	85.6	11.2	6.6	0.2	5.3	6.4	24.5	117.0	343.8	0.7	4.3	0.5	107.0	202.7
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299330	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 422.9;Oligodendrocytes: 1542.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	20.7	14.5	26.4	14.7	57.0	16.2	18.4	33.2	36.4	23.8	15.4	24.2	24.0	19.7	11.6	37.6	16.1	17.1	19.4	25.4	29.3	27.6	25.9	18.0	14.7	36.9	43.3	23.3	17.2	31.7	14.4	21.3	34.8	15.9	26.3	38.8	20.2	18.6	25.2	18.8	25.4	21.2	19.9	13.0	22.9	15.5	50.3	27.1	43.3	28.2	20.6	20.3	20.5	73.5	128.0	20.0	40.3	75.7	34.2	36.2	40.7	52.2	46.2	49.2	59.0	60.4	59.8	41.5	127.1	47.7	95.7	86.4	39.3	76.4	97.7	10.9	22.5	35.2	31.1	40.5	35.2	35.0	33.3	27.8	43.3	49.1	101.3	163.1	64.8	32.2	26.7	51.4	125.6	41.5	51.3	12.9	35.3	71.1	35.4	26.7	51.6	26.8	51.9	55.3	19.7	32.3	72.9	49.5	49.4	46.7	108.8	26.0	62.5	127.5	33.5	36.1	79.9	76.0	50.6	50.6	50.3	51.8	40.0	2.5	0.7	1.2	0.8	0.7	1.3	1.6	1.3	0.9	0.8	1.2	1.3	1.3	2.4	1.1	0.4	1.1	1.0	0.8	26.4	57.0	33.2	36.4	25.4	29.3	36.9	43.3	34.8	19.9	50.3	73.5	24.0	25.6	25.7	113.3	28.5	53.3	52.3	45.5	40.5	42.0	29.6	23.0	25.6	35.8	44.6	49.7	95.9	48.9	25.2	72.4	5.9	22.8	12.9	51.8	37.4	28.1	28.9	17.5	422.9	20.2	19.5	27.7	51.5	68.5	12.0	29.9	27.8	54.6	14.9	37.0	117.8	34.4	28.5	26.4	26.0	19.2	28.6	19.2	37.4	165.8	18.3	71.9	43.3	257.3	1542.2	30.3	48.0	25.6	34.1	52.3	50.6	20.8	66.3	101.7	13.1	40.5	25.5	31.2	37.9	66.7	70.8	25.0	30.6	29.3	38.8	106.8
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7187187-7219841	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 112.4;pituitary gland: 62.8;retina: 223.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.8;Cone photoreceptor cells: 102.2;Rod photoreceptor cells: 62.6"	"Cancer enhanced"	"Detected in all"		"glioma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0;hTERT-RPE1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122, HPA071006"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB001999: , CAB002000: , HPA010122: AB_1855169, HPA071006: "	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	13.1	19.1	41.9	9.3	49.6	3.6	10.0	32.1	112.4	23.5	0.0	18.5	4.9	23.1	6.9	6.3	20.7	10.8	19.6	86.3	17.5	10.3	7.1	14.7	4.4	7.2	0.4	30.3	6.3	7.2	62.8	8.9	5.6	16.6	3.5	223.2	7.2	12.8	6.1	4.7	8.4	11.1	0.0	13.9	10.3	18.9	7.7	8.7	11.0	2.8	2.9	13.3	16.4	36.2	0.5	15.2	29.4	9.1	8.4	14.6	1.5	14.1	12.5	10.8	11.3	0.7	4.0	2.4	6.4	12.1	1.6	1.8	1.1	6.7	3.3	17.6	6.0	9.4	35.1	1.4	8.0	0.3	40.0	17.5	0.9	7.7	11.0	45.5	11.5	10.1	3.1	10.1	15.2	1.0	9.3	5.1	3.8	0.8	1.6	10.5	1.6	1.0	6.6	0.3	12.4	10.5	0.4	0.8	2.6	7.0	6.5	7.2	16.4	30.6	12.6	7.4	7.8	1.5	0.9	2.1	19.3	6.9	8.5	0.4	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.0	0.1	41.9	49.6	32.1	112.4	86.3	17.5	7.2	0.4	5.6	0.0	7.7	36.2	3.4	0.0	1.5	14.0	1.5	2.7	2.2	1.8	6.2	41.8	4.8	3.7	3.2	1.5	2.2	3.7	102.2	0.6	3.3	0.4	0.0	0.9	1.8	2.4	9.5	7.0	15.0	0.8	22.8	0.2	0.4	5.5	2.0	3.2	7.0	3.4	10.0	2.2	3.9	20.2	17.5	0.8	4.1	11.0	10.3	1.3	7.2	7.8	3.6	8.4	5.5	11.1	0.0	4.5	4.2	0.2	0.1	10.1	0.2	1.7	1.3	0.3	3.0	62.6	0.0	1.4	4.5	6.5	2.9	3.2	1.8	0.5	1.1	6.8	0.5	1.1
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DMXL2	"DFNA71, KIAA0856, RC3"	ENSG00000104093	"Dmx like 2"	Q8TDJ6	15	51447711-51622833	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.2;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"U-937: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039375	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA039375: AB_10673610"	"unprognostic (5.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.70e-2)"	5.3	4.7	4.1	11.1	4.7	17.1	3.4	4.0	7.3	4.6	8.1	6.5	9.2	4.4	13.9	1.9	5.2	4.5	3.1	8.9	2.8	5.7	4.5	6.8	4.7	2.5	1.1	4.1	5.4	8.0	8.4	7.2	3.0	2.7	7.5	16.3	5.4	2.5	1.1	1.7	7.1	5.3	0.0	6.5	5.3	9.0	4.2	4.7	4.2	1.7	2.6	6.0	2.8	2.4	9.1	11.7	12.6	7.3	5.3	9.1	3.1	6.9	7.5	6.5	8.5	1.7	4.4	0.0	3.3	4.1	12.5	4.8	8.1	4.8	8.7	10.6	3.9	3.6	10.6	2.1	4.9	20.6	5.8	4.2	3.9	8.4	3.7	6.8	4.5	10.9	8.3	0.8	6.7	10.0	8.9	19.2	9.2	4.3	3.8	7.9	10.3	13.5	3.4	18.1	18.0	7.8	7.3	4.1	8.5	11.0	6.9	21.9	5.7	7.8	5.3	11.0	8.2	16.0	25.2	0.0	9.2	44.0	7.4	0.0	2.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	2.7	0.3	0.0	0.4	4.1	4.7	4.0	7.3	8.9	2.8	2.5	1.1	3.0	0.0	4.2	2.4	5.2	3.2	15.7	68.6	2.1	3.1	2.5	4.1	4.6	41.4	4.9	2.0	8.4	1.5	6.7	7.3	64.6	5.7	13.1	22.7	1.9	3.0	2.5	11.6	18.9	5.4	28.1	0.8	138.9	3.8	4.9	8.7	28.5	5.5	10.8	10.6	5.7	6.0	36.5	58.9	122.9	13.3	2.0	96.1	16.4	3.5	6.5	106.3	3.6	50.6	84.9	8.6	1.0	96.5	50.7	5.2	17.4	9.1	2.1	2.5	24.9	8.1	18.7	31.9	6.6	8.1	8.7	37.2	30.3	2.8	1.7	3.8	3.6	9.1	15.9	2.7
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845780	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.7;brain: 20.2;pancreas: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4634.9;Excitatory neurons: 3067.4;Inhibitory neurons: 3258.7;Oligodendrocyte precursor cells: 990.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.1;HAP1: 6.2;HMC-1: 4.3;JURKAT: 3.4;NTERA-2: 3.7;RT4: 6.7;SCLC-21H: 9.7;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.2	10.7	12.4	0.3	20.2	0.1	0.0	0.0	16.6	0.3	0.0	2.2	1.2	0.4	0.0	0.0	0.1	0.8	0.1	19.3	0.5	0.2	0.1	0.2	0.0	1.9	3.1	0.0	17.3	0.0	0.8	0.8	2.0	0.0	2.8	4.1	0.2	0.0	0.0	0.1	1.2	0.8	4.5	0.0	1.0	1.0	6.0	0.0	0.6	0.0	0.0	0.3	0.0	11.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	9.7	3.9	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.2	0.0	16.6	19.3	0.5	1.9	3.1	2.0	4.5	6.0	11.7	0.0	0.0	0.0	4634.9	0.0	0.0	0.0	0.0	0.6	21.7	0.0	0.0	1.5	4.3	0.6	0.0	0.0	1.5	0.0	2.3	0.0	0.0	12.4	0.1	0.1	0.1	4.2	2.1	3067.4	2.7	10.2	0.5	0.0	0.3	0.0	5.8	0.7	0.0	0.3	5.0	3258.7	1.4	0.0	0.0	0.0	5.7	0.3	0.0	1.8	58.1	0.0	1.4	0.0	990.7	48.3	0.8	1.9	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.1	1.6	2.6	0.3	0.0	4.4	0.0	0.4	3.2	0.0
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.0;endometrium 1: 58.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	0.6	8.2	16.5	0.2	24.5	0.1	0.5	32.0	34.5	5.8	0.0	19.8	0.5	58.2	2.5	0.3	5.2	0.1	0.2	42.7	21.6	5.3	0.0	1.4	0.1	54.0	24.5	0.7	3.9	0.0	10.8	0.2	53.1	0.3	1.6	11.1	0.1	8.9	6.0	3.6	3.4	19.9	8.6	4.7	7.8	7.3	32.2	1.9	17.1	0.9	0.0	0.3	1.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	16.5	24.5	32.0	34.5	42.7	21.6	54.0	24.5	53.1	8.6	32.2	14.8	0.1	0.0	0.0	147.9	0.0	3.3	0.4	0.0	0.0	27.0	0.4	1.3	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.4	0.9	21.6	0.4	10.3	0.0	673.4	4.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	32.0	1195.9	0.4	0.0	0.0	0.0	18.4	1.2	0.2	16.0	22.5	0.0	17.1	0.0	1947.8	290.8	0.3	0.0	3.8	0.0	0.1	0.1	0.4	0.8	6.1	0.0	0.7	0.9	1.2	4.0	0.0	1.6	0.0	0.2	0.0	0.0	0.2
DRAM1	"DRAM, FLJ11259"	ENSG00000136048	"DNA damage regulated autophagy modulator 1"	Q8N682	12	101877580-102012130	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 94.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 321.8;Early spermatids: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"BJ hTERT+: 532.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (8.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.19e-2)"	"prognostic favorable (6.52e-8)"	"unprognostic (1.15e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.07e-2)"	14.9	15.4	3.5	18.9	3.9	36.9	11.3	5.0	4.2	8.9	7.5	10.2	7.0	10.2	5.3	10.7	9.4	16.8	8.3	3.6	4.5	23.7	7.8	94.1	18.2	4.3	3.4	7.3	8.4	6.1	5.9	20.1	3.7	9.1	9.4	4.3	11.1	7.2	4.7	9.0	9.3	12.6	3.2	11.4	15.7	4.9	4.7	9.3	7.4	5.4	10.5	37.2	7.9	5.5	10.6	20.5	7.4	2.3	93.4	21.4	40.4	77.2	532.4	76.2	118.3	6.9	19.8	1.9	8.5	128.2	29.4	15.5	1.9	32.2	104.8	11.3	6.2	2.6	17.5	27.2	43.1	3.0	5.5	25.5	14.0	26.8	28.7	65.1	41.5	2.4	9.5	3.6	20.0	8.3	1.8	9.0	5.1	26.3	4.9	3.4	5.4	1.9	80.9	49.4	1.4	1.6	42.8	4.8	20.5	20.3	14.9	11.7	25.3	53.3	9.5	9.3	14.2	10.7	5.3	1.4	17.9	26.8	14.2	10.2	9.0	6.0	1.6	10.2	2.0	2.7	1.3	1.8	3.1	1.4	0.9	1.1	8.6	3.3	5.8	0.8	1.9	2.8	3.5	3.9	5.0	4.2	3.6	4.5	4.3	3.4	3.7	3.2	4.7	5.5	17.2	54.5	321.8	4.9	10.7	20.9	21.5	42.4	28.5	1.6	12.8	8.0	4.3	10.0	25.2	29.5	0.0	28.1	5.0	1.3	1.9	11.4	145.0	12.7	30.8	16.5	0.0	11.3	0.5	21.4	30.9	30.5	10.2	15.6	24.1	3.2	10.0	2.0	60.6	0.0	4.7	1.6	14.2	40.5	31.1	80.6	14.0	51.9	8.8	3.7	24.6	3.2	5.2	10.1	0.6	21.7	0.3	10.5	30.9	34.2	0.3	23.4	7.4	0.2	13.1	14.4	9.9	1.2	4.5	3.2	6.1	22.0	6.4	7.3	1.2	22.1
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	38.0	23.1	13.9	33.1	14.5	17.9	26.8	17.7	19.9	23.1	22.7	26.7	28.6	17.7	17.6	15.0	30.1	36.4	23.7	13.5	15.2	26.5	24.9	25.0	55.3	15.6	14.9	24.3	25.6	28.3	4.6	41.2	16.2	17.8	30.7	16.9	25.8	16.7	16.6	17.9	26.3	17.0	15.5	45.3	23.4	10.3	15.0	27.8	22.0	23.6	50.3	29.4	4.2	17.8	38.0	12.9	24.0	10.8	57.3	56.2	23.4	28.7	29.9	24.7	24.9	12.5	38.2	28.7	17.2	25.6	12.1	37.4	30.5	24.0	31.9	26.8	25.6	16.8	18.4	16.4	41.4	19.4	15.4	38.5	41.4	18.3	38.4	53.6	29.9	29.1	34.1	19.6	30.1	19.6	16.6	28.8	14.5	43.3	13.2	11.1	40.0	14.0	42.5	25.8	19.1	18.2	16.8	52.4	80.1	33.1	16.7	84.6	24.8	20.6	13.8	16.2	18.9	25.7	9.6	29.8	33.4	34.7	29.6	41.7	47.3	11.5	14.2	61.0	19.4	65.7	17.5	15.3	45.1	54.1	22.3	19.0	7.2	25.0	49.8	28.6	17.7	35.5	13.9	14.5	17.7	19.9	13.5	15.2	15.6	14.9	16.2	15.5	15.0	17.8	34.5	12.8	12.0	17.3	146.2	47.0	54.4	82.5	34.1	11.6	53.6	43.9	29.7	32.9	53.1	44.1	2.1	98.1	38.9	41.2	43.0	59.2	8.5	51.7	19.5	36.4	13.2	28.6	20.6	46.6	102.3	39.2	24.5	17.6	23.6	18.5	42.8	26.0	183.1	20.2	31.7	45.7	77.3	189.4	97.8	7.8	33.5	110.3	81.8	39.4	89.0	27.1	56.7	31.7	42.6	41.9	64.3	24.8	54.7	46.3	88.4	80.4	95.8	10.1	39.5	26.4	32.5	4.7	14.6	40.8	53.0	73.3	38.6	26.3	43.7	70.1
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
EFCAB3	FLJ25818	ENSG00000172421	"EF-hand calcium binding domain 3"	Q8N7B9	17	62343941-62416480	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 6.0"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 74.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046862	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA046862: AB_2679844"													"unprognostic (2.99e-6)"					0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	74.6	0.2	0.4	0.4	0.0	0.0	1.3	0.0	0.2	0.4	0.0	0.3	1.3	0.3	0.4	0.3	0.0	1.7	0.9	0.0	0.0	0.0	1.1	8.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.3	0.0	0.2	0.1	0.1	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1
EMB	MGC71745	ENSG00000170571	Embigin	Q6PCB8	5	50396192-50443248	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 152.5;intestine: 72.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 108.4;dendritic cells: 133.3;NK-cells: 153.5;Proximal enterocytes: 137.5;T-cells: 150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 281.5;U-937: 124.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.01e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.86e-3)"	18.4	22.4	1.7	28.4	1.6	152.5	12.1	4.0	2.9	8.6	2.4	9.7	72.0	3.1	2.7	8.0	5.8	12.9	5.1	1.9	5.4	2.5	4.7	15.9	55.9	6.9	7.8	2.1	2.1	24.2	8.4	13.4	5.6	29.1	11.6	10.5	5.5	20.4	1.3	32.3	68.3	8.0	3.5	25.0	14.3	10.9	3.7	28.4	20.7	3.6	48.4	16.8	2.8	3.1	38.8	2.9	6.5	0.1	2.9	8.7	0.5	1.7	0.0	2.7	0.3	0.3	91.6	74.3	2.1	3.2	0.0	55.7	15.3	43.5	0.4	24.0	38.8	34.5	10.2	0.0	0.5	69.9	0.2	0.6	23.3	6.9	28.2	44.6	0.0	28.8	0.0	86.8	52.4	41.0	43.2	39.3	27.2	0.0	19.9	65.5	0.2	98.6	0.0	29.8	21.2	19.9	0.0	10.1	1.1	13.4	4.3	281.5	0.1	0.1	32.5	0.2	0.3	1.0	0.0	59.3	0.1	124.1	8.3	9.5	34.1	38.7	44.5	4.4	54.1	20.7	39.9	41.0	22.3	13.7	23.5	31.8	30.2	37.3	1.4	25.7	53.6	42.8	1.7	1.6	4.0	2.9	1.9	5.4	6.9	7.8	5.6	3.5	3.7	3.1	3.3	67.3	17.3	1.6	78.1	18.2	2.0	21.2	8.6	3.3	6.5	8.0	1.9	10.0	27.7	0.0	108.4	12.1	133.3	1.2	0.0	0.8	0.6	1.0	0.4	3.8	7.3	21.9	51.9	0.9	8.5	7.8	15.8	0.4	19.0	0.0	20.7	1.6	20.6	1.7	28.7	11.3	8.2	31.4	86.4	1.5	2.8	63.5	10.6	41.2	78.0	2.1	153.5	0.0	1.6	15.7	4.4	6.8	71.1	9.6	137.5	0.4	34.3	9.0	0.0	2.3	4.6	1.0	3.8	6.4	12.6	8.5	150.9	0.0	15.4	2.4
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827523	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.0;neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013537	Uncertain					NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	26.4	49.8	5.0	8.0	4.3	5.6	32.6	4.6	4.8	45.6	6.8	20.7	8.3	61.5	3.8	24.7	27.1	18.0	26.1	4.1	4.1	28.3	33.3	28.2	5.8	5.5	5.1	36.0	26.8	10.1	6.3	35.5	5.3	28.9	10.2	0.3	24.2	22.4	7.7	35.8	17.5	22.2	5.1	47.9	21.4	12.3	6.3	3.1	17.6	13.3	4.9	17.3	28.1	4.8	37.7	33.1	32.5	94.2	20.4	13.0	94.7	14.1	31.2	22.3	29.0	27.4	28.3	4.8	63.6	15.3	31.3	38.2	14.3	38.3	11.9	6.2	25.6	1.3	19.0	43.2	11.8	0.7	0.9	15.3	56.7	14.2	33.1	24.8	84.0	1.5	71.9	1.8	18.4	66.4	0.7	15.0	54.7	56.3	47.5	51.4	15.6	8.9	28.6	19.9	0.2	27.4	22.0	10.4	22.1	45.1	26.1	6.7	71.3	27.6	42.6	51.3	21.4	0.2	0.8	1.7	4.0	12.0	51.2	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.7	5.0	4.3	4.6	4.8	4.1	4.1	5.5	5.1	5.3	5.1	6.3	4.8	47.1	9.6	12.6	1.6	1.9	20.5	10.3	13.9	15.9	0.1	22.0	19.7	5.7	7.2	8.5	5.5	0.0	68.5	1.1	9.1	0.0	12.3	28.5	4.8	21.8	51.2	3.0	10.8	0.3	6.6	11.2	6.5	12.8	8.0	1.3	10.7	113.2	22.4	9.0	0.0	0.2	17.4	8.2	4.1	3.4	9.9	8.1	1.3	3.6	1.9	1.5	1.7	0.0	0.0	1.0	20.6	7.6	4.1	1.4	13.3	1.3	4.0	4.2	0.2	6.6	5.7	6.3	1.4	10.2	12.1	17.8	206.5	1.2	2.9	19.9	8.0
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;fallopian tube: 11.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.3	0.4	10.0	0.0	13.3	0.0	5.6	10.5	11.5	2.9	0.0	0.1	0.0	0.2	0.0	0.1	11.2	0.0	3.0	9.9	12.7	5.1	0.0	0.8	0.0	4.9	16.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.7	1.2	1.5	0.3	0.0	0.0	4.3	0.0	0.4	3.3	8.0	0.0	1.6	1.7	0.0	0.1	0.1	6.1	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.3	10.5	11.5	9.9	12.7	4.9	16.9	7.6	4.3	8.0	6.1	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
ERLEC1	"C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB"	ENSG00000068912	"Endoplasmic reticulum lectin 1"	Q96DZ1	2	53787044-53818819	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031501, HPA031502, HPA031503"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425"	"unprognostic (1.27e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.92e-2)"	38.4	51.0	30.2	31.3	32.1	33.8	48.7	29.3	41.9	66.4	39.3	45.8	37.7	40.9	93.9	26.1	36.2	41.0	45.2	32.9	39.2	38.1	43.4	44.1	32.4	28.7	31.1	38.0	67.1	57.3	59.4	56.6	31.5	72.8	50.2	54.5	54.0	55.9	32.1	20.1	34.0	38.5	30.1	33.1	55.3	42.4	31.5	28.1	72.5	39.5	41.2	44.7	27.2	34.4	42.1	47.3	44.4	27.4	123.3	111.3	65.5	100.5	109.1	49.0	51.4	31.3	55.7	29.4	94.5	106.3	86.3	29.7	29.2	42.3	62.1	67.0	38.7	36.1	29.1	93.8	84.4	60.2	63.9	70.5	69.4	51.6	83.3	99.4	58.1	28.6	39.0	115.8	73.6	35.3	27.7	48.0	34.1	67.1	30.4	24.9	53.1	82.7	57.7	39.3	26.5	46.3	36.6	79.0	64.6	50.3	38.0	45.9	63.3	53.9	47.2	44.0	60.3	170.1	120.3	16.5	88.2	35.8	64.5	77.0	25.1	30.7	41.4	27.8	45.8	36.8	36.3	39.9	28.0	28.6	33.9	39.0	9.6	45.4	33.3	40.1	36.6	41.5	30.2	32.1	29.3	41.9	32.9	39.2	28.7	31.1	31.5	30.1	31.5	34.4	57.2	89.8	116.7	22.2	86.3	25.1	42.5	88.0	34.1	77.0	76.3	54.6	83.5	52.9	93.5	66.2	31.3	100.2	60.9	43.4	33.2	76.1	168.4	67.7	77.5	63.8	55.1	23.1	24.0	115.7	105.8	99.7	54.6	101.7	74.1	36.6	68.6	81.8	60.1	95.9	28.5	169.7	107.8	39.7	31.5	117.9	88.3	41.7	80.0	17.8	61.7	79.7	72.1	20.6	25.3	90.2	42.8	84.2	394.0	113.4	32.3	51.4	118.2	68.6	52.6	55.6	109.5	146.1	65.3	40.3	33.4	183.6	57.0	48.3	57.1	67.5
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039080-64130819	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 53.0;pancreas: 66.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009495, HPA027730"	Supported					NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	9.5	53.0	1.5	5.4	1.7	13.4	7.5	2.6	3.2	22.6	2.1	7.7	6.3	10.1	6.4	9.5	14.3	6.2	6.1	1.6	2.4	5.6	23.5	16.5	5.8	1.7	1.0	16.9	66.7	4.3	19.5	5.6	1.3	9.9	4.5	8.8	15.7	7.1	6.8	11.3	10.6	5.6	1.0	15.8	16.2	2.8	1.6	6.8	10.2	2.4	6.6	8.3	11.7	1.7	4.0	4.0	2.2	4.8	4.8	4.4	9.8	4.1	9.7	2.8	1.3	2.5	2.3	6.6	3.2	2.8	3.5	3.6	1.9	4.5	6.1	1.6	1.5	6.0	3.2	2.4	19.6	3.2	2.1	3.8	8.1	6.4	21.5	3.5	5.0	4.7	4.2	74.6	2.8	3.9	4.5	1.0	0.6	3.6	3.2	4.2	4.2	40.2	1.1	5.5	7.1	3.5	4.3	6.1	5.7	3.5	3.8	5.9	5.9	2.5	4.1	6.4	2.7	77.4	23.9	4.8	4.0	2.1	4.2	17.9	0.9	0.4	4.9	0.4	9.0	0.2	3.3	4.1	0.4	0.3	0.9	0.9	4.9	2.5	0.3	7.7	0.8	1.0	1.5	1.7	2.6	3.2	1.6	2.4	1.7	1.0	1.3	1.0	1.6	1.7	31.9	0.0	36.1	7.2	27.8	22.0	54.3	8.3	15.4	4.0	35.0	29.7	8.6	11.5	8.6	12.9	6.2	8.1	106.4	10.0	1.9	12.6	2.3	26.1	49.1	18.3	79.7	11.2	8.6	27.3	8.8	42.2	52.0	79.4	8.2	11.8	13.9	26.8	8.0	3.3	6.1	8.2	8.2	15.7	71.3	1.7	4.7	60.4	74.7	12.2	10.2	3.5	28.8	6.0	4.6	17.9	7.3	6.0	325.8	44.7	7.9	4.4	6.1	26.5	0.0	19.0	25.7	4.0	4.1	27.7	45.0	54.9	88.2	12.0	9.6	60.1
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639915-52695900	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 172.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 221.3;Extravillous trophoblasts: 215.8;Pancreatic endocrine cells: 264.7;Prostatic glandular cells: 171.4;Urothelial cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"	NA	NA		110000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (7.59e-4)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	17.9	8.6	12.2	20.4	11.7	47.0	16.4	11.8	12.9	59.0	11.3	18.5	17.9	12.0	15.1	172.5	10.0	18.9	15.5	12.1	16.6	14.6	31.2	15.2	14.9	11.7	13.3	8.5	18.9	11.1	12.6	44.4	12.8	9.6	17.8	30.6	37.4	14.0	9.1	18.9	16.5	12.0	9.9	14.6	29.0	5.4	15.1	8.3	13.4	8.2	30.4	32.6	62.4	10.9	100.6	24.2	19.9	21.4	54.4	61.3	38.0	42.4	52.7	34.1	56.9	33.4	158.0	26.3	50.7	28.3	42.0	61.1	27.1	84.1	84.9	22.0	14.5	3.6	25.1	42.1	46.2	60.2	72.1	54.5	54.2	43.9	44.5	79.9	48.2	32.3	18.1	50.8	46.2	15.8	36.0	37.8	11.8	46.5	15.5	21.5	59.8	38.1	52.3	97.1	18.5	49.6	28.9	17.8	39.4	25.7	24.8	22.3	40.0	60.7	29.5	49.6	37.4	26.9	28.8	22.7	88.0	30.3	28.7	20.6	5.9	11.7	5.0	6.9	11.0	4.6	9.4	6.3	4.9	3.1	5.5	5.5	14.7	6.7	9.4	3.7	11.9	2.5	12.2	11.7	11.8	12.9	12.1	16.6	11.7	13.3	12.8	9.9	15.1	10.9	33.8	16.0	27.6	0.0	18.8	0.0	79.2	0.0	19.4	23.4	29.7	11.8	0.0	38.6	15.5	38.6	16.7	24.3	23.3	33.4	3.9	221.3	0.6	32.4	23.8	32.6	10.9	9.9	0.0	130.6	215.8	20.5	56.1	64.0	6.3	10.9	21.0	62.5	42.9	42.1	0.0	10.7	0.0	42.7	0.0	1.6	6.2	49.7	0.0	0.0	45.0	12.2	15.5	0.0	0.0	264.7	18.1	12.8	60.0	171.4	29.0	15.1	13.1	26.4	19.7	14.6	20.9	0.6	3.6	25.7	0.0	91.4	32.1	10.4	20.3	145.8
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	118.2	21.3	53.1	28.8	69.9	4.1	70.1	53.2	74.4	48.0	44.1	52.2	36.8	61.1	44.2	41.3	89.9	59.6	36.8	54.0	62.7	18.0	5.1	59.8	12.9	77.7	62.6	114.8	96.5	17.2	81.2	133.4	57.1	56.8	42.1	72.6	93.3	60.4	7.6	56.0	47.3	10.7	60.8	7.2	42.6	34.6	62.0	5.6	62.6	9.9	14.9	65.4	73.0	55.4	1062.0	1.8	2.2	0.5	108.0	53.1	57.2	147.0	87.6	155.4	167.9	18.6	220.6	0.0	73.3	183.5	33.4	490.7	13.2	1270.5	254.4	0.9	1.6	0.0	35.0	3.3	35.9	0.7	0.6	91.9	28.2	73.8	356.5	293.7	1.1	1.1	0.9	0.8	110.0	1.8	1.5	22.3	9.8	6.8	2.2	1.2	10.3	0.5	19.8	3.2	1.3	2.6	117.4	48.3	3.6	29.6	1.3	13.9	0.3	93.7	2.5	473.0	44.6	0.9	1.3	0.9	71.9	5.7	3.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	53.1	69.9	53.2	74.4	54.0	62.7	77.7	62.6	57.1	60.8	62.0	55.4	9.4	131.4	243.3	196.6	0.7	16.3	902.0	359.6	2.2	3.6	29.6	20.4	26.4	18.6	380.3	14.7	0.0	16.5	0.6	20.9	0.0	133.5	8.6	61.3	125.0	13.2	13.1	0.0	0.4	464.1	6.0	125.3	23.0	123.0	2.5	38.1	7.5	0.4	6.1	3.3	4.6	70.3	65.1	2.8	5.2	14.5	281.1	9.1	3.6	45.9	2.1	340.6	0.0	15.6	1.2	1755.7	15.5	530.7	1.2	121.6	10.1	0.4	92.0	16.1	6.6	39.3	76.7	1.7	4.4	6.4	7.5	7.7	7.3	7.9	14.3	497.9
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 3691.0;vagina: 2600.3"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	379.8	15.5	107.9	137.8	112.9	111.8	241.8	112.3	146.5	1340.4	307.4	256.7	83.3	62.7	4.8	3691.0	22.4	87.7	343.4	116.6	130.7	34.0	27.5	272.5	191.4	162.8	120.5	12.1	73.1	443.0	32.7	338.8	155.7	22.9	210.6	33.3	514.9	17.1	119.1	692.7	122.3	52.4	133.1	127.4	181.2	45.1	118.2	137.6	74.9	306.1	292.9	362.3	2600.3	138.9	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	107.9	112.9	112.3	146.5	116.6	130.7	162.8	120.5	155.7	133.1	118.2	138.9	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 176.7;Leydig cells: 192.0;Oligodendrocyte precursor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 508.7;BJ hTERT+: 278.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		78000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	95.1	12.8	27.5	15.9	24.6	14.1	87.1	48.8	22.4	79.8	37.2	97.2	8.8	74.2	15.8	35.8	85.9	57.1	89.9	30.9	28.8	40.1	9.1	55.7	16.6	35.9	37.3	108.2	98.6	20.4	57.1	51.3	63.7	60.5	17.9	15.8	31.4	53.6	24.8	35.6	41.7	57.1	30.3	9.9	40.4	20.4	33.4	17.1	33.7	23.3	16.1	79.3	63.9	29.6	12.9	42.0	198.0	508.7	120.1	91.2	142.9	136.7	278.8	90.0	95.8	27.3	6.5	1.8	38.3	127.7	103.9	0.2	90.0	6.8	104.3	39.2	24.1	0.0	7.7	27.8	69.7	31.1	0.6	80.5	0.7	70.9	13.3	45.6	86.9	6.0	11.9	0.4	40.5	12.5	91.5	9.2	145.9	1.6	21.6	86.3	21.1	0.4	35.6	0.3	7.9	19.4	23.4	1.0	5.1	93.4	9.3	5.4	51.4	49.2	28.9	149.6	29.7	2.4	4.1	0.5	60.3	1.7	27.1	0.2	0.3	0.1	1.7	0.1	1.1	0.3	0.7	1.2	0.0	0.6	0.5	1.5	0.6	0.4	0.2	0.2	1.0	0.1	27.5	24.6	48.8	22.4	30.9	28.8	35.9	37.3	63.7	30.3	33.4	29.6	101.0	3.2	15.8	55.8	1.8	31.5	95.9	1.1	37.0	4.4	28.7	77.7	52.5	24.3	5.1	9.2	4.2	8.3	6.3	0.4	0.0	27.3	15.3	48.2	40.6	75.5	25.0	3.6	25.4	65.2	80.5	176.7	3.1	75.3	8.2	40.4	47.5	0.8	25.3	21.9	21.1	0.6	4.1	5.6	75.2	15.0	192.0	11.7	33.8	19.7	1.7	88.1	6.2	166.4	14.2	21.6	0.3	99.6	6.4	94.7	0.1	7.9	1.0	3.3	13.1	118.9	59.9	1.6	14.1	4.8	19.7	10.4	14.1	2.1	0.7	11.7
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 82.5;lung: 65.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 42.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		7400000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	1.2	14.0	1.1	4.1	1.1	0.5	4.5	2.7	2.1	3.0	1.2	18.0	21.3	2.4	0.2	3.2	4.2	10.2	2.2	1.4	1.0	40.2	82.5	65.4	0.8	0.7	0.8	27.5	29.5	0.2	2.0	2.1	0.9	5.2	6.0	1.5	1.1	0.7	6.6	1.7	20.0	1.1	0.7	22.7	8.8	5.9	1.1	0.2	0.9	1.9	0.2	6.4	3.2	1.3	3.2	48.8	1.0	11.7	0.1	0.1	24.5	0.2	0.1	0.2	0.3	173.9	6.5	5.3	23.0	0.1	2.4	2.8	9.5	1.8	0.1	3.2	13.8	0.5	2.8	176.4	5.2	0.6	4.7	1.1	0.2	8.4	0.2	0.3	0.2	3.5	18.1	0.7	3.9	40.3	0.1	3.6	29.2	30.9	4.5	8.2	274.3	30.9	22.9	0.4	1.8	2.9	1.8	12.4	5.9	5.9	11.7	2.5	1.1	0.0	23.4	0.3	0.7	1.6	1.9	3.7	0.1	1.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.1	1.1	2.7	2.1	1.4	1.0	0.7	0.8	0.9	0.7	1.1	1.3	0.3	0.0	0.0	0.3	0.3	0.6	0.7	0.4	0.0	0.9	2.9	2.0	0.9	78.6	0.1	3.7	0.0	1.3	0.1	12.9	3.9	10.9	0.1	1.6	0.3	0.7	4.2	0.0	0.5	4.9	3.8	9.6	9.7	2.9	0.0	0.7	3.9	31.2	0.3	0.0	0.5	10.1	0.0	0.9	0.5	0.0	0.6	0.7	0.0	1.9	0.6	0.6	0.0	0.5	0.1	3.0	4.4	1.5	0.1	1.7	15.9	21.6	0.1	0.4	19.7	141.2	0.7	3.0	9.9	0.8	0.4	8.8	0.4	36.7	38.6	0.5
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 523.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		20000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	74.6	63.1	42.8	22.3	51.3	7.4	90.4	50.9	52.4	45.5	57.1	122.2	52.8	75.5	120.3	57.7	75.9	19.6	47.2	40.1	41.6	96.7	71.5	49.9	24.4	54.4	52.3	68.9	83.2	59.9	38.1	48.0	52.6	124.4	74.4	10.2	64.0	51.4	16.3	91.3	92.7	36.2	48.1	55.3	70.2	30.4	50.0	74.8	91.1	17.8	23.8	114.7	58.6	58.3	134.4	225.0	22.3	32.9	14.8	25.0	385.7	49.0	39.3	106.6	108.4	227.1	223.1	21.9	18.1	172.9	172.8	215.9	42.1	311.5	103.0	121.6	20.8	18.4	192.7	110.5	107.8	16.2	63.1	40.2	132.1	148.5	448.3	125.2	365.4	94.7	30.9	6.6	67.0	29.2	49.3	38.5	34.5	146.6	192.1	21.6	5.8	18.7	143.8	224.6	24.7	23.1	247.3	132.6	27.4	160.9	110.3	44.6	523.3	27.8	84.5	334.1	175.6	4.8	1.7	17.0	102.2	29.2	29.9	10.1	0.3	5.0	0.5	0.8	2.7	4.1	1.7	0.8	1.4	1.6	5.1	3.8	0.2	7.3	1.5	17.9	2.0	1.5	42.8	51.3	50.9	52.4	40.1	41.6	54.4	52.3	52.6	48.1	50.0	58.3	133.7	51.3	30.2	3.9	11.0	50.6	42.9	73.2	29.0	3.3	86.6	43.4	10.0	57.2	62.0	47.8	39.6	28.7	36.8	344.9	0.0	93.8	15.6	103.6	24.4	92.9	49.2	10.3	34.1	67.1	207.1	28.8	88.7	133.8	24.7	34.4	151.3	52.0	14.6	1.7	34.3	82.8	38.7	11.3	12.2	22.4	16.1	11.1	5.4	22.5	11.6	9.1	2.1	25.1	40.9	385.7	161.0	27.8	3.4	115.2	157.3	6.5	76.1	10.6	0.0	4.4	25.9	4.4	6.9	46.4	51.7	49.8	9.9	84.6	93.0	88.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742732	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 314.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 423.3;hTERT-RPE1: 242.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	141.7	239.5	49.3	27.9	54.6	41.7	129.8	49.4	60.9	111.1	56.8	150.3	28.7	108.9	8.4	81.8	95.8	23.1	234.5	55.1	57.9	146.1	127.3	136.8	22.1	50.9	51.5	84.1	88.5	41.4	102.5	35.0	57.4	109.6	17.7	6.3	99.1	45.8	190.0	51.7	87.1	33.0	45.8	129.6	96.9	65.0	53.6	24.9	111.7	83.1	17.0	134.5	96.9	48.8	54.3	18.3	46.4	62.0	49.1	71.0	1.3	59.7	67.5	82.8	79.3	19.4	30.0	13.0	29.0	101.3	423.3	41.8	35.0	20.1	28.6	36.1	1.3	41.1	17.5	19.1	119.2	12.2	67.0	75.4	30.6	40.9	71.3	242.7	65.9	37.9	21.7	52.7	77.9	22.9	38.0	14.5	15.1	29.4	15.7	20.2	48.4	38.0	30.3	13.0	16.4	17.2	33.7	28.7	164.6	30.4	43.8	10.1	44.0	199.5	37.6	20.6	120.6	18.6	19.7	28.8	26.2	42.6	122.7	179.3	76.9	132.0	35.0	38.9	24.1	28.0	21.3	30.4	58.9	23.0	23.7	27.4	314.3	79.9	26.3	59.2	3.9	58.3	49.3	54.6	49.4	60.9	55.1	57.9	50.9	51.5	57.4	45.8	53.6	48.8	175.4	89.8	77.0	26.1	38.1	28.7	111.5	44.9	80.2	14.7	72.1	73.4	90.6	62.9	59.2	84.6	6.2	82.2	57.7	103.2	123.3	77.6	60.2	73.9	50.1	141.6	68.8	41.7	41.3	85.9	70.7	67.6	55.5	75.2	143.3	41.4	154.9	59.7	130.6	20.2	40.2	66.6	57.0	61.3	84.9	144.1	61.8	89.4	71.2	28.1	99.2	64.7	68.0	27.2	22.7	65.7	112.0	38.0	60.4	69.5	89.0	172.1	80.7	18.1	52.6	58.1	65.9	80.2	26.7	63.7	26.9	61.6	51.2	29.1	83.2	99.4
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480753-75503863	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 216.3;Extravillous trophoblasts: 384.2;Hofbauer cells: 242.4;Kupffer cells: 273.9;Langerhans cells: 393.2;Macrophages: 259.6;monocytes: 220.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 189.3;U-138 MG: 363.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	17.2	16.9	2.0	47.0	1.7	18.3	11.5	1.5	5.6	15.6	3.8	11.4	6.6	32.6	6.0	7.9	17.9	33.5	9.2	2.3	2.8	5.6	12.5	22.1	32.7	4.0	3.3	13.7	3.7	2.3	3.9	25.8	3.9	9.2	12.6	1.7	9.7	17.1	3.1	3.4	14.1	39.9	3.4	36.4	10.8	4.8	4.2	19.8	5.4	7.3	32.3	35.0	6.7	8.4	7.2	7.0	5.9	0.6	22.0	46.2	0.9	93.0	97.5	76.8	55.7	3.8	2.7	23.9	19.1	101.7	67.6	1.2	0.2	38.6	124.7	38.0	1.6	1.2	8.4	6.1	25.1	8.4	1.3	43.0	14.1	189.3	41.4	123.1	62.0	1.7	1.7	29.0	144.7	0.1	4.0	20.2	0.6	0.2	2.8	1.0	4.5	0.8	8.1	1.6	0.2	0.2	38.5	0.3	0.2	12.5	0.9	6.7	102.6	363.8	35.4	39.2	144.1	5.1	0.8	2.1	144.4	9.9	5.6	25.3	352.7	40.9	115.0	232.6	77.2	73.9	80.5	90.7	240.2	90.2	24.3	50.4	462.1	20.4	265.6	202.1	91.2	265.0	2.0	1.7	1.5	5.6	2.3	2.8	4.0	3.3	3.9	3.4	4.2	8.4	6.5	12.8	16.0	2.0	121.6	13.6	189.2	23.0	4.0	2.9	15.5	19.9	0.9	5.7	10.0	3.7	4.2	4.8	216.3	0.3	0.0	102.8	14.3	11.3	119.4	7.0	3.5	11.8	13.3	83.9	384.2	46.1	2.0	16.4	10.1	0.8	10.4	4.4	242.4	6.7	14.6	0.4	4.1	273.9	393.2	5.9	14.3	259.6	16.0	28.1	220.9	1.4	123.6	2.5	1.5	90.9	2.5	53.8	66.8	106.5	0.1	1.5	10.6	3.2	13.1	8.1	50.2	7.9	1.0	4.6	9.8	16.8	161.9	26.7	0.6	42.8
GNA11	"FBH, FBH2, FHH2, HHC2"	ENSG00000088256	"G protein subunit alpha 11"	P29992	19	3094362-3123999	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 330.6;Proximal enterocytes: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"HPA048886: AB_2680544"	"unprognostic (4.64e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.26e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.48e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	33.5	32.5	36.4	16.2	31.2	8.3	32.6	53.8	35.3	31.7	18.9	66.7	117.5	42.4	12.7	28.7	44.5	20.0	51.7	33.5	27.3	40.4	26.2	34.7	7.5	30.3	29.6	32.5	33.9	26.3	29.8	22.3	28.6	40.4	38.7	11.0	33.3	47.1	54.2	34.4	139.3	28.7	26.6	21.4	34.9	50.6	31.3	8.5	32.9	39.2	7.0	38.8	27.0	31.1	56.1	31.2	27.9	48.5	41.7	28.4	30.9	53.8	53.7	71.8	57.8	41.7	27.3	12.0	29.2	76.4	43.6	39.0	37.8	42.7	44.3	30.1	21.9	3.3	35.7	23.6	42.2	3.8	11.8	36.9	36.8	48.4	29.2	36.9	57.8	3.4	27.8	1.9	49.1	25.8	3.0	14.4	20.5	38.4	29.4	23.2	26.4	11.9	33.8	40.8	66.0	40.7	38.3	45.2	27.2	18.9	33.3	7.9	50.0	45.7	33.3	85.4	73.5	1.3	3.9	7.9	33.0	2.9	52.3	2.5	1.4	0.3	0.7	0.7	0.8	0.9	0.5	0.6	0.2	1.1	1.2	0.9	5.1	0.5	1.5	2.3	0.1	0.3	36.4	31.2	53.8	35.3	33.5	27.3	30.3	29.6	28.6	26.6	31.3	31.1	62.3	32.1	24.1	5.2	3.5	32.6	9.5	15.4	13.6	22.7	43.2	47.9	17.8	35.8	12.6	27.6	37.5	13.2	2.4	330.6	7.9	21.4	45.2	26.9	23.0	33.9	54.6	5.2	8.8	25.4	13.5	25.3	29.6	26.1	4.5	24.1	58.2	28.5	9.0	45.4	11.3	84.1	26.4	9.1	16.4	20.0	50.1	5.1	23.2	11.2	1.1	29.0	0.0	7.1	14.1	36.1	96.0	80.5	1.2	16.0	323.0	18.9	35.4	15.8	19.7	28.5	30.5	23.7	8.9	20.6	41.2	20.4	2.0	22.1	94.9	13.4
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673567-100679174	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"		NA	NA		940000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: AB_2677106"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	198.4	211.0	131.4	128.3	137.3	207.5	188.0	112.3	179.6	209.4	103.8	168.0	103.2	182.4	63.7	328.4	179.8	105.5	175.9	130.2	138.1	186.1	185.8	210.1	107.9	140.3	130.1	175.3	184.8	98.9	203.3	107.4	123.6	183.0	83.6	20.1	190.8	113.6	175.9	295.5	143.5	113.5	126.3	225.9	172.4	92.9	137.6	90.2	144.8	90.2	105.7	165.2	217.7	120.7	358.6	268.6	222.7	272.5	169.8	199.9	194.3	208.4	288.4	294.3	241.7	205.3	333.7	157.7	216.0	311.3	332.2	243.0	177.7	312.6	103.0	216.9	152.1	120.8	198.7	171.3	282.4	157.7	254.5	259.5	291.1	304.2	244.6	237.6	343.6	132.5	228.6	303.3	270.4	980.0	249.5	450.3	173.5	225.1	290.1	234.3	136.3	253.8	235.4	291.3	241.0	380.1	278.0	449.2	201.3	125.3	192.4	192.1	325.8	313.8	346.8	619.2	266.6	88.8	111.9	240.9	237.1	349.7	443.6	27.6	28.6	70.9	17.5	42.7	16.2	13.6	17.9	15.4	28.1	18.1	11.8	12.4	117.2	15.4	35.9	23.8	23.5	12.5	131.4	137.3	112.3	179.6	130.2	138.1	140.3	130.1	123.6	126.3	137.6	120.7	138.1	57.7	97.0	16.0	104.1	151.8	159.3	72.9	148.0	10.4	105.4	106.0	35.0	100.1	55.5	84.6	4.2	172.4	89.4	285.4	162.4	163.7	32.6	133.5	106.8	136.5	180.4	127.7	12.7	218.7	312.1	117.6	135.1	127.2	44.4	97.6	126.0	69.9	264.4	72.3	10.8	211.2	75.3	198.6	198.8	20.1	144.8	193.5	140.5	15.9	160.8	128.2	96.8	5.0	6.9	257.1	285.6	130.1	122.5	226.5	162.3	107.0	68.3	8.5	65.7	62.0	162.2	34.3	69.6	240.7	194.8	293.9	117.8	88.1	192.2	259.5
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 157.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 73.0;Kupffer cells: 26.5;NK-cells: 52.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 66.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 64.8;HDLM-2: 54.5;HUVEC TERT2: 19.4;RH-30: 21.6;TIME: 19.9;U-698: 18.2"	"Low region specificity"	"Detected in all"							HPA043381	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	3.1	2.6	2.7	7.7	3.0	2.5	1.8	3.4	4.0	2.3	3.0	2.9	3.5	2.4	0.6	2.7	2.0	4.5	3.0	2.7	3.7	4.4	3.4	7.2	14.1	3.9	3.2	1.5	1.6	1.0	1.2	2.7	3.7	2.1	3.8	157.0	1.1	1.3	0.9	0.9	5.2	3.7	3.4	19.9	2.4	0.8	3.3	5.5	2.4	2.7	18.4	3.3	1.6	4.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.5	1.0	0.9	0.3	0.0	64.8	0.7	0.1	0.0	0.0	0.0	0.1	4.6	54.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	19.4	8.8	0.0	0.4	1.5	0.0	4.6	3.6	0.6	0.0	0.0	12.0	21.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	19.9	0.0	12.6	0.0	0.1	0.2	2.9	18.2	0.3	0.2	0.0	0.1	8.8	1.1	30.4	47.3	27.3	3.7	4.6	21.1	20.3	4.5	2.9	11.7	1.9	26.7	66.7	1.9	3.4	12.7	2.7	3.0	3.4	4.0	2.7	3.7	3.9	3.2	3.7	3.4	3.3	4.6	4.5	0.0	1.1	0.0	4.6	0.4	0.0	0.0	0.0	2.7	0.2	0.3	0.8	0.0	0.6	0.0	73.0	0.0	15.5	0.0	3.9	0.0	1.1	0.1	0.1	5.2	0.0	8.0	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.1	2.5	0.1	11.1	0.0	0.4	0.0	0.0	26.5	2.0	8.2	0.6	13.6	0.0	1.0	9.5	5.9	52.5	0.0	0.1	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	14.8	6.6	0.1	0.3	0.1	0.1	0.0	0.1	0.3	11.4	0.4	0.0	0.0
GOLGA7	"GCP16, GOLGA3AP1, GOLGA7A, HSPC041"	ENSG00000147533	"Golgin A7"	Q7Z5G4	8	41490396-41510980	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046878: AB_2679854"	"unprognostic (2.93e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.88e-1)"	41.3	31.5	73.8	28.7	91.2	42.6	34.1	78.5	112.3	30.5	56.6	29.9	31.6	33.6	27.9	34.5	23.2	33.3	28.1	73.6	78.2	42.8	46.9	30.3	36.9	84.1	83.6	31.2	32.4	33.7	15.8	48.6	82.3	30.6	26.0	31.7	38.8	26.5	25.5	47.8	32.1	32.0	75.4	36.3	28.5	40.8	76.6	36.5	28.5	29.8	32.0	33.1	24.8	110.0	58.2	64.9	48.2	56.1	59.8	51.7	36.8	49.6	48.5	57.2	63.0	115.8	53.3	27.9	64.4	46.7	54.6	39.6	48.0	38.6	63.5	39.3	42.7	56.5	36.7	48.0	65.3	26.2	45.3	45.6	71.1	36.6	54.1	46.3	56.5	49.4	68.1	53.9	46.7	42.6	83.6	70.7	54.1	53.1	31.2	50.4	86.8	30.6	66.9	53.3	86.1	55.5	44.6	34.4	90.7	40.3	70.5	49.9	58.9	48.2	46.4	61.7	44.0	40.7	67.7	40.7	51.3	44.5	68.3	204.9	78.1	78.8	83.9	68.5	82.2	34.8	79.4	76.9	59.2	32.9	65.8	65.9	136.7	78.0	68.1	40.5	94.9	139.7	73.8	91.2	78.5	112.3	73.6	78.2	84.1	83.6	82.3	75.4	76.6	110.0	74.6	6.4	22.9	11.8	31.4	110.4	53.9	63.1	44.3	28.3	48.3	42.9	25.5	28.6	38.4	29.5	4.2	61.2	69.6	29.5	95.9	62.7	22.2	28.1	43.1	57.4	42.5	33.9	15.8	48.0	68.4	55.0	29.6	36.5	17.7	35.4	52.5	46.6	64.3	18.5	17.8	30.3	59.0	69.7	95.2	21.7	45.1	53.7	60.5	13.1	65.5	77.9	87.6	14.6	90.5	55.1	21.0	62.1	31.2	77.0	53.2	120.5	28.4	30.7	59.2	49.2	60.4	152.3	135.0	43.5	108.5	85.9	69.5	38.1	30.5	55.4
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GRIP1		ENSG00000155974	"Glutamate receptor interacting protein 1"	Q9Y3R0	12	66347431-67069162	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 16.4"	"Cell type enriched"	"Detected in many"	7	"Inhibitory neurons: 2829.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038856	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038856: AB_10673297"	"unprognostic (6.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	"unprognostic (8.57e-3)"	0.5	4.3	8.5	2.7	6.6	0.5	3.0	0.0	14.2	1.2	0.0	3.1	1.1	3.5	4.7	7.3	4.2	1.6	2.7	3.9	12.4	3.3	0.3	0.8	0.7	0.7	7.6	1.2	2.0	16.4	3.3	8.2	2.2	4.6	1.7	4.8	6.0	9.3	1.0	9.8	1.9	2.8	0.0	2.6	0.8	6.2	3.0	0.7	5.0	0.6	1.3	2.6	2.0	3.7	11.1	10.1	17.7	2.1	0.0	0.0	44.4	3.2	0.0	5.4	2.5	0.3	3.3	1.4	4.2	0.0	9.5	48.7	4.9	3.3	2.4	0.0	12.0	0.0	0.1	0.3	0.0	1.2	0.1	0.0	8.0	0.0	0.8	8.3	0.0	8.0	0.0	0.1	0.0	4.0	0.4	0.4	16.1	1.4	3.6	30.7	0.1	0.6	5.6	31.0	10.8	1.4	14.8	7.1	1.4	11.3	8.7	1.8	0.0	0.0	12.7	0.1	9.0	1.5	0.3	1.0	12.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.1	0.1	0.2	0.0	1.0	0.0	0.3	0.0	0.1	8.5	6.6	0.0	14.2	3.9	12.4	0.7	7.6	2.2	0.0	3.0	3.7	0.1	0.0	1.1	74.7	0.1	13.3	2.3	2.9	2.2	5.5	4.1	2.4	3.4	1.5	1.7	7.3	0.0	7.8	0.7	0.3	0.0	2.2	38.5	8.1	2.2	0.4	1.8	0.0	390.2	1.5	4.3	1.1	0.0	13.7	0.0	2.3	0.0	0.0	1.0	47.1	2829.7	0.7	0.0	2.4	1.6	34.0	0.6	2.1	7.2	20.6	1.0	0.5	0.0	158.3	44.4	1.9	0.5	0.7	0.1	3.8	0.2	0.4	1.1	1.8	0.0	1.0	0.6	0.3	1.2	2.3	17.8	16.6	0.8	1.2	0.7	3.1
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083532-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 429.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 10812.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 12.3;U-2 OS: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.1	0.0	0.6	0.2	0.9	0.8	0.4	1.7	1.4	0.1	1.3	0.1	1.4	0.1	0.6	0.1	0.0	0.2	0.1	0.7	0.5	0.5	0.1	0.1	0.3	0.0	0.0	0.1	4.8	0.0	0.2	0.2	0.0	0.4	0.2	30.4	0.1	0.0	0.3	0.2	0.7	0.0	0.0	0.2	0.1	429.9	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.4	0.3	0.1	2.0	1.2	0.4	0.2	0.4	0.3	0.4	0.2	0.1	0.2	0.1	8.8	0.6	0.1	0.1	0.0	0.8	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.8	0.0	1.6	0.1	0.1	0.0	0.1	0.1	1.6	9.8	0.2	0.1	1.0	2.1	0.1	0.2	0.1	3.5	0.1	12.3	0.2	0.6	0.2	0.3	0.0	0.1	0.3	0.0	1.4	0.1	0.5	5.9	0.3	0.3	0.5	0.3	0.1	2.5	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.9	1.7	1.4	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.4	0.1	3.2	1.1	0.3	0.0	0.1	0.1	0.0	0.0	134.9	0.1	0.0	0.3	1.5	0.0	0.0	6.2	0.1	0.0	0.0	1.9	0.6	2248.2	0.1	0.2	2.8	27.5	2.7	1.8	0.0	0.1	0.7	0.0	0.1	0.0	0.0	1.4	0.0	0.6	1.7	0.8	2.0	2.0	0.3	0.0	10812.1	53.4	2.9	0.0	1.0	0.1	6.7	0.0	0.0	0.1	0.0	1.2	39.9	0.0	0.1	0.1	0.0	0.0	16.1	6.6	0.4	0.1	57.0	27.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787528-28063714	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.5;heart muscle: 23.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 8.3;THP-1: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.2	0.2	15.6	0.1	19.4	0.2	0.1	9.4	19.5	0.2	4.4	0.4	0.3	0.3	0.3	0.1	1.5	0.0	23.0	17.9	11.0	0.3	0.4	0.4	0.1	21.8	20.0	0.1	0.1	0.0	0.5	0.9	19.0	0.2	0.1	2.4	0.2	0.1	0.3	0.8	0.4	0.0	12.5	0.3	1.1	1.6	22.5	0.0	0.3	0.0	0.0	0.4	0.1	11.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	3.2	0.7	0.0	0.5	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	19.4	9.4	19.5	17.9	11.0	21.8	20.0	19.0	12.5	22.5	11.8	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.1	8.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.8	7.4	0.1	0.0	0.0	26.0	0.0	0.0	1.8	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	7.4	0.4	0.0	0.0	0.0	3.6	0.0	0.1	0.0	4.7	0.0	0.2	0.0	89.5	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.7	0.3	0.5	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42183284-42194956	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 466.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 23.2;Cone photoreceptor cells: 83.4;Oligodendrocytes: 28.2;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.3;U-698: 3.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055479	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.5	0.9	3.5	0.8	3.6	1.3	1.4	3.8	4.1	2.3	2.2	1.3	0.3	1.9	1.0	0.8	2.3	0.2	1.6	3.2	3.2	1.0	1.9	1.1	0.7	3.3	3.2	2.7	0.9	0.2	1.0	0.4	3.6	1.5	0.5	466.0	1.1	0.5	2.6	2.8	1.4	1.0	3.0	2.1	0.8	2.6	3.5	1.0	1.0	0.9	0.9	1.1	1.4	4.6	0.1	0.6	1.3	0.5	1.0	0.9	0.3	0.5	0.8	0.8	0.7	1.1	0.4	1.6	0.8	0.1	0.2	0.4	1.4	0.2	1.4	1.3	0.6	0.4	0.1	0.2	0.4	1.5	0.5	0.3	4.3	0.8	1.1	0.4	0.1	1.2	1.0	1.5	0.2	1.3	0.6	1.0	0.0	0.3	0.3	0.2	0.8	0.1	0.8	0.5	0.6	0.9	0.0	0.2	0.1	0.2	0.1	0.9	0.0	0.2	1.7	0.6	0.7	2.7	1.3	3.9	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.5	3.6	3.8	4.1	3.2	3.2	3.3	3.2	3.6	3.0	3.5	4.6	0.2	0.0	0.0	23.2	0.0	0.3	0.1	0.0	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	83.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.0	8.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	6.7	11.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	2.8	0.1	8.1	0.0	11.6	28.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	53.0	0.0	0.5	0.4	0.5	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.1	3.4	0.3	0.5	0.0	0.2	0.1	0.0	3.0	37.2	68.2	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.3	0.4	0.3	0.2	0.4	0.4	0.3	0.0	2.2	0.0	0.0	0.2	0.4	0.3	41.4	0.1	0.6	0.0	0.7	1.0	66.5	1.4	0.5	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.4	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002615-8020342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 34.2"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 58.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	31	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 8.0"	"Cell line enriched"	"Detected in some"	5	"JURKAT: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.4	1.3	5.2	5.7	2.1	1.4	3.8	1.9	0.0	1.4	0.0	62.6	1.2	2.7	0.0	1.9	0.1	6.9	0.2	0.1	0.1	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.6	0.0	0.1	0.0	1.2	1.1	0.0	0.4	0.0	0.0	0.6	0.0	14.9	0.0	0.6	0.0	0.0	0.8	6.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.4	0.1	58.3	0.0	0.0	0.0	0.4	0.1	2.4	0.3	2.2	0.1	0.0	0.2	0.5
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2054.8"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	1.0	1.2	17.7	2.0	17.6	5.4	1.5	17.4	30.4	2.3	20.8	0.8	0.9	0.3	0.6	0.5	2.8	0.6	415.0	17.8	20.2	1.1	2054.8	3.2	4.0	48.0	24.9	3.2	88.0	0.4	5.8	2.3	25.8	2.7	0.0	4.2	1.2	1.3	1.2	1.1	0.5	1.0	21.5	1.1	1.1	0.7	18.7	0.1	0.4	0.2	4.4	1.6	0.2	21.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	17.7	17.6	17.4	30.4	17.8	20.2	48.0	24.9	25.8	21.5	18.7	21.0	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
HEPACAM	"FLJ25530, GLIALCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919205-124936412	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 222.6;choroid plexus: 79.7"	"Group enriched"	"Detected in some"	9	"Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"Hep G2: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			15.6	0.3	172.8	0.2	203.3	0.0	2.5	170.4	162.1	0.2	79.7	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	163.2	156.1	0.1	16.2	0.0	0.2	222.6	182.8	0.0	0.0	0.0	0.8	0.0	183.6	0.2	0.2	1.8	0.2	0.5	0.1	0.0	0.2	0.1	205.7	0.0	0.1	0.2	182.0	0.0	0.0	0.3	0.6	0.0	0.1	212.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	172.8	203.3	170.4	162.1	163.2	156.1	222.6	182.8	183.6	205.7	182.0	212.2	0.1	0.0	0.0	184.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	15.5	0.0	72.9	163.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.9;smooth muscle: 82.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 78.0;Distal enterocytes: 211.0;Intestinal goblet cells: 95.6;Paneth cells: 96.9;Proximal enterocytes: 156.2;Undifferentiated cells: 72.4"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.5;HEL: 25.4;HSkMC: 36.0;K-562: 72.5;LHCN-M2: 28.5;SuSa: 68.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA005824	Approved					NA	NA		3700000		"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	8.2	19.1	18.2	14.7	25.0	0.0	8.3	20.8	19.2	23.8	8.7	81.9	79.0	34.7	14.4	11.9	14.2	38.7	36.0	16.7	21.2	8.1	3.5	12.3	3.6	22.3	24.4	22.1	2.3	1.4	3.7	1.3	20.4	24.3	77.6	15.0	7.6	31.8	0.8	4.8	81.6	82.7	18.8	11.1	12.4	3.5	21.7	1.3	5.1	3.2	2.6	19.5	10.1	21.0	0.0	0.0	28.5	2.3	0.0	0.1	0.8	7.3	0.4	0.0	0.0	17.4	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	25.4	0.0	0.0	0.3	0.2	0.1	36.0	0.0	0.0	0.0	9.9	0.0	0.0	72.5	0.6	28.5	0.0	0.0	0.6	14.1	4.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	68.6	0.0	0.0	0.7	16.2	1.2	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	25.0	20.8	19.2	16.7	21.2	22.3	24.4	20.4	18.8	21.7	21.0	2.5	0.0	0.0	78.0	0.5	0.9	0.0	0.0	0.0	1.0	0.9	6.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	211.0	0.0	0.3	0.6	1.3	15.1	4.1	40.8	0.0	0.3	1.1	0.0	12.6	0.0	1.2	0.0	1.1	6.4	0.0	0.2	0.0	2.9	95.6	0.0	0.0	1.9	1.5	11.5	0.3	0.0	6.5	0.0	26.1	0.0	3.5	36.2	5.0	96.9	29.7	0.0	0.3	156.2	0.0	0.7	1.3	6.6	4.4	9.8	0.0	0.3	0.3	0.6	0.0	0.5	6.9	72.4	0.2
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021354-94114208	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 4.5;lymphoid tissue: 9.5;skin 1: 3.8;vagina: 4.5"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 10.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.4;HBEC3-KT: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA031517	Uncertain					NA	NA		260000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	9.5	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388751-176389761	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	146.1	175.6	143.3	87.0	146.2	133.1	113.5	147.2	175.0	104.7	168.0	199.4	118.9	111.7	51.3	130.0	105.0	80.5	318.7	139.8	146.0	182.7	163.3	95.7	132.9	143.9	142.2	118.7	108.7	204.9	125.1	54.6	141.6	127.9	96.3	45.5	163.2	92.7	422.5	140.8	136.6	68.1	145.3	129.3	148.6	66.0	149.0	110.7	114.0	297.9	92.7	152.3	105.2	145.7	104.9	166.6	99.0	172.6	98.5	186.4	262.2	66.6	109.7	164.7	206.4	176.0	202.2	183.3	149.9	107.1	214.2	127.3	146.2	260.6	65.9	424.0	234.0	92.6	161.7	244.7	137.4	149.7	230.1	238.2	213.2	93.7	113.3	126.3	141.7	146.5	104.0	341.5	124.0	315.9	165.3	178.1	124.8	195.5	181.7	157.1	75.6	324.7	265.5	158.7	107.9	141.5	71.4	295.2	310.5	100.7	173.3	233.7	96.8	118.5	124.7	110.2	142.5	165.2	216.6	158.4	150.5	254.1	77.5	284.2	743.6	219.8	391.2	975.8	389.5	618.1	540.1	452.6	930.0	496.0	488.1	464.2	124.6	308.0	1024.9	616.8	621.8	971.3	143.3	146.2	147.2	175.0	139.8	146.0	143.9	142.2	141.6	145.3	149.0	145.7	100.4	73.7	78.6	0.0	212.5	232.2	332.8	358.0	272.0	60.5	225.5	288.5	145.3	174.5	191.0	182.1	12.5	223.0	184.2	415.6	534.1	204.5	83.9	140.0	120.6	110.9	266.6	90.8	0.0	237.3	185.4	129.1	142.2	124.2	130.0	157.0	120.3	217.0	378.7	65.6	0.0	450.7	219.7	458.8	345.2	56.8	140.1	292.1	257.9	0.0	449.7	138.1	230.7	0.0	0.0	110.0	493.0	85.0	184.2	292.6	313.8	542.8	142.3	47.7	118.3	145.9	138.8	96.7	79.4	301.8	225.0	280.2	223.7	182.1	385.3	532.4
HPCA	DYT2	ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 517.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 198.3;Early spermatids: 155.4;Late spermatids: 119.7"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basal ganglia: 1309.6;hippocampal formation: 990.7"	"CAB012340, HPA043245"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	0.2	0.4	99.4	0.0	517.5	0.0	0.1	50.3	322.2	0.7	37.5	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.3	326.8	52.2	0.3	0.2	0.1	0.0	43.0	54.8	0.6	0.5	0.3	1.8	0.0	41.6	0.5	0.4	18.4	0.1	0.1	0.2	0.1	0.4	0.2	54.8	0.1	0.2	3.6	105.8	0.0	0.4	0.0	0.0	0.2	0.4	82.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.4	517.5	50.3	322.2	326.8	52.2	43.0	54.8	41.6	54.8	105.8	82.6	0.1	0.0	0.0	3.6	0.0	0.0	1.4	0.5	0.0	198.3	0.4	0.9	0.4	0.0	0.1	0.0	6.2	0.1	0.1	1.7	0.0	0.3	155.4	0.0	0.4	0.3	18.0	0.0	21.9	0.5	0.3	0.7	0.0	0.1	0.0	0.9	0.0	0.0	0.1	13.5	7.8	2.8	0.0	0.0	0.0	119.7	1.2	0.1	0.0	2.8	0.0	9.1	0.0	4.5	3.7	0.3	5.9	0.4	0.0	1.3	2.0	2.0	0.2	19.3	0.0	0.1	0.5	4.2	8.5	0.1	0.3	0.1	0.0	0.0	2.2	1.4
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFITM2	"1-8D, DSPA2c"	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	303655-309397	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 920.0;NK-cells: 1350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 23410.9"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 23410.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2"									"HPA004337, HPA044731"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		450000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA004337: AB_1851427, HPA044731: "	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	1086.2	307.0	90.3	258.0	90.2	177.0	681.0	89.6	116.6	785.6	101.4	358.6	40.9	702.8	52.1	237.2	903.8	97.4	619.6	92.0	97.9	703.1	1288.5	1069.9	99.9	94.4	89.4	650.1	211.1	112.0	200.6	145.3	94.9	406.1	41.8	27.0	228.9	102.5	195.9	236.7	305.6	200.4	92.8	1402.1	304.3	123.0	95.4	29.8	437.7	132.8	105.8	493.1	496.6	95.1	32.2	65.4	313.1	2.9	137.2	358.3	0.9	106.8	65.1	27.0	63.3	1.7	206.9	2.7	126.6	424.6	0.4	68.5	1.1	9.3	9.0	1.8	41.1	75.1	102.6	117.6	547.7	124.1	494.9	710.9	2.3	5.2	3.3	64.4	51.2	22.5	5.2	210.5	11.6	129.9	2.5	603.3	36.4	5.3	229.4	101.0	29.9	1.1	181.6	0.4	0.8	7.0	65.4	74.9	34.5	5.3	86.7	69.8	338.3	5.7	26.8	36.1	1.4	4.5	5.0	3.3	14.5	485.2	18.1	2706.4	537.4	3789.5	666.6	1421.9	480.8	846.9	590.1	639.5	612.5	799.2	511.7	510.3	23410.9	1225.0	2199.0	279.0	411.7	1376.6	90.3	90.2	89.6	116.6	92.0	97.9	94.4	89.4	94.9	92.8	95.4	95.1	920.0	307.7	540.0	5.9	301.1	104.4	251.1	161.4	215.1	0.3	59.7	66.5	51.8	154.4	209.2	248.3	0.0	8.3	814.7	22.5	487.2	433.0	7.8	67.1	468.6	828.4	9.6	100.7	0.0	256.7	16.9	515.8	30.5	78.5	530.5	68.8	752.1	684.1	223.4	0.0	0.0	39.4	24.4	372.8	255.9	31.5	507.6	645.9	209.9	12.2	177.3	80.5	1350.1	0.0	0.1	161.9	149.2	223.8	123.0	126.3	4.7	45.3	104.8	1.5	315.5	442.5	568.4	8.4	10.4	22.8	83.0	23.4	667.2	61.8	44.3	102.4
IFITM3	"1-8U, DSPA2b"	ENSG00000142089	"Interferon induced transmembrane protein 3"	Q01628	11	319676-329475	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 2128.0;Endothelial cells: 2064.8;Hepatocytes: 2268.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2907.6;non-classical monocyte: 3344.3"	"Group enriched"	"Detected in all"	6	"granulocytes: 2907.6;monocytes: 3344.3;NK-cells: 926.2"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 3222.7;BJ hTERT+ SV40 Large T+ RasG12V: 4076.3;HHSteC: 3609.8;HSkMC: 3476.2"									HPA004337	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA004337: AB_1851427"	"unprognostic (4.17e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (5.78e-7)"	"unprognostic (7.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.19e-1)"	1850.7	745.9	639.0	597.4	667.4	237.0	1281.1	644.9	909.9	1683.7	730.9	1212.1	235.2	1545.6	840.1	484.5	1933.7	702.4	1199.6	643.2	732.4	1299.5	2506.4	1573.4	272.7	745.4	671.4	1262.3	576.3	637.2	493.2	829.2	697.9	885.6	238.9	92.6	555.3	631.7	364.5	511.2	599.9	1121.8	666.2	1241.8	736.0	266.7	728.7	229.3	935.7	426.0	154.9	1203.7	1038.2	649.0	554.1	49.6	1930.0	508.9	952.4	1538.6	44.2	842.4	1638.0	3222.7	4076.3	65.4	1818.6	1.3	873.1	1276.4	826.0	872.0	1.1	619.9	176.8	19.2	57.1	8.1	578.4	570.2	3609.8	5.7	5.2	3476.2	136.1	257.3	561.7	418.1	610.5	5.2	3.1	5.0	290.3	1095.0	2.7	26.3	243.0	2.2	425.3	74.2	185.3	4.8	1741.5	50.1	1.5	3.5	1007.5	170.0	891.9	259.0	41.3	39.7	1130.9	192.1	131.9	180.6	34.8	2.5	3.4	10.3	89.6	7.6	315.3	520.4	740.1	563.7	115.7	2745.9	69.0	82.2	82.6	118.9	396.9	55.6	77.8	109.0	2907.6	926.2	3344.3	31.1	52.9	921.0	639.0	667.4	644.9	909.9	643.2	732.4	745.4	671.4	697.9	666.2	728.7	649.0	1971.3	532.0	709.5	32.0	35.5	317.2	684.3	856.2	1237.9	1.2	207.9	253.1	157.4	539.1	562.1	527.8	2.1	122.2	68.6	94.4	559.6	2128.0	27.3	164.2	1197.8	2064.8	54.1	92.0	0.0	1898.5	635.5	1572.4	103.5	207.0	242.7	223.5	2002.5	2268.4	539.7	0.0	0.1	228.2	132.2	491.4	463.2	102.3	1861.8	713.0	361.1	39.4	130.7	162.4	62.8	0.0	0.5	1135.8	198.3	1060.7	18.7	416.9	54.1	563.8	260.3	7.8	959.8	953.3	1483.2	26.9	12.5	222.4	209.1	125.7	96.6	303.3	263.4	270.6
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324429-33359864	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029226	Approved					NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA029226: AB_2672954"	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	40.8	22.3	14.3	36.4	14.6	30.8	32.3	15.7	15.2	26.3	9.6	28.9	26.7	22.4	23.2	25.2	23.8	30.2	21.2	15.0	16.2	32.0	76.6	29.7	28.8	17.4	15.6	23.5	29.2	40.5	7.7	49.5	16.9	27.2	30.5	23.6	30.2	24.1	32.7	20.5	27.4	24.0	15.7	33.5	31.6	20.9	17.5	33.1	41.2	24.8	29.7	39.8	9.0	18.6	47.3	24.4	27.4	24.2	55.8	80.8	23.7	44.6	74.2	32.9	36.1	31.7	57.2	42.4	35.4	49.4	36.3	28.4	23.3	37.0	43.8	33.8	26.0	62.8	29.0	20.2	33.9	50.8	43.3	58.2	38.4	43.6	37.7	39.4	63.1	40.3	67.6	198.2	56.5	22.8	38.7	22.2	24.9	46.6	25.6	29.5	75.0	62.4	33.7	44.0	22.5	24.1	50.5	42.4	39.3	20.8	58.2	36.8	61.3	39.3	24.7	58.2	28.2	102.3	132.7	43.2	66.3	64.4	50.5	77.3	45.4	27.7	23.6	64.0	23.1	56.2	31.5	28.6	37.4	57.0	37.0	29.0	166.7	28.0	80.3	54.3	41.2	35.2	14.3	14.6	15.7	15.2	15.0	16.2	17.4	15.6	16.9	15.7	17.5	18.6	101.2	109.0	45.8	17.6	69.3	45.8	57.0	72.3	18.8	51.9	42.5	29.7	33.5	34.3	78.8	44.1	29.2	28.1	43.8	25.3	21.5	73.0	17.7	37.9	58.4	75.5	26.9	27.1	26.3	90.5	92.4	61.1	35.7	44.5	39.2	30.3	53.9	81.3	69.2	58.9	29.4	28.9	46.8	82.1	47.5	10.7	32.6	77.6	37.4	30.9	86.8	34.3	42.2	34.2	27.2	64.7	25.5	30.9	137.3	63.9	37.6	28.7	59.6	30.0	19.7	54.9	44.9	38.5	17.5	21.5	44.9	20.1	38.3	25.1	27.5	72.2
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727133-118794535	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.9;eosinophil: 12.2;myeloid DC: 17.2;neutrophil: 29.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 17.2;granulocytes: 29.2;monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 181.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	51.9	34.3	15.9	40.3	16.2	7.1	41.5	18.1	17.3	27.1	20.4	52.1	48.5	31.9	26.2	53.5	35.8	39.3	20.2	14.6	22.3	33.7	120.3	48.9	25.4	26.0	20.3	37.5	22.3	22.2	15.4	32.8	24.6	22.5	61.6	25.6	34.7	27.1	31.4	20.6	60.8	40.6	22.2	29.9	35.8	16.6	19.6	16.0	29.8	55.9	34.5	31.6	27.4	24.6	31.6	37.2	17.4	48.0	39.0	113.5	33.1	63.3	86.2	29.2	37.6	21.8	55.0	0.1	111.4	86.6	84.8	29.1	19.0	26.6	32.3	181.0	16.5	5.1	30.9	55.8	23.4	0.6	13.0	104.1	23.5	40.0	48.8	87.9	61.8	0.0	16.6	3.3	41.9	44.8	0.1	8.5	16.1	57.8	38.6	0.1	43.3	0.2	43.6	32.9	6.5	6.0	102.3	35.5	24.7	22.8	22.8	28.9	79.3	56.7	26.7	99.7	50.5	0.7	16.8	0.3	125.6	16.1	24.6	0.2	10.9	12.2	0.0	2.7	0.1	2.9	0.0	0.0	17.2	2.5	0.0	0.0	29.2	0.1	1.1	2.9	0.1	2.9	15.9	16.2	18.1	17.3	14.6	22.3	26.0	20.3	24.6	22.2	19.6	24.6	36.0	70.5	48.5	1.0	20.2	17.2	37.1	17.2	18.2	2.1	32.4	26.3	11.5	37.1	46.0	29.5	16.7	8.1	2.8	61.9	9.8	36.1	38.1	25.8	34.0	58.8	93.2	4.8	0.3	98.3	31.9	38.7	38.7	27.3	0.0	13.6	78.9	149.0	41.2	0.0	2.0	138.4	16.2	124.8	140.6	7.3	24.2	120.4	21.4	73.1	199.7	43.7	2.1	0.0	6.9	87.9	27.0	18.8	1.3	42.3	70.8	25.2	49.7	11.2	32.9	14.4	26.2	7.5	28.9	37.2	12.1	9.4	2.7	7.1	29.5	30.8
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125843-37175054	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 50.2;placenta: 36.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 50.8;NK-cell: 186.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 186.4;T-cells: 50.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 525.8"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in some"			HPA062657	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	3.2	1.3	2.0	22.4	1.6	36.8	1.9	0.8	2.3	2.2	1.5	5.1	5.5	7.6	2.9	3.5	2.9	6.8	1.9	2.2	1.0	1.0	8.5	12.4	35.7	2.4	2.2	1.6	0.8	0.4	0.6	36.3	1.9	2.3	5.2	0.0	4.3	3.2	0.7	8.9	8.3	2.5	1.7	50.2	6.4	1.5	3.3	14.9	1.8	0.7	24.0	8.0	1.0	1.8	0.4	0.0	1.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	525.8	0.6	1.0	0.0	0.1	0.0	0.0	24.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.7	0.1	4.2	3.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	2.3	0.0	0.9	0.0	0.0	13.2	0.0	0.6	36.2	66.0	0.1	0.4	0.4	0.5	5.4	0.1	0.5	50.8	0.6	27.4	0.4	11.4	28.6	0.1	1.9	3.6	15.0	1.2	186.4	0.5	0.3	24.4	37.3	2.0	1.6	0.8	2.3	2.2	1.0	2.4	2.2	1.9	1.7	3.3	1.8	1.5	3.2	6.8	0.0	3.6	3.2	0.7	0.1	5.7	0.0	1.0	0.8	1.7	0.0	0.6	1.8	0.0	0.6	130.1	0.2	0.0	0.3	2.2	0.5	1.2	1.0	0.0	16.8	0.1	0.2	85.5	1.4	5.6	1.2	10.1	0.1	7.1	1.8	2.3	0.0	0.1	0.1	0.0	5.3	1.7	1.6	0.3	3.7	5.4	0.0	2.0	0.0	388.3	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.1	0.2	0.7	0.0	0.0	0.2	0.9	0.0	0.3	0.5	1.6	1.2	103.6	0.0	0.3	0.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
INAFM1	PRR24	ENSG00000257704	"InaF motif containing 1"	C9JVW0	19	47274885-47275723	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 100.3;Smooth muscle cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 58.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064015	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA064015: AB_2685177"	"unprognostic (3.88e-2)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-1)"	"unprognostic (4.36e-3)"	24.1	65.4	26.3	9.0	25.3	9.0	22.8	23.5	30.3	39.6	29.2	34.5	6.4	32.3	4.8	14.7	31.4	9.8	23.8	27.2	34.7	22.6	18.1	26.0	5.5	31.8	31.6	33.9	27.7	4.6	21.0	6.6	27.8	32.4	3.4	16.1	15.2	9.0	17.0	25.3	15.9	9.3	23.8	18.5	23.0	12.9	31.6	4.9	21.6	4.9	3.3	31.2	26.9	22.1	11.1	10.1	8.8	14.4	2.6	7.7	5.2	12.6	4.2	5.7	7.4	4.9	4.9	5.8	3.9	7.8	4.5	8.0	2.2	5.0	1.4	11.6	13.6	9.3	6.3	7.7	13.1	6.7	13.6	10.9	8.9	5.4	4.8	4.2	2.3	6.4	15.1	12.4	2.3	22.5	5.1	43.1	2.6	11.2	10.1	9.0	3.5	4.8	4.5	6.5	6.6	8.4	13.8	4.3	6.2	2.3	6.1	6.5	5.4	6.5	9.6	3.7	6.7	5.9	5.0	5.5	13.4	4.7	5.8	11.0	15.4	36.3	3.1	11.0	2.5	11.3	3.6	4.3	13.6	8.6	6.6	4.7	58.6	2.9	14.4	16.0	5.0	7.1	26.3	25.3	23.5	30.3	27.2	34.7	31.8	31.6	27.8	23.8	31.6	22.1	23.8	9.6	7.0	7.5	6.3	0.0	43.5	0.0	15.9	16.5	20.7	20.8	9.4	8.6	3.7	11.0	10.4	20.1	3.1	12.6	19.6	11.4	13.5	16.4	100.3	18.3	7.3	18.9	5.0	12.4	15.3	30.5	11.7	16.5	1.3	10.2	11.4	14.8	10.0	3.3	11.6	13.0	0.0	15.9	0.0	22.9	61.8	12.3	0.0	4.7	8.0	5.9	8.2	3.5	2.7	9.6	17.7	25.9	9.0	31.3	28.4	15.4	0.7	48.6	46.0	12.9	73.4	10.3	13.0	10.6	0.0	27.6	6.5	16.2	13.2	49.0
INAFM2	"LINC00984, OGU1"	ENSG00000259330	"InaF motif containing 2"	P0DMQ5	15	40323692-40326715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Early spermatids: 25.3;Hofbauer cells: 19.5;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;granulocytes: 2.6;monocytes: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (1.88e-7)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	11.3	8.4	16.1	9.9	17.9	12.7	7.6	15.5	17.1	8.5	15.2	49.9	6.7	12.2	5.8	8.1	21.3	11.0	28.8	16.4	18.4	7.9	6.7	11.5	5.8	19.3	16.9	10.0	11.5	12.2	10.4	17.6	16.9	10.8	13.4	12.6	9.4	22.5	13.6	6.5	12.9	17.3	18.2	10.7	28.2	10.2	17.0	5.2	26.9	15.0	6.2	14.4	7.8	22.2	18.7	1.8	16.8	10.7	14.2	6.9	38.6	23.0	11.5	18.0	14.8	6.9	3.7	1.6	19.8	12.6	10.6	41.7	26.3	27.1	25.1	5.5	8.8	50.4	6.9	3.9	18.3	27.0	34.3	18.2	9.8	6.7	18.8	26.5	18.7	12.9	27.6	39.6	25.4	2.7	7.9	21.5	12.3	14.5	14.1	3.9	20.2	44.8	13.2	21.3	35.9	14.2	8.2	9.7	8.3	28.6	9.4	33.1	24.5	24.8	18.4	12.6	16.8	10.2	2.7	4.8	18.4	43.5	24.1	0.6	1.0	2.6	0.1	1.1	0.1	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.7	0.1	1.0	1.1	0.2	0.6	16.1	17.9	15.5	17.1	16.4	18.4	19.3	16.9	16.9	18.2	17.0	22.2	6.4	0.0	3.7	3.9	2.3	0.0	1.2	0.0	0.0	7.8	6.8	5.5	18.0	4.3	0.6	3.7	4.2	3.3	3.1	4.3	0.0	2.3	25.3	2.2	3.8	6.0	2.4	1.7	3.4	2.6	0.6	2.4	3.6	2.3	1.3	1.8	12.1	2.7	19.5	8.4	4.5	1.4	0.0	14.1	0.0	4.6	1.2	13.8	0.0	6.5	8.0	6.7	4.1	4.0	1.4	2.3	1.9	4.9	0.4	3.2	1.4	0.8	1.5	4.8	0.0	2.4	9.8	32.4	4.4	1.1	0.0	1.4	1.7	4.9	1.5	2.4
IRAG2	"JAW1, LRMP"	ENSG00000118308	"Inositol 1,4,5-triphosphate receptor associated 2"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 60.3;lymphoid tissue: 202.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.1;B-cells: 6.2;dendritic cells: 42.9;Hofbauer cells: 14.1;Plasma cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 210.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Daudi: 634.3;REH: 221.9;U-698: 722.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA002967, HPA007356, HPA018505"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA		6700	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum, Plasma membrane"		"HPA002967: AB_1079161, HPA007356: , HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	9.6	1.9	8.5	47.2	5.4	60.3	6.5	2.3	5.6	2.4	3.2	10.1	8.7	2.5	2.8	5.2	5.1	7.8	2.4	6.6	2.6	9.4	6.2	7.7	171.7	6.0	4.4	5.7	30.7	1.5	2.4	4.4	6.1	3.4	9.2	1.1	3.6	4.4	1.1	5.8	19.1	4.5	3.6	37.5	10.1	1.0	2.8	95.1	4.9	1.6	202.8	14.5	8.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	634.3	0.3	0.0	0.0	0.2	0.0	2.4	0.0	22.1	0.0	37.8	0.0	0.1	0.0	49.7	54.2	0.0	0.0	0.7	0.0	0.1	0.0	31.5	7.8	40.6	0.0	0.0	54.5	91.2	0.1	0.0	0.0	221.9	0.3	63.8	0.7	29.7	0.2	0.1	0.2	0.3	0.2	0.1	0.0	36.7	0.5	0.0	1.5	0.0	0.1	40.4	7.8	722.4	0.2	21.8	0.0	80.2	21.0	210.1	23.6	40.8	20.2	66.1	14.9	24.2	22.4	51.0	25.5	25.4	151.3	49.0	51.5	20.8	2.7	20.2	8.5	5.4	2.3	5.6	6.6	2.6	6.0	4.4	6.1	3.6	2.8	4.6	13.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787916-52959209	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain					NA	NA		6300000		"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	13.9	22.4	0.6	1.0	0.8	0.0	10.2	0.7	0.9	5.1	0.4	36.6	1.1	16.3	2.5	5.7	9.9	2.2	10.6	0.5	0.8	11.0	17.1	22.1	0.8	0.8	0.8	3.6	3.1	2.1	2.3	5.8	0.8	12.6	2.7	0.1	2.3	7.2	4.6	2.3	12.5	5.8	0.8	27.9	16.6	0.8	0.8	0.2	9.7	2.5	0.4	17.9	5.1	0.9	0.0	0.0	0.3	0.0	1.4	0.4	0.1	0.3	1.3	0.3	0.7	0.7	0.0	0.0	0.1	4.5	0.5	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.3	0.3	4.5	0.0	0.0	0.7	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.5	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.7	0.9	0.5	0.8	0.8	0.8	0.8	0.8	0.8	0.9	264.1	54.5	26.8	2.9	1.7	3.2	4.7	1.5	2.8	1.8	3.6	13.8	12.6	5.7	8.7	5.5	2.1	1.5	2.9	5.5	1.9	3.0	21.3	7.7	41.8	120.5	16.4	5.3	3.6	5.4	16.8	40.2	6.1	22.1	10.1	1.0	77.1	110.5	2.2	0.0	19.5	14.0	0.0	7.2	8.2	6.1	9.3	5.6	7.2	63.7	9.1	0.4	0.0	1.5	4.2	19.6	7.7	8.2	2.9	3.2	6.5	15.1	6.3	2.0	98.6	18.6	143.9	0.9	1.1	0.5	3.1	3.4	46.0	13.6	14.0	2.3
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506459	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 327.2;Basal keratinocytes: 244.7;Urothelial cells: 247.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 144.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.9"	"Group enriched"	"Detected in many"	28	"granulocytes: 22.9;NK-cells: 7.1;T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"BJ: 326.2;HaCaT: 356.8;HBEC3-KT: 705.8;hTCEpi: 298.9;hTERT-HME1: 301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					NA	NA		3300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	45.9	8.3	20.1	27.8	16.7	5.8	55.6	16.6	20.3	64.3	42.8	65.4	74.2	43.1	9.5	25.1	25.3	37.2	29.2	17.2	20.9	42.7	8.8	29.3	18.7	20.8	18.8	5.6	42.0	14.0	6.2	76.8	19.3	24.4	62.4	7.3	81.0	30.8	27.7	46.6	67.4	39.0	20.5	41.2	66.1	26.1	25.0	33.9	21.1	42.6	21.4	55.0	26.8	16.5	77.5	64.8	26.7	49.1	1.4	0.9	146.3	326.2	34.6	32.1	20.0	36.2	141.3	0.7	90.9	86.8	73.8	356.8	17.7	705.8	58.1	0.7	16.6	1.9	64.8	58.7	4.8	21.4	2.4	6.2	298.9	2.0	301.4	32.9	209.6	40.8	0.3	5.5	41.6	3.7	5.9	17.8	48.2	214.2	54.5	1.1	82.3	1.6	48.0	106.6	0.8	3.4	61.2	0.1	69.7	28.0	13.1	1.4	97.9	44.9	41.1	84.2	56.8	4.8	3.6	1.9	1.7	7.2	185.0	4.4	0.2	22.9	5.3	0.0	10.7	0.2	6.7	6.4	0.1	0.5	12.8	5.9	0.7	7.1	0.0	0.0	8.1	4.3	20.1	16.7	16.6	20.3	17.2	20.9	20.8	18.8	19.3	20.5	25.0	16.5	327.2	9.6	19.5	88.5	8.8	244.7	236.4	43.4	88.8	1.4	55.0	72.8	32.5	22.8	10.5	27.6	56.3	103.8	14.4	139.6	5.9	34.4	31.2	82.5	34.8	196.0	57.4	1.7	4.0	62.1	26.5	20.8	219.7	149.3	8.2	103.4	11.7	21.5	25.5	1.7	6.1	128.8	20.3	3.2	20.8	46.8	4.1	10.0	51.6	119.9	1.7	1.3	29.9	1.5	8.8	127.9	104.2	2.6	109.0	184.8	54.5	52.2	9.2	13.9	0.0	11.8	18.4	7.7	20.2	141.5	84.0	22.3	30.1	44.0	146.3	247.6
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 608.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	4.2	1.4	0.3	36.7	0.5	36.8	2.3	0.3	1.0	2.4	0.5	5.5	6.0	2.3	1.0	2.5	3.0	7.0	1.4	0.3	0.4	2.6	10.6	22.0	62.4	1.6	1.1	1.3	1.0	0.5	1.2	3.0	1.4	2.4	8.6	0.0	5.3	1.4	0.9	1.4	19.7	3.6	0.7	64.9	8.6	1.0	1.6	55.2	3.5	0.9	46.4	6.9	2.3	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.1	0.0	1.1	608.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	134.3	0.0	0.0	43.3	3.5	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	26.0	0.0	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.1	3.8	0.0	5.3	24.4	17.0	56.6	48.0	27.7	4.8	21.4	42.7	22.3	1.7	9.4	29.7	14.3	24.2	121.7	6.0	15.6	43.6	0.3	0.5	0.3	1.0	0.3	0.4	1.6	1.1	1.4	0.7	1.6	2.1	1.2	6.4	10.5	0.7	19.1	0.8	0.3	0.0	0.0	0.4	1.2	1.0	1.9	0.0	1.9	1.8	0.0	0.2	118.6	0.3	0.0	0.1	0.5	4.1	0.6	2.3	0.0	4.8	3.6	0.0	0.6	1.4	1.1	0.9	5.1	0.1	5.3	4.9	19.3	0.0	2.8	0.2	0.0	30.0	3.4	0.7	0.0	31.5	1.8	15.9	36.8	0.1	152.4	0.5	1.6	0.0	0.0	0.0	46.6	0.1	0.9	0.3	6.7	0.9	0.0	1.2	0.7	0.2	0.2	0.1	0.3	0.7	84.9	0.1	0.0	0.2
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590056-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RT4: 369.7;SuSa: 297.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	39.9	38.7	20.1	36.5	30.8	6.4	27.7	39.7	23.5	39.7	40.3	20.1	15.9	36.8	10.5	24.5	26.3	47.3	80.0	18.2	32.7	52.1	18.0	25.7	15.8	42.5	33.0	64.7	25.7	82.7	11.9	47.4	46.4	29.8	21.6	80.4	32.1	28.1	16.3	41.4	16.3	56.7	45.3	21.4	34.2	14.7	30.2	18.0	62.6	30.5	21.6	43.1	16.0	54.6	49.1	57.5	37.4	119.9	134.1	90.0	141.7	93.8	75.5	32.5	32.5	50.7	164.0	0.4	179.7	106.3	113.4	60.2	19.3	88.5	46.7	9.7	17.2	11.7	69.1	69.6	52.8	8.3	7.0	65.8	41.3	72.7	61.1	194.1	78.7	5.9	11.6	23.9	87.4	19.4	5.0	6.8	28.3	29.1	28.5	0.1	76.2	6.8	83.5	369.7	7.7	23.0	108.6	33.2	40.1	297.0	26.2	22.4	240.5	199.4	61.9	41.4	80.3	5.9	10.4	5.5	80.3	3.3	100.6	6.2	0.6	0.9	0.4	1.1	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	20.1	30.8	39.7	23.5	18.2	32.7	42.5	33.0	46.4	45.3	30.2	54.6	39.8	28.9	22.9	134.8	4.9	128.4	64.0	127.7	42.7	118.4	50.4	23.4	145.5	80.1	35.3	77.3	77.2	55.1	9.4	32.4	1.9	78.7	0.6	61.7	61.1	47.2	7.3	2.1	36.3	101.8	26.9	65.4	57.6	100.2	49.5	21.2	27.8	18.2	27.6	15.2	35.9	19.9	14.2	44.3	56.7	3.1	19.3	29.3	46.2	75.9	17.4	70.9	2.1	184.5	156.1	165.9	23.8	25.9	9.2	103.4	11.2	32.4	27.0	60.2	32.9	29.0	63.3	1.7	2.4	27.7	103.7	39.7	10.9	18.1	15.5	77.7
IZUMO1	"IZUMO, MGC34799, OBF"	ENSG00000182264	"Izumo sperm-egg fusion 1"	Q8IYV9	19	48740852-48746909	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 18.9"	"Group enriched"	"Detected in some"	44	"Early spermatids: 156.4;Late spermatids: 112.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038104	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA038104: AB_10670655"	"unprognostic (2.03e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.31e-3)"	"unprognostic (6.92e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.0	0.6	0.1	0.4	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	18.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.4	0.3	0.2	2.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	2.9	0.0	0.4	0.0	0.3	0.5	2.0	0.0	1.3	112.7	1.2	0.9	1.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	3.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.2
IZUMO2	"C19orf41, MGC33947, SCRL"	ENSG00000161652	"IZUMO family member 2"	Q6UXV1	19	50152548-50163195	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	283	"testis: 64.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 730.7;Late spermatids: 355.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042143	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA042143: AB_10794078"			"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.31e-2)"			"unprognostic (1.81e-1)"		"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.75e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.2	0.3	0.8	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	730.7	0.1	0.1	0.4	3.6	0.0	1.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.4	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.3	355.2	4.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	3.4	0.0	0.8	0.0	0.1	0.1	0.3	13.1	1.3	0.3	7.0	5.5	0.0	0.4	0.0	0.2	0.0	0.4	1.4
IZUMO3	"bA20A20.1, C9orf134"	ENSG00000205442	"IZUMO family member 3"	Q5VZ72	9	24542952-24545946	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"testis: 13.6"	"Group enriched"	"Detected in some"	35	"Early spermatids: 248.7;Late spermatids: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	248.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"testis: 443.1"	"Group enriched"	"Detected in many"	51	"Early spermatids: 1750.8;Late spermatids: 2537.9;Spermatocytes: 824.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.5;RPMI-8226: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048496: AB_2680419"	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	2.9	1.9	15.2	1.2	15.3	0.5	3.3	15.1	20.9	2.7	15.1	3.0	0.5	2.6	2.5	2.6	5.1	1.9	3.0	14.6	14.4	4.3	5.4	2.1	1.8	15.1	15.7	6.5	8.6	0.8	10.1	0.4	15.2	7.5	0.8	2.9	2.4	2.4	2.6	2.5	2.0	0.7	14.9	1.6	3.9	443.1	15.6	1.7	4.6	1.2	2.2	2.5	2.3	15.7	0.6	0.5	0.3	2.7	1.1	1.2	0.3	0.4	0.6	0.4	0.0	0.2	0.5	0.4	0.6	0.6	0.0	0.5	0.0	2.9	0.1	1.2	0.2	0.0	1.1	0.8	3.2	0.0	0.4	0.5	1.1	0.7	0.8	0.9	0.0	1.5	0.0	8.5	1.1	0.1	0.8	0.2	0.3	1.1	0.7	0.7	0.0	10.9	1.2	0.3	0.4	0.7	0.4	0.9	0.4	0.2	0.5	1.0	0.0	0.3	0.1	0.1	0.2	0.9	1.1	0.8	1.4	0.9	0.2	0.0	0.7	0.6	0.6	1.1	1.5	2.7	2.1	1.6	0.9	0.7	1.7	0.7	1.6	0.5	1.6	1.2	2.2	0.9	15.2	15.3	15.1	20.9	14.6	14.4	15.1	15.7	15.2	14.9	15.6	15.7	1.0	0.0	0.0	31.0	10.3	2.4	4.1	32.8	4.0	3.4	2.5	2.3	1.5	5.7	19.7	9.2	8.4	0.5	2.6	2.0	5.9	2.5	1750.8	4.6	1.9	1.7	7.7	0.4	1.2	5.8	4.5	3.7	1.1	2.3	0.0	2.2	0.7	9.5	1.0	0.0	1.6	1.9	14.2	3.2	8.2	2537.9	28.6	4.3	12.4	0.0	11.3	6.6	1.0	1.5	28.0	1.8	0.7	19.9	8.2	6.8	1.9	11.1	12.1	8.6	6.6	2.6	2.1	824.6	14.3	6.3	1.7	1.6	5.6	2.4	4.4	7.0
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.2;skeletal muscle: 120.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	6.0	1.9	0.5	4.5	0.6	0.1	5.7	0.4	0.7	15.1	0.7	63.3	2.1	51.6	2.9	11.9	30.0	3.5	85.2	0.4	0.5	1.4	0.3	5.2	0.2	1.1	1.1	3.9	0.3	0.1	1.2	3.8	0.8	23.8	4.5	0.2	5.8	22.1	120.4	3.8	11.8	27.5	0.9	1.3	16.0	0.8	0.6	0.1	1.5	48.3	0.1	40.5	10.6	0.7	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.4	0.5	1.1	1.1	0.8	0.9	0.6	0.7	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909905-4918256	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.1"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 15.1;Excitatory neurons: 39.6;Inhibitory neurons: 18.6;Oligodendrocyte precursor cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.2	0.0	10.6	0.0	22.5	0.0	0.3	27.6	50.1	0.6	3.9	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	7.9	0.0	0.0	0.0	0.0	24.9	10.7	0.0	0.0	0.8	0.9	0.0	25.2	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.2	0.1	9.5	0.0	1.2	0.0	24.3	1.2	0.6	0.0	0.0	0.3	0.3	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	22.5	27.6	50.1	21.0	7.9	24.9	10.7	25.2	9.5	24.3	28.2	0.1	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	15.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	16.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	15.8	6.3	12.7	1.2	52.7	1.6	7.3	15.5	17.3	8.4	4.2	4.1	1.7	5.4	12.8	2.2	4.3	2.9	5.5	25.9	11.6	1.8	2.6	3.3	0.9	7.2	12.1	2.9	4.0	2.0	1.8	1.3	7.2	22.4	1.8	12.8	3.9	19.2	2.0	2.2	2.7	2.7	8.4	5.2	1.6	3.1	14.1	1.8	28.7	5.1	0.3	2.9	5.0	15.4	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	12.7	52.7	15.5	17.3	25.9	11.6	7.2	12.1	7.2	8.4	14.1	15.4	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.8;skeletal muscle: 4.0;tongue: 4.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;hTEC/SVTERT24-B: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042316			Uncertain	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	1.1	0.8	3.2	0.1	5.4	1.6	0.5	9.4	2.7	0.2	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.7	2.7	6.6	0.7	0.2	0.4	0.0	6.3	9.8	0.5	0.1	0.0	0.3	0.2	6.9	0.3	0.0	0.2	0.2	0.3	4.0	0.1	0.1	0.1	4.0	0.9	0.1	0.3	7.8	2.3	0.1	4.9	0.0	0.3	0.2	4.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.8	0.3	0.0	0.1	1.0	1.1	0.7	0.0	0.0	1.5	0.2	0.5	2.0	0.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.0	0.9	0.4	0.7	0.3	0.3	0.9	0.2	0.2	0.1	0.4	0.4	0.1	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.2	5.4	9.4	2.7	2.7	6.6	6.3	9.8	6.9	4.0	7.8	4.6	0.1	0.0	1.1	4.6	0.1	0.0	0.0	0.0	1.2	0.0	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.0	3.8	0.1	0.4	1.2	1.4	0.0	0.5	1.3	0.7	1.1	0.0	0.6	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.2	2.1	0.0	1.0	9.4	5.3	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.0	0.1
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;choroid plexus: 15.1;epididymis: 21.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"RPTEC TERT1: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	0.5	4.2	23.5	0.5	26.5	0.0	1.0	19.4	28.3	2.7	15.1	0.7	0.2	1.6	21.6	0.3	1.7	1.8	0.4	21.8	32.6	3.8	0.1	1.0	0.5	24.3	26.6	0.3	1.4	1.3	1.0	1.2	24.7	1.5	0.5	5.8	0.4	5.6	0.1	0.4	0.3	1.1	28.7	1.5	0.4	2.7	32.7	0.1	0.7	0.2	0.4	0.5	0.6	19.6	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.5	19.4	28.3	21.8	32.6	24.3	26.6	24.7	28.7	32.7	19.6	0.0	0.0	0.0	57.8	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	2.0	1.2	0.0	0.0	18.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	50.5	221.4	0.0	0.0	0.0	0.6	0.7	5.0	0.1	0.0	167.7	0.0	0.2	0.0	196.1	2.8	0.0	0.0	11.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 227.4;brain: 139.6;heart muscle: 307.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 54.3;Cardiomyocytes: 135.7;Cone photoreceptor cells: 25.0;Excitatory neurons: 23.3;Horizontal cells: 48.8;Inhibitory neurons: 41.9"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 12.7"	"Group enriched"	"Detected in all"	4	"amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	227.4	6.8	74.5	3.5	139.6	0.9	67.1	48.8	84.5	7.4	40.5	5.0	1.8	4.1	4.1	2.5	4.9	3.1	307.5	98.8	50.6	2.8	2.3	2.5	8.1	47.5	51.6	11.5	2.4	1.7	19.7	2.9	48.1	5.2	4.7	52.6	9.9	3.5	8.0	5.9	5.3	2.6	50.3	5.7	2.7	8.5	57.1	2.3	3.5	5.4	8.3	4.8	4.4	60.8	1.7	2.6	2.5	3.2	1.0	1.1	0.6	1.2	1.0	0.6	0.9	3.6	3.4	1.6	0.9	0.8	0.7	1.7	0.9	0.4	0.6	2.4	2.0	21.3	3.0	1.9	0.9	1.4	12.7	2.6	1.7	1.0	1.4	3.7	1.0	4.7	6.3	1.8	1.0	1.2	0.8	4.0	0.8	0.7	0.6	1.0	0.2	1.4	1.0	1.1	7.4	1.2	0.8	0.6	2.4	1.5	2.2	0.9	2.3	1.3	2.0	0.6	1.2	1.7	1.9	1.7	1.4	5.3	0.2	0.0	0.0	0.7	0.0	0.5	0.1	0.9	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	74.5	139.6	48.8	84.5	98.8	50.6	47.5	51.6	48.1	50.3	57.1	60.8	0.4	0.0	0.0	8.5	2.3	0.4	0.1	0.3	0.0	54.3	0.3	0.5	135.7	0.0	0.1	1.8	25.0	0.2	0.0	0.8	0.0	0.2	6.6	0.0	0.2	1.6	0.0	0.0	23.3	0.0	0.2	5.8	0.0	0.0	0.0	0.8	0.4	0.1	2.2	48.8	41.9	0.4	0.0	0.6	0.8	5.2	1.8	0.3	0.0	1.0	0.5	8.3	0.0	5.5	3.7	0.3	0.2	0.7	0.3	0.1	0.5	0.1	0.2	4.7	0.0	0.1	1.3	2.5	5.5	0.5	0.0	0.3	0.1	0.5	0.3	0.1
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297327-95386077	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.0;Leydig cells: 25.4;Oligodendrocyte precursor cells: 54.8;Peritubular cells: 42.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.8;BJ hTERT+: 18.0;hTERT-RPE1: 23.2;RPTEC TERT1: 35.2;U-138 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	6.7	1.5	21.8	0.8	20.0	0.0	5.4	15.2	31.2	10.7	12.2	9.8	1.2	10.6	3.6	2.4	10.1	1.5	6.0	22.1	16.8	8.4	2.0	2.4	0.4	15.4	17.2	10.1	2.4	27.0	6.4	5.3	15.2	9.3	0.9	0.5	5.6	14.7	1.5	6.0	3.7	5.1	15.3	2.6	5.5	12.2	18.0	24.4	19.7	1.8	0.5	9.0	10.6	19.3	13.8	0.0	0.8	6.1	5.3	4.2	0.0	6.3	18.0	10.1	9.3	0.0	0.0	0.0	0.6	8.3	5.5	0.2	4.0	1.1	4.3	0.0	1.4	0.0	1.8	0.0	2.2	0.0	0.0	2.9	3.6	2.2	10.0	23.2	0.0	1.0	0.0	0.0	0.8	8.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	35.2	0.0	0.7	0.2	0.3	0.3	6.8	0.0	0.3	0.1	0.3	16.3	3.8	0.0	4.9	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	20.0	15.2	31.2	22.1	16.8	15.4	17.2	15.2	15.3	18.0	19.3	0.4	0.0	1.1	13.4	0.5	0.4	0.8	0.0	1.2	8.1	1.0	1.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.2	7.9	0.2	0.6	0.3	3.7	1.0	4.2	0.0	39.0	0.0	0.1	3.5	0.0	0.3	0.0	7.5	0.0	0.5	0.1	0.0	5.1	0.1	0.0	0.0	0.4	1.3	25.4	0.1	7.2	1.9	0.6	0.5	0.0	54.8	3.0	0.2	0.0	42.9	0.0	0.5	1.0	1.5	0.0	0.0	0.0	8.3	3.7	0.1	0.9	0.2	0.9	0.0	0.0	1.5	0.3	0.1
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728606-21948772	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.5;retina: 18.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	0.6	2.2	11.9	1.3	16.4	0.0	0.6	13.8	24.5	11.0	0.0	6.9	1.2	6.2	0.6	4.0	2.5	1.1	0.5	17.8	12.8	8.2	0.2	0.5	0.0	7.0	7.9	1.3	0.5	0.0	4.2	1.0	13.7	0.5	4.1	18.1	0.5	0.3	0.3	0.5	3.8	6.0	4.3	0.3	0.8	0.4	9.0	0.0	6.4	0.0	0.0	1.0	1.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	16.4	13.8	24.5	17.8	12.8	7.0	7.9	13.7	4.3	9.0	10.6	0.0	0.0	0.0	148.2	0.1	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.5	0.0	0.0	14.7	0.0	0.1	0.0	0.3	62.6	0.1	9.8	0.2	2.1	1.6	0.0	0.0	9816.7	0.0	0.0	3.1	0.0	0.2	0.0	12.3	1.1	0.2	0.2	0.0	1982.4	0.6	0.0	0.0	0.0	4.2	0.0	0.5	3.6	119.9	0.6	45.9	0.0	5175.8	91.4	0.0	7.8	0.0	0.0	0.0	0.4	15.2	0.0	12.6	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.1	0.1	14.5	0.7	0.1
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389634	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 59.2;intestine: 75.1;smooth muscle: 53.1"	"Cell type enriched"	"Detected in many"	6	"Peritubular cells: 354.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 5.9"	"Cell line enhanced"	"Detected in some"		"REH: 8.8;SK-BR-3: 2.1;U-937: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	5.7	1.8	2.7	10.5	2.3	1.7	6.9	2.5	2.7	16.8	1.4	75.1	4.3	59.2	6.2	16.6	20.6	7.3	4.2	2.1	2.4	1.4	0.7	4.0	1.7	5.9	4.0	4.0	0.7	0.3	0.5	1.1	6.2	24.5	8.9	1.1	6.8	50.6	1.0	2.9	14.3	53.1	3.4	2.3	21.5	2.7	4.2	1.0	1.4	1.1	1.3	32.6	11.2	3.9	0.1	0.1	1.5	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.3	0.1	1.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	1.2	0.6	0.2	0.0	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.7	0.1	0.7	0.0	0.8	0.3	0.0	0.1	8.8	0.0	0.2	0.0	0.2	0.4	0.2	0.1	2.1	0.0	0.7	0.1	1.0	0.5	0.2	0.3	0.3	0.0	0.4	0.2	0.1	0.1	3.8	0.1	1.3	3.3	0.3	0.1	5.9	0.1	0.2	0.2	0.1	5.7	0.3	0.1	0.1	0.9	0.4	5.1	2.0	0.2	1.0	2.7	2.3	2.5	2.7	2.1	2.4	5.9	4.0	6.2	3.4	4.2	3.9	1.3	0.0	6.3	0.3	1.2	2.0	1.2	0.4	0.0	1.6	2.5	55.1	3.7	4.3	4.5	1.8	6.2	0.5	1.7	0.1	0.0	0.1	0.6	0.6	14.4	3.6	0.0	1.3	0.1	0.4	0.6	9.8	0.0	0.6	19.7	0.4	1.8	0.4	7.4	1.7	0.3	0.2	0.0	18.9	10.9	4.5	38.5	15.6	3.6	4.7	27.8	0.6	2.1	0.0	0.1	0.0	0.0	354.3	0.3	1.3	0.0	0.1	4.5	2.3	46.0	2.2	43.6	0.7	1.2	0.1	1.7	0.5	1.7	1.4	0.0	0.7
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.4;fallopian tube: 13.9;ovary: 12.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.4;SCLC-21H: 3.3"									CAB022649	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.3	5.1	2.5	0.0	3.0	0.0	0.7	1.5	4.0	1.4	0.9	1.2	0.5	2.9	35.4	0.4	13.9	0.5	5.8	4.0	2.3	3.4	0.2	1.1	0.0	3.0	2.7	12.7	4.0	0.2	1.7	0.1	2.3	0.5	0.3	0.2	0.2	1.1	0.2	0.3	0.5	1.9	2.2	1.3	3.0	0.2	2.1	0.0	0.3	0.2	0.0	0.2	0.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.5	3.3	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	1.5	4.0	4.0	2.3	3.0	2.7	2.3	2.2	2.1	2.1	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.1	8.7	0.2	0.0	13.8	0.0	311.8	0.0	0.0	2.7	0.0	1.9	0.0	12.7	1.8	0.0	0.0	0.0	791.1	0.0	4.1	0.0	0.0	0.1	2.8	0.1	0.0	12.2	0.0	0.0	0.0	1982.5	6.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	10.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.1
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.8;HEL: 8.1;NB-4: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	4.9	3.6	1.5	2.2	1.8	1.1	4.6	1.7	1.9	3.5	1.6	4.0	1.5	3.2	1.5	2.0	2.9	1.7	3.5	1.5	1.7	4.8	5.5	3.0	2.2	1.9	1.7	3.2	5.3	1.2	3.3	4.2	1.8	4.2	1.5	2.3	3.1	1.1	1.3	2.4	3.5	1.4	1.3	7.5	3.7	3.9	1.7	0.9	3.2	0.5	1.9	3.7	2.7	1.7	2.2	0.5	0.8	0.0	0.9	0.8	1.3	0.6	0.3	0.9	0.4	4.8	1.9	0.1	2.1	0.4	1.8	0.8	0.0	0.1	1.0	2.7	0.3	8.1	2.6	1.8	0.8	0.1	2.5	1.3	0.4	0.6	0.0	0.7	0.8	0.0	0.3	0.0	1.1	1.5	0.1	5.7	0.0	0.9	1.6	2.4	0.0	0.1	0.7	1.5	1.1	0.2	0.7	0.8	0.5	0.7	2.1	4.4	0.5	0.4	0.7	0.2	0.6	0.7	0.3	2.6	0.4	3.1	0.6	0.8	0.1	0.1	0.3	0.1	0.2	1.2	0.2	0.3	0.0	0.6	0.2	0.2	0.6	1.1	0.0	0.1	0.4	0.0	1.5	1.8	1.7	1.9	1.5	1.7	1.9	1.7	1.8	1.3	1.7	1.7	4.2	0.0	3.6	3.9	2.9	0.3	1.4	0.3	0.0	2.5	2.1	1.3	1.1	2.8	1.5	0.0	14.6	1.2	0.6	3.8	0.0	5.0	11.2	1.5	2.3	5.3	4.9	0.8	3.4	3.6	1.3	1.5	0.5	2.0	2.5	3.4	2.9	1.4	1.1	0.0	4.6	1.4	0.0	2.1	1.9	13.3	2.8	1.4	0.0	5.6	1.4	1.8	1.0	4.0	6.4	3.3	0.8	3.0	0.9	1.7	1.9	0.3	1.1	7.8	6.6	1.6	1.6	2.0	2.6	0.3	0.1	1.2	1.0	2.3	1.4	1.0
KIDINS220	ARMS	ENSG00000134313	"Kinase D interacting substrate 220"	Q9ULH0	2	8721081-8837630	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Neurogenesis		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014790	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA014790: AB_1852460"	"unprognostic (3.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (1.68e-1)"	"unprognostic (9.21e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (9.29e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-1)"	21.2	21.6	20.9	14.5	40.6	24.4	19.6	34.9	27.5	22.3	21.6	19.6	11.4	29.3	15.3	15.1	16.6	17.7	21.9	22.1	28.9	22.1	15.7	23.6	13.1	43.9	31.5	37.7	18.8	42.8	16.9	21.4	43.4	20.0	16.5	38.0	14.5	18.0	14.5	16.7	13.8	23.6	35.7	17.1	16.5	10.6	32.0	21.6	20.0	16.7	12.3	16.7	17.9	73.9	13.5	21.3	41.8	26.8	51.4	33.9	21.9	26.2	21.6	16.4	15.0	21.5	13.5	25.2	26.1	39.4	31.5	22.5	37.9	16.1	24.0	36.4	25.7	22.7	15.9	22.6	36.3	23.6	29.9	35.3	24.9	26.1	33.7	25.1	25.9	21.6	44.7	30.8	29.2	14.8	24.2	12.7	22.7	22.3	18.8	22.7	30.7	12.7	21.7	25.4	35.4	59.3	20.8	20.7	23.6	21.7	13.3	26.6	34.4	36.1	19.0	36.6	28.5	22.4	21.1	33.5	21.1	31.2	28.1	4.1	3.4	4.2	3.6	3.9	2.6	1.9	2.6	3.0	2.7	1.8	2.7	3.1	5.3	3.2	4.6	1.8	2.4	2.2	20.9	40.6	34.9	27.5	22.1	28.9	43.9	31.5	43.4	35.7	32.0	73.9	57.1	99.3	115.7	129.6	25.2	32.8	27.6	25.1	19.9	86.2	31.3	25.0	40.2	25.8	48.6	29.5	139.7	21.5	35.0	33.9	0.0	33.3	1.3	32.3	77.8	51.8	43.3	36.4	108.3	23.6	10.0	55.0	39.8	53.1	35.4	144.0	47.8	30.9	28.8	154.8	149.2	23.4	44.7	52.7	46.0	5.9	69.6	45.9	24.9	60.9	44.2	60.5	34.0	162.3	322.2	29.0	29.8	65.5	27.3	25.7	24.5	10.5	34.4	58.0	6.6	65.4	54.2	28.1	23.4	26.4	29.5	10.9	40.2	52.1	23.9	36.0
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000			"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.3	1.4	0.9	0.8	3.1	0.1	2.5	0.8	1.5	1.8	47.1	2.1	2.7	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.1	128.7	0.4	3.5	1.0	0.5	0.5	0.1	1.2	135.2	0.3	30.4	0.5	8.0	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.6	2.4	2.0	0.5	0.8	0.5	1.3	1.5	0.5	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.1	0.8	1.5	4.2	1.1	0.5	0.5	0.5	0.6	0.8	0.5	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.6;liver: 17.7;pancreas: 6.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000	"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.6	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.2	17.7	1.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.3	2.8	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		25000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.9	1.1	37.4	1.2	43.9	0.0	3.5	0.0	56.1	4.6	0.0	2.2	1.5	4.5	2.2	0.9	2.7	2.1	11.8	49.1	0.0	4.2	0.8	1.0	0.7	0.0	0.0	2.3	2.5	4.1	1.9	6.7	0.0	1.6	0.8	16.2	3.2	2.0	0.8	2.8	1.7	4.6	0.0	3.3	1.4	5.3	0.2	0.3	2.2	1.4	0.3	2.3	2.9	4.6	0.0	2.1	23.9	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.4	0.0	0.4	0.1	30.2	0.0	0.0	0.0	21.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	13.5	0.0	0.0	56.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	1.2	0.1	2.4	4.9	21.6	0.3	0.4	2.1	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	43.9	0.0	56.1	49.1	0.0	0.0	0.0	0.0	0.0	0.2	4.6	2.1	0.0	0.0	271.0	0.0	0.3	0.1	0.0	0.0	21.8	0.7	0.3	7.3	1.5	0.0	0.0	2.1	0.1	0.0	1.8	0.0	0.3	8.6	0.8	3.7	2.3	0.0	0.0	271.6	0.2	0.2	1.8	0.0	0.2	0.0	14.9	4.2	0.0	0.3	132.9	220.5	0.3	0.0	0.0	0.0	16.5	0.3	0.1	3.6	167.7	0.0	51.1	0.0	240.8	324.2	0.2	7.7	0.4	0.0	0.0	0.0	0.0	0.0	19.5	26.3	0.0	21.9	0.2	3.1	0.0	0.1	0.3	0.1	0.5	0.2	0.0
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9;skin 1: 7.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.3	0.0	0.0	3.7	0.0	0.0	2.9	0.0	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.2	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.1	3.0	0.0	1.0	0.0	0.1	7.3	0.4	0.6	0.0	1.3	1.5	0.0	0.1	0.2	1.3	0.2	4.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 290.0"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 598.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Immune cell enriched"	"Detected in single"	1177	"plasmacytoid DC: 117.6"	"Lineage enriched"	"Detected in single"	1177	"dendritic cells: 117.6"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 130.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.2	0.3	0.4	0.0	7.3	2.6	0.5	0.4	0.0	11.2	1.7	1.1	0.0	2.8	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.1	53.1	0.5	0.0	290.0	0.5	0.0	5.1	7.2	0.0	0.2	0.1	5.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.9	0.1	0.3	0.7	20.8	0.1	130.9	0.0	0.0	1.0	0.2	0.5	6.0	0.0	0.0	2.7	0.5	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.5	0.2	0.4	2.6	0.5	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.3	1.2	1.0	1.7	0.5	0.0	0.0	101.2	64.4	0.4	4.3	1.0	0.0	0.0	0.1	81.8	15.2	1.9	0.1	0.5	13.0	1.6	1.0	9.0	0.0	0.1	0.4	0.0	0.4	9.2	21.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	598.0	4.1	0.0	0.9	1.1	0.0	1.4	56.9	0.0	0.6	0.0	0.0	0.0	0.1	0.2	11.8	0.0	0.6	28.4	28.8	0.1	0.4	0.0	0.0	0.0	0.4	0.2	2.8	3.5	0.3	0.0	0.6	0.0	24.3	3.7
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 15.0"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 19.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 105.4"	"Low region specificity"	"Detected in all"			HPA014053	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.4	0.5	4.7	1.0	2.8	0.0	0.1	0.8	3.5	0.1	0.0	0.5	0.3	1.8	0.0	0.0	0.3	0.2	0.3	4.1	6.7	0.3	1.2	0.2	2.1	15.0	11.7	0.0	0.2	0.0	0.0	0.9	3.7	0.0	0.5	0.1	0.6	0.0	0.3	0.1	0.4	1.0	8.4	1.3	0.1	0.2	5.9	0.9	0.1	0.3	0.5	0.0	0.0	6.8	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.8	0.8	3.5	4.1	6.7	15.0	11.7	3.7	8.4	5.9	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.4;salivary gland: 12.8"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.5	0.9	6.4	0.3	13.4	0.0	0.1	0.0	10.0	2.2	0.0	3.7	0.6	0.6	0.3	0.3	1.2	0.2	1.3	16.3	5.2	0.3	0.4	0.1	0.0	0.9	9.4	0.3	0.1	0.0	1.9	0.0	2.0	1.0	0.3	0.4	12.8	1.2	0.0	0.1	1.3	0.3	0.2	0.0	0.7	0.2	22.4	0.0	1.6	0.1	0.0	0.6	0.8	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.4	0.0	10.0	16.3	5.2	0.9	9.4	2.0	0.2	22.4	4.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRRTM4	FLJ12568	ENSG00000176204	"Leucine rich repeat transmembrane neuronal 4"	Q86VH4	2	76747685-77593319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.6;retina: 6.8"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 3972.6;Inhibitory neurons: 2310.6;Oligodendrocyte precursor cells: 3758.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	10	"Karpas-707: 125.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.72e-4)"	"unprognostic (7.20e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.93e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.77e-3)"	"unprognostic (3.54e-2)"		"unprognostic (7.99e-2)"	0.4	0.6	5.8	0.3	11.4	1.7	0.2	0.1	17.6	0.4	0.0	0.5	0.8	0.4	1.5	0.8	0.2	0.7	0.1	13.5	1.6	0.2	1.3	0.8	0.4	0.2	4.1	0.6	0.5	0.0	1.0	0.9	1.2	0.6	0.5	6.8	0.9	1.5	1.6	0.8	0.5	0.3	0.0	0.5	0.6	0.3	0.0	0.1	0.7	0.3	0.2	0.3	0.5	14.5	1.4	1.7	0.9	0.8	0.0	0.0	0.9	0.3	0.0	0.0	0.0	2.1	0.5	1.0	2.2	0.8	0.7	0.8	0.2	0.0	0.3	0.8	2.5	0.5	4.8	3.1	0.4	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.5	125.8	0.0	2.8	0.5	0.7	12.2	0.2	1.2	0.5	0.1	2.6	0.0	4.1	3.7	1.4	0.8	0.7	0.8	2.0	1.4	0.9	0.0	2.9	3.7	0.1	0.2	0.0	2.4	0.1	2.8	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.1	0.0	0.1	0.0	5.8	11.4	0.1	17.6	13.5	1.6	0.2	4.1	1.2	0.0	0.0	14.5	0.0	0.0	0.5	208.6	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.3	0.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	1.1	0.4	0.2	0.4	0.0	0.0	3972.6	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	2310.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	84.3	0.0	2.8	0.0	3758.4	176.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.7	2.3	6.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 95.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7;Gastric mucus-secreting cells: 87.7;Inhibitory neurons: 77.8;Late spermatids: 118.5;Suprabasal keratinocytes: 69.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 64.8;LHCN-M2: 102.3;NB-4: 34.7;RT4: 54.7;SK-BR-3: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"			"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.3	0.2	3.5	0.4	2.5	0.2	16.4	1.6	5.3	2.8	1.6	1.7	2.6	0.9	1.2	4.1	23.4	37.3	0.0	4.3	4.1	20.5	0.9	1.7	0.4	2.3	7.3	0.4	12.3	16.1	0.4	0.8	3.0	11.1	3.3	1.0	5.8	15.2	0.2	95.5	1.2	0.3	1.9	2.8	41.3	34.1	8.0	0.3	0.2	0.0	1.9	14.2	6.3	2.1	1.4	0.0	0.0	1.5	0.0	0.1	0.1	8.0	1.5	6.6	2.5	1.0	0.0	0.0	0.0	64.8	0.0	14.0	1.5	1.3	20.6	0.0	7.4	0.0	1.9	0.0	0.2	0.0	0.1	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	102.3	24.3	0.0	34.7	2.0	14.6	0.3	0.0	0.4	4.3	3.2	54.7	3.9	0.1	0.4	32.1	0.0	6.3	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	13.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	2.5	1.6	5.3	4.3	4.1	2.3	7.3	3.0	1.9	8.0	2.1	0.5	0.0	2.0	2.3	5.5	29.8	21.0	30.6	6.2	0.0	23.4	17.1	1.4	42.9	23.9	46.0	0.0	0.1	0.1	4.0	7.9	12.4	245.7	5.2	0.3	1.0	2.4	2.7	4.6	19.1	0.7	0.8	87.7	5.7	0.0	0.4	0.0	0.1	0.1	0.0	77.8	3.9	8.2	0.0	2.8	118.5	2.1	0.4	5.4	0.0	0.6	0.0	0.0	0.0	0.4	30.9	6.0	0.0	4.5	40.6	5.7	0.2	21.4	0.0	0.0	0.0	1.3	4.2	1.7	3.5	69.0	0.3	1.1	0.0	3.5	53.7
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 38.8;Exocrine glandular cells: 62.3;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	8.5	15.0	11.2	5.3	10.8	28.4	8.7	19.9	14.9	8.6	12.8	8.5	6.2	7.9	12.5	16.1	6.9	7.4	8.4	10.9	11.2	11.8	26.3	8.3	7.8	10.6	9.9	16.2	24.9	9.2	8.9	6.8	11.1	12.3	7.8	11.0	16.3	7.9	30.3	9.6	9.0	7.4	10.5	8.7	11.7	14.1	10.0	11.4	12.4	15.2	9.0	7.3	9.6	12.7	8.6	3.6	9.3	18.0	16.4	10.1	4.3	9.0	11.1	9.2	8.6	2.6	11.0	20.1	10.1	11.9	5.2	8.0	8.8	9.2	10.4	9.4	7.9	26.8	5.7	7.7	9.3	10.1	15.3	10.3	13.3	12.5	8.9	9.7	11.6	12.4	15.8	7.5	9.3	5.0	19.0	13.8	13.2	10.1	7.1	12.1	11.0	15.0	15.0	3.7	15.2	15.5	7.5	19.3	10.9	7.3	7.7	14.3	13.8	9.3	6.2	12.9	6.2	12.1	7.2	10.6	10.5	13.1	7.9	0.5	0.3	1.6	0.3	0.2	0.5	0.4	0.5	0.5	0.2	0.5	0.4	0.7	0.1	0.3	0.3	1.1	0.3	0.2	11.2	10.8	19.9	14.9	10.9	11.2	10.6	9.9	11.1	10.5	10.0	12.7	31.3	19.2	23.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	27.8	17.8	0.0	0.0	11.2	7.3	0.0	13.7	27.0	0.0	5.9	38.8	0.0	19.4	23.8	12.9	0.0	0.0	0.0	62.3	22.7	9.2	0.0	32.5	10.1	26.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	48.6	0.0	0.0	9.8	0.0	0.0	19.6	13.8	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	10.4	11.0	22.7	0.0	0.0
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017055-79453667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in many"	7	"Astrocytes: 1765.2;Excitatory neurons: 2453.9;Inhibitory neurons: 2438.2;Oligodendrocyte precursor cells: 1208.9;Oligodendrocytes: 4001.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 7.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	4.0	5.9	11.9	1.1	16.4	0.8	3.1	0.0	27.1	4.3	0.0	3.8	1.8	4.1	3.6	2.1	3.9	3.0	2.6	14.1	0.0	5.3	1.4	2.8	0.7	0.7	1.3	8.2	3.3	12.5	6.9	1.2	0.0	8.5	1.6	11.6	1.6	8.1	1.9	1.3	2.0	2.5	0.0	1.9	2.2	3.6	10.8	0.6	6.5	2.3	0.4	4.4	3.0	17.0	0.1	0.6	19.5	0.3	4.0	6.2	0.3	3.5	6.4	0.7	1.0	0.1	0.3	0.1	0.1	2.2	2.6	0.3	1.1	0.1	0.9	1.0	0.8	0.3	0.5	1.1	5.8	0.5	1.0	4.7	0.3	0.4	0.2	3.6	0.9	0.7	0.6	81.9	1.7	0.8	0.2	0.4	4.3	0.7	0.2	0.3	0.2	1.4	0.2	0.3	2.9	4.9	0.8	0.3	1.9	2.9	0.4	0.6	1.1	2.8	1.0	7.6	0.5	0.4	0.0	0.2	1.8	0.1	1.2	0.8	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.9	0.2	0.2	0.3	0.1	0.0	11.9	16.4	0.0	27.1	14.1	0.0	0.7	1.3	0.0	0.0	10.8	17.0	7.9	9.6	12.5	1765.2	0.3	1.0	1.3	0.6	6.2	29.3	3.2	6.7	7.5	4.3	3.3	1.8	20.9	0.4	0.7	1.6	5.9	0.4	25.1	9.1	18.3	5.8	2.4	0.0	2453.9	1.0	0.1	11.0	0.5	4.5	0.0	11.6	2.2	2.0	0.2	47.1	2438.2	1.6	0.0	0.0	0.3	32.5	6.5	1.0	1.8	327.9	0.0	24.5	0.0	1208.9	4001.5	0.4	1.5	19.9	0.5	3.5	1.1	1.7	2.1	23.3	13.1	11.0	12.8	4.8	0.9	1.3	1.0	0.4	0.7	8.9	1.4	0.7
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MARCHF2	"HSPC240, MARCH-II, MARCH2, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	65.7	33.0	102.2	20.3	101.5	29.4	49.8	99.5	106.6	24.2	66.4	96.2	15.7	34.4	53.9	32.4	27.1	15.3	101.1	90.9	94.3	35.6	59.1	41.9	19.5	113.7	102.5	15.8	19.2	15.3	30.5	19.8	106.0	40.8	14.0	9.1	25.5	28.8	89.5	34.5	31.4	30.1	109.2	51.2	32.9	18.9	105.1	14.2	47.9	48.6	14.5	49.8	26.1	96.7	11.4	14.2	6.3	29.5	37.9	12.6	10.7	12.3	14.7	9.5	9.8	7.0	5.5	4.4	34.8	26.7	12.6	8.1	8.2	17.5	7.3	22.7	20.3	34.2	6.6	15.9	20.5	5.0	49.6	14.7	20.1	9.2	8.1	13.9	38.2	17.8	4.9	24.5	7.5	21.5	7.0	16.7	13.3	14.0	34.2	11.0	2.0	11.4	22.4	13.9	3.1	17.7	0.8	12.9	24.2	21.5	10.2	10.8	38.9	13.3	8.4	44.5	10.4	21.7	28.2	5.0	21.6	10.2	10.7	52.6	18.5	31.3	10.6	28.6	10.8	7.2	10.6	8.6	13.1	7.3	7.2	9.6	23.4	7.9	25.7	51.8	14.9	17.4	102.2	101.5	99.5	106.6	90.9	94.3	113.7	102.5	106.0	109.2	105.1	96.7	23.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	8.1	9.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	5.7	1.5	0.0	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"intestine: 363.9"	"Cell type enriched"	"Detected in some"	42	"Proximal enterocytes: 231.8"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		310000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 45: Enterocytes - Digestion"			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.3	0.0	0.0	8.2	249.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	363.9	0.3	0.1	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.9	0.0	3.8	0.0	0.1	0.2	231.8	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.1
MICOS10	"C1orf151, FLJ36999, Mic10, MINOS1, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial contact site and cristae organizing system subunit 10"	Q5TGZ0	1	19484403-19629821	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 453.9;Cytotrophoblasts: 283.4;Extravillous trophoblasts: 279.7;Hofbauer cells: 531.0;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059930	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	4.9	5.0	11.5	3.1	11.6	2.6	6.0	11.9	13.6	8.6	11.0	9.3	5.1	7.0	6.2	7.2	7.3	4.1	12.6	11.5	13.1	9.7	4.0	4.6	4.3	12.9	11.7	6.4	5.2	11.1	9.5	4.0	13.1	8.5	8.8	5.9	5.1	8.3	14.3	4.8	6.0	7.0	11.3	3.6	6.7	3.4	13.8	4.0	6.5	16.8	5.9	7.0	6.2	11.1	10.0	13.3	7.3	8.4	13.7	13.6	4.5	8.3	9.6	9.5	10.1	9.3	8.7	8.1	6.8	11.0	7.7	6.9	12.8	10.9	15.2	12.7	9.1	7.1	21.2	13.0	6.0	11.6	5.1	10.7	17.5	9.5	11.6	7.4	14.1	6.0	15.8	5.9	14.4	17.2	5.8	15.0	6.2	12.5	16.7	5.7	9.3	10.8	23.3	5.9	15.4	6.7	9.6	7.4	7.1	5.7	7.1	6.7	9.3	7.4	5.7	9.5	8.3	3.8	6.8	8.4	5.8	21.3	7.1	3.8	4.8	5.7	3.6	6.6	3.3	4.3	4.9	4.1	5.1	4.1	6.3	4.5	3.2	2.3	7.0	5.0	4.9	5.9	11.5	11.6	11.9	13.6	11.5	13.1	12.9	11.7	13.1	11.3	13.8	11.1	63.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.9	0.0	0.0	0.0	0.0	283.4	25.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	279.7	52.8	0.0	0.0	0.0	0.0	0.0	0.0	531.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	183.5	5.3	0.0	0.0	0.0
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	30.9	55.3	34.4	21.2	37.2	34.2	26.4	51.4	47.1	28.8	27.8	30.1	37.4	36.5	23.8	20.7	34.6	32.3	43.9	37.8	32.2	105.3	116.7	29.6	20.1	32.2	30.7	41.6	20.0	43.3	24.4	23.6	33.7	24.8	32.9	31.5	20.8	22.3	72.2	29.0	32.7	38.4	29.0	27.0	43.3	20.2	30.4	26.1	22.9	76.9	21.6	30.8	21.7	34.1	42.2	71.8	45.4	53.3	70.8	66.6	20.6	45.8	101.6	65.7	89.8	42.2	77.2	56.8	37.3	63.5	54.0	49.1	57.7	40.7	76.9	51.9	46.6	38.3	37.1	61.2	56.4	53.3	40.1	66.6	36.2	72.4	66.5	90.4	57.7	53.4	60.0	64.5	77.6	37.9	46.7	49.9	19.0	45.0	17.3	50.5	60.9	37.4	80.8	31.0	34.8	49.8	54.2	65.9	42.0	45.2	39.3	50.5	36.2	32.6	50.1	65.7	38.4	33.9	62.6	39.2	65.1	69.6	22.5	21.5	60.0	110.8	16.8	49.8	14.7	15.1	14.7	15.5	26.0	17.5	14.4	12.0	48.8	15.2	54.5	16.5	15.3	35.4	34.4	37.2	51.4	47.1	37.8	32.2	32.2	30.7	33.7	29.0	30.4	34.1	30.4	54.5	36.0	47.7	23.4	9.9	16.0	22.6	14.2	31.9	25.3	19.6	35.8	25.8	38.3	35.0	20.9	20.7	16.9	25.9	80.3	35.6	10.7	42.0	43.0	22.7	14.4	25.0	185.5	26.7	18.8	31.1	45.9	48.2	18.3	31.5	23.9	60.4	34.8	16.8	205.9	24.4	16.2	36.9	13.4	12.5	26.8	40.1	12.4	64.6	38.0	51.3	10.3	146.8	97.5	51.4	24.9	25.9	25.0	10.7	29.3	110.7	34.0	33.8	6.6	29.0	27.2	54.5	40.0	14.2	14.2	21.5	19.0	73.4	23.6	14.2
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604181	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	22.6	44.4	19.3	24.5	21.0	36.3	32.4	23.9	29.7	26.2	24.2	37.6	26.5	22.1	27.8	23.2	25.1	20.2	57.5	20.4	20.4	76.3	32.2	23.0	26.9	21.8	20.6	22.7	21.3	45.9	27.0	24.5	20.2	28.5	34.1	45.7	23.4	22.1	56.4	22.9	27.4	21.1	20.8	22.6	30.6	27.0	19.7	28.8	37.6	61.5	29.7	23.5	18.7	24.2	35.2	20.0	46.2	29.6	40.4	53.8	39.7	58.3	47.5	60.8	42.0	29.0	55.6	54.4	36.8	56.0	31.3	45.9	45.9	49.1	83.4	55.5	46.5	94.2	20.5	34.3	48.7	71.4	52.7	46.8	47.7	34.5	24.4	54.4	41.2	50.5	33.9	23.9	100.3	30.8	47.9	68.1	31.5	123.2	30.3	51.9	117.2	36.6	121.3	28.6	36.9	28.6	39.8	46.4	39.6	40.2	45.3	66.7	51.1	26.4	23.6	54.1	48.9	17.7	24.8	39.6	26.1	59.0	66.8	34.0	24.8	35.1	30.6	30.5	28.0	42.1	26.9	30.9	27.3	24.4	23.7	30.2	23.3	30.2	25.6	25.1	40.3	23.9	19.3	21.0	23.9	29.7	20.4	20.4	21.8	20.6	20.2	20.8	19.7	24.2	22.0	38.5	26.8	70.2	51.3	30.0	39.8	51.9	26.2	27.1	24.0	17.8	74.5	30.0	46.8	51.5	22.9	60.7	31.8	52.2	144.8	43.3	40.7	39.7	28.4	24.3	30.5	65.2	126.1	27.2	42.6	32.0	27.0	28.7	24.7	26.5	17.9	24.0	36.5	42.1	142.5	25.7	57.0	28.8	22.1	16.2	33.8	28.5	48.0	55.3	43.1	63.9	43.3	77.9	121.7	36.9	51.7	36.1	29.3	27.8	31.3	108.4	56.0	49.0	59.2	37.6	30.7	86.9	48.5	23.0	25.6	70.3	45.5	47.4	34.2	30.0
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632163-1635263	"Enzymes, Predicted intracellular proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.9"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 11.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 7.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	7.1	2.8	0.4	0.3	0.5	1.3	4.1	0.1	1.0	16.7	0.0	5.0	1.9	15.4	0.0	2.8	11.0	2.9	15.0	0.3	0.0	3.2	3.3	14.3	1.1	0.4	0.0	29.9	1.6	0.0	5.7	2.8	0.1	11.8	0.1	0.1	1.0	1.1	0.5	3.1	3.4	1.2	0.0	3.0	4.3	5.2	0.1	0.0	2.4	0.0	0.1	11.9	10.9	0.2	0.6	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.2	1.2	4.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.4	0.0	0.2	2.7	0.0	1.9	0.9	0.0	1.1	0.0	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.3	0.0	3.9	0.2	1.1	0.0	0.2	0.1	0.0	0.2	0.0	1.5	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.0	0.7	0.1	2.2	0.1	11.3	0.3	1.7	0.4	0.5	0.1	1.0	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.2	2.2	0.0	0.5	1.0	1.1	13.4	0.8	0.7	0.6	1.3	1.7	1.5	9.6	1.5	0.4	1.8	0.0	4.0	27.4	3.0	0.0	1.2	1.0	4.0	3.5	2.2	3.0	2.7	0.3	0.5	2.2	90.5	4.6	1.0	0.0	1.4	12.1	1.0	5.7	3.3	0.6	1.9	4.1	1.0	18.5	6.2	98.2	1.3	19.6	0.0	1.2	0.5	64.9	0.0	0.2	4.3	0.9	177.9	4.3	0.5	2.7	1.0	0.5	7.7	0.0	0.7	5.3	2.1	10.5	0.7	15.8	10.3	8.1	2.1	1.7	0.9
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668779-110806558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.2;skeletal muscle: 4.1"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 4.8;Leydig cells: 5.3;Oligodendrocytes: 17.0;Peritubular cells: 19.5;Skeletal myocytes: 23.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"LHCN-M2: 24.7;RH-30: 23.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.0"	"Not detected"	"Not detected"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	0.1	0.2	1.5	1.7	3.0	0.0	0.0	0.8	1.5	0.0	1.6	1.9	1.1	0.0	0.0	1.4	0.0	1.1	1.5	1.2	1.1	0.0	0.3	1.0	0.6	2.7	6.2	0.1	0.1	0.0	0.0	0.3	1.7	0.2	2.5	0.0	0.1	0.0	4.1	0.1	2.4	0.5	2.9	0.0	1.3	1.6	2.0	0.1	0.0	2.0	2.0	1.2	0.0	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	0.8	1.5	1.2	1.1	2.7	6.2	1.7	2.9	2.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	5.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	17.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.1	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	25.8	62.4	19.7	16.2	18.5	33.3	22.3	18.6	25.2	23.1	13.9	36.5	31.1	25.9	4.3	31.0	23.4	6.9	28.0	22.2	15.7	29.5	59.8	33.1	12.7	20.4	18.8	22.0	53.6	11.0	23.5	7.5	18.6	28.9	8.7	3.5	22.9	8.0	29.2	25.8	35.8	8.6	17.4	42.8	29.7	21.8	21.1	8.6	24.4	10.5	6.6	26.3	21.7	17.5	70.8	74.2	21.6	60.3	20.3	15.4	55.4	84.5	33.2	57.5	45.5	103.6	36.8	43.3	67.0	49.4	37.8	87.2	24.7	57.1	12.7	57.4	61.3	31.7	46.2	73.2	41.1	56.8	51.3	29.0	36.2	46.4	24.7	15.2	31.7	41.7	84.1	41.4	25.6	59.3	48.9	64.1	59.3	43.2	63.6	77.8	23.2	71.9	36.5	42.6	45.3	47.1	31.1	56.2	50.3	10.3	38.3	61.9	47.6	45.4	45.8	77.3	100.4	59.0	58.1	36.0	51.1	71.5	72.7	1.4	13.4	9.8	7.1	13.1	5.8	5.4	4.3	7.9	9.2	4.5	4.6	6.2	7.6	4.8	5.6	18.8	4.2	9.6	19.7	18.5	18.6	25.2	22.2	15.7	20.4	18.8	18.6	17.4	21.1	17.5	15.3	16.0	14.7	12.1	19.8	8.3	9.4	18.2	5.7	15.1	15.6	11.9	10.2	15.7	14.8	11.0	10.4	20.4	26.0	71.0	3.9	31.0	15.0	11.3	15.6	14.3	12.6	12.4	13.6	37.4	49.3	14.9	30.5	17.4	15.9	31.1	12.8	43.8	39.3	23.5	14.6	41.2	14.2	18.8	9.2	49.1	9.3	18.1	14.2	8.4	19.2	5.8	14.4	9.0	10.3	35.8	45.3	9.1	51.7	22.0	75.7	11.7	10.5	13.2	13.1	11.8	16.9	13.6	20.1	12.4	12.5	17.0	12.0	115.1	72.7	14.2
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"NEDD4 E3 ubiquitin protein ligase"	P46934	15	55826922-55993660	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.6;tongue: 58.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA		6500	"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	6.2	3.6	1.7	4.0	2.0	6.2	6.9	1.9	2.0	5.4	1.9	5.7	4.1	7.1	2.9	4.3	3.5	5.6	4.5	1.5	2.7	6.7	27.4	5.3	3.1	2.5	1.9	4.0	1.8	5.4	2.1	15.6	2.6	5.5	4.4	4.5	3.1	7.6	67.6	9.2	8.1	8.0	2.0	4.9	3.4	1.8	2.2	5.6	7.1	58.1	3.0	5.6	4.4	2.6	21.5	32.8	9.0	8.8	11.5	18.5	14.1	40.0	62.9	29.1	28.5	14.5	6.3	4.8	10.4	15.4	70.2	34.6	9.7	26.3	48.2	11.1	5.6	26.1	7.2	7.9	59.0	10.6	2.3	30.8	64.7	35.2	58.9	14.2	24.3	14.9	11.5	0.0	86.4	10.7	15.2	0.1	2.2	10.9	5.1	10.5	67.5	3.1	11.9	42.3	0.7	5.1	17.4	12.5	15.7	15.8	15.2	8.8	84.5	63.9	20.6	13.5	66.0	3.4	8.1	12.3	42.0	24.6	15.7	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	1.7	2.0	1.9	2.0	1.5	2.7	2.5	1.9	2.6	2.0	2.2	2.6	35.9	93.0	116.7	28.4	1.6	12.1	3.4	5.5	8.6	0.7	4.6	8.0	5.7	7.2	44.8	0.0	22.9	23.2	2.0	5.2	1.9	3.3	1.7	1.7	13.3	31.1	0.0	17.5	4.2	5.8	7.5	18.5	5.1	1.6	73.2	4.2	17.5	20.5	4.7	0.0	11.9	4.0	2.0	2.2	2.3	1.6	5.6	8.8	1.8	30.0	1.1	8.6	6.2	69.9	28.7	2.9	0.8	7.2	1.9	4.5	25.8	13.4	75.5	6.7	0.0	11.5	17.7	5.3	7.2	7.1	10.4	13.8	9.4	4.8	5.6	1.9
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 21.9;retina: 34.6"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 206.4;Excitatory neurons: 307.1;Inhibitory neurons: 345.9;Oligodendrocyte precursor cells: 172.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Group enriched"	"Detected in many"	41	"amygdala: 6.6;basal ganglia: 12.4;cerebral cortex: 21.9;hippocampal formation: 17.5;white matter: 16.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 21.9;REH: 20.6;RPMI-8226: 32.7;RT4: 24.7;SCLC-21H: 26.9;U-2 OS: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064630			Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA064630: AB_2685305"	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	1.2	0.0	6.6	0.3	12.4	0.1	1.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	17.5	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	34.6	0.2	0.0	0.0	0.3	0.5	0.0	0.0	3.1	0.2	0.8	0.2	0.4	0.6	0.0	1.2	0.1	0.0	16.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	8.7	0.0	0.0	20.6	0.0	32.7	4.0	24.7	26.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	12.4	0.0	21.9	17.5	0.0	0.3	0.0	0.3	0.0	0.2	16.3	2.0	0.0	0.0	16.6	6.1	0.0	0.0	0.0	0.0	206.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	307.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	17.8	0.0	2.2	0.0	172.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143945	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;lymphoid tissue: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	2.7	7.2	6.1	6.4	19.8	2.4	2.8	3.6	9.3	1.6	1.0	8.5	1.6	2.2	0.6	6.1	0.8	4.8	2.6	4.1	8.3	2.7	0.7	5.9	6.3	6.9	0.8	1.6	2.5	10.7	1.2	3.4	6.4	1.1	2.4	7.5	2.7	1.2	4.4	1.8	2.8	1.6	1.7	22.7	2.2	8.0	3.5	5.4	8.8	2.2	6.2	4.9	2.9	4.2	86.8	94.4	133.9	0.3	19.3	111.6	22.2	84.0	13.2	72.9	39.3	19.9	54.0	21.3	50.4	18.0	70.2	37.9	86.4	83.6	89.0	0.3	55.7	17.2	32.8	21.3	23.9	55.8	43.7	67.9	54.7	29.5	41.2	70.5	49.2	50.5	25.9	25.7	47.4	23.5	31.9	30.4	64.7	25.8	68.8	0.1	26.2	43.0	51.4	18.3	87.8	63.5	110.9	8.6	12.5	21.8	1.7	40.3	24.1	0.1	0.3	0.1	0.5	27.5	24.7	47.6	58.9	38.9	59.6	0.3	0.9	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.1	6.1	19.8	3.6	9.3	4.1	8.3	6.9	0.8	6.4	1.7	3.5	4.2	4.9	0.0	4.5	4.6	6.5	7.8	0.6	10.4	13.1	2.2	5.2	8.9	1.3	0.0	3.6	0.0	0.0	1.4	2.1	15.9	0.0	0.4	3.1	2.1	4.0	10.6	10.8	0.4	96.5	3.1	0.5	4.9	1.5	0.9	2.5	18.0	2.9	0.4	6.6	0.0	176.6	2.6	6.1	11.4	14.6	5.7	0.6	16.6	3.6	8.4	7.3	39.9	1.0	79.4	3.1	1.3	1.5	0.0	13.7	4.9	2.9	0.1	2.4	1.6	6.6	5.3	3.6	17.9	22.2	18.8	3.3	0.8	5.2	98.7	2.8	1.4
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239887	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;brain: 19.9;skeletal muscle: 19.4;tongue: 11.9"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 43.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.1	24.2	8.1	0.2	15.6	0.0	0.4	17.3	11.6	0.3	3.1	0.3	0.1	0.6	3.4	0.6	0.1	0.0	0.0	11.5	10.6	0.2	0.0	0.0	0.0	17.9	16.4	0.1	0.2	0.6	2.2	0.3	19.9	1.0	0.1	1.5	0.4	0.3	19.4	1.7	0.1	0.2	6.8	0.0	0.1	0.3	12.2	0.2	0.0	11.9	0.0	0.0	0.5	18.6	0.0	0.4	21.2	35.8	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.7	0.4	0.4	0.0	5.3	0.0	0.1	0.0	1.5	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.8	92.7	0.0	0.9	0.0	0.3	0.1	0.1	3.6	27.3	43.9	1.0	0.3	2.5	2.4	9.6	0.4	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	15.6	17.3	11.6	11.5	10.6	17.9	16.4	19.9	6.8	12.2	18.6	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.9	0.2	0.0	0.1	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	3.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	43.9	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.5	0.0	0.3	0.3	0.8	1.2	0.3	1.4	0.4	0.0	0.1	0.0	0.2
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123803865-124825640	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 56.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1721.6;Inhibitory neurons: 636.4;Oligodendrocytes: 2869.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 3.0;HEL: 6.4;Karpas-707: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	0.9	0.4	24.2	0.1	33.6	0.7	0.3	30.1	39.3	0.3	9.8	1.0	0.0	0.1	0.3	0.2	0.3	0.2	1.1	29.2	25.3	0.1	0.2	0.2	0.2	40.7	28.0	0.1	0.1	0.0	1.8	0.1	37.4	0.2	0.1	6.6	0.3	0.2	2.9	0.1	0.3	0.3	34.8	0.1	0.2	0.4	28.8	0.5	0.1	3.4	0.2	0.5	0.3	56.8	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.4	0.0	0.0	1.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	33.6	30.1	39.3	29.2	25.3	40.7	28.0	37.4	34.8	28.8	56.8	0.5	0.0	0.0	97.3	0.0	0.1	0.0	0.2	0.0	3.0	0.0	0.1	1.3	0.0	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.1	1.7	0.2	0.1	0.3	1.8	2.1	1721.6	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	47.1	636.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	47.8	0.0	15.8	0.0	19.1	2869.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
NKAIN3	"FAM77D, FLJ39630, NKAIN3-IT1"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-63014000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"brain: 18.9"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;SCLC-21H: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.2	1.7	18.9	0.3	11.8	0.9	0.3	0.8	9.9	0.6	0.0	0.4	0.3	0.4	0.7	0.2	0.2	0.3	0.3	16.1	10.6	0.4	2.0	0.2	0.3	3.7	11.2	0.4	0.3	0.7	0.0	0.2	2.2	0.3	0.4	1.7	1.2	0.4	0.6	0.7	0.4	0.2	1.4	0.4	0.3	0.4	16.1	0.1	0.2	0.1	0.1	0.2	0.0	4.8	0.4	0.6	2.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.5	0.1	0.1	0.4	0.1	0.9	1.2	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.5	1.3	0.1	0.2	0.3	0.5	0.8	0.4	1.1	1.9	0.3	0.2	0.0	0.6	3.7	0.3	0.3	0.4	0.2	0.6	0.3	0.4	0.4	0.5	0.5	0.4	0.3	0.6	0.5	0.2	0.6	0.4	1.2	0.9	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.1	0.0	18.9	11.8	0.8	9.9	16.1	10.6	3.7	11.2	2.2	1.4	16.1	4.8	0.0	0.0	0.0	1258.6	0.0	0.4	0.1	0.0	0.0	10.4	1.3	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.2	6.3	0.0	0.0	0.0	35.7	0.7	0.1	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	168.5	0.0	0.0	0.0	0.0	4.2	0.3	0.0	1.8	21.5	0.0	0.0	0.0	811.8	3.8	0.6	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.2	0.0	7.6	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 68.1;choroid plexus: 20.3;kidney: 52.2"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 80.8;Oligodendrocyte precursor cells: 76.4;Proximal tubular cells: 264.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.9;MOLT-4: 42.8;SK-MEL-30: 9.3;SuSa: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029876	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	0.1	0.8	41.3	0.2	41.0	0.1	0.1	28.7	68.1	2.3	20.3	1.7	0.3	0.4	0.4	0.0	0.3	0.1	0.0	45.7	44.7	52.2	0.0	0.1	0.0	39.1	40.3	0.1	0.1	0.0	2.4	2.8	39.9	0.1	0.1	3.1	0.1	0.1	0.0	0.4	0.4	0.0	37.5	0.1	0.3	2.2	40.3	1.2	0.8	0.1	0.0	0.1	0.6	36.1	0.1	2.0	7.5	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	1.3	0.8	0.0	3.9	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	42.8	0.0	5.2	0.0	0.1	7.8	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.1	9.3	29.5	0.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.5	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	41.0	28.7	68.1	45.7	44.7	39.1	40.3	39.9	37.5	40.3	36.1	0.0	0.0	0.0	23.8	1.9	0.3	0.0	1.7	0.0	2.6	0.0	0.1	0.3	0.0	0.1	11.0	0.0	3.3	0.0	0.0	5.9	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.6	3.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.3	1.5	0.0	1.0	0.0	80.8	0.0	76.4	0.1	4.2	0.0	0.0	0.0	0.0	0.0	264.8	0.1	1.9	0.0	0.0	0.3	0.4	6.0	0.0	0.0	2.3	0.8	0.1	0.0	0.1
NLGN1	KIAA1070	ENSG00000169760	"Neuroligin 1"	Q8N2Q7	3	173396284-174286644	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biological rhythms, Cell adhesion"		"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 13.8"	"Group enriched"	"Detected in many"	31	"Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9"	"Group enriched"	"Detected in some"	9	"glioma: 3.8;melanoma: 2.2;renal cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006572, HPA006680, CAB033261"	Enhanced		Uncertain	"Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	NA		82000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear bodies"	"CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400"	"unprognostic (2.81e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.08e-5)"	"unprognostic (7.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.07e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.41e-3)"	"unprognostic (5.37e-2)"	2.0	1.0	12.6	0.5	10.8	0.0	0.7	31.0	12.1	3.1	0.0	2.0	0.2	2.1	2.5	2.5	3.0	1.6	3.2	12.5	15.2	2.9	0.0	0.4	0.2	5.3	5.4	1.3	0.8	0.7	1.8	0.5	4.0	2.2	0.9	13.8	0.3	3.0	0.2	0.3	0.6	2.7	4.4	0.0	0.8	7.0	20.5	0.2	0.9	1.0	0.1	2.9	1.3	7.2	0.1	0.0	6.1	0.0	11.8	12.4	0.0	5.2	12.8	0.6	0.8	0.0	0.5	0.0	0.2	25.9	4.7	0.0	3.7	0.0	1.3	0.0	6.0	1.7	0.1	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	10.0	24.9	0.0	0.0	1.7	0.1	0.0	0.0	0.0	7.2	0.0	1.7	0.0	26.2	6.4	4.7	0.1	2.5	1.7	0.0	0.0	12.3	1.1	0.6	0.0	3.1	13.5	1.3	9.9	11.6	11.7	0.0	0.0	4.6	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	10.8	31.0	12.1	12.5	15.2	5.3	5.4	4.0	4.4	20.5	7.2	0.3	0.0	0.5	66.6	0.0	0.8	0.4	0.0	0.6	14.3	0.1	0.0	4.4	0.0	0.0	3.7	4.2	0.3	0.0	0.0	0.0	0.3	55.9	0.6	12.4	0.8	0.0	0.0	1484.7	0.0	0.2	8.2	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1700.0	0.0	0.0	0.0	0.3	12.5	25.7	0.4	14.2	60.9	0.0	24.9	0.0	4004.1	1261.9	0.1	0.0	14.3	0.0	2.6	0.0	8.5	0.0	10.3	6.6	2.9	2.1	0.4	1.6	0.1	0.9	0.1	0.1	1.6	0.0	0.3
NLGN2	KIAA1366	ENSG00000169992	"Neuroligin 2"	Q8NFZ4	17	7404874-7419860	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 32.7;Horizontal cells: 57.2;Oligodendrocyte precursor cells: 45.8;Sertoli cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 42.2"	"Low region specificity"	"Detected in all"							"HPA055321, HPA069278"	Enhanced		Approved	Mitochondria		NA	NA		14000		"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA055321: AB_2682783, HPA069278: AB_2686105"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.81e-2)"	25.0	18.1	25.6	4.8	26.0	0.4	21.2	13.5	25.3	61.9	0.0	36.4	1.5	57.9	7.5	10.2	46.1	7.7	18.2	23.7	18.6	16.6	9.3	16.7	2.7	18.1	15.2	66.6	9.4	7.6	23.7	3.8	13.9	29.7	2.2	15.5	13.6	9.0	11.7	14.8	16.6	12.3	12.1	16.9	16.3	6.7	20.9	0.8	14.2	2.4	1.8	31.2	32.4	19.0	7.1	9.8	42.2	24.4	12.6	18.0	1.0	11.6	18.2	19.4	17.9	2.2	2.4	0.1	5.5	16.4	11.4	3.9	7.9	4.9	10.0	10.8	7.9	3.1	9.6	1.6	6.3	3.1	10.4	14.1	3.8	15.9	2.4	29.1	6.5	3.9	2.9	5.6	7.9	6.6	1.4	3.1	7.2	0.4	4.7	12.9	5.0	1.4	5.6	1.5	0.6	17.0	5.3	2.5	3.0	8.3	6.9	0.4	9.0	16.6	20.6	10.5	5.7	6.4	2.2	1.2	17.3	2.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	26.0	13.5	25.3	23.7	18.6	18.1	15.2	13.9	12.1	20.9	19.0	5.4	0.0	2.6	25.8	0.5	4.7	3.1	3.3	7.4	32.7	5.6	5.2	11.0	5.7	1.0	0.0	8.4	0.4	3.4	0.1	0.0	2.7	2.0	1.5	25.3	6.8	0.0	0.0	23.5	0.4	6.3	11.5	0.5	2.3	0.0	5.8	6.1	3.2	1.0	57.2	24.8	0.3	0.0	0.8	1.8	2.9	17.1	0.7	1.8	5.6	0.6	22.3	0.0	45.8	13.6	1.6	0.0	22.2	0.3	3.0	0.1	1.3	0.8	16.8	32.9	10.8	10.7	0.5	1.1	1.2	3.8	0.8	1.7	4.3	0.3	1.2
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.8	1.8	10.1	0.0	2.2	9.8	12.7	5.1	0.0	3.4	1.3	2.3	0.4	0.7	2.0	2.5	4.5	14.8	28.5	0.3	1.3	1.1	0.8	6.5	5.6	11.6	0.4	5.2	1.7	3.6	4.4	1.1	1.9	9.2	0.8	1.9	0.3	0.6	2.6	3.7	1.6	2.2	1.1	2.6	8.9	14.3	0.7	0.2	0.5	2.1	1.4	4.2	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.1	9.8	12.7	14.8	28.5	6.5	5.6	4.4	1.6	8.9	4.2	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NOMO2	"NOMO, PM5"	ENSG00000185164	"NODAL modulator 2"	Q5JPE7	16	18417325-18562211	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 300.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046697, HPA061174"	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (2.58e-3)"	"unprognostic (4.11e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.54e-2)"	55.9	66.1	119.0	27.6	128.5	31.1	54.7	106.5	141.4	54.0	108.0	65.4	34.8	59.8	53.5	57.2	48.2	22.4	191.7	133.8	124.9	76.7	96.6	73.8	23.9	112.0	108.8	48.4	300.4	76.8	104.2	49.1	112.6	59.5	35.6	42.3	63.3	31.7	126.2	60.5	56.7	41.5	100.3	61.8	88.5	50.4	112.7	23.1	55.9	52.2	29.6	61.3	50.5	116.5	71.1	101.3	37.5	104.5	141.0	85.9	110.3	122.1	144.6	101.5	125.4	87.7	108.6	83.0	433.3	213.4	71.0	80.5	81.2	84.8	88.1	67.7	64.5	37.0	98.2	313.5	195.5	88.7	252.1	91.2	112.6	117.2	106.8	107.9	113.1	70.3	52.3	185.4	120.6	213.9	33.2	197.2	72.9	107.0	42.3	71.1	50.8	230.1	150.9	63.6	52.6	44.2	94.4	128.5	82.4	75.2	99.6	185.8	106.1	60.7	47.0	127.4	86.8	95.6	112.0	44.6	135.3	92.9	85.1	21.8	12.6	11.8	14.3	11.9	11.6	10.8	14.0	14.5	14.1	9.8	9.3	11.8	13.8	8.3	15.4	22.8	22.4	17.5	119.0	128.5	106.5	141.4	133.8	124.9	112.0	108.8	112.6	100.3	112.7	116.5	0.5	6.4	2.8	2.0	3.8	0.4	0.4	0.6	2.8	0.9	0.5	0.3	124.4	0.0	1.4	0.0	4.2	0.4	1.3	0.4	1.9	0.2	0.2	0.3	0.8	3.2	0.0	2.5	6.4	0.7	0.3	9.1	4.1	0.6	0.0	0.7	0.7	0.8	0.1	0.0	5.1	0.2	0.0	0.8	0.2	0.4	0.0	1.2	0.0	5.6	0.2	0.3	2.1	8.5	7.6	0.4	0.1	0.4	22.7	0.4	0.6	0.1	1.9	0.6	6.6	0.6	4.8	1.2	1.3	3.3	0.6	0.4	3.2	1.1	0.4	0.1
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2 stomatin family member, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"kidney: 255.0"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 20.2;Early spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NTERA-2: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB037267, HPA049486"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678688-153693992	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.1"	"Group enriched"	"Detected in many"	6	"Adipocytes: 99.6;Endothelial cells: 52.5;Hepatic stellate cells: 132.8"	"Group enriched"	"Detected in all"	4	"ovarian cancer: 39.2;renal cancer: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 158.5"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 18.7"	"Low region specificity"	"Detected in many"			HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	67.1	8.7	1.7	3.4	1.5	0.0	44.3	1.4	1.4	8.8	1.5	10.1	1.5	31.0	5.5	4.3	36.4	5.9	15.8	1.3	1.4	28.8	4.3	24.2	2.3	1.5	1.5	27.7	3.9	8.4	3.8	17.7	1.5	4.4	2.0	0.1	3.7	12.1	7.2	6.6	9.3	9.7	1.8	2.2	8.8	1.3	2.4	1.9	14.0	11.1	1.3	12.8	9.7	1.4	0.0	1.3	0.1	0.0	158.5	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	28.0	0.0	19.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	15.9	0.0	0.0	2.1	0.0	0.1	0.0	1.9	0.0	5.7	1.0	0.1	0.0	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	1.4	1.4	1.3	1.4	1.5	1.5	1.5	1.8	2.4	1.4	99.6	0.0	6.9	0.0	0.2	1.5	0.5	0.0	0.6	0.0	0.5	0.5	4.5	2.8	0.0	14.7	0.0	0.2	0.1	0.0	0.0	0.7	9.1	6.2	8.8	52.5	0.0	0.0	0.0	0.0	1.3	15.2	0.0	15.4	0.0	0.0	132.8	2.4	0.3	0.0	0.0	0.0	0.0	4.7	4.0	11.5	10.2	0.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	4.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	1.4	2.2	0.5	0.1	0.2	1.0	0.7	0.3	1.4	0.2	0.0
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35791591-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Excitatory neurons: 69.1;Inhibitory neurons: 68.9;Microglial cells: 34.7;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.9;ASC TERT1: 21.1;BJ hTERT+: 20.2;HHSteC: 20.1;HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.93e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.59e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.99e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.86e-2)"	12.4	8.2	9.3	1.7	9.4	0.3	10.3	14.4	9.9	25.7	7.7	15.6	1.8	20.5	8.7	3.2	15.1	3.2	12.8	9.1	11.4	6.7	8.6	9.1	2.3	11.8	9.4	9.4	3.2	1.3	13.8	4.7	11.5	10.9	2.8	4.1	5.3	6.5	10.8	8.3	7.5	9.9	8.2	4.9	7.8	4.8	10.7	2.2	6.0	8.6	1.7	12.1	14.7	7.9	0.0	2.9	2.2	0.0	30.9	21.1	1.9	9.3	20.2	7.0	6.4	4.5	4.3	1.8	3.0	17.9	12.8	1.2	3.6	0.2	6.1	2.2	1.0	1.8	4.3	3.4	20.1	0.4	0.0	23.8	1.8	8.9	0.6	7.6	12.7	2.5	0.7	0.2	13.4	1.0	0.5	0.8	3.5	1.0	3.7	2.4	0.2	0.5	1.8	1.4	1.1	0.7	0.4	0.1	0.6	3.8	0.2	0.0	8.2	8.5	7.8	3.2	1.2	0.5	0.6	4.8	10.4	0.6	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	9.3	9.4	14.4	9.9	9.1	11.4	11.8	9.4	11.5	8.2	10.7	7.9	2.7	3.2	3.4	35.6	0.0	1.1	0.6	0.6	1.2	5.1	0.7	1.4	0.7	1.5	0.3	0.0	2.1	0.4	0.5	0.7	0.0	0.6	0.3	1.4	9.2	4.4	0.0	0.0	69.1	0.8	0.2	7.2	0.5	2.0	1.3	9.6	6.1	4.5	0.4	3.3	68.9	0.7	0.0	0.3	2.1	0.3	9.3	0.3	0.0	34.7	0.0	6.8	0.0	51.8	16.3	0.6	3.6	7.9	0.2	2.7	0.2	0.6	1.1	2.2	0.0	5.1	3.4	4.5	3.1	0.1	1.6	0.3	0.7	0.8	1.1	0.4
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.0;Endothelial cells: 174.4;Hepatic stellate cells: 184.6;Sertoli cells: 282.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 48.6"	"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 39.3"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 39.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 444.6;hTERT-RPE1: 371.6;TIME: 369.5;U-87 MG: 425.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"	NA	NA		780000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	125.2	42.3	9.3	43.3	9.4	3.7	62.2	0.0	26.0	36.9	13.3	26.6	21.3	51.6	35.7	19.7	34.5	54.1	80.8	48.6	9.1	52.7	53.1	63.7	23.7	4.0	3.9	43.0	33.0	24.4	9.0	133.7	2.1	21.3	23.6	11.6	19.3	38.4	55.9	22.1	21.0	55.9	5.7	66.7	18.6	12.9	13.4	18.2	49.7	46.6	12.4	35.3	20.0	10.7	57.4	217.8	11.1	1.1	204.8	224.7	1.3	224.4	216.2	109.6	118.2	28.9	132.4	1.1	26.6	444.6	116.8	15.8	13.8	65.2	89.3	0.7	11.2	0.6	24.5	48.7	74.3	20.8	1.6	277.3	11.2	261.7	116.8	371.6	304.0	1.4	0.7	1.4	221.3	96.8	1.4	3.9	5.5	11.9	204.2	9.6	24.8	1.2	109.7	1.3	5.1	2.7	23.0	17.5	0.9	9.2	1.0	3.3	369.5	156.4	36.9	193.0	153.8	0.7	1.1	0.7	425.2	26.4	143.5	0.4	2.5	0.5	0.6	0.4	1.0	0.7	0.7	0.6	2.3	0.6	0.6	0.6	0.4	1.2	0.3	39.3	0.6	0.9	9.3	9.4	0.0	26.0	48.6	9.1	4.0	3.9	2.1	5.7	13.4	10.7	366.0	0.0	20.2	80.3	4.3	15.7	10.6	5.5	7.4	10.5	4.2	5.5	67.6	28.6	13.0	18.4	4.2	61.5	29.4	0.6	1.9	57.9	1.3	11.3	116.9	174.4	4.2	3.2	105.4	18.9	13.4	58.5	6.6	11.0	7.6	62.3	184.6	12.5	135.4	0.0	14.4	1.8	16.2	62.7	33.3	5.5	42.3	46.0	12.4	78.7	5.8	3.4	0.0	11.6	2.3	15.4	0.0	21.1	1.6	4.1	3.0	59.8	5.4	0.9	282.7	13.1	117.9	0.2	1.3	2.7	10.5	67.2	3.8	61.1	1.5	3.3
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 154.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	19.9	57.0	105.7	10.5	114.4	1.7	17.4	87.8	154.7	30.1	71.3	28.3	6.0	32.5	25.9	9.7	27.9	15.4	30.9	114.3	100.6	33.0	4.8	22.4	7.5	94.4	92.0	36.0	20.3	42.6	60.4	16.9	93.9	28.3	9.7	56.9	21.1	25.5	3.4	11.4	13.1	27.5	80.5	16.8	20.2	30.6	96.6	5.5	28.1	5.7	7.2	23.5	18.2	102.9	56.5	68.3	40.2	37.7	53.0	58.4	15.2	37.4	72.3	66.3	66.8	38.2	1.2	0.0	12.6	70.7	48.9	24.1	33.5	5.8	42.4	0.3	33.0	20.8	32.5	70.7	53.5	0.6	3.3	67.4	4.5	48.2	8.1	54.1	46.4	0.3	40.3	35.1	59.2	10.0	0.9	17.9	31.3	0.7	34.9	32.4	22.1	2.7	67.4	0.3	80.8	58.0	44.9	13.0	64.9	26.5	53.2	19.7	31.0	70.6	36.4	2.6	45.6	6.5	1.4	14.7	9.5	0.6	36.7	0.0	0.7	1.2	2.4	0.3	0.7	5.6	0.8	2.6	1.5	6.9	1.0	1.8	0.0	2.8	0.3	3.5	0.6	1.1	105.7	114.4	87.8	154.7	114.3	100.6	94.4	92.0	93.9	80.5	96.6	102.9	3.8	0.0	3.1	16.0	2.2	3.2	3.6	8.5	7.4	26.5	5.8	5.0	5.5	1.5	6.1	12.9	2.1	7.3	0.5	2.6	1.9	14.7	9.6	4.7	12.0	6.9	29.4	1.3	21.0	1.6	6.8	10.4	3.1	3.9	5.1	7.6	5.7	0.3	3.2	16.8	27.1	2.6	4.1	0.9	2.2	14.4	13.1	0.7	3.6	2.8	2.1	17.3	2.1	12.1	5.9	2.9	1.8	10.5	2.6	3.3	0.2	7.8	3.6	15.4	19.7	4.9	9.2	21.3	12.8	1.4	2.3	4.4	1.4	12.9	2.2	2.9
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918503-51225575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 145.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	1.1	2.0	40.9	1.1	60.9	0.3	0.8	145.0	74.4	2.2	0.0	11.3	0.9	1.1	3.0	2.0	0.8	1.2	5.2	62.7	16.8	0.4	0.5	0.4	0.3	0.0	2.2	0.9	1.4	0.0	6.0	0.0	7.2	2.8	2.6	7.2	2.4	8.4	0.2	0.9	2.6	1.0	4.7	0.2	2.3	5.6	15.7	1.2	0.6	0.8	0.2	2.3	3.1	22.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	31.3	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	3.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	40.9	60.9	145.0	74.4	62.7	16.8	0.0	2.2	7.2	4.7	15.7	22.0	0.1	0.0	0.0	4025.1	0.0	0.0	0.3	0.0	3.4	116.0	3.1	3.7	19.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	201.6	0.1	2.8	1.0	1.8	0.0	3206.3	0.0	0.0	2.3	0.0	0.1	0.0	0.2	3.3	0.2	0.1	77.4	2116.2	0.0	0.0	0.0	0.6	103.4	2.5	0.6	1.8	174.3	0.0	22.7	0.0	4897.8	678.0	0.2	0.0	0.7	1.4	0.5	0.0	0.2	0.0	9.7	0.0	2.5	1.3	13.3	5.8	0.6	0.1	0.3	0.1	0.1	0.0	0.1
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	11.4	18.7	15.1	14.0	22.8	12.8	19.7	23.1	14.9	16.7	14.9	20.8	14.9	13.5	17.8	13.3	19.4	15.1	19.8	13.0	19.5	28.4	31.1	11.9	23.4	18.8	17.9	13.5	17.9	18.1	10.4	11.5	21.1	20.8	20.0	20.5	19.5	16.7	28.2	12.8	14.2	12.4	15.6	20.2	17.3	8.2	18.3	20.2	20.1	29.9	21.5	14.8	10.5	27.3	31.2	13.0	8.3	7.9	41.7	39.0	24.6	12.7	13.9	10.9	13.7	4.0	18.7	69.8	26.3	13.1	37.8	31.2	31.1	31.3	13.3	55.1	17.9	22.0	10.4	16.1	20.3	54.3	14.7	37.3	33.6	10.4	22.4	24.1	9.3	34.3	42.7	20.1	29.2	19.5	18.0	19.4	12.4	47.4	28.5	22.1	27.7	29.1	23.6	20.5	8.7	4.3	26.0	41.9	37.6	38.4	19.5	20.1	5.4	5.6	10.8	27.8	13.5	16.3	23.4	46.2	16.8	42.2	14.1	20.1	14.4	32.1	19.4	24.1	25.6	35.6	23.7	23.1	15.4	35.0	33.9	31.5	17.2	30.9	35.1	8.2	23.6	15.9	15.1	22.8	23.1	14.9	13.0	19.5	18.8	17.9	21.1	15.6	18.3	27.3	8.4	19.2	11.5	37.9	25.7	6.0	18.2	35.6	13.6	7.8	15.0	12.3	27.2	8.6	33.0	25.8	12.5	22.9	14.4	8.4	25.4	11.2	5.8	31.6	10.8	6.3	6.0	15.6	18.3	5.5	10.0	12.0	5.6	18.4	6.3	10.9	6.4	18.7	15.8	1.7	31.7	17.7	36.7	10.1	9.7	12.7	9.9	12.9	7.2	29.0	11.3	10.9	15.5	52.8	106.5	3.8	10.9	8.6	16.8	12.3	8.5	32.4	63.1	20.5	6.6	12.0	8.6	14.3	13.6	17.3	6.8	18.3	20.7	17.1	14.6	17.1
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 879.4;tongue: 394.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 933.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol		NA	NA		370000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	92.7	90.4	45.7	35.8	53.5	50.1	64.0	45.9	55.9	52.3	36.8	55.4	63.2	39.7	21.9	61.8	37.7	41.6	105.7	54.9	49.2	72.3	73.8	58.9	45.7	48.0	53.9	92.1	35.4	33.1	33.8	57.5	52.9	34.1	57.2	48.8	46.3	41.4	879.4	77.9	69.6	43.4	44.3	57.3	56.1	72.8	45.4	30.1	27.1	394.5	37.6	43.8	56.3	49.0	83.3	23.1	12.8	17.8	171.4	175.6	15.2	97.6	110.7	72.1	119.0	41.1	108.1	0.7	37.6	134.3	113.2	75.6	17.3	93.5	54.8	192.9	9.2	17.2	32.1	22.0	175.4	0.6	59.5	94.6	72.6	69.2	71.8	177.9	62.4	23.8	21.5	123.7	98.7	17.6	8.3	2.3	5.2	22.4	10.3	1.4	25.5	8.5	87.9	57.6	2.8	13.6	84.9	25.0	64.3	49.9	54.6	11.4	171.6	58.8	28.9	81.0	27.5	63.3	23.5	0.6	88.3	14.3	11.4	47.9	2.5	0.3	56.1	1.5	43.3	18.0	71.2	65.8	0.5	11.7	28.0	34.5	1.7	51.2	3.8	5.2	109.6	30.2	45.7	53.5	45.9	55.9	54.9	49.2	48.0	53.9	52.9	44.3	45.4	49.0	68.2	67.3	29.4	18.6	25.9	74.4	46.6	104.5	67.2	38.7	30.5	32.9	237.7	68.6	81.3	31.3	18.8	112.8	89.8	199.8	33.2	135.5	281.9	36.0	38.6	82.4	42.6	126.5	48.9	114.0	39.8	91.6	88.7	37.4	70.8	92.8	47.8	30.9	31.6	90.9	26.6	106.4	65.1	15.1	26.0	933.6	95.7	14.5	90.7	25.3	36.6	36.4	119.4	13.6	28.1	166.3	186.9	103.4	86.3	92.3	209.9	162.4	73.7	103.4	111.7	63.1	106.6	102.0	13.7	58.1	77.9	75.4	107.5	166.3	44.1	75.0
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9 endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 3551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		10000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	151.0	93.0	61.1	118.6	59.3	149.0	113.4	60.7	60.8	135.6	94.3	158.1	149.9	101.2	141.4	105.2	109.6	106.2	111.0	58.4	71.5	114.8	264.5	130.0	89.7	64.5	62.8	124.6	270.0	171.6	71.5	141.3	63.5	116.4	132.6	75.5	189.0	102.1	59.6	119.8	143.2	110.2	60.8	106.0	137.2	38.9	66.7	72.6	129.4	65.5	94.2	119.7	103.5	63.7	86.8	170.8	86.2	214.4	440.4	295.6	190.5	211.9	268.4	153.4	154.6	180.2	274.5	110.0	345.3	255.2	118.5	152.9	81.3	137.5	121.2	142.0	97.6	124.0	115.3	164.8	287.1	196.9	307.3	273.7	217.6	150.7	152.6	529.4	258.6	71.7	96.0	427.9	162.2	149.5	53.7	239.7	97.7	172.0	121.2	69.8	3551.9	281.5	116.5	210.6	88.4	116.4	300.3	205.5	176.6	158.1	245.4	381.0	238.9	206.0	122.3	140.4	136.4	253.4	234.6	112.9	173.8	141.6	290.4	175.7	241.2	274.6	72.9	213.0	68.5	50.5	61.1	65.0	172.6	54.3	46.8	54.1	246.4	58.8	182.4	149.0	74.4	218.9	61.1	59.3	60.7	60.8	58.4	71.5	64.5	62.8	63.5	60.8	66.7	63.7	83.3	86.6	116.7	22.2	65.8	57.7	85.4	103.3	43.9	44.1	61.2	46.6	14.1	80.1	111.8	73.5	77.2	142.4	64.5	153.0	9.8	144.8	6.7	34.0	73.3	90.2	103.6	53.4	19.5	110.1	124.6	113.6	65.7	60.0	91.1	61.6	81.4	161.1	144.8	50.5	27.0	167.3	107.8	121.1	99.1	10.7	113.4	106.1	119.2	29.0	125.0	87.2	53.5	23.6	24.4	94.7	155.4	79.0	141.1	56.5	154.0	53.9	74.0	50.9	92.1	68.3	66.9	38.1	46.4	51.3	51.6	197.7	59.5	64.9	102.4	65.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822470-10838087	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.0"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 2.6"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042337			Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.0	2.5	7.5	1.1	8.7	0.0	0.0	11.5	6.8	0.0	1.7	4.0	1.0	0.0	0.0	0.1	0.2	0.1	0.0	5.4	11.6	0.0	0.0	0.0	0.0	22.4	16.5	0.0	0.0	0.0	0.0	0.0	14.0	0.1	2.6	0.2	0.0	0.0	0.0	0.3	1.9	0.8	11.8	0.0	1.4	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.5	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	8.7	11.5	6.8	5.4	11.6	22.4	16.5	14.0	11.8	24.0	10.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PREB	SEC12	ENSG00000138073	"Prolactin regulatory element binding"	Q9HCU5	2	27130756-27134666	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 369.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013582, HPA014133"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA013582: AB_1855694, HPA014133: AB_1855695"	"unprognostic (2.32e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.28e-2)"	45.2	46.0	40.0	28.6	41.4	16.5	39.5	41.5	47.9	38.7	37.3	34.0	27.7	57.3	104.8	41.0	46.1	25.9	62.5	42.0	42.6	49.0	137.2	33.4	33.3	44.2	41.4	49.9	73.9	30.8	42.8	22.6	41.4	42.7	27.7	16.7	60.0	34.6	134.5	29.6	36.0	40.7	41.8	51.5	42.5	35.1	42.1	31.0	30.3	112.0	38.3	34.9	32.3	42.6	63.5	62.2	35.4	56.5	84.8	30.2	65.8	44.6	46.5	63.5	44.4	59.1	38.7	78.3	45.9	44.5	68.7	35.3	70.3	56.3	41.3	58.7	63.2	64.2	30.7	128.3	111.1	74.3	58.2	28.8	67.5	60.2	68.2	34.2	44.7	61.4	48.0	68.3	57.6	73.4	69.2	56.5	37.2	81.5	64.8	63.9	70.9	369.2	46.9	33.2	79.8	42.8	42.8	88.3	65.7	36.1	39.4	125.3	25.0	33.9	48.7	29.8	51.0	150.5	67.9	95.1	56.4	83.4	65.4	73.7	61.0	103.3	50.4	52.2	53.7	44.5	42.1	50.2	62.5	43.9	40.1	41.7	25.4	65.0	55.8	74.1	50.9	63.9	40.0	41.4	41.5	47.9	42.0	42.6	44.2	41.4	41.4	41.8	42.1	42.6	9.7	16.0	12.7	5.5	33.5	18.0	9.8	14.3	9.1	12.2	21.8	19.0	14.2	20.0	10.6	20.2	12.5	45.3	22.8	17.3	35.2	29.8	5.9	5.8	14.7	10.8	8.4	30.7	7.4	35.1	60.3	18.2	28.1	11.9	23.6	13.1	16.1	36.1	38.0	6.7	7.7	28.5	20.3	19.8	16.3	9.1	23.6	17.9	19.6	8.4	16.6	25.3	24.7	9.5	9.1	30.9	20.4	44.8	101.5	18.4	30.0	29.2	3.8	10.9	32.9	10.2	21.0	32.1	44.8	18.7	17.3	77.4	22.6	16.2	22.3	12.9
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	1.4	1.4	2.0	0.5	3.5	0.0	3.3	3.0	3.5	1.4	4.1	5.0	0.5	1.8	1.1	4.7	2.7	1.9	40.8	3.9	2.1	13.6	0.7	1.4	0.1	0.9	1.3	1.5	1.8	8.3	1.3	0.5	0.9	3.8	1.4	13.5	4.3	2.6	38.7	0.7	1.3	3.1	0.3	1.3	2.2	1.1	1.3	0.4	3.3	36.4	0.1	1.8	1.3	1.5	0.0	3.8	2.1	0.0	0.7	0.5	2.3	1.9	1.5	2.5	4.3	3.9	4.9	0.0	0.6	0.6	7.5	0.1	8.0	0.0	7.1	0.0	8.8	0.0	7.0	5.5	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.8	0.8	2.0	0.0	0.0	1.1	0.1	0.0	0.0	5.6	0.0	5.5	0.0	0.0	0.0	14.1	1.3	2.0	5.5	6.0	0.1	0.0	6.0	3.3	0.0	0.0	1.5	2.3	2.8	6.6	0.0	0.0	0.0	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.5	3.0	3.5	3.9	2.1	0.9	1.3	0.9	0.3	1.3	1.5	1.1	9.6	4.8	30.7	2.0	0.9	8.0	6.7	2.2	42.0	19.4	9.5	328.5	24.3	14.3	49.7	50.1	1.0	0.2	6.1	54.8	9.5	3.9	14.4	2.9	10.3	14.4	0.0	109.4	4.8	0.4	15.3	5.1	17.4	2.5	11.7	9.7	8.1	0.1	26.9	119.0	6.3	8.2	0.0	1.6	4.8	6.8	1.4	5.4	18.7	0.0	18.6	0.0	84.9	20.4	6.2	3.0	29.3	0.0	21.2	0.2	82.4	10.7	115.5	6.6	24.5	17.2	7.2	3.7	17.7	0.4	0.4	1.2	5.3	6.1	13.4
PRKCB	"PKCβ, PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 124.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	13.4	10.5	32.9	2.4	40.4	0.3	10.8	70.7	70.5	79.4	0.0	33.9	5.3	39.5	8.6	6.7	47.0	10.9	15.6	46.0	20.1	8.7	2.4	12.9	3.3	15.6	8.0	124.3	4.7	4.3	85.6	7.0	16.2	39.1	2.3	19.8	5.4	13.9	4.5	5.0	14.5	10.4	24.5	1.7	12.4	14.6	29.2	0.5	10.6	1.8	1.0	34.1	51.0	34.0	0.1	1.5	24.1	8.6	1.2	4.2	0.5	2.5	4.1	1.0	0.8	1.1	1.5	0.2	0.3	4.4	0.5	1.6	3.4	0.2	0.4	4.1	1.4	1.7	13.8	1.6	0.3	0.0	0.3	4.1	0.1	1.9	0.1	14.0	1.0	0.7	0.2	1.5	0.2	3.1	0.6	0.5	5.0	0.1	1.1	17.6	0.9	0.4	0.2	0.8	4.1	4.3	0.2	2.1	0.5	3.5	7.6	0.0	1.3	14.5	5.2	0.7	1.4	3.7	0.5	0.2	5.3	0.2	0.5	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	3.2	0.1	0.0	0.0	0.1	32.9	40.4	70.7	70.5	46.0	20.1	15.6	8.0	16.2	24.5	29.2	34.0	2.3	3.2	0.0	22.9	0.9	1.1	1.4	1.7	0.6	82.3	1.6	1.7	0.8	1.5	1.2	0.0	31.3	1.9	1.9	9.5	1.9	1.1	2.0	4.4	10.4	5.0	6.1	0.0	24.4	1.5	0.8	11.4	2.0	1.6	0.0	1.7	3.3	0.1	0.4	20.2	19.5	4.2	2.0	0.0	2.4	9.8	36.1	0.5	0.0	5.6	0.6	5.7	1.0	8.5	1.6	3.0	9.0	40.3	0.7	1.8	15.2	1.0	5.6	37.1	6.6	2.9	11.7	2.4	3.1	0.4	0.4	2.6	2.7	0.6	2.5	1.3
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236897-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	873.7	718.9	473.2	701.4	488.1	1590.2	1435.8	482.6	527.4	1091.1	505.6	1033.5	747.7	884.8	989.4	1154.9	1366.8	732.8	676.4	457.2	487.8	641.2	817.0	631.4	1358.7	519.6	485.3	2527.6	1504.7	721.7	582.6	763.8	514.8	716.2	922.6	286.5	1204.1	638.1	1167.2	1242.9	788.2	823.6	514.0	821.7	753.6	230.4	490.2	1703.2	820.4	1152.2	1590.1	1026.2	896.4	532.7	1606.0	1783.0	1498.7	2930.0	2671.8	4139.8	2576.4	1409.8	2832.1	2364.7	2463.4	3845.9	1671.3	3592.6	1735.5	2068.5	1668.5	1216.3	1867.9	6501.5	1729.1	3457.2	3068.4	1205.2	1939.5	2508.6	3610.1	3145.0	1193.1	4375.7	3664.7	1935.6	3427.8	2880.2	2705.8	2328.3	1610.6	2717.9	2117.6	3742.7	2435.7	2703.6	1535.1	1487.1	1504.9	2218.3	1536.5	3279.6	2733.5	2152.4	1969.8	2163.4	865.3	2682.2	4446.4	1015.6	1882.1	2802.9	2089.8	1297.4	1032.1	1029.1	2315.5	1767.8	2293.6	2063.5	1242.5	2470.7	1440.5	577.1	1163.9	290.3	829.2	908.1	1333.4	1732.3	1391.2	1062.0	1405.6	1689.0	1597.5	1348.6	138.6	1092.2	861.8	1037.0	1465.0	3377.9	473.2	488.1	482.6	527.4	457.2	487.8	519.6	485.3	514.8	514.0	490.2	532.7	896.6	576.9	935.7	0.0	698.1	0.0	0.0	0.0	0.0	0.0	3642.0	3742.9	0.0	0.0	452.5	498.4	0.0	3252.2	821.7	0.0	1749.1	1773.1	0.0	590.9	1560.3	523.7	0.0	0.0	0.0	3361.4	4389.3	783.3	0.0	818.8	671.1	1822.8	0.0	0.0	1964.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.4	0.0	0.0	1169.6	0.0	0.0	0.0	0.0	2097.2	0.0	0.0	200.2	0.0	0.0	2538.2	253.6	0.0	0.0	0.0	689.9	0.0	0.0	0.0	0.0	3206.0	503.5	2464.9	0.0	0.0
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 706.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 152.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"NK-cell: 70.1"	"Lineage enriched"	"Detected in many"	18	"NK-cells: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	18.7	29.2	170.9	21.0	171.2	0.9	7.4	168.7	253.4	362.4	153.7	349.6	57.5	706.0	25.0	9.4	256.6	28.5	287.6	176.0	181.8	26.0	82.7	32.5	6.6	198.8	164.5	45.2	225.0	1.4	15.2	8.6	163.0	142.2	6.4	0.8	10.0	54.6	212.3	11.6	73.5	125.4	171.7	12.3	103.4	5.1	183.5	2.9	6.8	68.8	2.9	171.4	75.1	173.2	29.8	0.0	0.5	0.0	12.4	17.9	1.1	2.1	3.6	1.7	1.5	0.0	47.4	0.3	0.4	0.9	0.1	0.2	7.6	0.1	0.2	146.0	4.0	0.1	0.0	1.2	40.6	0.0	0.2	15.6	22.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	3.7	2.7	0.1	1.3	0.4	0.1	173.8	0.0	1.5	0.8	0.0	0.0	1.5	201.7	3.5	0.0	0.1	1.8	1.3	0.1	0.0	0.8	0.6	0.4	0.5	0.3	0.3	0.0	0.6	0.1	2.7	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.6	0.1	1.0	0.0	0.5	0.2	0.4	70.1	0.0	0.2	0.0	3.4	170.9	171.2	168.7	253.4	176.0	181.8	198.8	164.5	163.0	171.7	183.5	173.2	1.0	0.0	1.5	64.9	3.1	11.6	13.2	26.9	10.2	2.0	4.4	4.4	190.0	78.6	43.8	11.0	0.0	3.0	44.0	2.1	0.0	62.7	0.2	26.5	546.4	6.2	115.4	4.4	14.2	278.2	5.5	41.7	31.1	11.3	1.3	0.6	30.7	104.0	22.7	1.7	19.2	73.7	10.2	3.1	50.3	0.6	8.4	20.3	64.0	13.1	433.5	6.9	61.8	71.9	11.5	63.5	87.7	11.3	1.9	66.1	96.8	0.2	97.0	2.7	6.6	16.6	78.6	0.3	5.8	2.6	5.8	2.3	7.3	0.5	105.8	28.5
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 1066.8;Endothelial cells: 562.9;Hepatic stellate cells: 344.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 120.4;EFO-21: 80.5;HUVEC TERT2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA052020: AB_2681697"	"unprognostic (8.64e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-1)"	190.0	29.0	60.4	19.2	61.8	0.1	168.9	61.7	72.3	100.7	67.7	35.7	12.5	63.1	27.8	25.1	51.7	39.6	123.2	59.3	65.8	70.5	16.7	163.3	26.2	65.7	68.1	33.0	17.1	23.8	20.8	97.0	72.7	42.1	21.1	4.1	45.9	27.5	43.3	55.9	44.1	72.6	62.7	40.2	33.9	11.9	66.6	11.4	71.7	98.7	24.5	45.9	49.6	62.4	0.1	1.1	4.9	0.1	120.4	6.2	4.0	0.9	2.1	10.2	4.9	11.5	0.1	0.0	80.5	3.0	0.5	0.0	4.6	0.1	8.9	0.0	0.2	0.0	0.7	3.7	3.0	0.0	0.0	4.2	0.1	1.8	0.4	3.5	37.6	1.5	0.1	0.2	0.6	0.0	0.6	0.8	23.3	0.0	0.0	0.1	0.1	0.0	0.6	0.6	4.8	9.8	2.9	0.0	17.3	4.8	1.2	3.2	6.7	19.3	7.1	0.4	2.4	0.0	0.1	0.3	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	60.4	61.8	61.7	72.3	59.3	65.8	65.7	68.1	72.7	62.7	66.6	62.4	1066.8	0.0	5.7	1.6	6.2	34.4	5.4	0.9	9.6	0.6	24.0	24.8	2.2	0.0	1.0	3.7	0.0	1.1	3.7	0.1	3.9	0.6	1.6	22.2	52.8	562.9	4.2	0.0	0.2	0.7	1.7	126.9	3.1	38.5	0.0	1.4	344.8	1.3	3.4	0.0	1.0	0.2	20.3	8.4	40.5	3.6	38.8	4.1	23.2	45.0	2.6	15.5	0.0	1.5	0.3	0.0	0.0	21.8	5.2	4.8	0.0	1.0	0.1	1.8	6.6	10.5	26.3	26.6	59.1	2.6	27.6	1.5	4.0	14.0	0.1	4.3
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 144.6"	"Group enriched"	"Detected in many"	12	"Adipocytes: 287.8;Endothelial cells: 366.0;Hepatic stellate cells: 555.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"Karpas-707: 2.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 174.9;white matter: 60.0"	"Low region specificity"	"Detected in all"			HPA075527			Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075527: "	"unprognostic (1.62e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (4.85e-2)"	"unprognostic (6.88e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-3)"	"prognostic favorable (2.50e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.21e-2)"	86.9	32.6	17.7	23.0	19.7	0.2	71.7	26.9	22.7	33.5	21.3	24.4	10.2	25.9	3.9	18.9	22.8	28.7	91.3	19.2	25.8	84.1	23.9	144.6	55.0	37.3	25.7	7.4	19.7	28.1	22.3	8.6	34.2	29.7	8.6	1.1	22.1	12.9	19.3	22.8	30.0	24.4	31.6	11.4	25.7	6.3	23.5	7.3	71.9	26.9	30.3	28.5	30.5	42.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	17.7	19.7	26.9	22.7	19.2	25.8	37.3	25.7	34.2	31.6	23.5	42.4	287.8	0.0	1.9	0.3	3.6	16.3	0.3	0.0	2.2	0.6	5.9	2.8	8.7	1.5	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	20.8	0.4	7.3	366.0	0.0	13.5	3.5	0.7	0.1	10.7	0.0	0.2	0.0	0.0	555.4	7.3	0.5	0.0	0.2	0.0	0.0	31.2	19.1	6.7	1.2	1.3	26.6	5.6	0.0	0.2	0.0	0.0	6.5	0.0	0.0	1.2	1.3	0.6	0.0	0.0	0.0	0.5	0.0	2.8	4.9	0.3	0.9	0.9	14.5	0.0	1.7	1.5	0.0	0.5
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	294	"intestine: 2713.5"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	4.6	1.1	3.2	0.7	0.5	0.3	3.2	0.2	0.0	4.0	2713.5	2.0	0.0	0.2	0.3	1.8	0.2	3.3	5.0	2.6	0.0	7.6	2.2	8.1	9.2	0.3	3.0	0.0	0.1	0.1	3.4	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1886.7	1.0	3.4	0.1	3.6	1.0	9.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.2	0.3	3.2	3.3	5.0	8.1	9.2	3.4	3.4	9.0	5.3	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905271	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	434	"retina: 463.8"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"WM-115: 1.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA015783, CAB022363"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022363: , HPA015783: AB_2669298"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	0.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	463.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	230.5	0.0	0.0	0.5	0.0	0.0	0.0	475.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	11.5	0.0	0.0	1.5	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	107.7	0.7	0.0	0.0	0.0	0.9	0.7	2.5	0.5	1.8	0.0	0.1	393.9	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1926.6	0.0	1.7	0.3	0.1	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0
RIC3	"AYST720, FLJ11608, PRO1385"	ENSG00000166405	"RIC3 acetylcholine receptor chaperone"	Q7Z5B4	11	8106056-8169055	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 175.2;Cone photoreceptor cells: 143.9;Rod photoreceptor cells: 204.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 12.8;granulocytes: 4.5;T-cells: 6.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.3;HMC-1: 2.6;NTERA-2: 5.0;SCLC-21H: 8.3;SH-SY5Y: 5.8;SuSa: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065016	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"			"HPA065016: AB_2685404"	"unprognostic (2.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.45e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-9)"	"unprognostic (4.37e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.52e-2)"	3.1	13.5	17.9	5.2	17.8	1.9	6.4	24.6	21.7	8.9	14.8	11.3	1.9	10.9	21.5	5.7	10.1	3.5	9.8	17.0	20.3	10.5	3.5	3.7	7.7	15.5	15.5	19.7	18.0	11.7	31.3	0.3	16.0	16.9	2.1	42.2	16.0	10.3	5.9	14.2	8.2	6.1	14.1	7.3	8.5	7.4	16.2	2.1	22.9	2.4	7.1	10.5	5.9	17.3	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.3	5.8	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.1	1.2	0.5	0.0	0.0	0.1	0.0	0.1	4.5	0.6	1.3	2.2	0.8	1.4	11.9	4.6	2.4	0.6	12.8	6.7	5.9	1.9	1.8	1.7	1.6	2.6	0.8	17.9	17.8	24.6	21.7	17.0	20.3	15.5	15.5	16.0	14.1	16.2	17.3	1.5	6.4	15.5	56.2	79.1	36.3	55.9	8.2	58.6	175.2	34.8	47.0	14.0	42.9	20.7	23.9	143.9	0.5	7.2	0.1	0.0	33.5	2.9	0.2	1.6	4.2	7.7	4.4	95.3	28.5	0.3	10.8	2.0	0.2	24.6	9.5	6.4	4.9	0.2	95.9	90.1	4.4	8.2	1.0	2.2	4.5	33.5	2.2	12.4	17.8	3.3	52.3	4.1	101.0	50.4	14.6	1.4	46.6	18.6	38.6	3.1	6.6	19.4	204.9	0.0	9.0	7.0	51.0	39.5	15.9	39.6	0.5	19.8	1.1	1.5	38.2
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639688-18672108	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	207	"retina: 213.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 160.6;Rod photoreceptor cells: 162.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059546	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA059546: AB_2684058"	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	6.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	1.9	0.0	0.0	0.0	160.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870776	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 160.6;pituitary gland: 60.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.4;monocytes: 3.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		150000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	11.1	12.0	111.1	9.3	127.5	0.4	7.2	57.0	134.7	2.2	0.0	7.6	2.5	1.3	0.4	1.6	12.8	5.5	0.9	133.0	160.6	1.6	1.0	6.4	2.7	37.5	24.9	0.7	4.0	17.4	60.1	2.4	46.7	6.4	2.8	34.1	3.4	1.9	0.8	3.2	4.1	2.4	10.8	18.3	3.9	2.3	68.3	1.0	2.5	0.7	1.8	1.9	3.6	50.2	0.0	0.0	0.7	1.0	2.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.1	0.4	0.0	2.1	61.7	0.0	0.0	3.4	0.1	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.4	0.0	0.3	0.7	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	71.8	115.1	14.9	0.0	0.0	0.2	0.0	0.0	0.0	9.9	2.8	0.1	5.6	0.0	0.0	0.0	19.4	4.4	0.7	0.0	2.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.7	111.1	127.5	57.0	134.7	133.0	160.6	37.5	24.9	46.7	10.8	68.3	50.2	1.0	0.0	1.1	64.3	0.5	4.8	0.4	0.0	0.0	34.1	11.4	4.3	1.0	1.5	0.6	0.0	25.0	1.2	1.4	0.8	0.0	0.0	16.2	23.5	0.3	2.9	54.2	0.8	495.8	0.0	5.0	1.5	5.6	0.4	0.0	0.2	0.0	0.5	17.8	240.6	394.3	3.6	0.0	14.4	59.7	21.4	2.8	23.8	10.6	87.1	22.8	14.3	0.0	188.0	247.7	1.4	0.1	1.2	0.1	5.8	0.8	0.9	0.7	33.3	0.0	10.7	2.5	2.3	3.8	0.2	6.5	2.5	0.7	0.1	0.5	0.3
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151993859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1760.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0"	"Cell line enhanced"	"Detected in all"		"OE19: 4936.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		270000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	775.1	376.9	71.1	244.8	76.6	133.7	519.6	75.5	139.8	478.0	78.5	867.3	461.4	110.1	56.7	1760.5	188.7	212.4	340.9	72.4	132.8	735.0	157.7	689.8	133.3	148.2	105.0	234.0	145.0	36.3	71.0	326.9	108.5	164.9	924.2	51.3	422.8	105.0	106.0	483.4	448.0	288.2	98.2	111.2	189.1	145.8	138.8	118.3	143.5	145.4	289.8	338.4	803.1	110.3	1251.3	1085.9	3.4	241.6	1351.4	1711.3	972.5	730.1	912.1	613.8	606.5	1975.4	1671.4	2.3	689.1	1208.0	661.7	2227.5	337.0	2786.6	495.3	242.5	127.1	163.8	461.5	468.1	507.0	60.2	126.7	470.8	2195.5	660.6	738.6	487.6	1326.0	78.9	2.9	3.6	753.8	940.0	11.0	376.5	163.6	4936.7	1671.4	1.6	242.4	27.1	2348.3	317.0	11.1	9.5	1259.2	374.3	539.8	1213.0	882.2	130.5	1654.9	285.5	737.2	1362.3	459.2	34.4	7.8	225.2	1709.5	51.7	977.8	359.5	1235.2	299.7	425.7	758.7	443.3	232.4	652.3	539.0	2005.4	140.1	237.7	363.1	43.6	355.0	664.7	329.6	1180.0	1313.4	71.1	76.6	75.5	139.8	72.4	132.8	148.2	105.0	108.5	98.2	138.8	110.3	1197.3	2554.5	537.7	3.9	244.0	1594.8	1171.4	2183.2	795.6	11.6	241.1	281.4	111.2	693.4	994.6	950.9	4.2	1271.5	476.2	3820.4	1524.1	1811.7	314.2	901.0	104.6	1061.2	1078.1	114.2	0.4	2105.0	527.4	1751.3	432.8	1270.7	289.5	840.0	864.5	206.9	1023.1	16.8	0.9	1723.1	272.6	795.2	3945.6	274.2	647.1	1338.1	1632.8	28.1	1544.2	24.8	285.3	4.0	0.6	4570.5	3391.8	64.7	244.5	2782.5	2146.1	495.6	620.3	32.5	144.7	801.6	529.5	30.4	115.9	1940.1	1242.0	375.8	801.0	38.5	1998.0	2290.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2477.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1369.9;SK-BR-3: 1618.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	166.8	79.1	81.3	61.9	79.8	0.8	159.7	78.6	98.0	333.0	70.8	139.7	121.5	78.4	19.8	2477.7	68.2	81.6	122.3	79.8	80.1	219.0	209.9	161.3	28.4	104.2	80.9	83.4	41.0	76.6	42.0	71.8	84.9	77.8	105.0	7.0	438.1	38.1	51.7	474.9	109.8	79.0	84.8	118.5	100.4	60.3	103.4	25.0	72.4	52.1	205.0	163.2	713.3	84.6	670.4	318.1	16.0	36.7	102.5	386.8	42.8	367.9	341.4	302.7	265.2	315.4	366.1	0.3	577.5	553.0	69.0	479.6	1.1	839.2	175.3	1.9	0.6	0.4	260.5	90.8	117.5	0.2	0.9	182.7	787.6	731.6	567.9	390.9	1369.9	0.0	8.5	0.8	677.3	918.7	0.9	1.4	69.0	1171.0	887.9	0.9	187.4	1.8	1150.3	236.1	0.8	1.9	267.6	1618.0	55.7	140.5	504.7	3.5	743.9	178.2	289.5	171.5	848.6	0.5	3.5	2.4	525.0	0.9	122.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	81.3	79.8	78.6	98.0	79.8	80.1	104.2	80.9	84.9	84.8	103.4	84.6	275.6	38.5	25.5	10.4	6.8	633.9	995.4	531.6	157.6	0.5	225.4	191.3	33.0	124.4	290.6	108.5	2.1	20.3	4.4	500.7	72.4	610.9	4.9	50.9	172.5	293.5	139.0	16.0	0.0	193.9	8.7	112.2	96.8	128.5	19.1	154.1	365.9	132.7	5.0	0.0	0.1	286.4	164.8	15.7	95.4	17.4	67.1	7.4	112.1	5.6	7.2	72.5	0.0	7.5	0.7	1307.3	610.0	61.3	5.6	1141.1	353.3	169.7	48.6	2.1	6.6	70.9	91.2	8.0	1.3	1028.7	908.8	8.2	12.9	1528.4	320.2	1522.5
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063003-30083208	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA		41000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: AB_2676962"	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	139.9	294.5	208.6	169.1	228.0	253.0	169.9	187.2	246.6	153.8	196.2	143.0	123.9	152.1	408.6	91.0	205.9	182.1	151.8	234.6	308.8	205.2	302.3	167.5	218.9	214.0	258.8	255.7	231.4	236.5	138.9	309.2	247.6	228.2	143.5	219.1	212.9	172.7	111.1	70.8	140.5	139.1	219.5	159.0	161.1	104.3	290.5	243.4	245.4	129.0	186.5	141.0	64.0	218.5	119.9	112.4	147.9	79.9	209.3	149.8	69.7	139.2	247.0	128.5	173.7	72.2	139.9	80.9	183.5	156.0	134.7	97.7	100.8	112.4	146.9	33.6	49.5	112.2	87.3	119.2	189.6	48.8	130.6	175.2	260.0	121.6	125.5	257.4	192.0	150.7	128.4	191.2	142.9	74.2	128.4	88.8	96.0	253.6	61.3	98.7	88.4	107.4	220.3	100.4	48.6	162.5	140.6	160.5	208.2	115.7	112.2	93.3	144.0	89.6	230.5	35.0	56.5	103.4	110.6	81.0	215.8	118.4	146.5	964.6	252.9	443.1	321.2	253.2	364.8	233.1	473.0	377.9	247.0	302.4	776.2	543.6	478.1	258.8	335.3	212.0	483.8	920.3	208.6	228.0	187.2	246.6	234.6	308.8	214.0	258.8	247.6	219.5	290.5	218.5	179.8	169.9	147.6	79.0	458.5	0.0	331.6	0.0	154.8	291.5	247.8	166.2	135.4	261.7	82.3	211.5	123.0	235.9	566.8	142.2	127.2	387.5	629.8	235.9	114.8	170.8	115.3	145.4	128.0	358.9	254.5	181.7	170.7	133.6	223.3	325.7	240.2	273.4	292.0	139.7	157.8	122.0	0.0	448.6	0.0	908.1	218.7	387.9	0.0	60.9	298.5	317.2	358.4	82.9	111.7	250.1	137.0	294.2	505.1	280.7	252.6	289.7	212.1	252.5	177.5	203.7	177.1	194.7	133.9	133.4	0.0	276.9	794.4	167.8	115.9	310.6
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360611-78480739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Uncertain	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	17.9	22.4	18.4	12.7	20.5	8.5	28.2	24.5	29.1	23.9	23.9	19.6	16.0	25.0	23.2	24.7	29.6	20.2	24.7	20.4	22.4	28.6	17.8	17.8	12.1	18.4	21.5	22.8	25.2	47.1	15.7	23.4	21.4	34.3	22.3	40.2	31.5	29.8	10.6	17.7	15.6	26.6	20.0	13.6	27.9	14.1	23.3	14.6	39.8	16.3	13.4	25.0	11.4	19.0	32.7	23.9	23.4	76.1	35.5	45.5	40.8	30.0	46.1	26.5	56.1	9.3	61.1	48.1	31.4	45.5	65.7	26.2	34.9	57.0	45.9	17.4	32.5	20.5	17.8	20.1	22.7	13.6	16.5	28.6	54.5	27.3	41.2	62.5	41.3	25.0	8.4	33.6	50.9	39.2	25.2	26.7	19.9	14.3	26.0	29.5	38.3	55.3	43.5	38.6	70.9	40.6	27.6	38.5	26.7	24.9	52.5	26.1	36.6	26.3	19.3	30.0	24.2	20.9	29.4	27.6	50.1	50.4	22.6	20.3	11.4	13.2	7.5	12.7	9.3	7.6	8.7	9.2	14.8	6.5	7.1	6.3	6.8	10.3	16.6	4.5	9.1	8.0	18.4	20.5	24.5	29.1	20.4	22.4	18.4	21.5	21.4	20.0	23.3	19.0	59.5	25.6	22.4	45.7	20.3	39.1	31.5	33.6	38.7	72.1	33.4	22.7	36.1	21.5	30.4	40.5	70.9	13.8	21.7	19.1	13.7	24.2	42.2	34.9	30.2	31.4	35.4	12.0	80.0	30.5	24.8	34.3	36.7	34.1	12.0	41.7	27.1	15.7	19.2	32.0	100.1	34.2	20.3	33.7	33.1	15.3	20.2	25.1	30.2	45.0	19.1	47.4	19.6	76.4	60.3	29.8	14.9	28.6	23.9	44.6	14.2	24.7	65.4	68.2	13.1	33.5	25.4	25.6	23.1	30.8	45.3	10.5	21.2	30.8	18.8	33.7
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles		NA	NA		75000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA071167: AB_2686352"	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	45.1	69.6	4.6	7.1	6.8	7.9	43.5	6.3	8.2	38.1	4.5	37.4	7.7	35.2	0.2	49.9	31.9	5.0	65.0	5.0	4.5	49.0	48.4	40.9	12.1	6.3	5.2	34.9	51.9	4.7	33.8	7.3	5.6	37.0	2.4	1.1	49.3	6.1	90.9	56.4	38.4	3.5	6.4	46.5	47.0	28.3	5.4	8.3	38.6	3.2	7.2	39.5	38.6	8.2	19.7	30.2	11.2	8.8	8.3	6.8	14.5	21.6	20.7	26.3	19.4	30.0	15.7	45.1	49.3	10.9	15.7	20.5	9.0	18.7	1.8	29.8	68.3	25.7	11.7	8.5	26.1	30.5	17.4	9.7	20.9	21.2	10.3	3.3	18.9	49.3	38.2	18.3	11.6	38.3	50.5	14.6	16.5	27.9	59.4	43.1	9.1	67.5	4.8	13.1	8.3	20.0	26.2	8.0	39.1	3.4	32.1	13.7	29.0	20.9	17.5	29.3	29.6	43.3	84.8	52.9	16.7	41.1	15.2	41.0	47.5	52.8	94.4	51.7	86.8	98.8	91.3	91.1	58.1	100.3	83.3	86.6	6.7	76.0	71.4	102.4	101.0	100.9	4.6	6.8	6.3	8.2	5.0	4.5	6.3	5.2	5.6	6.4	5.4	8.2	23.0	16.0	37.1	12.4	33.8	38.2	23.8	57.3	54.1	18.5	27.3	19.3	39.1	30.0	43.7	33.1	4.2	86.4	27.2	19.0	9.8	49.0	1.7	16.3	20.8	33.1	30.1	14.5	9.9	69.4	55.1	27.1	27.0	26.3	25.3	16.6	32.9	37.9	57.3	18.5	11.9	24.3	42.7	21.3	26.7	5.3	17.1	23.0	24.9	7.5	41.3	20.2	30.9	9.5	17.4	48.5	19.9	18.8	56.1	24.7	36.8	24.4	22.6	10.9	13.1	16.7	27.3	20.0	5.5	46.7	40.1	71.3	33.4	20.5	30.1	22.5
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905372-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	23.2	27.4	31.1	15.5	39.9	11.4	25.4	41.3	33.3	28.1	33.6	23.3	19.8	26.0	17.5	39.9	38.3	19.5	15.5	28.9	33.1	34.4	28.3	25.5	15.6	51.5	42.9	27.1	36.5	15.8	31.8	18.8	47.7	31.7	9.8	7.4	43.9	20.4	13.9	36.3	20.3	12.3	39.7	25.1	26.4	22.0	40.6	8.3	32.7	5.8	9.4	22.0	25.0	53.5	53.6	53.9	25.7	56.8	50.7	31.7	29.6	35.5	33.1	39.3	46.7	44.9	51.1	22.5	32.1	30.7	23.1	63.7	24.7	38.2	14.5	34.8	21.7	15.8	19.0	44.3	65.6	16.9	23.2	48.8	24.2	34.8	21.2	32.9	27.2	25.2	35.7	25.3	23.3	67.8	21.5	31.6	38.8	31.1	18.6	25.9	18.1	34.6	49.8	47.5	33.8	45.0	23.9	49.9	31.4	18.1	50.6	41.5	29.6	44.8	30.5	81.1	35.7	57.8	62.6	21.0	59.1	26.9	30.1	1.7	4.4	1.9	3.9	4.9	2.0	5.1	2.7	2.6	4.8	3.4	1.5	2.9	2.1	5.8	4.5	12.0	2.3	3.7	31.1	39.9	41.3	33.3	28.9	33.1	51.5	42.9	47.7	39.7	40.6	53.5	16.9	9.6	7.3	12.1	22.9	17.1	25.0	20.8	33.0	19.7	40.0	23.5	3.0	21.5	14.1	49.7	75.0	40.0	59.6	53.0	7.9	20.8	0.8	63.2	23.2	17.8	18.7	11.6	8.3	12.5	38.1	18.2	43.3	42.1	17.2	27.8	15.7	13.4	38.0	21.9	8.0	36.1	20.3	20.1	24.9	1.9	21.8	24.2	21.4	5.6	21.0	29.6	33.0	16.6	18.9	16.1	25.3	17.3	16.0	30.0	47.6	10.1	33.2	52.2	0.0	15.8	15.7	19.0	26.1	30.8	20.2	59.0	20.4	26.9	31.1	28.1
SCAMP5	MGC24969	ENSG00000198794	"Secretory carrier membrane protein 5"	Q8TAC9	15	74957219-75021495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 179.9;parathyroid gland: 103.1;retina: 283.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"plasmacytoid DC: 27.7"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 27.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046645	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA046645: AB_2679734"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (5.67e-5)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.34e-6)"	"unprognostic (7.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-2)"	3.0	20.6	106.7	4.3	125.2	2.6	3.1	75.1	179.9	2.8	12.5	5.8	41.6	5.7	3.6	1.5	5.0	5.6	5.5	128.7	74.8	16.7	4.2	2.8	7.9	113.9	67.4	6.0	53.4	103.1	67.7	6.7	112.5	4.6	4.9	283.7	7.2	2.7	0.6	2.1	30.4	3.2	35.8	8.5	15.6	10.7	80.6	4.4	6.5	0.8	10.0	5.9	1.8	124.4	1.5	17.8	3.8	12.6	0.3	0.2	0.5	0.4	0.6	4.0	1.4	4.9	8.9	28.0	8.5	1.1	3.3	1.2	15.6	1.1	1.4	4.4	2.0	3.5	2.1	25.8	2.7	0.4	11.5	1.3	2.1	1.0	0.3	2.8	1.7	10.1	0.2	22.1	1.0	15.1	1.1	10.2	13.4	2.1	7.1	0.4	3.2	6.7	1.0	8.6	88.1	49.3	19.8	13.6	27.6	2.7	7.7	34.0	1.1	1.2	8.2	1.6	1.3	1.8	2.4	2.6	3.0	21.2	4.3	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.8	0.4	0.1	27.7	0.0	0.4	106.7	125.2	75.1	179.9	128.7	74.8	113.9	67.4	112.5	35.8	80.6	124.4	2.2	0.0	1.1	14.7	2.5	0.3	0.5	0.4	2.8	113.3	3.2	2.7	3.0	7.2	0.4	5.5	125.1	0.1	35.5	2.9	1.9	4.4	0.5	0.4	0.7	3.6	62.5	0.0	75.1	43.3	0.3	1.9	12.8	0.3	0.0	4.1	6.8	0.6	13.8	70.7	99.3	5.0	0.0	6.9	0.2	0.7	2.1	2.0	1.8	6.5	0.4	29.9	0.0	32.2	26.2	6.8	5.3	6.4	8.9	0.8	34.0	13.0	2.7	168.0	0.0	0.9	2.8	1.8	4.7	1.7	0.1	0.1	0.6	2.0	2.7	0.3
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118162806-118176639	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;heart muscle: 12.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;thyroid cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	0.6	1.5	19.1	0.3	20.7	0.0	0.7	14.9	34.0	1.4	0.0	1.7	0.6	1.6	1.3	1.8	1.3	1.3	12.8	20.9	12.3	0.4	0.0	1.1	0.0	5.7	13.3	1.3	0.1	0.0	0.8	0.0	9.1	1.0	0.7	3.7	0.5	1.2	7.3	0.2	1.1	1.9	4.9	0.1	0.3	0.2	19.5	1.8	0.7	7.5	0.0	0.3	0.4	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.1	20.7	14.9	34.0	20.9	12.3	5.7	13.3	9.1	4.9	19.5	22.1	0.1	0.0	0.0	3.9	0.0	0.4	0.6	0.7	1.8	8.8	0.1	2.0	16.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.0	21.9	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	13.5	32.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.9	0.0	0.9	0.0	2.5	7.4	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.1	1.9	0.0	0.9	0.8	0.1	0.6	0.0	0.1	0.0	0.1	0.5	0.0	0.3
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216909-1232067	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 406.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	86.5	91.8	44.2	78.8	47.8	56.2	80.2	47.2	65.3	84.4	72.5	95.9	117.1	91.8	43.9	66.3	74.6	66.2	134.6	45.5	44.8	89.6	160.7	82.0	53.4	53.2	46.1	85.4	104.6	61.5	78.5	73.3	47.0	76.9	60.4	25.7	83.5	52.2	78.9	72.9	116.8	58.2	43.5	78.0	93.6	71.7	50.5	34.6	81.8	47.7	39.6	82.2	71.6	45.9	139.7	123.7	67.1	214.0	320.0	160.4	80.5	266.1	241.4	191.2	159.4	147.0	236.2	87.8	201.8	258.0	137.4	140.4	77.5	117.1	58.2	147.9	133.0	153.6	185.7	207.8	147.4	156.7	199.2	199.0	59.5	144.6	81.2	186.5	155.9	57.3	129.2	225.0	95.7	101.1	77.8	158.9	61.7	158.0	167.1	85.8	86.5	234.4	127.2	66.4	243.3	86.7	177.2	208.2	182.8	59.0	108.0	176.7	198.8	196.2	107.0	149.5	154.2	138.9	141.2	144.6	222.9	289.7	87.1	14.4	21.5	30.8	19.3	14.6	14.6	13.5	27.6	28.4	21.9	16.8	16.0	14.1	16.9	26.8	23.2	14.0	25.1	11.8	44.2	47.8	47.2	65.3	45.5	44.8	53.2	46.1	47.0	43.5	50.5	45.9	92.9	22.4	19.2	18.6	62.5	119.8	74.0	24.6	46.7	34.5	51.2	47.6	35.7	68.6	28.9	49.7	18.8	124.1	68.4	240.0	11.7	79.0	39.1	49.0	76.2	77.8	65.5	32.8	21.1	71.4	284.4	117.1	81.1	60.8	36.2	61.4	76.4	117.1	122.4	38.7	23.5	174.9	30.5	73.7	154.8	36.8	95.4	62.8	167.2	13.1	50.8	64.9	111.2	13.6	17.5	73.0	213.5	76.0	202.5	101.5	406.2	57.7	18.4	40.0	59.2	69.8	75.1	101.7	63.5	53.2	114.2	168.0	73.4	88.7	181.0	71.1
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA048980: AB_2680585"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	24.8	42.6	34.6	26.1	34.8	19.3	29.4	27.3	43.6	37.3	32.6	46.6	32.8	31.9	14.5	49.2	37.1	28.7	37.0	33.2	33.3	36.4	37.3	33.8	32.9	36.5	34.3	30.8	107.7	24.7	55.0	21.9	34.8	62.6	24.3	11.0	70.1	25.9	34.2	36.7	46.1	17.4	27.6	51.5	91.4	39.8	33.6	27.5	48.7	23.4	28.3	33.1	35.6	31.9	37.8	21.1	30.6	34.1	33.2	18.1	43.4	35.0	22.9	26.0	33.7	12.0	30.9	23.3	23.7	37.9	15.6	30.0	29.2	42.9	10.4	58.4	68.8	15.9	56.9	11.3	31.6	23.1	33.1	30.2	29.5	29.1	17.4	29.2	46.0	48.6	19.8	31.4	19.4	60.5	32.1	23.5	20.5	75.8	14.0	59.3	19.3	51.1	26.8	33.0	18.8	24.2	38.6	55.4	27.5	24.2	46.3	38.9	40.2	8.8	31.8	23.4	20.6	47.1	23.2	31.0	37.4	19.0	22.9	1.1	14.6	16.3	18.7	15.7	15.6	17.7	11.5	14.9	18.9	22.3	13.8	11.3	3.3	35.4	11.9	31.6	11.7	15.8	34.6	34.8	27.3	43.6	33.2	33.3	36.5	34.3	34.8	27.6	33.6	31.9	5.3	3.2	10.3	14.0	32.8	11.5	32.4	33.1	14.8	57.0	12.1	7.1	8.3	27.1	42.1	7.3	18.8	42.8	23.9	46.4	1.9	20.2	17.5	5.1	3.8	14.3	31.3	18.1	27.1	45.3	54.3	14.0	176.4	6.7	15.9	3.1	21.8	24.0	24.2	26.9	34.6	135.3	50.8	17.2	8.3	31.7	22.7	11.8	16.0	13.1	21.6	13.4	30.9	15.6	15.1	21.3	40.6	19.2	30.5	46.1	36.2	4.4	60.2	34.0	39.5	14.4	13.8	83.5	44.4	19.8	10.4	45.6	16.7	3.3	47.7	60.0
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	106.5	38.1	20.5	55.3	22.5	66.2	56.1	21.0	25.4	39.2	15.7	53.7	48.4	35.9	31.0	79.4	27.9	47.0	72.8	19.2	23.7	40.4	45.0	49.0	40.9	25.3	19.7	24.2	64.0	41.3	30.3	57.5	24.4	34.3	57.9	39.0	56.4	36.1	172.0	35.8	47.0	50.3	23.4	46.5	36.3	109.5	21.0	34.1	38.6	98.4	51.9	63.8	41.8	27.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.5	22.5	21.0	25.4	19.2	23.7	25.3	19.7	24.4	23.4	21.0	27.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55443277	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 13.5;Excitatory neurons: 19.4;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 2.9;HMC-1: 2.8;THP-1: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058935: AB_2683857"	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.0	0.4	20.2	0.0	19.7	1.1	0.0	0.5	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	10.4	0.0	0.0	0.0	0.0	5.1	4.9	0.0	0.0	0.0	4.9	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.3	9.6	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	19.7	0.5	20.2	25.9	10.4	5.1	4.9	3.6	4.6	9.6	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	13.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	16.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.1	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"adrenal gland: 13.8;brain: 51.1"	"Cell type enriched"	"Detected in some"	18	"Horizontal cells: 477.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"cerebellum: 51.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEK 293: 19.3"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.8;olfactory bulb: 15.7;white matter: 4.0"	"Low region specificity"	"Detected in all"			HPA059173	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA059173: AB_2683938"	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.0	13.8	1.7	0.5	0.5	0.1	0.0	51.1	3.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.6	0.7	0.4	0.0	0.1	1.2	1.5	3.4	0.0	0.0	0.1	1.7	0.0	3.8	0.1	0.0	0.3	0.8	0.0	0.3	0.3	1.5	0.0	5.3	2.5	0.2	0.2	5.4	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	51.1	3.4	0.6	0.7	1.5	3.4	3.8	5.3	5.4	0.8	0.1	0.0	0.0	0.3	10.8	0.0	0.0	0.0	0.0	11.5	22.7	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.5	0.0	1.9	0.0	1.1	5.2	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	477.8	25.9	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.0	1.6	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	4.5	0.0	0.0	0.1	1.9	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901598-13240416	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 48.5;LHCN-M2: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	0.5	2.8	12.5	0.8	12.7	1.3	0.6	0.0	14.8	0.3	0.0	3.2	0.8	0.4	1.1	0.5	0.2	0.4	0.6	10.9	6.3	1.9	0.6	0.2	0.4	6.9	5.9	0.4	0.6	0.1	0.9	0.4	6.2	4.2	0.9	3.7	0.9	0.7	1.5	0.9	0.9	0.6	1.7	0.4	0.5	0.7	11.0	0.1	2.1	0.0	0.3	0.2	0.2	4.2	0.8	0.4	0.6	0.5	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.5	0.5	48.5	0.1	0.7	0.6	0.1	0.2	0.1	0.6	0.2	0.6	0.9	0.3	0.1	0.6	0.6	1.5	0.1	0.1	3.3	0.4	0.1	0.6	0.4	1.0	40.5	5.5	0.4	0.7	10.2	0.7	0.5	0.6	0.4	0.3	10.9	1.5	10.1	0.5	0.4	1.4	0.4	4.4	0.9	0.4	0.4	0.6	5.8	0.6	0.4	0.9	1.0	0.5	0.4	0.3	1.0	0.8	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	12.5	12.7	0.0	14.8	10.9	6.3	6.9	5.9	6.2	1.7	11.0	4.2	0.0	25.6	20.1	5.2	0.1	0.1	0.5	0.2	0.0	0.8	1.7	0.8	1.3	1.5	7.0	1.8	0.0	0.1	0.0	0.3	1.9	1.4	4.8	0.1	0.5	1.1	0.0	0.0	265.0	0.0	0.0	2.0	0.0	0.3	11.4	0.0	0.0	0.0	0.0	0.0	427.9	0.3	0.0	0.0	0.4	3.4	0.3	1.0	0.0	5.6	0.0	0.5	0.0	636.3	4.9	0.1	2.3	0.0	0.0	1.8	0.0	1.3	11.8	0.3	0.0	6.6	0.2	0.5	2.0	0.0	0.1	0.1	1.3	0.0	0.8	0.6
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 187.4;Syncytiotrophoblasts: 746.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	23.3	14.1	12.0	10.8	13.9	28.2	22.8	16.2	16.0	19.3	13.3	15.9	16.0	19.4	15.6	14.0	17.4	15.8	15.0	12.3	12.4	14.6	22.6	17.6	14.0	13.6	14.6	19.2	14.1	14.6	10.3	50.1	13.2	16.8	14.6	19.1	16.1	13.8	21.5	22.3	16.2	14.5	12.2	13.4	15.7	23.3	13.5	14.1	17.5	17.3	13.0	14.1	17.1	16.9	15.5	13.7	29.1	26.3	24.5	21.3	29.6	14.2	19.2	20.6	10.1	10.5	19.7	20.1	15.3	18.0	14.4	17.6	20.3	20.7	25.3	8.1	16.4	10.8	10.6	27.8	34.2	10.7	15.8	25.8	36.5	12.1	27.9	23.1	17.5	18.5	17.7	18.4	17.0	10.6	29.1	21.9	35.5	17.1	21.0	33.3	43.7	21.3	19.5	19.3	33.1	29.3	42.0	20.9	37.7	24.8	13.3	24.4	18.8	22.0	19.8	12.0	15.4	24.0	10.7	36.8	16.3	13.1	20.2	13.7	8.1	35.4	4.1	3.6	4.5	20.4	4.4	6.3	13.0	19.2	8.7	6.6	4.7	8.7	2.2	12.5	2.5	5.8	12.0	13.9	16.2	16.0	12.3	12.4	13.6	14.6	13.2	12.2	13.5	16.9	43.0	12.8	9.7	8.8	24.7	85.7	55.7	45.0	71.2	22.3	43.5	32.0	13.3	20.0	20.5	16.5	8.4	187.4	15.3	27.3	31.3	24.5	70.5	21.9	26.7	35.7	22.6	27.0	20.1	22.7	34.0	42.5	21.9	34.5	4.5	37.8	33.9	23.6	34.3	35.3	20.9	17.8	40.7	20.3	99.2	71.3	22.7	31.1	49.8	23.4	27.0	38.3	4.1	25.6	40.2	22.3	18.2	19.5	17.9	49.7	23.5	28.9	17.0	18.6	19.7	36.2	34.4	70.0	51.0	67.7	75.7	746.2	17.3	17.4	20.6	50.8
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741125-150763477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	15.8	78.6	16.4	20.8	19.0	44.7	17.1	17.4	24.9	48.0	17.3	17.7	13.5	33.4	18.6	46.1	27.2	14.3	16.2	16.9	16.7	12.1	61.2	13.2	35.8	15.8	15.5	24.4	20.9	15.9	11.0	43.1	17.9	19.4	15.4	7.8	16.4	34.7	12.3	30.4	12.9	29.4	15.5	24.4	17.9	8.0	16.5	25.1	8.0	12.8	45.3	23.5	39.6	26.0	54.0	13.4	10.5	20.1	35.4	26.4	41.7	22.9	26.5	27.3	32.4	28.4	24.7	31.3	31.0	24.1	22.8	31.4	28.6	20.7	25.6	24.4	19.5	61.5	16.0	94.7	50.4	34.3	16.0	24.1	47.0	16.3	36.9	21.7	21.5	60.2	15.5	110.8	17.4	66.4	58.7	17.4	33.1	52.3	26.0	44.0	22.7	110.4	17.4	17.9	38.4	19.1	17.4	15.4	39.8	23.8	99.5	50.0	15.0	17.7	15.8	40.1	31.0	130.6	55.9	42.0	17.6	48.6	9.2	8.9	2.2	8.6	1.6	1.2	2.5	2.2	2.8	2.5	2.0	2.2	1.4	1.4	4.7	1.4	1.3	2.6	1.6	0.9	16.4	19.0	17.4	24.9	16.9	16.7	15.8	15.5	17.9	15.5	16.5	26.0	15.9	6.4	4.8	6.8	99.0	146.7	82.3	11.8	153.1	47.0	32.3	22.2	17.8	25.8	11.7	22.0	37.5	192.0	62.6	30.2	13.7	8.5	3.4	56.0	29.2	22.5	38.3	226.7	14.1	6.6	23.4	28.8	44.4	96.5	10.2	18.7	20.7	54.4	32.6	35.3	11.0	39.9	14.2	115.5	102.7	2.1	44.1	70.4	44.4	14.0	22.7	32.7	32.0	5.0	11.5	10.5	17.9	30.9	128.7	56.7	20.7	17.9	16.5	2.8	13.1	11.8	29.9	0.7	10.8	154.1	142.4	389.4	86.1	28.6	34.5	81.8
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637844	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Receptor	"Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 187.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 98.7;Hepatocytes: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.42e-4)"	42.0	52.4	25.2	19.4	25.3	20.5	38.1	26.2	27.1	53.0	27.4	42.0	46.0	50.7	45.0	54.1	46.9	22.1	34.0	25.8	30.2	25.5	187.6	27.5	16.9	28.3	28.7	46.1	45.7	39.0	22.0	27.6	29.4	35.5	31.2	7.2	35.0	38.5	17.6	53.9	40.0	34.8	26.2	24.2	42.1	20.2	33.3	19.1	29.7	13.5	22.2	46.3	43.5	27.1	184.3	162.6	59.8	175.3	205.7	138.7	66.5	127.1	91.2	115.8	105.9	97.6	76.8	87.8	71.9	151.7	69.8	108.8	94.5	151.3	57.8	144.7	175.6	78.0	225.0	112.7	131.7	145.0	67.6	142.9	163.0	131.2	197.7	59.4	90.2	114.5	30.1	156.2	139.7	1.8	88.2	215.2	68.8	101.5	184.4	101.4	59.6	258.3	111.0	36.5	57.6	65.5	123.3	89.5	70.0	32.0	106.9	98.7	68.5	90.0	69.9	96.4	19.2	43.2	71.6	2.5	97.2	123.9	191.8	24.3	39.5	24.2	43.0	39.3	46.2	26.5	62.5	51.3	48.9	21.1	51.7	43.6	10.7	28.7	42.5	35.1	65.5	43.5	25.2	25.3	26.2	27.1	25.8	30.2	28.3	28.7	29.4	26.2	33.3	27.1	11.0	3.2	13.6	6.8	12.3	18.4	16.8	24.6	14.2	10.1	26.8	18.9	9.2	15.7	12.1	7.3	0.0	44.8	10.7	33.0	0.0	33.0	0.9	7.0	23.7	14.4	10.3	23.5	5.6	33.5	98.7	29.2	18.3	10.1	7.0	19.4	13.9	97.5	38.8	5.0	6.4	28.2	12.2	10.5	7.8	1.8	27.4	10.8	19.6	5.6	9.5	13.8	14.4	5.0	4.4	32.1	31.5	25.6	22.4	25.9	58.4	13.7	6.8	7.7	19.7	12.1	23.9	6.0	10.3	40.0	21.5	36.5	13.6	26.2	47.3	16.1
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 568.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1013.8;Endothelial cells: 398.9;Hepatic stellate cells: 374.4;Hepatocytes: 227.4;Pancreatic endocrine cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;intermediate monocyte: 1.6;myeloid DC: 3.9;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.9;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 188.6;MCF7: 306.8;PC-3: 281.2;SK-BR-3: 188.3;U-251 MG: 193.6;WM-115: 202.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: AB_2732748"	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	234.7	81.7	107.0	20.7	98.6	0.7	181.7	83.4	119.7	92.6	60.6	77.4	27.2	92.7	10.7	47.3	77.7	34.8	568.2	82.4	88.5	207.5	408.3	289.1	22.0	96.4	95.5	57.9	47.7	24.0	95.6	51.3	99.3	129.1	11.9	3.0	149.1	42.4	144.6	45.3	81.2	18.8	87.0	143.8	109.5	36.3	116.2	7.9	188.4	109.0	7.4	77.4	72.6	94.7	32.5	188.6	5.0	38.6	6.2	8.6	5.7	138.1	81.9	67.9	22.5	25.4	41.9	0.1	63.4	59.2	9.1	30.9	15.0	13.7	7.1	0.4	45.0	3.1	80.8	61.6	44.3	0.5	13.9	9.2	13.7	20.2	5.9	32.1	68.2	15.0	24.0	2.9	4.8	306.8	0.6	35.7	7.5	76.8	281.2	27.6	8.1	50.5	16.0	2.9	35.3	33.1	9.7	188.3	12.8	5.0	152.6	16.8	176.4	21.5	30.7	1.9	193.6	5.1	4.6	0.7	2.5	3.6	202.4	0.0	2.2	0.0	0.5	1.6	0.2	0.0	0.1	0.1	3.9	0.0	0.4	0.5	0.0	0.0	0.5	2.9	0.1	0.7	107.0	98.6	83.4	119.7	82.4	88.5	96.4	95.5	99.3	87.0	116.2	94.7	1013.8	3.2	10.5	4.2	7.3	15.2	19.6	17.1	7.4	2.6	79.5	65.0	25.5	88.6	47.3	12.9	0.0	1.0	11.4	13.3	5.9	36.1	16.1	37.2	36.8	398.9	21.5	17.3	3.4	8.8	0.8	53.5	33.6	67.8	0.0	5.1	374.4	227.4	2.6	3.3	5.5	77.0	22.4	30.9	35.1	35.8	82.0	7.0	33.8	31.9	2.2	17.2	7.2	4.0	3.6	326.8	9.3	44.4	4.9	51.8	1.2	14.7	27.3	5.0	26.3	22.3	69.1	7.0	15.4	3.4	11.4	1.0	8.8	9.5	18.0	66.6
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	12.2	13.9	21.6	6.1	22.2	17.6	19.5	25.7	27.7	14.6	21.2	14.7	10.3	12.3	19.5	12.6	15.2	7.4	20.0	22.1	22.0	18.2	15.1	9.7	16.1	21.6	21.4	22.5	21.5	18.0	14.9	7.3	22.2	16.1	11.2	16.0	22.7	13.4	35.6	14.8	13.5	8.4	21.3	12.6	17.7	6.9	21.3	12.4	18.6	37.9	12.2	12.4	11.9	22.4	5.7	3.7	7.4	8.9	13.1	9.5	5.8	2.0	10.0	12.1	10.5	7.1	5.3	7.8	2.4	10.3	3.4	6.1	9.8	10.4	7.7	3.8	15.7	4.7	8.1	10.3	16.5	8.6	5.9	7.4	17.3	4.8	9.9	6.9	12.2	5.1	7.9	12.3	8.4	11.2	12.1	13.0	2.8	14.1	2.7	10.8	6.5	20.8	15.5	6.4	9.2	6.0	5.0	11.1	12.8	3.7	9.3	9.3	4.8	5.1	5.3	4.5	3.9	8.2	9.8	16.9	7.9	8.5	4.1	4.0	5.8	2.9	3.1	3.1	5.9	5.9	8.6	4.5	8.4	7.2	9.3	6.0	0.5	5.5	4.5	6.4	5.4	5.4	21.6	22.2	25.7	27.7	22.1	22.0	21.6	21.4	22.2	21.3	21.3	22.4	161.1	83.3	109.3	11.8	295.0	166.7	202.2	157.3	191.2	71.6	400.9	477.3	350.9	237.4	160.3	204.1	20.9	308.7	127.8	285.6	573.2	160.0	114.0	156.8	81.1	138.2	345.2	135.7	10.5	199.6	190.6	127.8	150.3	127.2	91.4	55.4	161.3	380.1	256.1	55.5	12.8	356.5	262.4	164.5	200.6	131.9	189.2	187.7	211.7	5.6	125.8	196.4	124.6	7.5	13.8	193.7	314.0	149.0	275.8	238.2	486.7	623.4	223.7	109.5	124.9	133.6	202.7	256.0	55.5	271.5	274.1	308.8	186.3	151.7	308.8	272.2
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380503-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"							HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	2.8	5.1	1.4	0.6	1.9	0.4	1.9	3.6	3.9	7.0	5.0	3.6	0.1	1.4	0.3	2.1	3.2	2.7	0.7	0.8	4.3	2.5	0.9	11.1	0.4	2.3	2.5	2.5	0.1	10.1	1.1	0.3	6.9	13.8	0.7	5.8	1.3	4.4	1.6	1.2	0.4	3.4	1.9	0.6	0.9	1.9	2.1	0.7	0.5	5.3	0.2	3.7	2.2	0.5	7.7	3.3	1.6	0.0	6.5	2.1	0.1	19.9	0.4	4.0	4.6	0.0	0.0	0.0	7.8	46.8	13.0	34.1	2.4	8.2	4.1	0.0	7.2	1.1	10.0	0.2	0.0	20.3	0.4	2.4	0.2	0.1	0.7	27.6	0.0	1.8	0.0	0.4	0.5	0.0	4.1	0.2	13.8	0.0	3.0	0.0	0.0	0.0	10.8	0.0	6.2	49.1	7.9	5.2	0.1	13.6	0.0	2.0	8.5	0.5	19.1	0.6	30.3	0.0	0.0	0.0	48.1	7.9	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.5	0.0	1.4	1.9	3.6	3.9	0.8	4.3	2.3	2.5	6.9	1.9	2.1	0.5	0.9	0.0	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.7	2.3	0.8	0.9	0.0	1.3	0.0	0.0	0.0	0.1	0.0	5.9	0.2	5.2	0.9	0.5	0.4	0.0	2.1	0.6	0.0	0.1	1.5	0.0	2.1	6.3	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.2	5.3	0.0	4.8	0.0	0.0	0.0	21.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	5.0	1.8	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208827	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	44.7	54.3	57.8	46.7	62.4	34.3	43.9	61.9	53.2	33.9	60.6	57.6	55.7	29.8	30.5	36.8	44.0	29.1	98.5	49.8	61.4	80.3	62.8	61.1	70.6	56.4	55.5	29.4	42.2	69.7	23.6	29.3	54.9	39.0	56.2	54.4	65.2	45.7	202.5	35.2	45.4	37.6	60.5	53.1	44.6	21.1	66.9	56.2	56.6	174.0	86.9	42.1	27.0	74.4	128.8	79.1	102.3	106.2	134.9	66.9	150.1	122.6	107.0	121.2	129.6	188.8	117.7	228.7	129.0	98.6	95.8	102.3	183.3	106.4	157.3	147.2	131.9	204.1	74.3	218.3	62.2	158.1	106.9	65.4	77.9	101.0	99.1	77.2	123.2	92.6	211.1	89.2	108.8	113.0	175.9	161.0	173.3	110.3	115.2	171.6	156.4	227.1	73.2	162.2	191.6	90.5	62.5	201.8	115.8	126.0	60.5	171.6	103.8	100.1	100.4	112.0	125.8	113.9	114.0	201.7	92.8	174.9	112.6	35.6	25.4	22.7	25.6	30.2	26.1	42.6	21.5	26.6	36.2	37.8	23.6	23.4	3.0	30.8	19.9	42.2	41.5	26.0	57.8	62.4	61.9	53.2	49.8	61.4	56.4	55.5	54.9	60.5	66.9	74.4	32.0	134.6	44.2	21.5	71.2	63.7	43.2	34.3	101.9	39.5	58.1	50.2	176.9	55.8	47.1	46.0	108.4	35.8	83.8	63.3	74.3	32.4	2.5	34.5	43.2	49.9	44.4	48.6	25.6	38.0	40.3	31.3	37.8	48.6	15.8	45.4	41.7	114.7	71.0	40.4	23.8	58.4	24.4	122.4	102.3	6.9	23.3	54.4	42.7	20.6	95.8	38.4	30.9	19.1	42.6	35.8	26.6	25.2	120.6	68.4	50.1	65.7	31.8	58.1	26.3	43.5	43.0	22.7	35.1	75.4	57.4	35.4	62.9	36.8	81.9	38.8
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897548	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	9.0	9.7	8.1	8.1	7.9	23.2	7.9	7.0	8.0	10.1	4.2	9.1	5.9	10.6	5.6	6.6	12.8	6.9	6.3	6.9	5.9	7.1	30.6	12.1	9.5	8.6	8.0	8.7	11.7	6.0	6.1	5.3	7.5	7.6	4.8	4.6	10.7	7.9	17.5	8.3	8.0	9.4	6.9	11.1	8.6	6.9	7.8	10.3	8.8	5.1	8.2	10.9	7.7	7.8	9.6	8.2	12.6	22.1	27.9	17.7	24.8	13.3	15.5	18.5	17.0	10.2	10.0	9.2	2.6	16.1	17.8	8.7	15.1	13.7	12.8	20.3	10.6	15.3	10.3	15.9	18.4	23.0	11.3	13.8	18.6	20.7	9.3	11.7	15.4	15.2	5.2	9.3	15.8	7.9	12.7	12.9	11.3	8.0	15.8	6.7	8.5	6.4	8.8	12.5	2.7	9.1	14.1	9.5	12.9	6.9	8.2	20.3	15.5	14.8	8.4	19.7	16.5	16.8	11.9	9.0	13.0	23.2	11.5	0.0	1.6	0.9	1.0	3.1	0.9	0.9	1.6	1.2	2.0	0.7	0.8	0.6	0.1	0.4	2.9	1.1	2.4	0.8	8.1	7.9	7.0	8.0	6.9	5.9	8.6	8.0	7.5	6.9	7.8	7.8	2.4	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.6	7.3	0.0	1.8	1.8	0.0	1.9	2.4	0.0	24.2	1.7	0.5	0.0	0.0	0.0	2.9	6.9	0.8	0.0	1.6	0.0	1.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	15.4	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	1.2	4.6	0.0	0.0
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38990859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 34.9"	"Group enriched"	"Detected in some"	19	"Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.4;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"AF22: 17.5"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 23.6"					"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.5	0.0	0.7	1.3	0.1	0.0	0.6	0.0	0.0	34.9	0.0	0.0	1.1	1.8	0.0	0.0	2.1	0.0	4.7	5.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.5	0.0	1.1	1.8	4.7	5.1	5.0	2.0	0.9	1.3	0.0	0.0	1.5	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.4	75.5	0.4	0.3	0.0	0.0	0.1	0.0	1.1	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	109.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.1
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906654-99974534	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	9.3	9.4	7.6	9.3	8.3	11.3	12.3	12.9	8.9	9.5	10.2	9.5	8.9	10.8	10.9	12.0	8.0	8.5	8.1	7.6	7.8	9.7	18.3	9.3	9.2	7.6	7.1	10.9	12.1	11.0	7.6	10.7	7.7	12.4	9.8	10.9	12.8	11.3	16.7	17.6	9.4	10.5	6.7	10.5	10.9	7.9	7.9	11.4	13.2	13.0	10.3	7.7	9.8	10.9	12.9	12.4	11.2	13.0	14.0	13.2	22.3	9.7	13.1	10.1	8.4	14.1	15.8	25.2	9.2	9.5	17.7	14.1	9.6	13.6	7.1	21.3	7.7	16.0	16.3	8.3	15.9	22.5	5.3	12.2	15.9	10.9	15.7	11.7	12.0	21.9	22.4	12.5	8.2	15.4	14.5	8.4	10.0	15.3	8.8	10.8	20.3	10.5	13.7	15.5	6.2	11.9	19.1	13.3	10.2	7.0	13.8	6.9	9.1	6.5	9.9	11.1	8.3	18.5	24.4	4.8	9.2	9.5	6.9	18.6	3.6	7.3	6.4	3.9	9.1	6.3	7.7	7.2	4.6	5.1	8.8	8.4	4.0	14.5	8.2	2.8	4.6	4.6	7.6	8.3	12.9	8.9	7.6	7.8	7.6	7.1	7.7	6.7	7.9	10.9	25.1	16.0	32.6	35.6	26.2	10.6	19.2	13.9	34.7	14.9	20.1	20.6	19.1	14.3	19.4	23.9	20.9	24.7	21.5	10.7	29.4	19.0	67.2	13.5	21.6	18.7	25.2	26.9	41.9	19.4	19.5	18.0	28.1	15.6	26.0	24.0	18.5	25.0	10.4	10.1	40.5	15.7	20.3	12.7	10.6	36.7	25.7	17.1	8.8	45.0	24.8	21.8	24.7	48.7	47.4	15.7	18.1	18.0	24.4	30.9	17.8	21.1	19.6	13.5	39.5	19.6	20.2	33.6	18.1	27.3	12.1	27.4	26.6	27.0	16.2	18.3
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014365-94028597	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.3;intestine: 13.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0"	"Not detected"	"Not detected"							HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.1	0.0	0.3	1.7	0.5	0.0	5.4	0.4	0.6	2.8	3.7	13.0	7.6	0.8	16.3	6.0	1.4	1.8	0.1	0.3	0.2	0.4	0.1	4.0	0.0	0.3	0.6	0.1	6.7	4.6	0.1	0.1	0.2	3.9	13.4	1.2	8.8	0.1	0.1	9.1	8.1	0.3	0.1	0.4	7.3	0.2	0.2	0.2	0.1	0.0	1.2	0.2	2.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	4.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.6	0.3	0.2	0.3	0.6	0.2	0.1	0.2	0.3	0.4	16.0	15.9	1.0	0.2	1.7	2.2	6.4	2.8	3.0	5.6	3.7	0.1	0.0	9.9	0.0	12.5	0.2	0.1	39.4	1.9	4.4	1.9	15.9	2.1	0.2	0.0	0.0	3.9	8.2	0.0	0.1	10.2	19.7	0.0	0.1	0.0	0.0	0.2	0.0	2.4	31.7	10.2	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.5	0.0	1.0	1.6	7.1	38.0	0.7	0.0	1.5	19.2	0.1	16.1	14.8	0.0	1.0	0.5	0.2	0.1	2.7	1.8	0.3	0.3	0.0	15.7	1.6
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 128.5;pituitary gland: 98.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 139.9;U-87 MG: 92.2"	"Group enriched"	"Detected in all"	5	"amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1"	"Group enriched"	"Detected in all"	8	"amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	2.5	6.8	55.0	2.5	70.6	11.9	2.4	28.8	128.5	5.3	13.3	10.8	4.4	3.9	1.5	1.8	3.8	6.8	1.7	76.1	24.5	3.4	2.3	3.4	1.0	16.8	20.1	3.1	10.8	0.9	98.5	2.3	17.8	4.6	2.0	2.5	3.0	1.4	2.1	1.8	4.3	2.7	15.8	2.5	7.8	4.6	23.3	1.2	2.7	0.7	0.6	4.1	4.1	55.3	4.6	21.9	3.4	10.1	4.4	11.7	2.3	14.3	9.5	5.9	3.9	7.4	12.2	5.8	2.1	10.3	32.2	3.7	5.0	9.2	4.4	10.2	3.9	1.8	8.7	4.4	4.9	2.7	5.2	6.8	3.8	41.4	14.4	26.7	10.4	0.9	4.9	6.5	11.4	10.8	1.7	21.1	2.7	8.1	47.8	0.0	2.4	5.7	4.9	3.9	139.9	22.5	4.3	12.1	3.0	4.0	3.9	1.8	39.7	28.9	9.6	22.4	39.0	3.7	2.5	2.7	92.2	2.2	34.5	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	55.0	70.6	28.8	128.5	76.1	24.5	16.8	20.1	17.8	15.8	23.3	55.3	0.9	0.0	2.8	8.1	0.4	4.2	10.7	6.2	0.6	6.2	4.6	3.4	3.2	4.3	5.9	1.8	4.2	0.4	5.0	1.3	0.0	4.0	0.1	4.5	2.9	1.6	52.7	0.4	60.6	3.6	1.9	2.2	3.1	11.1	15.2	2.2	1.8	0.2	0.7	8.4	16.6	2.8	8.2	1.2	2.1	0.2	1.8	6.1	3.6	5.6	0.1	1.0	6.2	8.5	4.8	29.8	1.2	1.5	1.0	10.5	3.4	0.5	7.4	1.9	0.0	1.9	2.8	1.6	3.8	0.6	2.7	0.7	5.3	1.7	1.5	18.9
STX3	STX3A	ENSG00000166900	"Syntaxin 3"	Q13277	11	59713456-59805882	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 313.2"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 74.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 167.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002191, HPA069176"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nuclear membrane"	"HPA002191: AB_1080165, HPA069176: AB_2686098"	"unprognostic (2.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (1.64e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.07e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-2)"	16.4	24.1	10.1	23.7	11.8	59.2	20.1	18.3	14.6	21.1	11.8	51.0	59.5	29.7	36.7	21.4	15.1	39.1	16.4	10.8	11.2	58.6	15.4	40.7	9.7	11.7	11.9	18.7	24.0	34.1	19.4	50.3	13.4	20.2	56.3	313.2	21.6	24.6	10.9	26.2	44.1	26.4	9.7	23.4	47.5	22.1	12.4	7.4	27.8	17.9	13.8	28.3	18.3	13.1	40.1	23.8	0.9	11.0	20.5	11.5	33.1	21.1	37.7	49.4	61.0	109.4	38.2	11.2	38.9	16.1	85.6	44.0	63.5	22.0	59.4	9.6	12.0	12.7	16.4	34.0	51.1	41.7	116.4	21.0	46.6	38.3	46.2	30.5	39.7	16.6	110.5	23.0	21.5	23.8	0.4	28.9	60.1	63.1	18.2	14.5	40.8	18.6	92.7	94.5	27.0	41.4	9.0	48.0	167.2	79.9	52.1	29.0	54.0	20.8	44.0	28.6	19.3	25.8	49.4	22.8	27.8	27.0	29.0	42.5	6.3	74.1	2.4	1.9	2.5	1.0	3.3	1.6	7.1	3.1	3.0	0.9	60.7	0.5	1.2	1.0	0.0	2.7	10.1	11.8	18.3	14.6	10.8	11.2	11.7	11.9	13.4	9.7	12.4	13.1	17.0	67.3	30.6	2.6	9.5	50.7	69.5	12.8	30.1	373.0	43.5	15.2	10.2	31.5	18.9	11.0	394.0	10.1	5.9	124.6	17.6	40.2	4.8	37.8	9.6	30.2	26.3	4.4	40.4	25.6	15.9	12.8	29.6	68.5	58.2	14.9	20.7	5.6	16.0	72.3	33.0	36.5	18.3	18.9	49.7	7.5	3.7	26.4	37.4	24.4	28.7	48.4	11.3	3.5	25.3	48.9	64.1	7.5	5.8	87.2	34.0	69.5	13.3	400.3	6.6	10.0	15.9	4.6	20.6	29.4	60.1	40.5	17.9	5.6	26.5	87.7
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	38.3	44.0	33.1	34.2	36.2	22.3	33.9	37.4	36.4	36.3	32.3	37.5	38.3	31.4	24.4	35.8	29.8	27.7	39.8	33.2	37.8	33.5	35.8	36.2	31.1	38.0	36.6	30.4	27.7	38.4	23.2	32.3	37.7	29.9	28.6	8.5	29.9	26.5	45.8	44.3	35.9	31.6	36.1	43.7	32.4	14.9	36.2	28.4	29.5	33.8	37.1	38.1	32.6	39.0	51.9	70.6	16.0	36.1	51.1	52.1	33.8	47.7	79.2	47.5	48.7	22.1	53.2	35.4	58.9	80.8	54.4	36.6	15.2	52.6	45.6	60.3	43.8	25.3	48.7	59.7	58.3	29.2	80.1	50.2	36.1	82.1	61.1	58.5	64.3	22.3	29.9	38.6	84.9	80.3	28.0	44.8	33.1	36.9	36.7	24.0	47.1	46.1	45.9	38.7	13.1	24.6	40.6	41.1	17.4	20.7	33.7	38.7	74.4	48.3	21.8	55.8	26.6	41.2	37.0	14.6	73.3	46.4	29.7	21.3	21.7	27.3	17.6	23.8	15.4	12.7	14.7	17.9	18.8	17.5	11.0	14.2	23.0	24.6	21.9	11.1	9.0	11.2	33.1	36.2	37.4	36.4	33.2	37.8	38.0	36.6	37.7	36.1	36.2	39.0	34.9	44.8	22.7	7.8	32.6	65.1	34.6	56.3	31.9	7.4	22.3	20.6	23.6	48.6	35.2	22.0	12.5	31.1	35.9	69.7	29.4	60.6	12.9	22.1	26.6	46.0	25.7	11.1	4.8	67.7	35.7	51.7	43.3	29.0	60.3	42.1	33.9	20.0	89.5	5.0	3.6	39.5	38.7	49.6	149.9	15.7	38.5	83.2	30.2	2.8	51.7	24.1	42.2	3.0	16.0	73.4	58.5	35.3	23.0	61.6	77.7	50.8	31.3	6.9	39.5	40.6	36.4	9.4	6.7	27.0	65.1	33.1	35.4	39.0	47.9	36.2
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806860-62832051	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	34.2	31.8	31.2	22.2	32.1	41.9	34.4	35.3	39.0	42.0	34.6	27.5	22.7	30.6	42.6	34.9	33.1	25.0	27.2	31.3	32.1	38.3	51.0	32.7	25.1	34.2	31.8	42.2	51.1	27.0	29.6	27.4	31.7	43.6	22.4	18.8	51.8	26.9	27.7	41.4	28.4	23.9	31.3	35.5	36.0	29.0	32.9	30.4	37.9	20.2	31.6	28.4	34.2	33.5	40.9	25.4	34.5	29.9	44.6	50.2	31.0	39.2	54.9	64.7	52.0	18.8	39.0	26.0	35.9	55.9	37.8	41.7	29.7	37.2	47.8	60.4	28.3	23.0	33.0	39.2	55.3	26.9	33.5	40.7	41.6	58.6	70.3	50.5	31.9	37.0	21.0	71.7	34.5	48.4	36.5	43.8	11.3	36.2	36.8	37.1	32.3	70.2	28.8	20.7	26.3	21.6	31.4	49.4	63.6	25.7	54.4	35.9	36.8	46.8	24.6	54.6	25.1	64.2	38.1	27.4	38.0	18.7	29.6	11.7	11.4	36.2	10.4	14.1	9.3	11.0	8.1	10.1	10.4	11.3	7.5	7.6	17.8	13.1	12.7	12.9	13.0	6.6	31.2	32.1	35.3	39.0	31.3	32.1	34.2	31.8	31.7	31.3	32.9	33.5	30.3	22.4	29.3	12.7	64.1	67.2	79.5	37.9	13.6	21.0	38.0	27.9	5.6	20.0	27.6	11.0	27.1	55.3	57.6	29.8	29.4	45.7	113.1	28.2	28.6	33.1	32.9	23.5	16.0	59.6	75.1	39.5	23.9	34.0	52.7	25.2	30.0	24.4	46.5	18.5	15.4	54.8	22.4	39.5	53.5	143.7	39.1	33.2	46.2	12.2	51.6	30.3	44.3	10.1	16.6	44.1	36.0	25.2	47.2	61.2	44.8	32.6	20.7	18.6	32.9	34.1	33.6	32.2	30.1	19.8	64.2	177.6	40.4	28.0	26.2	75.5
SYNDIG1	"C20orf39, DSPC2, FLJ14220, IFITMD5, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469629-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;heart muscle: 26.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 157.4;Microglial cells: 472.2;Oligodendrocytes: 214.3"	"Cancer enhanced"	"Detected in many"		"glioma: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 15.4;RH-30: 43.4;RPMI-8226: 43.6;SCLC-21H: 10.0;U-87 MG: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.16e-6)"	"unprognostic (1.40e-3)"	1.8	0.9	23.7	1.5	23.2	0.0	0.5	27.6	26.8	3.2	8.6	0.8	1.2	3.2	0.7	0.2	4.2	8.8	26.9	21.1	21.0	4.9	0.0	0.7	2.0	28.4	23.0	0.9	0.7	0.2	0.7	0.2	28.4	3.3	0.9	1.8	0.3	12.3	0.1	0.2	2.1	2.2	27.8	0.7	1.6	0.8	25.3	1.6	4.8	0.1	2.4	1.7	2.0	36.4	0.0	0.3	2.6	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	15.4	0.0	0.8	0.0	0.0	2.6	0.0	0.0	0.0	43.4	43.6	0.0	0.0	10.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	23.2	27.6	26.8	21.1	21.0	28.4	23.0	28.4	27.8	25.3	36.4	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.2	0.7	0.6	1.2	0.0	0.0	157.4	0.0	0.0	2.0	0.0	0.8	0.0	21.9	0.0	0.0	0.1	3.3	69.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	472.2	0.0	1.9	0.0	41.7	214.3	1.5	0.0	7.2	0.0	0.0	0.0	5.9	0.0	0.5	0.0	0.5	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366499-70417090	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	10.2	10.1	10.3	7.3	10.1	1.3	9.9	9.3	10.0	8.1	13.3	13.7	19.6	9.0	7.9	8.2	7.2	8.4	14.9	8.4	9.3	21.7	20.3	9.5	6.6	10.0	9.8	7.2	7.4	24.9	6.6	9.3	9.8	12.9	15.1	16.4	9.5	11.9	28.7	5.7	16.0	10.7	10.8	9.1	15.5	3.9	10.6	5.1	11.2	29.3	6.4	8.6	6.1	9.7	14.0	9.1	15.3	10.3	11.7	13.4	10.6	10.8	11.1	7.4	8.3	8.7	12.8	0.0	10.0	12.7	7.5	11.6	15.7	11.6	17.5	1.9	8.0	5.2	13.9	11.4	10.3	0.0	1.7	10.5	9.2	9.4	5.3	13.1	16.6	5.8	3.1	2.7	13.4	10.2	7.2	2.1	11.1	13.9	10.9	9.0	22.4	3.9	16.0	20.7	11.1	19.4	14.6	12.0	8.8	9.9	22.7	3.6	18.5	17.7	12.1	6.9	8.7	3.7	15.0	0.0	15.6	1.8	14.9	0.3	3.0	0.1	2.3	3.1	2.7	2.5	2.8	2.7	3.0	2.0	3.8	3.1	0.3	2.3	2.1	1.9	2.3	1.1	10.3	10.1	9.3	10.0	8.4	9.3	10.0	9.8	9.8	10.8	10.6	9.7	36.6	38.5	46.6	0.0	17.8	6.0	28.7	49.4	9.1	44.9	25.9	15.4	89.4	48.6	43.3	75.4	81.3	38.3	13.1	50.1	140.8	49.0	36.9	56.0	26.5	38.4	19.8	5.7	0.0	39.2	31.5	21.7	21.9	85.7	9.5	33.5	37.1	50.4	24.7	30.3	0.0	41.2	44.7	23.6	9.1	9.8	30.4	16.9	14.2	0.0	28.8	37.1	28.8	0.0	0.0	35.7	43.5	41.3	4.2	25.8	87.3	77.0	31.5	88.0	26.3	37.6	27.8	68.9	12.9	12.5	4.8	10.9	17.4	25.0	62.6	30.3
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891084-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 310.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	32.0	10.9	21.6	38.3	19.8	64.2	23.0	14.6	19.7	50.4	44.7	123.8	30.7	139.8	46.4	22.9	61.1	44.6	56.1	26.8	12.3	83.5	26.2	32.4	53.8	17.8	14.3	24.7	28.3	134.2	16.8	41.3	15.4	22.7	28.3	9.6	20.5	40.2	110.0	12.2	35.3	91.2	14.4	39.8	34.3	48.1	13.0	59.0	56.7	149.9	41.3	51.6	23.8	16.8	23.2	26.1	46.7	50.5	16.4	45.3	40.2	61.9	103.6	57.3	58.0	15.0	73.8	118.6	15.0	41.5	72.1	1.0	35.8	45.0	87.6	9.4	20.2	45.9	17.1	31.6	26.2	85.7	50.0	55.4	8.9	35.3	24.4	47.7	89.4	81.6	57.0	19.8	60.3	17.7	119.5	80.5	26.3	3.6	23.6	104.9	75.8	34.7	47.3	42.4	40.7	36.5	23.0	21.1	25.6	104.9	20.5	65.4	61.4	75.1	84.3	19.0	91.4	48.1	63.7	310.4	32.8	76.9	68.2	2.9	7.6	23.2	3.8	25.2	6.2	7.1	3.7	3.1	7.4	9.0	3.3	4.2	20.5	9.7	28.2	6.2	3.3	3.9	21.6	19.8	14.6	19.7	26.8	12.3	17.8	14.3	15.4	14.4	13.0	16.8	38.3	12.8	6.7	50.9	42.0	7.9	14.0	5.0	4.6	12.4	15.1	9.8	73.9	22.8	8.3	27.6	0.0	20.1	30.7	26.0	76.3	13.8	27.6	19.4	27.6	39.9	44.3	11.6	75.9	40.8	27.6	15.5	7.1	25.8	2.5	24.3	27.8	19.8	31.0	10.1	37.7	11.9	36.7	68.6	21.4	50.2	23.3	52.2	10.6	91.8	51.0	9.8	25.7	45.8	9.2	38.7	17.6	19.9	40.7	37.3	13.1	77.3	14.8	1.1	39.5	17.4	79.5	13.0	19.4	3.4	8.7	29.1	32.0	7.4	11.9	35.9
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75283503-75482169	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 157.7;Microglial cells: 307.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 25.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 84.7;HUVEC TERT2: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA040145: AB_2676860, HPA059885: AB_2684152"	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	14.8	70.6	13.2	15.7	12.5	3.4	20.1	12.5	15.1	10.0	7.1	8.7	4.6	8.5	18.4	9.4	10.7	14.1	33.8	10.5	13.8	25.2	11.7	11.9	34.2	15.9	12.0	44.8	15.0	22.1	5.3	20.7	16.7	12.3	10.4	1.6	27.6	4.3	82.8	21.4	10.3	10.2	12.0	21.0	11.0	5.3	20.0	10.7	24.3	54.9	32.6	8.4	9.2	10.5	12.9	14.9	9.2	0.6	21.3	22.8	12.0	11.0	5.8	8.7	9.6	84.7	15.5	2.7	2.4	15.7	4.2	12.0	23.4	11.0	9.0	42.6	24.3	41.5	19.8	25.9	5.4	20.0	0.5	25.0	19.7	9.7	22.4	14.9	61.6	46.0	12.0	1.3	10.0	6.2	29.4	3.6	12.9	24.7	8.8	26.4	8.7	15.2	8.5	9.3	16.9	5.2	4.8	14.6	8.0	4.8	5.0	0.7	26.2	9.8	12.1	5.2	13.0	0.7	0.1	0.3	17.4	18.5	14.7	5.0	0.4	0.0	0.7	0.1	0.0	0.6	11.2	2.5	0.6	0.5	10.4	4.9	0.5	0.5	0.1	9.9	25.0	2.3	13.2	12.5	12.5	15.1	10.5	13.8	15.9	12.0	16.7	12.0	20.0	10.5	17.8	6.4	29.1	32.3	2.6	36.2	10.0	2.0	19.9	1.6	33.1	41.1	81.4	10.0	6.1	14.7	0.0	10.8	32.4	8.0	15.6	12.3	25.5	14.3	17.7	32.6	21.0	5.0	78.0	7.4	9.7	17.3	7.1	8.7	5.1	81.5	26.0	19.4	26.6	1.7	157.7	10.7	24.4	24.8	25.8	5.2	3.7	12.9	21.4	307.3	33.6	0.4	1.0	40.7	5.1	4.9	2.9	7.2	2.1	16.4	3.4	10.8	3.9	0.6	6.6	24.8	21.6	2.4	7.7	24.2	44.2	4.9	25.2	8.1	15.5	10.6
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968915	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 893.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	37.4	16.5	22.1	4.4	35.3	1.1	30.8	21.4	24.4	33.2	17.9	30.5	7.1	42.3	16.5	60.4	27.8	12.6	37.1	22.0	22.2	24.3	18.6	34.0	5.7	26.6	28.6	22.3	30.0	13.4	16.8	31.6	25.2	20.4	9.5	10.0	29.6	10.9	22.0	27.8	19.8	17.4	20.6	13.5	25.8	29.7	30.3	3.7	24.8	5.0	10.2	23.8	35.3	42.6	62.4	36.8	29.1	18.4	17.0	31.7	28.9	18.6	21.1	18.0	20.2	59.2	22.9	0.3	24.8	24.6	21.3	47.4	20.1	23.8	19.0	0.5	14.9	0.3	22.3	24.7	57.9	0.1	0.8	16.5	15.8	21.4	39.2	23.0	38.2	0.1	24.3	12.5	14.2	32.2	0.2	0.7	21.9	23.4	14.6	0.1	35.0	0.2	28.1	33.4	12.9	16.8	39.2	12.8	16.8	42.9	13.3	0.6	54.7	14.3	23.9	12.5	25.6	4.4	4.6	0.4	17.8	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	35.3	21.4	24.4	22.0	22.2	26.6	28.6	25.2	20.6	30.3	42.6	212.1	169.9	49.2	299.7	1.6	35.8	115.2	36.4	39.3	42.4	53.7	28.6	107.2	51.5	48.6	58.8	10.4	32.3	0.8	87.7	25.4	116.0	19.1	132.2	97.0	166.0	46.0	2.7	293.8	83.7	11.3	56.6	86.6	290.7	5.7	87.7	100.3	49.1	3.8	126.2	187.3	45.4	32.6	6.1	12.1	13.7	33.8	5.2	64.0	266.1	1.6	32.8	0.0	345.3	893.8	178.3	82.0	63.9	5.9	151.4	37.8	26.0	39.2	52.4	78.9	64.1	118.7	63.0	83.9	139.2	60.1	33.7	4.1	120.8	33.1	194.6
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.9"	"Group enriched"	"Detected in many"	4	"Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2"					"Low region specificity"	"Detected in many"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	21.3	5.2	9.4	4.9	9.6	0.1	16.3	9.2	11.5	8.3	10.4	3.4	3.9	7.6	4.7	3.4	6.4	10.6	8.4	9.1	10.3	19.1	7.9	9.2	6.6	12.2	9.6	3.2	9.8	6.8	3.1	17.4	11.5	4.0	3.3	1.1	4.0	6.5	5.9	2.4	3.6	14.9	10.0	33.9	3.4	1.9	12.1	2.1	12.7	5.7	5.0	6.7	2.5	10.4	0.1	94.8	3.5	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	1.2	0.0	194.9	0.0	38.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.3	0.1	0.7	0.0	0.0	0.0	24.7	65.9	0.0	0.0	0.0	6.2	0.7	0.0	0.2	47.2	0.0	0.0	0.1	2.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	1.5	0.1	0.1	8.4	0.1	1.2	0.0	0.5	0.1	0.1	0.5	0.0	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.4	9.6	9.2	11.5	9.1	10.3	12.2	9.6	11.5	10.0	12.1	10.4	226.1	0.0	4.4	0.3	1.6	3.2	0.2	0.0	0.6	0.2	41.4	23.9	2.8	4.3	0.0	1.8	0.0	0.0	1.0	0.0	9.8	35.2	0.4	0.7	1.1	188.9	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.9	1.3	0.3	151.0	1.1	0.1	0.0	0.1	0.0	0.0	9.1	3.0	1.8	2.1	1.2	1.8	33.7	0.6	0.4	0.0	0.5	0.6	0.9	0.0	6.8	2.5	1.3	0.0	35.8	0.7	0.0	0.0	1.5	2.5	0.2	0.5	0.2	2.8	0.0	1.1	5.2	0.0	0.6
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.0;testis: 4.6"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 74.6"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.4;head and neck cancer: 3.4;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 0.9"	"Region enhanced"	"Detected in single"		"thalamus: 2.5"	"Group enriched"	"Detected in some"	6	"gdT-cell: 14.8;memory CD8 T-cell: 3.9;naive CD8 T-cell: 4.9"	"Lineage enriched"	"Detected in single"	16	"T-cells: 14.8"	"Cell line enriched"	"Detected in many"	12	"GAMG: 427.6"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	6.0	0.3	0.1	0.5	0.2	0.6	2.9	0.3	0.5	1.5	0.0	0.3	0.2	0.3	0.0	3.4	0.3	0.1	0.1	0.2	0.1	0.2	0.5	3.5	0.5	0.1	0.2	0.7	0.3	0.0	0.1	0.8	0.4	0.5	0.2	0.5	1.5	0.0	1.6	1.8	0.2	0.1	0.2	0.6	0.5	4.6	2.5	0.2	0.7	0.5	0.7	0.3	1.7	0.8	15.6	7.2	0.2	0.4	0.9	4.6	0.3	0.0	4.4	1.6	2.9	0.0	8.2	0.2	2.6	0.0	427.6	2.2	0.0	1.7	1.1	0.6	0.0	0.3	2.1	0.0	1.0	0.5	0.4	0.5	1.4	18.8	31.3	0.0	0.0	0.9	9.8	0.9	4.8	1.2	0.1	0.8	0.0	0.2	36.2	0.2	3.2	0.9	0.0	0.4	0.3	0.0	2.5	0.1	0.7	0.4	0.6	0.2	1.4	18.6	15.6	2.9	9.1	0.5	5.6	0.3	20.2	0.7	0.3	0.9	0.3	0.4	14.8	0.4	0.1	0.1	1.3	3.9	0.1	0.3	0.7	4.9	0.6	0.7	0.1	0.6	0.4	1.6	0.1	0.2	0.3	0.5	0.2	0.1	0.1	0.2	0.4	0.2	2.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	9.3	4.9	4.9	0.0	0.4	0.9	0.1	0.0	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 266.6"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.2	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.4	3.1	266.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.3	0.0	0.0	0.0	0.3	144.5	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	1.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 174.7;liver: 204.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	174.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.6	204.6	0.0	0.2	0.0	0.0	0.0	1.4	8.1	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107572-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 195.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"			"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	6.5	3.9	5.4	5.2	6.0	5.3	4.6	7.7	8.8	3.3	6.3	2.6	2.0	2.8	2.1	3.1	2.8	3.7	9.6	5.2	5.6	1.9	2.3	10.7	5.7	6.8	6.0	1.7	1.2	1.8	0.9	7.8	6.6	2.1	2.6	2.8	2.9	1.3	47.3	1.8	2.6	3.9	6.9	6.2	2.1	3.6	5.4	2.2	10.4	21.8	3.0	3.8	1.5	7.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.3	5.6	0.0	0.2	0.0	0.3	0.1	1.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.3	23.2	0.0	0.0	49.6	1.6	0.1	0.2	0.0	0.0	0.1	0.3	27.7	36.4	0.9	0.0	0.4	0.0	0.0	3.0	0.6	0.0	0.0	0.0	4.2	0.0	0.1	0.4	1.2	0.3	0.2	0.0	1.9	0.5	0.0	14.9	68.3	0.6	0.9	0.1	0.3	2.1	0.0	17.0	0.1	3.4	0.1	76.6	31.7	195.8	5.0	13.4	0.0	0.3	0.5	0.8	18.9	0.9	0.1	0.8	118.1	5.0	6.4	2.6	0.0	11.8	5.4	6.0	7.7	8.8	5.2	5.6	6.8	6.0	6.6	6.9	5.4	7.6	30.5	0.0	6.0	2.9	0.9	2.4	0.1	0.4	0.6	1.6	0.5	1.8	1.2	1.5	0.8	0.0	0.0	0.3	7.5	0.0	0.0	0.2	13.1	0.6	0.2	16.7	0.0	4.4	18.7	2.0	0.4	1.5	0.0	0.3	44.4	0.0	7.9	0.1	50.9	0.0	22.4	0.0	0.0	37.8	46.4	7.4	0.9	45.9	3.6	46.9	19.4	0.5	16.5	2.0	1.9	0.4	0.0	0.0	0.7	0.1	0.0	0.0	1.4	1.3	0.0	1.4	0.6	13.1	7.5	0.1	1.7	0.3	4.2	0.1	0.0	0.1
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 75.5;liver: 33.7"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	1.0	0.4	2.2	75.5	0.6	0.2	0.1	0.3	0.5	0.5	0.2	0.7	3.3	33.7	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.0	0.0	0.1	0.3	0.0	0.1	68.8	0.3	0.1	0.1	2.4	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.7	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189149-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	28.0	35.2	7.5	10.5	7.6	3.7	25.6	7.9	7.9	29.2	18.2	23.9	12.7	31.1	31.3	25.4	27.9	17.5	21.7	7.4	7.7	25.1	34.6	26.7	7.7	8.8	9.4	24.8	46.8	36.6	20.0	18.1	8.4	23.4	15.5	5.9	35.6	21.3	19.5	24.2	21.4	18.1	8.5	19.4	29.4	20.2	8.3	8.3	30.7	11.1	12.4	23.8	23.6	8.4	22.0	45.1	17.7	18.0	59.4	40.4	22.4	37.6	55.4	53.7	60.5	19.1	49.0	12.5	25.2	50.3	30.7	50.5	14.9	29.7	39.3	18.4	15.4	9.4	21.3	56.2	41.8	18.5	22.8	41.3	56.1	36.9	50.5	42.3	32.3	7.9	11.2	30.7	43.6	51.2	12.1	15.7	8.4	62.1	39.2	15.6	22.1	24.7	42.5	37.9	16.3	18.6	39.0	44.3	24.5	16.8	28.8	14.1	26.0	47.5	21.2	23.1	28.1	31.0	25.5	7.4	18.1	11.5	39.5	33.4	20.5	25.0	14.1	18.1	15.3	15.0	14.6	12.6	23.4	16.3	13.0	12.9	28.3	23.1	18.5	39.2	17.2	13.5	7.5	7.6	7.9	7.9	7.4	7.7	8.8	9.4	8.4	8.5	8.3	8.4	5.5	16.0	5.3	8.8	11.2	3.3	6.1	7.3	18.8	4.4	6.1	5.0	1.5	7.2	7.6	1.8	14.6	9.8	5.0	4.0	0.0	8.2	13.9	5.2	7.4	8.7	1.8	5.5	6.6	4.9	10.4	14.9	13.7	6.3	2.5	5.3	5.0	4.8	4.1	0.0	7.1	3.5	6.1	2.5	4.5	6.2	5.3	5.6	1.8	4.7	5.3	5.4	4.1	9.0	7.3	5.3	6.1	4.5	54.3	7.7	3.5	3.0	30.0	7.6	6.6	10.1	7.4	7.0	5.4	19.5	4.7	11.9	9.1	5.7	4.1	3.8
TM9SF2	P76	ENSG00000125304	"Transmembrane 9 superfamily member 2"	Q99805	13	99446311-99564048	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005657	Supported					NA	NA		2100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA005657: AB_1080303"	"unprognostic (9.77e-3)"	"unprognostic (3.51e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.21e-7)"	"unprognostic (6.49e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.21e-1)"	66.6	67.2	34.4	66.7	37.4	64.6	90.6	35.9	41.4	100.2	62.5	115.8	119.4	63.6	119.0	56.1	76.6	73.6	51.0	35.8	40.3	108.4	169.4	78.6	62.1	35.9	35.1	53.2	90.2	126.8	41.5	98.2	36.6	97.8	123.7	41.9	109.6	73.2	36.3	56.6	119.3	65.7	39.8	62.4	104.1	59.6	36.9	49.7	121.2	48.3	71.3	90.0	44.4	44.9	187.3	56.7	75.8	107.8	223.2	134.8	108.2	124.1	154.5	86.6	134.8	93.1	234.7	72.1	100.0	150.1	88.4	183.1	81.1	108.7	117.8	80.8	57.8	89.6	90.9	100.2	118.0	235.8	100.0	106.2	132.4	75.1	76.8	133.2	110.4	72.8	90.7	70.0	103.0	62.8	59.1	91.9	66.3	335.7	70.0	49.3	61.0	78.7	178.9	137.3	71.7	87.5	71.7	285.6	94.8	145.5	174.0	280.5	109.1	69.6	50.7	70.5	77.8	96.6	120.8	29.0	163.8	120.0	103.0	192.4	156.4	174.9	57.7	180.5	72.8	86.9	68.4	65.3	139.6	60.1	62.8	58.4	251.3	76.0	182.1	159.6	109.6	178.1	34.4	37.4	35.9	41.4	35.8	40.3	35.9	35.1	36.6	39.8	36.9	44.9	68.9	83.3	76.3	29.0	72.5	40.9	57.3	132.8	48.9	20.6	82.9	40.5	44.0	70.1	170.7	86.5	18.8	99.3	94.5	141.1	11.7	98.6	149.2	101.0	75.6	65.4	83.0	47.9	36.6	102.7	122.8	74.6	89.2	93.9	54.5	35.2	87.4	172.9	116.0	21.9	44.4	167.9	128.1	137.6	57.2	41.8	50.1	100.7	72.9	44.0	97.4	42.7	42.2	34.2	44.8	83.4	116.7	52.3	143.1	69.0	123.5	70.8	187.7	25.3	19.7	44.1	104.1	109.7	56.3	69.8	52.1	171.4	53.2	43.2	119.4	104.0
TM9SF4	"dJ836N17.2, KIAA0255"	ENSG00000101337	"Transmembrane 9 superfamily member 4"	Q92544	20	32109714-32167258	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064099	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA064099: AB_2685190"	"unprognostic (3.10e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.37e-6)"	"unprognostic (3.85e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	23.4	21.1	16.7	23.4	16.9	16.3	22.6	14.8	19.5	26.5	20.7	32.1	29.6	25.0	30.4	30.3	34.8	22.1	24.4	17.6	17.9	26.6	33.7	24.4	18.9	15.3	15.8	28.7	30.5	52.6	17.0	39.6	16.3	28.0	37.2	17.7	30.7	26.8	23.3	32.0	29.0	31.8	14.0	23.6	29.8	18.0	18.9	21.0	24.7	24.3	24.2	27.9	22.9	16.2	59.0	41.1	46.1	53.2	88.7	71.9	59.1	47.8	71.9	65.6	63.7	122.2	71.1	41.0	88.2	78.2	102.4	94.8	52.4	101.9	56.4	23.5	29.4	94.4	34.6	93.1	78.3	45.9	52.0	76.2	76.3	49.7	79.6	80.3	59.1	48.3	60.4	74.5	51.8	62.5	46.5	36.4	41.2	71.2	50.0	43.9	65.1	51.4	57.2	41.3	39.0	45.7	88.6	57.7	51.4	61.0	72.4	52.0	48.5	119.2	36.7	63.7	59.1	74.9	65.9	38.2	94.4	149.6	54.6	24.0	48.4	9.9	20.0	50.5	24.8	16.5	17.7	22.9	41.8	13.1	19.4	16.4	11.7	18.8	67.8	13.7	19.1	34.6	16.7	16.9	14.8	19.5	17.6	17.9	15.3	15.8	16.3	14.0	18.9	16.2	16.4	25.6	25.2	33.0	16.2	7.0	17.4	27.1	17.6	12.2	15.7	16.1	16.0	14.3	36.5	9.2	16.7	29.4	11.9	25.2	1.9	19.0	53.5	18.0	25.2	18.4	13.9	12.4	31.2	18.5	21.7	20.4	23.4	24.9	8.2	19.3	16.8	26.2	24.0	8.4	37.1	31.7	20.3	19.1	10.5	57.5	16.8	22.5	7.2	24.4	25.2	14.0	10.3	28.6	34.8	19.8	25.7	10.9	23.1	22.1	29.8	14.0	32.8	12.3	6.6	19.9	25.8	26.5	9.7	21.8	11.4	37.6	16.8	23.4	27.5	21.9
TMEFF1	"C9orf2, CT120.1, H7365"	ENSG00000241697	"Transmembrane protein with EGF like and two follistatin like domains 1"	Q8IYR6	9	100473149-100577636	"Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 28.9"	"Cell type enhanced"	"Detected in single"		"Endometrial stromal cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BEWO: 14.8;NTERA-2: 29.8;REH: 20.4;SCLC-21H: 25.4;SH-SY5Y: 16.9"	"Low region specificity"	"Detected in all"							HPA051501	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA051501: AB_2681509"	"unprognostic (1.96e-1)"	"unprognostic (2.30e-1)"		"unprognostic (9.69e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.02e-2)"		"unprognostic (3.59e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.04e-6)"	"unprognostic (1.30e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.44e-3)"	0.0	0.0	6.1	0.0	16.2	0.0	0.0	10.3	10.7	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	9.0	9.3	0.0	0.0	0.0	0.1	13.8	12.7	0.3	0.0	0.0	0.2	0.3	13.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	8.4	0.1	0.1	4.0	13.6	0.2	0.8	0.1	0.0	0.0	0.1	28.9	0.0	0.0	12.0	0.6	0.1	0.4	14.8	0.9	0.2	0.6	0.8	0.8	0.1	0.0	2.7	0.4	0.2	0.0	4.6	0.0	0.7	0.0	6.7	0.0	0.3	0.7	0.6	0.0	0.0	0.4	0.0	0.7	0.2	0.5	1.9	5.3	0.2	0.0	0.9	0.1	7.7	0.0	29.8	0.0	0.4	20.4	10.3	0.0	0.5	0.0	25.4	16.9	0.1	0.0	0.4	6.8	0.0	0.1	2.7	2.3	3.9	0.1	0.9	4.6	3.5	4.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	16.2	10.3	10.7	9.0	9.3	13.8	12.7	13.2	8.4	13.6	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM147	"MGC1936, NIFIE14"	ENSG00000105677	"Transmembrane protein 147"	Q9BVK8	19	35545600-35547526	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (6.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (4.98e-6)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	78.5	153.3	75.1	36.6	80.3	41.8	71.1	84.8	85.8	72.7	117.4	67.6	43.2	77.5	101.8	105.0	64.1	36.3	112.2	74.1	83.1	96.5	63.8	68.2	29.9	80.8	79.0	69.1	149.6	129.5	76.1	46.1	79.6	54.8	54.0	42.0	80.6	58.1	137.7	118.9	52.3	57.5	80.9	58.6	84.0	76.3	80.3	26.7	99.7	85.8	45.1	77.2	73.5	85.2	161.2	353.2	68.9	162.0	298.4	135.8	110.5	94.3	167.2	124.6	115.2	168.6	96.9	93.3	156.8	156.4	135.1	62.8	119.9	147.4	101.7	140.8	156.3	99.3	98.9	200.3	237.2	145.4	105.6	148.8	226.3	117.5	291.5	107.2	115.6	126.8	127.9	325.2	134.1	201.6	82.4	80.8	96.9	492.8	141.3	79.1	62.3	225.4	198.5	164.6	60.5	101.0	93.7	215.3	204.9	69.2	78.2	121.4	73.8	140.5	109.9	81.0	205.0	165.9	182.2	52.8	122.3	195.7	115.6	41.0	219.7	103.3	100.6	212.6	142.6	177.0	135.9	116.3	199.9	149.0	101.0	102.6	12.2	106.1	154.0	237.5	147.1	237.4	75.1	80.3	84.8	85.8	74.1	83.1	80.8	79.0	79.6	80.9	80.3	85.2	74.4	44.8	44.1	7.2	71.5	101.2	135.7	195.5	63.2	55.3	167.2	165.1	101.5	118.7	110.2	156.3	18.8	176.3	63.2	59.6	111.6	223.0	102.5	56.4	72.5	96.8	88.9	42.5	6.0	255.2	228.7	94.7	51.0	68.1	50.2	90.9	82.8	95.5	260.6	45.4	8.0	105.9	140.4	133.6	113.3	333.8	139.4	96.5	240.1	7.5	83.7	138.9	71.1	10.1	12.2	179.9	74.1	121.1	136.0	349.1	100.3	277.1	77.9	62.8	118.3	58.1	138.9	327.9	155.7	94.9	167.8	138.3	60.6	86.1	144.3	200.6
TMEM150A	"FLJ90024, TM6P1, TMEM150, TTN1"	ENSG00000168890	"Transmembrane protein 150A"	Q86TG1	2	85598547-85603196	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HHSteC: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019015	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA019015: AB_2204758"	"unprognostic (2.80e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.09e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.54e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.87e-3)"	18.7	16.3	10.0	5.2	10.8	1.2	17.0	9.8	11.1	16.3	11.1	21.0	6.5	17.7	6.3	11.0	17.1	10.4	15.5	9.7	10.3	32.8	38.5	19.3	6.0	11.9	10.7	17.1	37.9	8.0	11.7	22.4	10.9	17.4	4.1	1.4	14.9	10.2	53.7	9.3	12.9	11.5	10.6	9.7	20.6	24.4	11.3	2.5	14.9	27.2	4.2	22.2	13.1	10.1	2.7	5.1	6.3	9.3	52.9	23.7	15.3	5.2	9.1	4.3	2.0	23.6	7.1	0.8	19.8	15.3	8.0	2.2	6.8	13.7	2.0	1.2	6.7	1.5	3.0	39.9	49.6	0.4	4.7	28.5	18.4	7.0	9.9	20.6	15.2	1.0	14.0	1.5	17.5	11.9	0.4	6.9	11.5	10.8	5.1	4.1	0.6	15.8	13.4	10.6	1.0	3.9	5.4	35.4	13.5	5.9	8.7	6.2	12.6	5.2	4.4	4.5	1.8	10.6	2.8	5.2	8.5	6.0	2.3	0.0	15.2	7.2	5.5	17.9	6.5	5.3	6.2	5.6	12.8	8.1	6.9	4.2	0.7	8.4	15.1	7.6	1.5	6.0	10.0	10.8	9.8	11.1	9.7	10.3	11.9	10.7	10.9	10.6	11.3	10.1	24.1	9.6	14.9	10.7	9.0	4.5	15.3	16.0	10.2	6.8	15.3	12.7	5.2	12.8	16.2	14.7	0.0	133.5	10.4	3.5	29.4	16.9	137.5	5.0	9.0	14.9	3.0	1.7	3.9	14.4	18.2	14.3	5.6	6.0	10.2	5.2	15.7	19.7	37.9	3.3	5.0	5.2	16.2	10.3	13.1	64.8	19.9	14.6	10.6	9.4	15.2	6.5	7.2	5.5	5.9	12.8	7.0	24.5	5.9	20.3	16.4	85.0	8.3	3.4	13.1	14.6	11.7	2.4	5.6	7.9	3.7	146.0	7.0	9.2	7.0	13.1
TMEM150B	"DRAM3, TMEM224, TTN2"	ENSG00000180061	"Transmembrane protein 150B"	A6NC51	19	55312801-55334048	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"intestine: 64.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 18.1;Kupffer cells: 11.8;monocytes: 8.0;Proximal enterocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;HMC-1: 3.8;THP-1: 2.9;U-937: 18.1"	"Not detected"	"Not detected"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.18e-2)"	3.7	1.8	0.5	5.8	0.8	0.7	1.1	0.4	1.0	0.3	1.2	10.2	64.1	0.4	0.1	0.6	0.8	2.9	0.8	0.4	0.7	3.2	2.2	11.9	3.5	1.3	0.7	0.3	0.9	0.1	0.2	5.6	1.6	0.3	7.3	0.0	0.6	0.4	0.2	0.2	57.0	4.1	0.5	5.7	1.4	0.5	3.4	0.7	0.3	0.2	1.6	2.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.6	0.0	1.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	1.8	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	18.1	0.1	1.9	5.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.5	0.8	0.4	1.0	0.4	0.7	1.3	0.7	1.6	0.5	3.4	1.3	0.0	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.5	1.5	0.0	1.8	0.0	0.0	0.0	18.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.7	3.5	0.0	11.8	1.3	0.0	0.0	3.2	0.0	0.0	8.0	0.0	0.0	0.0	0.9	0.3	1.4	0.0	0.9	0.6	68.9	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.7	0.3
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 134.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	13.1	43.1	12.9	4.6	15.3	1.9	22.0	9.7	16.8	15.1	6.3	7.7	7.4	4.9	134.9	3.6	7.4	6.5	12.7	15.7	12.7	17.3	13.9	6.2	14.7	12.9	15.9	31.5	3.4	5.4	8.4	9.8	14.7	12.6	4.3	4.5	17.0	7.6	6.9	4.3	6.9	6.9	12.0	14.3	5.0	3.2	12.2	9.1	11.4	9.7	12.8	5.0	5.2	12.5	0.1	1.0	8.8	10.9	0.1	0.1	0.4	1.9	4.7	1.3	1.2	0.0	0.6	0.3	0.9	0.3	3.6	0.2	5.0	0.0	1.4	0.4	2.3	0.7	1.2	0.1	0.0	0.0	1.0	4.5	0.6	0.0	0.0	0.8	2.7	5.3	0.0	0.0	0.2	32.2	0.6	0.8	3.9	0.0	0.5	1.0	0.2	1.2	0.2	4.8	20.1	3.5	0.5	0.4	2.8	4.1	0.5	0.2	0.8	0.5	0.3	0.1	1.1	0.1	0.5	0.4	0.6	0.1	2.2	2.6	0.3	0.5	0.2	0.2	0.1	1.0	0.3	0.2	0.1	1.1	0.2	0.2	1.4	0.5	0.3	0.6	0.1	0.1	12.9	15.3	9.7	16.8	15.7	12.7	12.9	15.9	14.7	12.0	12.2	12.5	30.7	0.0	1.1	36.6	0.2	2.4	3.5	1.9	0.6	1.1	19.3	13.6	10.1	5.7	6.1	14.7	2.1	88.6	1.4	0.2	0.0	7.2	5.5	2.6	11.2	24.8	1.2	3.0	35.6	2.5	1.3	13.1	0.5	10.5	6.3	104.7	25.4	20.4	5.7	1.7	24.2	1.1	0.0	1.0	3.6	2.9	14.3	1.8	1.8	7.5	7.8	14.8	0.0	17.6	13.1	1.4	0.2	9.8	1.2	4.9	0.4	2.6	7.1	2.2	0.0	3.9	7.8	1.1	4.1	1.6	1.1	117.3	0.6	1.8	4.3	0.9
TMEM170A	"FLJ37611, TMEM170"	ENSG00000166822	"Transmembrane protein 170A"	Q8WVE7	16	75443054-75465497	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.15e-2)"	"prognostic favorable (2.36e-9)"	"unprognostic (4.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.53e-3)"	8.2	9.8	7.7	10.6	10.6	36.6	6.0	9.2	9.0	7.7	7.9	12.1	14.5	8.0	6.0	8.4	7.6	7.8	7.2	7.4	9.3	9.2	12.7	8.0	11.9	11.3	10.2	10.2	10.2	3.9	8.7	10.2	9.9	7.6	10.1	14.9	6.5	3.2	3.7	7.8	13.7	6.3	9.3	9.2	7.3	17.4	8.5	6.8	9.7	4.9	9.7	8.1	7.8	16.9	14.2	17.1	21.8	22.3	9.5	7.7	38.9	9.2	5.2	7.4	11.3	35.3	30.7	19.6	17.0	4.4	16.4	25.9	18.3	8.9	13.0	12.0	11.4	10.6	16.4	22.4	6.3	25.3	27.3	6.7	6.8	12.5	9.4	8.7	6.5	22.7	21.8	15.2	3.9	28.8	22.3	16.8	26.1	17.2	9.2	43.5	8.5	15.7	5.1	18.3	12.8	14.9	22.4	7.0	12.6	25.6	9.4	11.6	9.6	12.6	21.4	10.1	10.2	13.7	17.3	60.3	9.8	14.7	14.4	14.5	26.6	38.2	27.9	29.1	36.6	28.9	29.1	31.8	24.0	28.8	30.9	27.3	33.3	25.4	26.9	26.8	23.1	21.6	7.7	10.6	9.2	9.0	7.4	9.3	11.3	10.2	9.9	9.3	8.5	16.9	39.7	19.2	15.0	20.5	49.0	19.9	45.7	37.8	26.7	25.6	37.7	27.1	9.3	40.0	25.3	20.2	37.5	73.0	65.0	86.2	25.4	26.8	40.5	62.5	23.6	37.2	34.1	17.1	17.6	19.3	51.5	24.3	16.8	67.7	28.6	57.3	35.3	24.2	37.2	37.0	15.9	37.6	22.4	31.8	29.7	8.7	24.2	38.3	21.4	11.2	41.2	43.7	42.2	24.1	29.8	23.3	67.6	21.4	29.2	57.5	53.5	30.2	32.4	38.3	32.9	19.9	20.1	88.5	61.8	19.7	20.0	53.4	49.0	36.7	56.0	67.8
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.9	7.6	65.4	0.6	71.3	0.2	6.2	135.5	104.1	4.1	38.6	8.9	1.9	3.6	1.5	1.8	6.3	2.7	4.5	71.7	51.3	42.7	9.9	6.7	0.5	64.7	54.9	5.9	4.6	2.3	12.9	3.2	65.5	11.6	1.7	15.7	21.9	1.6	2.8	3.3	3.2	2.4	65.7	2.6	8.6	2.2	51.5	0.5	12.3	1.9	0.5	3.9	3.0	108.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	71.3	135.5	104.1	71.7	51.3	64.7	54.9	65.5	65.7	51.5	108.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM202	FLJ27523	ENSG00000187806	"Transmembrane protein 202"	A6NGA9	15	72398302-72408367	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	116	"testis: 12.3"	"Group enriched"	"Detected in some"	34	"Early spermatids: 67.6;Late spermatids: 58.5;Spermatocytes: 61.2"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"																		"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205648	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	25.7	32.6	32.8	17.2	33.6	10.9	25.5	33.8	36.8	28.1	33.1	30.2	22.2	29.9	26.4	31.4	24.2	16.4	45.9	32.9	33.4	33.2	49.2	20.5	27.0	33.6	33.6	27.7	26.2	30.7	25.6	15.9	33.4	27.1	18.2	16.4	26.8	21.8	49.7	43.6	28.5	16.9	32.8	30.4	30.1	19.1	34.9	20.3	25.1	45.9	22.7	27.8	27.6	33.0	38.0	39.3	36.5	60.7	53.1	41.1	43.6	48.4	46.6	55.1	41.1	32.6	33.3	39.0	45.7	42.2	53.0	72.6	45.3	48.1	32.1	71.0	43.5	27.0	45.5	37.4	44.3	63.1	26.8	39.6	75.4	36.0	47.4	36.8	35.8	50.5	64.2	44.4	43.2	65.2	50.5	54.6	60.8	72.4	63.2	54.2	51.1	78.2	46.5	27.2	48.3	47.3	38.6	48.8	39.2	25.0	68.8	50.6	32.0	56.3	30.1	63.6	55.1	23.8	80.0	49.5	43.5	46.3	47.3	4.7	3.8	4.1	5.2	4.3	6.4	8.3	5.8	6.5	4.6	4.5	8.7	6.0	1.9	7.5	3.9	4.8	4.0	2.6	32.8	33.6	33.8	36.8	32.9	33.4	33.6	33.6	33.4	32.8	34.9	33.0	23.2	9.6	6.8	4.6	21.4	17.6	22.7	7.0	23.9	33.6	29.6	33.8	13.5	40.0	7.9	31.3	4.2	30.5	23.7	15.9	52.8	49.4	3.5	15.3	24.2	20.7	16.3	29.8	5.7	42.0	26.3	22.3	14.8	13.3	5.7	31.7	21.4	41.1	29.3	32.0	6.2	13.4	10.2	27.1	13.2	9.4	22.1	20.8	24.9	5.6	54.2	58.8	24.7	2.5	6.1	41.7	10.8	20.7	13.3	37.2	18.5	59.2	4.9	25.7	13.1	19.5	32.5	18.6	15.9	28.5	27.3	19.4	24.4	36.2	18.6	17.9
TMEM204	"C16orf30, CLP24, FLJ20898"	ENSG00000131634	"Transmembrane protein 204"	Q9BSN7	16	1528688-1555580	"Predicted membrane proteins, Transporters"	"Stress response"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 208.2;Endothelial cells: 95.9;Hepatic stellate cells: 133.2;Peritubular cells: 67.4;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 156.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 156.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ: 16.5;BJ hTERT+: 21.2;fHDF/TERT166: 14.2;HHSteC: 36.9;HSkMC: 14.8;TIME: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014028	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014028: AB_2204906"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (8.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.62e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.53e-2)"	48.6	20.9	15.1	7.8	13.4	0.5	43.3	13.2	16.3	36.8	11.0	28.4	6.5	35.9	4.0	12.1	26.9	12.9	70.4	11.8	12.2	45.9	17.2	71.5	16.4	13.8	14.3	17.5	15.8	7.4	14.6	12.8	15.1	28.3	2.8	0.5	16.8	14.4	18.0	18.9	25.3	11.2	12.1	24.2	22.1	8.2	16.1	7.9	49.0	16.1	5.4	28.8	20.7	11.7	0.1	0.1	0.9	0.1	7.5	12.5	0.2	16.5	21.2	2.5	2.6	0.6	0.1	0.1	0.1	14.2	0.0	0.3	0.0	0.0	1.1	0.1	0.1	0.0	0.8	0.2	36.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.7	0.0	0.2	0.0	0.2	0.5	0.3	0.5	0.1	1.8	0.4	0.0	0.0	12.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	4.4	0.3	0.7	0.0	24.5	0.9	45.2	0.6	80.0	55.0	1.8	1.3	156.6	82.2	2.8	34.1	0.8	0.6	38.1	41.1	15.1	13.4	13.2	16.3	11.8	12.2	13.8	14.3	15.1	12.1	16.1	11.7	208.2	0.0	3.7	0.7	4.5	5.7	7.1	17.1	1.2	0.2	3.4	4.4	8.3	0.0	1.6	0.0	0.0	0.5	6.5	0.0	0.0	0.3	0.8	1.9	33.6	95.9	0.0	5.7	0.7	0.2	0.2	31.8	0.0	0.8	0.0	2.3	133.2	1.1	0.4	0.0	0.6	0.0	2.0	3.8	5.7	1.3	23.6	5.6	7.2	30.0	1.4	0.2	12.3	0.0	0.6	0.0	0.0	67.4	0.5	1.1	0.0	0.1	0.2	0.8	118.3	3.3	43.0	0.0	0.2	0.7	3.1	0.4	15.3	17.2	0.0	5.1
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792006	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	13.1	20.9	10.4	9.4	12.0	6.4	12.8	12.4	13.4	13.2	11.6	15.7	11.0	12.9	9.7	13.3	11.7	5.5	27.9	10.4	10.5	17.3	22.5	11.1	12.0	11.6	10.2	11.4	19.8	8.0	13.2	7.1	11.8	14.8	7.4	5.2	15.3	7.2	16.1	13.3	14.4	5.3	10.0	16.6	15.4	6.7	10.4	7.3	13.8	8.5	7.0	12.2	11.1	12.1	29.2	24.4	14.3	19.6	11.8	13.5	19.5	15.3	13.4	16.9	14.1	21.5	34.9	21.6	36.8	11.1	22.5	43.3	17.3	18.9	9.6	34.7	32.5	16.1	26.9	25.9	20.6	20.0	18.4	14.4	18.8	11.2	13.9	20.3	13.9	28.2	24.8	15.8	12.6	42.3	20.3	44.3	28.2	30.2	29.2	24.7	17.3	48.8	26.8	18.3	24.3	32.0	16.0	32.3	43.0	14.5	48.1	18.4	13.9	20.2	24.4	18.7	18.5	32.1	27.5	25.1	24.0	17.8	21.5	21.0	41.3	25.0	71.3	46.2	68.8	77.6	69.8	69.9	46.8	81.8	74.9	73.0	19.0	66.2	29.8	75.6	66.8	41.5	10.4	12.0	12.4	13.4	10.4	10.5	11.6	10.2	11.8	10.0	10.4	12.1	31.9	12.8	5.6	4.2	24.1	13.5	15.3	39.7	8.6	17.9	27.6	45.0	18.8	52.9	25.2	20.2	12.5	49.4	22.8	30.2	62.6	37.2	2.6	29.1	26.9	28.9	20.5	18.5	6.1	44.3	42.9	22.0	15.3	22.3	19.7	22.4	31.8	36.0	37.6	6.7	8.0	32.6	38.7	20.1	13.6	3.4	32.6	16.2	19.6	4.7	16.2	16.5	35.0	6.0	5.7	36.1	19.3	26.4	25.4	22.4	32.1	52.3	39.6	18.0	19.7	22.3	17.9	6.9	19.7	21.3	13.9	14.2	24.3	34.2	43.4	17.1
TMEM237	"ALS2CR4, JBTS14"	ENSG00000155755	"Transmembrane protein 237"	Q96Q45	2	201620184-201643570	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 89.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052596, HPA054732"	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA052596: AB_2681879, HPA054732: AB_2682587"	"unprognostic (1.70e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.06e-1)"	"unprognostic (8.30e-6)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.96e-6)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	4.1	15.1	6.3	1.7	6.5	2.3	11.0	7.1	7.8	5.0	6.0	3.0	0.8	6.0	4.6	6.0	5.8	4.1	7.7	6.8	6.7	5.4	1.9	5.1	2.3	6.9	6.9	8.4	1.9	5.0	3.0	5.2	7.2	7.8	3.7	89.3	5.1	4.8	7.7	18.5	1.8	5.8	7.1	1.4	2.2	3.0	6.4	7.0	4.6	9.2	3.1	4.1	3.4	6.8	3.7	7.2	32.3	16.4	7.8	10.1	3.1	22.6	9.9	14.7	28.4	5.9	5.3	3.7	6.9	21.9	12.7	6.8	5.6	24.4	27.1	6.9	20.6	10.7	21.4	19.4	15.1	10.4	2.1	9.0	5.0	20.4	5.1	24.8	25.5	23.4	7.8	13.0	29.8	5.2	29.7	16.3	32.7	1.9	23.8	43.9	30.8	7.6	12.2	9.7	33.7	47.4	21.4	8.4	12.6	20.3	12.5	18.7	6.8	26.8	7.3	8.6	9.5	6.0	14.9	11.4	22.7	9.7	17.0	0.0	0.0	0.0	1.0	1.1	0.9	0.7	1.0	1.6	1.3	0.1	1.1	1.4	0.0	0.9	0.7	0.3	1.8	0.5	6.3	6.5	7.1	7.8	6.8	6.7	6.9	6.9	7.2	7.1	6.4	6.8	6.8	6.4	9.6	12.4	1.6	71.2	81.7	46.7	50.7	33.3	17.1	41.4	20.2	2.8	18.9	18.4	41.7	21.0	3.1	0.6	13.7	11.1	8.9	16.3	10.9	11.6	4.8	8.6	16.5	7.6	26.8	25.8	3.1	7.7	5.1	19.9	10.4	2.7	9.4	32.0	15.3	4.5	18.3	2.2	12.2	7.0	21.8	2.9	12.4	4.7	5.7	38.5	0.0	14.1	10.8	6.5	1.9	21.4	3.0	36.9	0.7	3.9	19.8	160.3	6.6	33.2	20.6	33.3	22.0	30.0	45.3	15.1	4.2	39.8	5.3	29.2
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	6.9	25.3	35.0	3.8	36.0	2.2	14.6	33.9	44.3	14.9	32.2	16.0	46.0	15.3	25.7	11.1	13.7	8.9	8.9	37.5	36.7	18.6	23.1	9.9	4.8	32.1	30.3	23.4	17.6	23.3	29.5	6.0	32.0	15.7	3.7	22.3	21.0	18.3	18.5	8.7	35.2	10.8	31.5	5.3	13.3	6.5	35.1	5.1	15.9	9.9	5.3	14.4	11.6	35.1	3.4	0.7	5.8	9.5	6.0	0.9	5.6	5.2	9.9	4.9	9.8	27.1	18.8	0.3	20.1	5.3	10.9	14.8	0.0	18.3	4.4	11.9	11.1	0.5	5.4	6.0	16.0	0.3	0.5	7.3	10.9	5.3	0.9	35.9	7.2	13.7	2.6	11.7	4.9	4.1	6.0	0.5	4.9	0.1	12.8	8.1	4.2	12.3	25.3	0.3	17.0	11.5	5.1	33.7	0.1	8.7	43.8	0.6	2.5	2.1	10.6	0.4	1.6	11.7	8.3	3.1	0.4	0.2	0.2	0.7	0.2	0.2	5.1	0.2	7.1	4.0	7.3	2.9	0.5	2.6	10.0	5.4	0.4	7.4	0.2	3.4	6.0	3.5	35.0	36.0	33.9	44.3	37.5	36.7	32.1	30.3	32.0	31.5	35.1	35.1	5.1	6.4	3.9	11.1	6.2	5.7	10.7	14.7	13.1	27.7	27.7	30.6	6.1	14.3	9.3	16.5	29.2	37.1	4.8	0.9	11.7	16.6	2.8	4.1	5.0	6.4	11.4	5.2	20.1	6.4	16.9	8.7	2.6	5.5	8.9	18.0	3.6	9.6	2.9	11.8	22.0	7.8	10.2	0.0	1.9	5.5	23.3	1.1	7.2	2.8	3.4	28.8	5.2	8.5	6.5	5.0	5.5	23.3	5.5	5.5	149.1	25.6	7.4	41.1	0.0	12.1	7.5	3.9	5.2	4.0	3.7	16.3	4.7	15.3	15.0	5.7
TMEM263	"C12orf23, MGC17943"	ENSG00000151135	"Transmembrane protein 263"	Q8WUH6	12	106955719-106978778	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014453, HPA042339"	Uncertain		Approved	Vesicles		NA	NA		14000	"Cluster 40: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA014453: , HPA042339: AB_10795503"	"unprognostic (2.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (7.84e-4)"	"unprognostic (4.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.53e-1)"	20.6	27.1	14.5	20.4	15.6	7.4	22.3	14.2	18.2	41.6	21.8	17.8	17.3	28.3	33.4	9.5	16.2	30.4	28.6	15.5	22.1	29.4	44.6	15.3	21.1	13.2	17.1	29.3	23.4	20.7	37.5	43.2	16.5	28.5	19.2	16.8	21.0	21.6	11.5	8.6	15.3	29.9	13.3	16.4	30.9	19.4	21.4	31.0	33.6	14.2	19.7	22.1	13.9	13.5	32.7	28.2	54.1	37.4	125.8	141.6	23.5	123.1	114.0	59.0	74.6	30.1	14.0	3.2	37.5	174.3	33.3	14.9	34.4	48.6	80.9	61.5	38.0	45.5	41.0	65.0	65.1	2.4	28.3	98.6	23.1	63.9	53.8	137.3	73.4	35.1	22.1	12.1	83.6	26.7	35.4	21.4	17.7	21.1	60.3	77.1	41.3	7.9	60.7	27.3	28.2	38.6	67.3	31.2	51.2	41.9	36.5	13.7	86.7	50.6	30.7	66.9	31.6	50.8	31.5	30.3	39.2	7.7	79.4	11.7	1.4	1.6	15.8	1.6	18.3	15.7	15.2	13.7	4.3	16.8	26.8	24.9	1.0	19.8	0.6	14.8	17.4	13.9	14.5	15.6	14.2	18.2	15.5	22.1	13.2	17.1	16.5	13.3	21.4	13.5	31.6	9.6	23.6	12.1	33.5	0.0	52.0	0.0	53.5	24.4	47.7	25.8	55.4	22.8	11.2	23.9	31.3	40.4	54.3	12.4	92.0	19.2	34.8	19.9	75.7	26.4	28.8	10.9	15.4	33.0	72.6	61.5	50.0	32.4	29.9	33.7	33.2	44.4	13.5	11.8	16.5	65.1	0.0	6.7	0.0	37.2	47.2	10.4	0.0	22.5	9.6	34.1	22.6	24.1	8.4	17.3	13.2	43.6	68.3	48.6	23.0	47.7	12.4	21.0	26.3	39.1	41.7	51.2	22.5	12.7	0.0	36.0	36.3	30.6	16.4	44.2
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284948	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	62.9	57.0	60.3	59.1	70.2	53.7	54.0	65.2	67.5	61.3	72.8	64.7	43.9	62.0	50.2	58.1	47.4	60.0	45.3	67.2	73.5	77.3	99.6	91.7	53.5	63.3	64.5	47.6	70.8	96.2	47.6	48.5	64.6	64.7	70.8	57.0	55.2	58.6	29.2	38.3	46.4	79.1	73.5	62.1	59.4	28.8	69.5	47.6	84.5	40.4	60.9	66.4	34.8	82.1	54.2	60.6	91.5	77.6	228.2	212.0	76.3	217.9	171.3	82.3	128.2	56.3	129.1	61.9	148.3	194.8	82.7	62.4	41.5	120.4	211.5	84.9	63.8	60.4	55.1	56.7	129.2	73.7	104.6	197.2	116.5	116.9	63.7	175.2	262.4	59.1	59.4	107.8	158.4	37.2	27.1	54.2	32.7	46.1	46.7	44.4	65.6	78.5	315.3	131.1	64.9	62.9	111.9	52.8	74.9	105.8	58.6	224.8	234.5	103.8	116.9	65.6	153.3	90.3	136.1	27.9	81.7	137.2	165.7	44.5	85.8	59.0	37.1	84.7	44.8	27.1	37.3	36.7	78.6	22.6	34.8	34.5	138.3	42.5	87.5	33.2	53.0	61.5	60.3	70.2	65.2	67.5	67.2	73.5	63.3	64.5	64.6	73.5	69.5	82.1	73.2	163.5	132.5	7.5	38.8	71.2	33.7	67.6	42.1	24.5	53.1	27.6	43.8	40.0	96.1	66.2	45.9	39.6	51.0	67.6	11.7	51.0	11.1	46.7	57.0	68.0	36.2	20.8	15.8	111.2	52.1	65.7	43.3	76.0	39.8	31.4	66.0	79.1	54.3	20.2	14.5	44.3	54.9	89.3	79.1	9.5	45.4	57.8	48.0	10.3	62.4	40.7	35.0	17.1	15.6	101.6	38.5	62.4	55.8	80.9	31.1	33.2	95.2	24.0	32.9	56.1	77.2	45.0	21.2	41.8	78.3	94.4	43.3	62.5	28.8	65.9
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281761	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4"	"Not detected"	"Not detected"							HPA043162	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.9	1.6	0.5	3.7	0.7	0.4	14.8	0.5	1.0	16.4	0.9	29.1	43.3	3.8	28.2	14.1	15.2	23.9	2.0	0.3	0.7	12.3	12.3	14.5	1.2	0.6	0.5	2.5	35.7	59.1	18.2	5.7	0.5	21.9	26.1	0.3	27.7	13.4	1.2	8.6	34.4	1.7	0.5	0.7	42.2	2.6	0.6	5.3	50.0	1.9	4.4	16.1	9.3	0.4	68.7	0.2	0.0	0.0	6.7	1.6	0.1	0.1	0.0	0.0	0.0	11.6	54.4	0.0	0.1	0.0	0.0	31.7	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	44.6	0.0	0.1	0.6	28.2	1.6	0.0	1.5	0.2	0.0	94.9	11.2	0.1	0.8	25.6	0.1	1.9	30.4	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.7	0.5	1.0	0.3	0.7	0.6	0.5	0.5	0.5	0.6	0.4	0.6	28.9	31.9	0.0	0.6	64.9	124.0	19.5	61.5	0.0	32.2	16.5	1.9	47.1	24.5	40.5	0.0	28.0	1.1	90.8	13.7	24.8	0.9	23.8	3.9	3.9	23.4	0.0	0.0	37.2	11.4	5.5	62.7	45.3	2.5	0.7	4.2	14.1	2.0	0.0	0.0	73.1	20.3	1.0	6.8	1.6	8.7	1.5	5.4	1.0	0.6	2.9	2.1	0.0	0.1	31.9	75.3	79.0	0.4	101.1	73.6	1.0	22.7	0.3	13.1	2.4	5.4	5.9	3.6	43.3	63.6	35.8	3.6	0.9	64.7	131.9
TMEM33	"FLJ10525, Pom33"	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935129-41960803	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	12.4	16.1	8.0	19.4	10.5	14.9	16.0	13.1	11.4	11.4	16.0	18.7	21.1	11.1	25.5	21.2	12.3	17.2	10.5	9.6	12.8	24.2	39.9	15.1	17.0	15.5	13.5	10.5	18.2	30.1	11.0	20.0	14.7	17.2	21.3	13.0	17.9	11.8	8.4	11.9	16.9	11.3	14.1	13.9	19.1	9.9	12.1	14.9	23.8	12.4	20.1	21.8	10.8	18.8	36.9	42.4	36.7	51.3	46.7	31.8	44.9	49.5	53.9	41.5	47.5	52.4	123.4	64.8	74.7	41.5	85.5	57.4	124.4	65.0	56.1	17.1	26.2	80.7	49.7	45.9	54.4	108.7	67.6	33.4	69.0	52.5	78.3	26.5	32.7	37.3	86.8	24.7	57.4	32.6	96.5	67.9	67.2	58.1	50.0	42.7	57.8	51.6	58.2	53.5	40.8	58.4	40.5	38.0	62.4	35.3	42.9	37.4	53.0	48.3	65.0	48.9	89.5	44.5	76.9	77.4	51.7	88.4	71.2	41.2	32.1	21.7	14.9	31.0	17.6	13.0	15.3	14.2	22.9	12.0	13.6	15.0	43.2	16.5	35.2	17.9	19.0	16.4	8.0	10.5	13.1	11.4	9.6	12.8	15.5	13.5	14.7	14.1	12.1	18.8	25.1	60.9	34.3	20.9	25.0	73.3	35.7	42.4	24.5	19.2	36.9	16.4	18.0	27.1	40.5	55.2	16.7	56.3	35.2	58.9	23.5	44.6	2.9	26.9	31.2	25.9	35.0	25.0	33.6	38.1	49.3	30.5	36.2	33.4	38.7	23.1	24.7	84.4	57.3	28.6	32.8	40.4	34.6	67.5	51.0	4.7	20.2	55.7	56.9	11.2	55.9	33.9	16.5	32.6	40.3	54.1	47.4	23.3	32.5	73.7	41.6	41.1	29.7	20.4	26.3	26.5	55.6	31.0	28.7	47.5	66.9	133.1	28.3	39.7	43.0	64.5
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627075-34657285	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 110.7;Astrocytes: 85.5;Leydig cells: 74.3;Muller glia cells: 148.0;Peritubular cells: 92.9;Sertoli cells: 92.1;Skeletal myocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 348.1;RPTEC TERT1: 83.6;U-2197: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	40.0	20.8	34.8	8.5	38.3	0.0	18.8	27.1	39.5	46.7	41.6	25.9	8.6	45.7	33.4	34.6	35.1	28.6	36.1	30.8	35.8	27.7	24.8	21.9	6.2	36.5	38.7	21.7	11.3	5.6	6.6	1.2	33.7	32.9	14.9	17.8	29.6	45.6	23.8	6.3	11.5	51.0	37.8	7.5	13.8	4.9	39.5	3.1	20.2	31.1	4.2	36.2	20.1	33.4	0.0	1.7	50.7	21.4	43.8	33.1	0.0	112.6	0.3	21.8	18.7	0.1	0.0	0.0	9.2	348.1	0.0	0.1	14.5	4.0	32.0	0.0	9.9	0.0	13.2	0.0	25.3	0.0	0.0	30.0	0.1	8.9	9.7	38.9	24.8	0.0	0.0	0.0	41.6	0.9	0.0	0.0	6.0	0.6	0.3	0.0	25.3	0.0	83.6	33.0	0.5	0.0	0.1	1.3	0.0	5.4	0.2	0.0	0.9	44.0	4.4	74.4	4.8	0.0	0.0	0.0	18.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	38.3	27.1	39.5	30.8	35.8	36.5	38.7	33.7	37.8	39.5	33.4	110.7	19.2	0.6	85.5	0.1	8.2	15.9	0.9	1.8	8.3	10.8	12.7	27.7	10.0	1.5	16.5	6.2	0.0	0.6	0.0	7.9	0.8	0.4	7.6	4.6	29.8	0.0	0.0	4.3	5.3	0.2	48.3	1.1	6.2	2.5	0.7	46.4	17.5	0.1	30.3	25.6	0.0	0.0	0.8	11.7	3.8	74.3	1.2	65.8	13.1	0.0	148.0	0.0	5.0	2.2	3.0	0.0	92.9	0.1	14.3	0.0	13.4	2.0	7.3	92.1	84.7	67.1	0.3	2.1	1.9	5.3	0.1	0.7	0.8	0.0	12.1
TMEM59	"C1orf8, HSPC001"	ENSG00000116209	"Transmembrane protein 59"	Q9BXS4	1	54026681-54053504	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075447	Approved					NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA075447: "	"unprognostic (2.63e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.49e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.38e-2)"	257.6	359.7	181.9	164.6	220.8	259.7	341.4	240.3	253.8	343.6	379.5	488.3	364.1	208.7	415.5	241.8	403.2	299.3	275.7	178.4	202.0	473.7	505.7	264.0	162.6	240.6	205.0	225.4	586.1	532.5	170.2	325.8	239.1	350.2	485.3	254.2	550.3	279.9	194.5	194.7	369.1	219.8	235.7	188.7	433.0	174.9	204.6	186.9	341.3	247.6	189.2	289.2	202.6	286.8	188.9	122.3	142.8	185.2	844.1	371.1	182.8	347.9	499.1	211.5	276.0	99.1	391.9	96.7	322.6	595.6	257.7	281.1	166.2	237.5	221.9	237.7	177.4	133.5	266.6	166.1	317.8	165.7	268.7	408.3	411.2	207.5	219.2	566.9	246.6	127.8	158.9	326.3	245.1	91.6	97.9	137.3	201.0	528.3	226.3	94.0	251.6	403.2	257.6	248.0	208.2	173.3	381.5	386.0	398.3	266.2	184.9	348.4	259.3	259.8	90.7	193.3	187.8	289.0	338.7	114.5	349.4	275.4	222.3	1183.5	654.6	831.5	439.7	532.9	461.8	449.3	465.9	480.4	520.9	405.2	430.3	426.4	1196.5	430.4	595.9	527.1	576.1	1153.8	181.9	220.8	240.3	253.8	178.4	202.0	240.6	205.0	239.1	235.7	204.6	286.8	355.3	233.9	181.3	49.6	221.3	404.2	637.0	1214.2	237.3	150.2	409.0	325.1	155.1	479.0	991.8	437.7	118.9	477.7	244.5	905.2	160.4	527.8	357.1	348.5	201.9	279.5	408.2	277.0	44.3	352.5	528.7	410.6	226.8	217.2	155.2	89.5	334.4	413.2	320.2	132.9	42.1	672.8	1131.1	302.9	290.3	183.1	432.7	225.4	690.1	27.2	209.3	473.5	190.5	60.3	176.6	329.3	1064.8	354.0	692.8	583.2	1015.8	468.8	977.4	183.6	368.1	198.6	350.4	488.9	210.1	245.5	414.3	687.1	227.2	185.8	534.9	750.4
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 282.6;pituitary gland: 82.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.9;Bipolar cells: 92.2;Excitatory neurons: 110.7;Horizontal cells: 50.5;Inhibitory neurons: 88.0;Muller glia cells: 67.9;Oligodendrocyte precursor cells: 42.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.0;ASC diff: 42.6;EFO-21: 25.3;Hep G2: 27.3;hTERT-RPE1: 23.3;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	1.9	16.8	205.4	1.3	228.2	0.0	1.6	90.2	282.6	2.7	29.6	8.4	0.5	2.6	0.4	2.3	1.4	1.9	10.4	238.3	265.6	3.1	0.5	1.3	0.2	133.0	121.9	0.6	3.2	3.9	82.1	0.9	119.1	1.8	0.8	21.2	1.2	1.3	2.9	0.7	3.5	2.2	100.3	0.5	2.6	2.4	177.3	0.1	5.8	0.2	0.1	0.7	2.3	166.3	0.0	1.0	0.3	36.0	42.6	2.0	0.0	3.9	0.7	1.4	0.8	0.1	1.8	0.1	25.3	2.3	3.6	0.5	10.7	0.1	1.2	0.2	1.7	0.0	0.5	27.3	6.5	0.0	0.5	15.8	0.0	0.5	1.2	23.3	0.0	1.5	0.0	0.3	1.0	1.6	0.2	0.0	3.3	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.6	21.0	2.5	0.0	0.0	0.3	0.3	0.0	0.4	0.8	8.4	0.3	2.4	5.3	2.1	0.3	1.4	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	205.4	228.2	90.2	282.6	238.3	265.6	133.0	121.9	119.1	100.3	177.3	166.3	0.2	0.0	0.0	35.9	0.0	0.0	0.2	1.9	0.0	92.2	0.1	2.5	0.5	0.0	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.5	1.7	0.4	11.7	0.4	0.0	0.0	110.7	0.0	0.1	4.1	0.0	0.3	0.0	0.3	0.0	0.0	0.2	50.5	88.0	0.0	0.0	0.0	0.3	1.6	0.3	0.1	0.0	18.7	0.6	67.9	0.0	42.3	18.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	27.5	0.0	1.2	4.1	3.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0
TMEM60	"C7orf35, DC32"	ENSG00000135211	"Transmembrane protein 60"	Q9H2L4	7	77793728-77798434	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062625	Approved					NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA062625: AB_2684811"	"prognostic favorable (3.09e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.73e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.43e-3)"	15.9	23.9	17.5	17.6	17.4	10.6	29.6	18.4	21.4	21.7	19.5	24.9	17.7	16.6	29.7	15.3	18.9	18.6	17.1	17.4	19.3	30.4	35.5	18.9	29.2	18.0	17.5	23.3	18.2	39.8	17.5	23.5	18.2	17.4	24.3	14.1	21.2	19.9	22.9	16.5	17.0	19.6	18.9	20.4	16.4	24.1	17.8	20.4	25.8	20.3	27.7	16.9	13.1	19.1	45.7	30.3	46.2	54.4	61.6	54.5	21.2	41.8	79.9	44.2	69.9	28.4	56.8	35.1	10.0	39.4	150.6	46.8	44.0	24.6	49.7	27.5	41.9	19.0	26.9	39.9	43.4	26.9	33.9	39.9	35.1	32.8	39.6	42.8	31.9	32.0	45.7	68.2	70.4	49.3	20.4	68.7	32.3	55.3	39.4	24.1	36.6	50.7	52.9	33.9	23.2	37.4	31.4	43.7	66.0	48.7	52.8	49.0	21.2	55.6	38.7	49.2	31.4	27.6	46.6	51.1	42.3	55.8	50.2	208.6	51.3	100.2	29.2	58.7	32.4	88.9	51.0	36.9	40.3	72.5	42.9	36.6	52.7	32.3	54.7	52.6	79.4	41.2	17.5	17.4	18.4	21.4	17.4	19.3	18.0	17.5	18.2	18.9	17.8	19.1	16.5	9.6	11.5	2.9	33.5	30.0	34.6	61.7	25.6	7.6	37.5	42.4	8.0	20.0	29.0	44.1	8.4	56.4	17.6	22.0	52.8	28.4	9.4	17.7	13.7	20.1	9.1	14.5	6.1	29.8	40.2	26.9	11.7	14.5	24.7	21.1	24.7	26.3	70.8	13.5	6.5	30.6	61.1	43.5	38.9	10.9	45.7	39.1	28.4	7.5	42.6	21.5	21.6	3.0	7.9	27.6	31.4	35.3	15.4	35.4	30.3	50.5	31.4	12.4	52.6	12.6	50.5	49.8	40.3	31.0	33.4	43.9	20.8	16.4	23.6	39.3
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787594	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	0.3	0.2	1.8	0.1	2.2	0.0	0.2	4.7	2.4	0.2	1.4	1.3	0.0	0.1	0.0	0.5	0.1	0.1	1.3	3.7	3.0	0.1	0.8	0.1	0.0	3.8	1.7	0.1	0.5	0.0	0.4	0.0	3.5	0.1	0.1	2.5	0.2	0.1	0.8	0.3	0.2	0.4	6.1	0.1	0.3	0.3	1.6	0.3	0.1	0.2	0.1	0.2	0.4	8.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	1.7	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	1.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	4.7	2.4	3.7	3.0	3.8	1.7	3.5	6.1	1.6	8.2	0.4	0.0	0.0	2.0	0.0	0.9	0.7	0.0	4.6	4.7	0.2	0.6	0.8	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	1.8	0.0	5.1	0.2	0.8	0.7	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	8.3	0.0	0.8	0.9	0.2	4.1	2.0	0.6	0.1	0.1	0.1	0.0	0.0
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	34.1	102.3	103.1	20.8	104.4	27.8	45.0	93.5	126.6	76.8	122.7	45.0	25.4	70.9	65.4	31.1	75.4	39.5	51.3	107.8	113.2	73.8	73.8	44.5	23.5	99.4	111.5	81.4	73.9	92.2	63.4	28.5	102.8	60.3	25.4	43.9	60.7	45.9	44.9	35.5	30.4	37.5	100.2	31.2	49.8	67.0	112.5	26.3	68.5	24.9	17.7	45.7	51.8	100.2	63.1	117.0	72.6	168.9	38.5	54.5	128.5	48.6	51.5	76.0	68.2	115.7	99.8	33.2	69.2	73.4	70.1	123.3	76.5	80.1	37.3	21.3	131.9	58.1	182.4	76.6	73.8	28.2	51.9	65.0	87.0	71.2	43.0	91.3	47.7	46.2	105.6	35.5	66.2	81.0	34.1	46.1	111.0	57.3	285.3	60.7	108.4	44.0	87.9	48.0	67.6	137.7	86.7	146.9	91.8	107.4	180.3	48.5	35.7	84.8	70.0	68.5	59.8	143.9	135.2	26.1	64.4	30.1	42.0	49.8	59.8	33.7	45.7	41.8	52.2	54.5	44.0	37.8	51.5	49.2	64.6	42.7	41.0	32.9	38.5	56.1	43.0	75.5	103.1	104.4	93.5	126.6	107.8	113.2	99.4	111.5	102.8	100.2	112.5	100.2	20.9	51.3	49.5	17.0	13.4	12.9	31.4	65.6	27.3	61.0	56.2	65.7	39.3	40.0	48.0	36.8	31.3	44.4	9.3	7.9	17.6	88.8	58.0	37.3	58.6	26.3	31.8	43.6	15.7	74.7	52.1	59.9	20.9	46.4	13.3	46.3	30.0	40.4	28.1	8.4	22.1	26.9	36.7	13.4	11.9	60.9	70.8	15.6	23.2	8.4	11.8	102.3	25.7	15.6	10.1	40.3	18.8	53.0	18.8	28.5	8.3	56.9	54.5	32.8	13.1	33.3	42.1	54.8	76.7	14.5	13.9	13.0	13.0	130.7	28.4	27.8
TMEM91	"DSPC3, FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 212.0;Late spermatids: 451.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 193.3"	"Group enriched"	"Detected in all"	8	"granulocytes: 193.3;monocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 20.1;HSkMC: 20.5;TIME: 19.8"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	24.0	12.8	32.3	6.9	43.1	36.2	19.7	19.5	35.2	39.1	27.7	26.6	3.5	18.6	10.2	22.6	30.2	8.2	16.4	29.3	49.0	20.3	9.6	23.3	6.5	29.2	33.3	20.1	17.7	4.1	26.2	9.4	28.4	23.0	3.9	9.2	11.4	8.6	5.4	66.3	14.3	8.7	23.3	37.5	12.3	37.8	52.7	5.7	20.5	7.3	7.6	29.8	31.3	24.2	3.3	7.0	5.4	2.7	6.4	13.6	5.0	2.6	3.4	1.3	2.1	0.5	2.9	1.5	2.4	3.0	2.1	0.9	1.3	2.4	3.0	2.3	3.6	20.1	5.7	11.1	12.3	3.4	5.2	20.5	12.6	4.0	9.8	14.8	9.2	3.7	3.8	6.2	2.1	6.3	2.5	6.6	2.3	0.9	4.2	4.2	1.2	1.4	3.4	1.6	1.4	3.3	5.0	1.0	4.1	3.8	1.3	9.9	19.8	3.1	3.0	2.9	2.7	3.8	0.6	1.1	6.5	4.6	1.2	36.8	51.9	4.0	5.9	12.3	7.4	0.7	3.4	3.1	9.5	1.4	8.0	3.9	193.3	1.5	9.1	14.6	4.7	41.2	32.3	43.1	19.5	35.2	29.3	49.0	29.2	33.3	28.4	23.3	52.7	24.2	20.2	3.2	22.4	23.8	3.5	17.8	22.9	59.8	7.4	8.3	10.7	15.9	5.3	2.8	25.0	7.3	6.2	2.7	10.6	0.7	1.9	5.3	212.0	12.0	12.1	13.7	14.4	4.8	11.7	3.2	84.3	21.7	1.1	4.8	34.2	13.0	20.0	3.8	15.7	8.4	18.9	1.6	10.2	67.6	8.4	451.5	14.0	51.6	8.8	7.5	30.7	4.1	20.6	5.0	5.8	3.8	18.5	7.2	1.7	6.5	2.3	2.5	13.5	6.4	6.6	4.8	8.6	4.9	9.0	9.7	21.3	8.6	7.8	3.7	1.7	10.4
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319200-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.4;pancreas: 322.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 121.5;Exocrine glandular cells: 196.4;Granulosa cells: 212.9;Hepatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 341.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	4.3	26.0	5.2	7.3	6.3	6.7	11.7	6.6	9.0	5.7	6.5	14.3	16.4	6.7	4.7	7.4	13.1	10.2	3.4	6.3	5.4	7.1	113.4	17.4	7.1	14.9	14.2	18.1	322.0	6.5	1.6	6.8	14.9	10.8	12.6	6.3	3.7	3.3	15.5	9.8	11.2	5.7	5.0	4.6	38.8	58.0	7.4	7.6	4.2	9.1	8.2	26.6	5.2	6.8	46.1	120.4	214.8	105.5	28.0	40.2	70.5	44.1	27.9	67.9	90.3	341.0	34.3	126.3	46.4	17.0	140.1	48.7	137.1	75.0	52.7	60.3	102.1	47.8	56.9	143.0	25.7	76.9	36.4	84.0	10.0	66.4	27.5	8.3	21.1	80.1	101.3	92.1	22.7	81.8	120.0	72.4	95.6	187.7	30.6	94.8	236.5	112.8	85.6	210.6	154.1	67.0	70.0	55.1	36.3	118.2	97.0	35.8	13.8	72.8	56.8	62.9	81.7	74.3	159.0	115.9	14.6	54.7	44.3	0.7	2.2	2.2	7.8	2.7	9.2	11.1	6.4	9.4	16.1	5.5	10.4	9.8	1.0	9.5	1.0	9.3	6.6	5.2	5.2	6.3	6.6	9.0	6.3	5.4	14.9	14.2	14.9	5.0	7.4	6.8	4.2	9.6	61.5	3.3	7.7	14.5	6.0	32.8	18.8	11.3	22.5	21.5	9.0	121.5	19.1	14.7	16.7	34.2	5.0	6.1	15.6	23.3	22.3	7.5	14.3	7.1	38.8	40.3	2.9	196.4	84.0	14.4	49.5	11.4	1.3	212.9	6.4	226.9	22.0	3.3	4.5	16.2	26.4	6.7	34.7	49.1	13.4	9.9	16.0	0.0	11.4	8.2	4.1	4.0	1.0	47.7	3.5	11.3	15.3	13.9	4.0	6.3	12.2	9.1	6.6	10.4	12.4	91.3	65.5	22.7	11.2	10.7	6.4	65.1	29.4	7.9
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TMPRSS11A	"ECRG1, HATL1, HESP"	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909395-67964140	"Enzymes, Predicted membrane proteins, Transporters"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 86.1;lymphoid tissue: 28.4;vagina: 41.7"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 50.7"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	19.9	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.4	12.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	28.4	0.3	41.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.3	0.2	0.3	0.9	0.4	1.1	0.1	0.3	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.2	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.1	0.2	50.7	0.0	0.0	0.0	0.0	0.0	7.2
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371887-42396091	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.7;stomach 1: 14.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 274.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	0.5	0.3	3.8	0.2	4.0	0.1	8.7	4.0	3.7	6.3	2.0	0.2	1.3	0.7	0.0	0.2	23.7	8.6	0.0	3.4	4.1	2.4	0.5	3.4	0.5	4.9	4.7	0.0	3.0	0.0	1.5	0.2	3.7	0.4	0.1	3.9	9.2	0.4	0.1	0.1	1.1	0.0	3.5	0.4	14.5	0.0	4.7	0.9	2.9	0.0	0.4	1.0	0.0	2.7	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	32.9	0.0	66.2	26.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.0	14.0	0.0	1.5	3.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.8	1.5	0.0	0.0	33.9	1.6	0.0	0.0	3.2	0.3	0.1	0.0	1.7	0.0	0.2	0.7	274.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	1.7	1.8	0.0	0.0	0.3	0.9	0.3	0.0	0.5	0.0	0.8	0.5	3.8	4.0	4.0	3.7	3.4	4.1	4.9	4.7	3.7	3.5	4.7	2.7	0.1	12.8	3.7	2.3	0.4	0.3	2.3	8.1	0.0	0.2	17.7	9.9	0.6	24.3	10.8	7.3	0.0	0.0	0.1	1.4	5.9	16.1	1.4	17.1	0.4	0.2	0.0	2.7	0.0	13.8	0.1	1.3	23.4	5.2	0.0	0.2	0.4	0.0	0.1	0.0	0.0	2.0	16.2	0.0	0.5	0.6	0.3	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.1	11.8	1.4	0.0	0.4	2.4	2.9	0.0	39.8	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.1	2.5	5.0
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane O-mannosyltransferase targeting cadherins 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	5.9	4.4	3.6	3.8	3.8	1.7	6.7	5.8	4.7	5.6	2.1	4.5	5.4	6.4	5.2	9.1	3.9	5.7	3.8	3.9	4.6	8.1	9.0	5.2	2.9	3.4	3.9	5.3	3.2	6.2	2.8	10.2	4.1	7.4	4.7	7.9	3.8	6.3	1.7	12.5	4.4	9.2	3.2	3.9	3.8	4.1	3.6	4.0	6.3	4.3	4.5	6.8	4.7	4.1	13.2	14.0	12.6	11.9	28.8	25.4	22.5	28.1	26.6	15.8	16.9	20.3	9.2	4.1	5.0	25.8	9.6	28.9	13.5	22.4	26.5	2.4	10.2	4.0	9.5	9.3	15.0	4.3	2.5	21.7	12.0	30.5	12.0	16.2	24.9	3.4	8.9	1.4	17.8	7.9	3.0	5.5	9.7	5.0	7.3	2.6	27.4	4.1	13.7	21.3	10.7	10.6	22.8	16.1	7.3	13.3	25.9	4.3	26.4	21.8	12.0	19.4	13.7	4.5	6.3	4.7	6.8	5.0	16.5	7.4	1.3	2.3	1.8	1.1	2.2	2.3	2.0	1.4	0.9	1.8	2.4	2.0	1.3	1.2	1.6	0.9	1.7	0.7	3.6	3.8	5.8	4.7	3.9	4.6	3.4	3.9	4.1	3.2	3.6	4.1	15.9	12.8	8.2	19.6	6.9	34.2	24.4	29.1	24.5	12.5	11.4	8.1	11.1	5.7	20.0	7.3	27.1	29.6	3.5	6.7	3.9	14.5	26.8	23.7	22.2	16.9	3.6	9.5	51.6	10.8	18.2	23.8	8.6	21.9	9.5	12.4	15.7	19.2	8.2	13.5	46.8	5.9	75.3	5.9	6.0	18.2	20.2	3.7	8.8	20.6	2.8	8.3	2.1	28.1	42.4	12.4	4.9	19.5	4.6	18.0	7.3	13.9	34.9	23.4	19.7	17.1	22.3	12.0	8.7	32.6	40.5	17.8	5.2	14.1	7.1	14.4
TMUB1	"C7orf21, HOPS, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081085-151083493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	33.1	53.3	26.8	25.6	24.7	23.0	34.3	25.6	38.6	34.0	19.4	52.7	47.2	33.6	8.6	54.2	32.8	14.9	50.4	24.9	24.6	56.3	131.3	41.6	26.3	29.6	25.9	37.0	93.5	20.3	68.8	20.4	27.0	51.2	8.3	5.2	44.1	14.9	84.5	47.0	56.7	9.0	24.2	53.6	66.8	25.9	29.4	17.9	51.3	20.0	12.1	40.8	38.9	23.7	88.3	77.5	18.0	93.2	11.6	14.2	67.2	35.3	29.3	30.8	34.3	67.5	104.6	58.6	73.9	17.4	39.9	58.6	20.0	31.2	6.8	108.0	74.4	24.8	74.8	104.7	29.5	31.3	84.8	22.0	25.4	25.8	6.9	23.4	22.9	59.3	159.4	77.4	14.0	141.2	104.5	134.5	77.2	51.7	48.3	64.8	22.7	108.5	32.2	67.4	65.6	73.2	28.6	43.6	47.9	10.6	34.0	42.9	28.3	39.0	28.5	49.3	59.1	121.2	72.5	41.4	89.8	58.2	50.4	4.2	3.1	23.8	5.7	4.3	5.0	5.3	8.7	6.4	3.2	11.2	8.7	4.8	5.3	3.7	2.6	4.8	12.1	2.4	26.8	24.7	25.6	38.6	24.9	24.6	29.6	25.9	27.0	24.2	29.4	23.7	24.0	6.4	3.2	7.5	51.2	26.4	25.9	26.0	31.9	15.2	45.7	34.8	9.9	28.6	15.9	22.0	14.6	93.1	50.2	136.7	35.2	73.1	11.9	15.8	11.7	21.5	41.3	23.2	4.5	109.6	60.2	18.3	52.0	29.3	15.9	23.3	25.4	51.4	44.2	20.2	5.3	85.9	46.8	30.4	61.2	5.1	12.5	32.4	32.0	6.5	44.8	28.9	70.0	2.5	7.2	96.3	109.7	16.6	67.8	39.3	191.0	37.9	6.4	16.0	39.5	9.3	21.8	22.3	15.6	39.5	36.9	94.5	52.8	25.4	84.0	37.9
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257655	"Predicted membrane proteins, Transporters"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		26000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	11.0	8.8	5.8	10.8	6.3	10.7	11.3	6.7	8.7	7.8	7.4	12.3	10.6	8.1	10.8	9.1	6.6	8.5	4.8	5.4	6.6	10.2	12.6	9.3	12.4	6.5	6.8	6.6	9.1	9.4	5.5	13.2	7.0	7.9	12.2	6.8	8.3	9.2	5.2	9.8	9.3	9.9	6.9	10.7	10.4	5.0	7.0	11.6	11.4	4.4	10.5	13.0	6.6	7.0	27.0	23.8	33.8	18.4	26.0	20.3	35.5	33.5	26.8	33.2	42.2	24.9	49.0	38.8	30.0	22.6	15.6	26.1	60.3	21.5	60.4	38.6	19.6	28.4	19.4	24.7	22.4	66.2	27.4	24.4	19.5	22.2	16.3	24.0	29.7	31.2	23.6	25.9	32.1	32.6	29.7	35.5	38.3	42.2	28.5	30.9	60.9	23.4	32.2	34.8	21.1	15.5	26.6	17.8	24.6	22.2	25.8	28.6	19.0	34.9	32.2	24.8	30.9	22.4	23.9	31.4	15.4	36.6	33.5	10.5	12.2	6.2	8.6	14.7	10.6	7.7	8.8	9.0	13.6	6.3	8.5	10.1	4.3	11.5	11.0	15.7	11.0	12.4	5.8	6.3	6.7	8.7	5.4	6.6	6.5	6.8	7.0	6.9	7.0	7.0	43.0	38.5	29.1	24.5	55.9	108.6	63.1	80.5	71.2	13.7	40.7	20.8	9.2	44.3	55.7	35.0	12.5	73.9	82.6	38.2	9.8	62.1	2.5	22.0	42.2	47.5	17.4	81.2	8.9	67.6	149.3	48.4	32.1	28.0	43.6	24.4	43.2	44.0	73.2	10.1	11.2	29.2	63.1	61.1	84.3	4.3	24.8	65.7	55.2	18.7	70.0	27.0	46.4	22.1	25.2	50.3	44.0	28.6	79.2	58.4	29.3	32.4	42.2	32.6	59.2	37.3	49.4	59.5	68.7	79.0	97.3	57.7	62.5	58.7	46.5	59.5
TMX3	"FLJ20793, KIAA1830, PDIA13, TXNDC10"	ENSG00000166479	"Thioredoxin related transmembrane protein 3"	Q96JJ7	18	68673688-68715108	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014157	Uncertain				"Intracellular and membrane"	NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014157: AB_1858469"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.20e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	22.7	16.2	11.7	24.1	13.0	14.1	19.2	14.2	15.4	15.0	9.9	12.7	18.2	16.6	20.4	14.1	13.8	16.5	20.8	13.5	13.2	14.6	16.2	19.5	27.9	11.1	11.2	13.0	11.9	15.9	9.6	19.8	12.1	17.7	16.3	26.0	10.6	13.0	11.0	16.7	18.8	21.0	11.4	22.6	14.0	11.4	12.1	23.3	17.7	21.0	22.7	20.1	11.2	11.5	11.1	17.4	32.9	25.9	66.6	70.7	24.5	85.7	91.0	61.0	67.7	8.4	31.9	31.4	16.6	125.4	25.9	40.8	21.9	42.9	92.8	30.3	19.6	28.8	27.4	14.7	70.6	62.0	45.7	56.5	27.1	66.2	59.2	61.8	78.4	27.0	18.9	42.5	73.1	6.9	33.3	19.6	13.9	9.1	28.2	30.7	65.5	38.5	51.7	24.2	31.5	24.5	42.0	26.7	31.8	32.4	17.6	52.1	76.4	108.4	30.0	24.7	63.6	28.4	30.4	29.4	65.5	50.1	81.3	2.2	2.9	2.4	3.8	4.7	5.5	3.1	3.9	3.6	4.7	2.1	4.3	4.4	0.7	4.9	3.3	6.4	4.4	2.7	11.7	13.0	14.2	15.4	13.5	13.2	11.1	11.2	12.1	11.4	12.1	11.5	31.4	28.9	27.8	36.2	25.0	20.3	17.2	17.6	12.0	29.1	21.0	15.6	25.1	10.0	18.8	16.5	18.8	15.0	44.3	10.6	1.9	15.2	8.9	18.7	38.5	27.3	18.0	17.0	77.9	10.2	20.8	34.5	13.3	25.6	20.3	24.2	34.2	26.6	18.6	26.9	45.6	13.8	14.2	23.3	26.8	3.3	24.2	23.9	24.9	32.8	18.2	20.5	20.6	49.8	53.1	15.4	15.4	16.6	29.8	19.4	17.5	8.0	28.8	32.5	39.5	23.6	32.0	23.8	28.3	21.7	24.3	12.4	23.3	22.9	9.4	16.6
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 44.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	11.9	65.9	4.1	5.3	4.4	0.4	8.7	5.2	5.2	21.4	2.8	24.0	39.4	10.5	14.9	5.0	10.9	20.4	47.7	3.3	4.7	91.6	35.8	45.8	4.5	8.0	6.2	1.7	17.4	10.7	7.5	20.3	5.2	6.8	20.4	1.8	46.8	22.4	3.3	1.6	42.0	11.9	4.6	28.2	22.1	3.9	8.1	2.7	23.4	5.5	4.3	17.5	4.0	3.6	0.0	1.4	15.1	0.2	3.1	1.0	14.7	0.3	0.6	1.2	5.0	2.5	4.0	0.0	10.4	0.4	1.8	0.2	7.7	1.6	1.9	0.0	53.0	2.8	14.5	2.2	8.1	0.1	2.5	0.3	0.0	0.4	0.3	2.1	58.3	0.0	0.7	1.8	6.8	2.0	0.2	0.4	24.5	11.1	9.4	0.1	52.2	2.0	90.5	65.4	12.5	7.4	0.7	1.3	0.0	20.0	8.0	1.9	2.5	12.3	3.8	0.1	6.5	15.8	0.0	0.2	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	5.2	5.2	3.3	4.7	8.0	6.2	5.2	4.6	8.1	3.6	40.0	118.6	45.0	18.6	1.7	2.5	20.3	1.8	14.8	0.0	19.4	3.8	62.5	64.3	19.9	103.0	0.0	40.5	0.0	18.0	189.8	6.8	0.6	63.4	9.0	38.0	9.6	2.7	1.8	7.2	53.5	10.0	14.8	87.5	2.5	1.8	18.2	32.9	4.1	0.0	2.9	16.9	6.1	0.8	3.6	1.5	4.1	1.5	5.4	3.7	0.0	0.5	0.0	10.1	0.4	4.7	30.5	0.7	2.2	9.1	68.3	111.1	5.7	0.1	0.0	11.6	16.6	0.6	8.9	13.8	2.0	24.2	1.9	9.6	35.5	28.3
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533124	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 276.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	97.9	20.7	29.1	43.1	24.2	57.2	80.1	25.1	29.7	63.1	19.4	33.4	30.9	38.4	44.1	92.1	47.1	32.9	51.2	26.2	21.4	45.7	21.1	70.8	54.2	31.7	32.2	47.2	33.1	35.7	15.7	81.9	29.7	34.8	27.1	7.9	47.7	34.1	24.9	74.3	34.8	33.3	31.2	48.5	24.7	23.2	32.8	40.1	46.5	42.1	44.6	55.0	56.1	31.4	96.2	135.6	128.3	44.5	186.6	59.3	59.6	49.3	91.8	51.1	38.0	134.8	54.6	31.5	93.2	26.4	18.9	97.0	35.9	88.5	41.4	55.9	13.9	88.9	15.8	118.2	63.5	31.8	20.3	58.8	77.2	52.8	92.1	94.8	191.5	31.8	48.8	23.0	15.0	83.3	50.0	23.3	29.5	61.2	0.1	167.9	14.9	5.3	203.9	131.9	27.5	42.3	19.7	133.7	149.5	43.7	54.1	79.8	276.3	13.0	52.8	12.4	35.1	10.7	42.0	11.8	42.2	65.4	57.5	16.2	51.5	56.3	92.1	102.1	41.3	13.8	70.7	81.1	33.9	13.7	82.3	79.3	54.7	95.2	172.8	13.6	61.8	84.3	29.1	24.2	25.1	29.7	26.2	21.4	31.7	32.2	29.7	31.2	32.8	31.4	141.9	16.0	55.1	13.1	18.5	34.9	40.3	54.6	35.3	2.1	29.5	23.2	11.3	25.8	39.0	33.1	77.2	7.8	38.4	32.8	7.9	43.8	2.4	44.7	38.9	95.3	64.2	35.6	12.9	24.8	74.4	18.8	18.3	75.1	7.6	41.2	156.7	21.1	50.5	3.3	7.4	37.0	34.6	129.3	12.9	4.1	39.1	66.5	14.2	35.6	51.8	23.7	89.6	4.5	13.5	64.2	21.6	41.0	18.4	55.7	23.4	8.0	29.6	7.1	98.6	10.2	43.1	5.0	19.0	80.2	36.4	7.7	55.7	10.4	30.6	69.7
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451465-69507666	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	70.1	5.3	22.8	15.3	37.6	1.0	61.0	35.0	34.1	16.4	14.9	62.5	38.8	32.6	8.5	10.8	24.6	27.4	16.9	23.6	25.4	25.9	4.6	34.4	8.7	36.9	33.4	3.4	20.0	3.2	6.6	28.1	33.7	34.5	39.4	3.1	26.6	24.7	17.9	10.6	38.8	31.3	30.0	26.7	75.3	9.5	34.5	3.6	14.5	5.6	7.5	46.0	14.9	62.4	51.3	103.9	2.1	0.3	2.3	0.0	12.0	0.2	1.9	2.6	6.8	45.1	154.7	0.0	211.3	2.3	9.2	101.2	7.2	11.5	3.0	42.1	20.4	2.9	3.5	10.0	1.1	0.1	1.8	2.2	3.1	1.4	1.5	7.5	39.4	20.5	1.1	0.0	1.2	168.0	0.6	0.9	2.6	153.2	266.8	4.0	2.1	2.0	29.7	92.9	34.5	13.2	0.6	134.8	17.9	17.3	59.3	2.2	34.5	0.2	0.8	0.1	17.5	1.2	6.1	1.0	1.1	0.1	0.2	0.0	0.0	0.0	2.3	0.0	19.5	0.0	3.1	2.8	3.3	0.0	1.0	0.2	0.0	0.1	0.0	0.2	1.1	0.5	22.8	37.6	35.0	34.1	23.6	25.4	36.9	33.4	33.7	30.0	34.5	62.4	108.8	32.1	6.9	4.9	1.5	3.6	10.9	59.6	2.2	2.9	45.1	15.6	1.7	31.5	29.5	29.5	6.2	2.0	1.6	125.8	3.9	125.2	27.9	25.5	3.8	48.4	40.2	8.0	1.7	189.3	11.9	8.2	71.4	36.6	1.3	2.5	10.4	0.1	25.3	1.7	1.0	106.7	36.7	8.5	16.1	6.6	0.6	9.8	28.4	15.0	15.6	44.7	0.0	11.1	75.3	193.4	120.9	0.0	0.2	50.4	68.3	1.8	27.6	1.5	13.1	39.7	26.8	4.3	18.5	2.9	3.1	3.0	3.9	7.5	66.3	29.6
TSPAN18	TSPAN	ENSG00000157570	"Tetraspanin 18"	Q96SJ8	11	44726465-44932423	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 83.5"	"Group enriched"	"Detected in many"	6	"Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.09e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-2)"	22.2	46.1	5.8	10.4	4.3	1.2	10.0	30.5	8.2	14.4	3.6	47.9	6.7	46.7	3.6	21.0	20.8	13.3	83.5	26.1	4.6	14.5	4.9	22.4	7.7	5.1	10.4	7.4	1.6	3.9	5.4	30.2	4.9	15.8	9.9	1.0	3.3	41.4	14.7	6.3	16.4	46.6	8.9	14.1	16.6	4.0	10.8	4.0	14.8	19.9	4.2	23.1	10.2	2.3	0.0	0.6	36.7	0.5	0.0	0.0	0.0	0.6	0.5	2.3	0.1	7.3	61.5	0.0	16.4	1.0	35.2	0.0	6.6	0.2	0.6	48.7	2.4	0.2	5.0	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	14.3	0.2	1.1	0.0	0.1	0.0	0.0	0.1	33.0	0.1	1.0	0.1	38.4	0.2	0.0	0.0	31.9	36.2	0.4	0.1	0.1	99.8	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	1.6	1.0	0.0	0.0	1.6	0.1	0.0	0.8	0.2	1.1	0.5	0.0	0.0	1.3	0.2	0.3	0.5	0.0	0.0	0.3	1.7	5.8	4.3	30.5	8.2	26.1	4.6	5.1	10.4	4.9	8.9	10.8	2.3	72.2	0.0	3.7	5.5	1.5	1.7	0.1	0.0	0.6	1.8	1.0	0.3	22.3	0.0	0.0	7.3	0.0	0.1	1.1	0.0	0.0	0.4	29.7	0.7	0.9	51.8	0.0	3.6	2.7	0.2	0.2	6.8	0.5	1.4	1.3	0.0	70.3	1.0	0.4	1.7	4.1	0.0	0.0	2.5	2.6	5.6	2.8	3.4	7.2	2.8	0.2	0.1	0.0	4.0	1.3	0.7	0.0	1.5	0.6	0.2	0.0	20.2	0.0	0.5	0.0	4.9	2.0	0.6	1.0	0.0	1.1	0.3	3.0	3.2	0.0	0.1
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144707-129169699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	3.2	4.4	8.2	9.1	8.0	3.9	3.0	6.9	7.2	2.0	5.4	6.4	3.6	1.5	10.9	3.9	2.1	3.1	8.6	6.8	11.9	64.8	28.2	5.0	16.3	10.8	13.4	2.4	21.2	11.1	19.9	3.8	12.2	7.4	3.4	1.3	18.8	7.0	13.0	7.6	12.3	2.2	11.0	16.9	6.2	11.4	14.1	6.7	8.4	4.4	14.4	7.9	3.8	10.0	1.5	4.3	1.0	23.2	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.7	2.1	18.4	1.8	0.4	12.9	1.7	12.3	4.0	0.5	18.7	14.0	38.2	0.8	8.2	0.9	5.5	0.8	0.9	3.8	0.2	1.2	0.0	0.5	9.4	0.4	2.6	0.0	4.6	11.5	0.1	8.5	0.8	4.5	3.9	0.5	0.4	1.4	5.0	5.8	6.9	2.3	0.7	13.6	5.3	4.7	2.4	0.1	0.1	1.8	1.9	0.6	48.8	5.8	8.1	0.4	18.4	2.7	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.6	1.3	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.4	8.2	8.0	6.9	7.2	6.8	11.9	10.8	13.4	12.2	11.0	14.1	10.0	0.9	0.0	0.6	3.3	27.8	2.5	0.7	0.8	0.6	3.5	10.5	9.8	6.2	0.0	0.2	5.5	4.2	0.1	7.6	0.7	13.7	2.2	2.5	2.7	0.5	1.4	3.5	5.2	3.6	8.7	0.2	6.7	0.0	1.6	0.0	1.4	0.4	15.8	8.4	0.0	1.7	0.6	0.0	23.6	84.0	4.2	2.8	32.0	1.8	3.7	44.8	8.4	0.0	3.5	0.1	2.4	1.1	32.7	1.3	1.9	1.0	59.2	2.2	1.7	0.0	11.3	1.0	0.8	4.1	0.4	3.0	0.1	2.2	8.4	0.4	1.3
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561542-38688920	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 542.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 274.9;Excitatory neurons: 215.6;Hepatic stellate cells: 407.3;Inhibitory neurons: 249.8;Oligodendrocyte precursor cells: 353.4"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.5;JURKAT: 380.9;MOLT-4: 239.7;SCLC-21H: 129.0;U-266/70: 163.2"	"Low region specificity"	"Detected in all"							"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	56.1	125.6	355.5	17.2	433.8	1.3	33.5	369.5	542.1	42.6	271.3	68.1	36.3	43.8	37.6	33.6	36.5	25.8	70.3	413.7	334.3	56.2	45.0	67.4	41.1	290.3	298.8	19.6	19.8	13.9	28.0	25.1	283.6	18.8	64.6	286.9	12.5	26.8	153.9	19.4	34.0	51.1	291.7	96.3	14.5	4.8	331.7	15.7	51.3	232.3	28.9	29.7	16.9	384.6	0.1	0.0	2.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.8	1.6	0.0	109.5	14.9	0.5	0.0	67.2	0.0	0.1	1.2	1.5	0.0	0.0	0.0	0.0	0.0	380.9	0.0	0.4	1.7	0.4	239.7	0.0	11.2	0.1	0.0	14.6	4.6	0.0	11.0	1.4	129.0	14.4	0.0	0.0	4.3	6.5	0.0	0.3	0.0	0.1	3.1	0.1	1.0	163.2	54.8	0.0	5.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	355.5	433.8	369.5	542.1	413.7	334.3	290.3	298.8	283.6	291.7	331.7	384.6	116.1	12.8	23.8	274.9	1.1	10.6	2.7	6.3	6.2	92.0	1.0	3.8	34.1	1.5	4.6	11.0	43.8	0.4	0.2	69.1	23.5	0.4	0.0	2.1	1.6	153.3	18.7	5.3	215.6	0.6	0.4	14.0	4.6	5.6	10.1	108.1	407.3	4.8	45.1	97.6	249.8	23.5	0.0	15.0	10.0	1.9	0.6	1.5	14.2	46.9	0.0	102.3	0.0	353.4	50.6	0.9	21.9	3.0	1.5	2.4	40.3	9.8	1.2	107.4	59.2	26.5	11.7	0.6	3.3	9.9	6.5	0.8	2.6	27.0	35.7	0.9
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 96.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 213.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.1"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	25.4	12.9	11.0	7.1	12.1	0.6	25.0	96.6	13.5	29.6	9.7	18.0	7.9	32.3	11.5	15.4	23.2	35.2	128.8	6.9	12.6	45.8	54.8	35.8	5.4	12.3	13.0	35.3	13.1	28.1	8.6	58.7	14.5	27.6	6.2	14.8	18.0	24.4	16.8	27.9	12.3	23.6	8.6	20.6	13.4	5.1	17.1	19.1	18.4	12.4	7.1	18.4	22.3	7.6	1.5	12.7	20.1	16.1	19.2	15.5	48.3	26.7	82.3	20.1	26.1	30.6	11.6	0.8	23.9	14.6	19.7	3.1	9.5	9.6	11.8	5.0	9.3	36.3	8.5	20.6	42.2	0.2	3.0	17.7	7.4	40.4	16.9	50.4	55.7	1.1	1.0	1.1	17.6	16.7	0.0	0.8	25.5	7.8	7.4	9.9	213.0	3.1	61.7	7.4	36.8	22.6	18.8	36.6	16.4	45.9	13.7	0.2	27.2	8.5	28.8	14.8	25.7	0.2	0.6	0.3	20.3	0.5	10.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.2	11.0	12.1	96.6	13.5	6.9	12.6	12.3	13.0	14.5	8.6	17.1	7.6	60.1	0.0	4.1	10.4	0.8	19.2	13.3	22.4	13.1	68.7	19.8	9.0	50.1	11.5	6.5	12.9	2.1	53.1	0.2	1.7	5.9	21.1	3.0	2.3	24.9	43.1	6.0	5.3	16.8	9.1	105.1	22.2	2.0	5.7	0.0	13.0	41.0	36.7	6.2	33.7	45.5	2.3	2.0	3.2	3.5	4.1	17.4	7.1	12.4	30.9	0.8	4.0	0.0	9.0	2.0	9.9	0.6	17.3	1.4	13.8	2.4	22.4	2.5	4.7	19.7	1.4	20.9	1.3	3.4	9.7	11.9	80.7	1.5	6.4	2.5	10.5
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 43.2;urinary bladder: 205.7;vagina: 52.4"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 29.1"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049879	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.8	0.0	0.2	0.1	0.3	0.1	0.3	0.5	0.4	31.8	0.2	0.1	0.0	0.0	0.0	43.2	0.5	0.2	0.1	0.3	0.3	0.5	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.2	6.8	0.0	0.1	4.2	0.2	0.1	20.7	0.1	0.0	0.1	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.3	205.7	52.4	0.2	0.0	0.4	0.2	0.2	0.4	0.1	0.4	0.0	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	3.8	0.3	0.0	0.2	0.2	0.2	0.1	0.5	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.5	8.1	0.0	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.2	0.5	0.2	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.3	0.2	0.3	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.2	0.0	0.0	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.4	1.3	0.0	0.4	0.1	0.1	0.0	0.0	29.1
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205143	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 33.8;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Club cells: 198.3;Glandular and luminal cells: 80.9;Urothelial cells: 46.3"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 147.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.7;CACO-2: 40.6;RPTEC TERT1: 36.5;RT4: 147.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA031799, HPA031800"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favorable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	10.2	0.0	0.4	0.1	1.6	0.2	0.2	0.3	0.6	4.8	0.0	0.0	0.1	0.5	0.0	3.5	7.9	8.0	1.8	0.4	0.0	10.2	0.1	1.2	0.0	0.1	0.0	0.0	6.5	0.0	0.2	7.6	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	33.8	0.6	0.0	3.7	0.0	0.2	17.0	88.8	1.4	0.3	0.1	17.7	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	40.6	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	36.5	147.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.3	0.6	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	1.5	0.0	0.2	0.3	0.6	32.2	0.0	0.5	0.2	0.4	0.5	24.3	198.3	0.0	0.0	3.5	0.4	0.1	0.0	15.6	3.5	25.1	9.4	0.9	0.0	0.0	1.9	0.7	11.1	4.0	11.2	80.9	2.5	0.5	0.0	0.5	0.5	1.7	1.2	0.2	24.4	0.3	3.1	1.5	0.0	1.1	1.8	0.0	1.1	0.2	0.0	0.5	0.5	0.8	0.2	0.0	0.4	0.9	0.2	10.9	27.8	1.2	0.0	0.5	4.6	0.2	0.5	0.3	0.0	1.5	0.7	0.1	0.0	46.3
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"urinary bladder: 70.1"	"Group enriched"	"Detected in some"	7	"Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 144.4;RT4: 160.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.2	70.1	2.4	0.2	4.0	0.4	0.1	0.4	0.0	0.1	26.2	0.0	0.0	0.0	0.1	0.2	9.0	0.0	0.2	0.4	0.2	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	144.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.1	160.9	0.0	0.1	0.3	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.9	0.0	0.4	0.6	1.0	0.0	0.0	3.2	0.0	0.0	10.5	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.5	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.5	0.1	9.6	0.1	0.4	0.0	6.9
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 120.6;esophagus: 64.8;lung: 50.0;urinary bladder: 42.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 121.8"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1"	"Not detected"	"Not detected"							HPA010506	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	120.6	0.7	0.1	0.1	0.4	0.1	1.4	0.0	0.4	8.0	1.0	1.2	0.0	0.7	0.2	64.8	10.0	0.1	10.6	0.0	0.2	0.6	1.0	50.0	0.1	0.1	0.2	6.9	1.3	0.0	1.7	0.0	0.2	2.7	0.0	0.2	8.3	0.0	0.5	4.1	0.9	0.0	0.0	2.1	2.9	4.2	0.7	0.0	1.4	0.0	1.8	42.2	12.1	0.1	1.1	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.2	0.0	0.4	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.3	3.9	0.0	0.1	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.2	0.0	0.7	0.1	0.3	121.8	3.3	0.0	0.3	1.7	0.4	18.3	4.6	0.4	0.2	0.0	0.3	20.0	20.4	3.7	4.2	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.9	1.1	0.5	1.3	0.1	0.7	0.1	0.1	1.7	0.0	0.0	6.1	0.3	2.5	0.0	12.2	0.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	11.1	0.2	0.0	0.0	1.1	0.0	0.1	2.1	2.8	0.1	0.4	0.0	0.2	14.2
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 984.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 3000.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 3000.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	36.7	47.2	23.1	56.2	29.1	22.8	36.6	15.9	32.7	30.3	5.4	58.6	56.0	32.4	23.2	33.0	16.0	59.8	22.0	17.1	23.7	36.6	58.5	29.6	31.4	29.1	24.9	22.9	30.8	38.4	10.4	39.2	27.3	34.0	59.8	30.2	23.5	23.1	19.9	19.5	60.4	33.9	24.5	52.5	47.6	22.3	35.8	22.3	32.5	28.9	20.7	47.9	16.4	38.0	65.8	128.2	43.8	82.2	88.3	54.8	77.3	87.4	87.4	64.3	98.0	85.1	166.1	42.2	143.9	70.6	81.5	79.8	62.4	59.5	80.5	102.7	80.9	55.5	89.2	97.3	89.6	68.5	51.4	77.4	46.7	87.3	76.2	93.2	67.6	41.3	69.8	70.2	68.7	177.9	66.7	21.9	63.0	146.6	75.3	41.8	79.8	101.1	92.5	72.1	36.4	89.1	57.5	62.4	83.8	62.6	124.4	49.0	89.8	81.3	75.0	68.8	83.6	105.4	145.0	66.8	84.4	37.6	92.8	131.6	570.4	76.0	62.8	393.0	69.2	56.6	59.3	65.4	174.3	49.5	53.9	60.5	3000.2	69.0	666.9	59.2	73.9	501.6	23.1	29.1	15.9	32.7	17.1	23.7	29.1	24.9	27.3	24.5	35.8	38.0	164.8	89.8	124.1	35.3	68.6	161.1	984.4	188.9	665.9	36.1	429.1	187.1	27.9	125.8	273.3	275.8	58.4	91.7	71.0	511.1	23.5	223.1	7.2	372.8	197.7	148.2	310.6	29.9	80.1	137.9	123.5	193.6	367.0	708.6	135.4	111.2	48.2	108.4	121.7	28.6	84.6	254.1	168.9	335.2	270.7	11.5	35.8	322.6	129.9	45.0	231.1	50.4	51.5	51.8	141.2	160.7	508.1	35.3	92.5	553.1	361.1	72.6	289.7	51.6	92.1	59.2	293.5	83.6	44.6	672.6	129.7	175.8	127.3	67.5	241.7	629.2
WDR83OS	"Asterix, C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668073-12669415	"Predicted membrane proteins, Transporters"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	152.2	219.2	204.0	80.1	213.4	203.3	156.9	213.2	226.5	164.0	199.2	138.5	103.9	146.9	276.1	174.0	223.2	138.0	206.8	198.6	212.5	194.9	189.2	133.3	128.7	209.9	205.9	226.2	210.0	204.7	164.8	119.7	211.1	160.6	151.4	50.2	180.9	135.9	226.7	175.1	128.5	169.6	216.9	146.5	164.7	80.4	210.8	129.8	190.1	234.1	174.2	164.4	144.8	223.7	190.9	204.4	223.1	252.8	338.2	267.0	96.4	135.3	230.3	211.6	181.7	170.0	161.1	86.2	310.0	390.4	143.5	150.9	242.7	255.9	175.2	180.9	333.0	107.4	170.3	259.6	262.1	183.5	148.5	287.1	343.2	208.0	243.7	309.9	265.2	161.2	196.2	196.3	253.5	661.5	136.8	399.3	187.7	254.4	584.9	110.0	117.7	310.1	241.7	217.2	182.3	278.6	155.2	162.4	193.5	148.2	197.6	295.1	156.7	289.8	78.2	317.2	205.8	342.4	428.4	126.5	245.4	313.2	189.0	612.8	502.8	492.3	329.2	469.3	312.0	445.2	308.6	336.5	466.7	394.4	280.0	305.8	485.8	451.4	503.7	319.2	396.0	635.4	204.0	213.4	213.2	226.5	198.6	212.5	209.9	205.9	211.1	216.9	210.8	223.7	198.5	80.1	54.6	11.8	156.8	171.7	193.7	391.7	272.0	42.3	310.7	424.2	129.4	168.7	204.5	342.1	27.1	435.7	153.8	233.0	401.1	255.5	7.9	128.6	184.0	185.7	195.3	126.4	10.5	255.8	333.8	205.2	162.6	162.7	147.9	239.7	183.1	314.3	287.5	50.5	10.6	282.6	301.1	212.5	230.2	22.7	170.6	209.3	297.1	13.1	254.5	264.8	179.2	13.0	39.4	243.4	295.7	144.8	256.0	230.9	398.1	586.3	103.6	55.7	98.6	140.9	187.6	87.3	98.4	353.6	221.3	405.1	172.2	279.8	262.4	241.1
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916523-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005065	Approved					NA	NA		320000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB005065: AB_2218378"	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	379.0	262.9	246.2	374.2	324.1	527.2	251.7	147.4	343.0	269.6	88.3	475.2	327.3	275.6	220.9	892.8	243.9	333.0	187.3	366.2	269.6	224.9	190.9	275.8	429.3	163.3	195.7	227.7	191.5	233.3	109.0	339.2	222.5	265.8	445.9	285.3	244.8	291.2	95.0	399.4	375.4	356.5	170.1	272.8	365.4	226.8	276.9	434.8	289.7	168.9	566.1	501.0	343.2	205.0	1902.4	879.2	1605.4	457.7	396.6	490.9	808.0	877.6	1099.2	1124.6	1098.2	602.4	1149.5	816.5	857.1	1349.3	937.2	785.0	1025.5	1213.5	1630.1	765.1	454.2	779.5	579.0	378.1	524.8	311.5	840.3	475.4	1524.0	936.7	1430.1	923.8	1008.7	584.9	887.8	758.9	920.2	660.6	1357.1	535.4	548.0	2269.0	1026.7	569.7	468.6	544.8	1023.1	963.5	889.7	642.7	669.5	609.8	1365.4	1094.7	896.0	374.6	879.0	554.6	834.3	693.7	798.3	503.6	625.3	994.6	925.8	595.2	2303.2	1340.5	427.5	705.8	559.0	589.1	559.3	484.8	463.3	537.3	497.3	395.9	348.3	441.8	616.5	503.7	726.9	313.4	663.9	1087.2	246.2	324.1	147.4	343.0	366.2	269.6	163.3	195.7	222.5	170.1	276.9	205.0	199.4	250.0	228.9	43.1	637.6	1007.0	438.4	309.3	507.6	120.4	285.9	209.9	87.0	188.8	321.3	263.0	89.6	243.4	491.2	552.7	121.3	405.2	1092.9	359.6	245.6	216.0	265.3	137.3	150.2	421.3	551.6	277.4	448.5	578.8	452.9	122.1	183.1	104.5	276.3	134.6	92.5	525.2	244.1	303.5	641.2	2118.0	125.6	456.9	391.3	56.2	334.9	110.9	407.8	51.3	91.5	771.0	452.7	147.1	457.2	427.2	310.6	160.4	292.0	96.3	131.5	229.4	290.4	170.2	92.6	908.0	1184.7	408.9	596.5	116.5	371.7	794.9
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type palmitoyltransferase 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Urothelial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.8	5.7	5.2	7.8	5.2	9.7	8.9	6.6	7.1	9.3	6.6	16.9	11.2	6.7	5.1	37.2	12.9	8.7	9.1	5.4	5.7	9.2	2.2	6.1	9.6	5.5	5.0	5.3	11.2	14.9	11.7	6.2	5.8	8.2	18.2	16.1	10.2	5.4	1.6	18.8	11.3	6.1	5.3	5.7	18.5	14.4	5.0	11.7	8.7	2.9	22.4	22.4	15.4	5.2	41.6	19.3	18.0	15.5	6.3	7.2	17.3	19.4	17.8	21.3	24.4	11.7	9.7	21.1	13.1	16.3	47.9	61.3	26.0	12.8	23.3	26.4	22.6	11.1	12.6	9.7	14.6	15.2	18.5	8.3	14.7	9.0	12.5	19.9	136.8	28.9	10.7	10.3	22.1	13.5	19.6	12.2	15.1	38.7	17.6	21.3	25.0	5.0	21.9	27.0	31.3	23.0	23.2	28.0	10.7	17.3	13.2	17.6	39.6	18.9	13.2	29.2	15.8	8.7	28.5	19.2	22.6	15.5	33.6	11.6	4.7	32.7	8.5	7.9	7.8	8.7	6.6	9.6	5.9	5.5	6.2	8.3	6.0	6.3	6.4	5.6	9.4	4.6	5.2	5.2	6.6	7.1	5.4	5.7	5.5	5.0	5.8	5.3	5.0	5.2	8.1	9.6	10.7	28.7	9.6	24.2	22.3	27.2	14.2	12.0	7.5	4.8	34.1	12.8	41.3	16.5	10.4	8.7	10.6	20.1	5.9	25.1	120.5	21.5	6.6	11.3	15.6	11.6	27.2	19.2	18.8	9.2	24.5	30.8	12.0	16.2	12.8	0.9	6.1	16.8	34.9	24.7	36.7	6.8	8.3	46.6	7.8	6.2	3.6	9.4	20.8	52.8	18.6	19.6	20.9	20.4	16.4	2.2	10.4	47.4	15.5	3.5	57.0	8.8	0.0	5.4	7.4	58.1	31.7	21.3	36.2	6.3	11.4	7.7	21.4	103.0
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type palmitoyltransferase 17"	Q8IUH5	12	76764103-76853696	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 17.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	15.6	14.1	18.6	12.1	20.4	23.7	16.1	23.1	25.9	15.8	11.8	13.7	7.5	21.7	12.3	8.0	12.8	10.5	12.5	19.8	18.9	11.0	9.8	10.6	14.8	18.2	18.6	20.1	10.2	12.7	11.0	16.4	18.9	14.1	10.1	31.0	8.1	12.8	11.8	10.2	10.3	14.6	19.2	14.4	8.5	12.8	19.4	14.9	11.8	14.2	11.4	11.7	11.7	27.8	8.2	9.5	30.1	15.4	17.6	18.5	14.6	16.2	13.4	10.5	9.2	7.8	5.8	11.2	9.5	15.9	10.5	7.5	12.1	10.1	16.2	9.5	12.6	16.4	13.1	12.0	11.9	16.5	13.9	17.6	10.3	10.0	14.7	35.2	12.2	15.2	18.0	5.2	13.8	7.6	12.0	21.9	22.1	3.6	11.3	16.1	10.7	12.3	12.0	12.3	11.7	20.1	17.8	6.4	10.7	25.7	14.4	16.3	16.9	14.3	11.0	8.8	9.3	8.1	8.5	11.9	5.4	7.6	15.0	6.2	2.3	5.7	3.6	2.4	2.9	2.5	2.9	2.6	2.8	3.9	3.0	2.5	5.9	2.0	2.5	17.1	1.3	1.5	18.6	20.4	23.1	25.9	19.8	18.9	18.2	18.6	18.9	19.2	19.4	27.8	33.4	32.1	18.3	75.7	20.1	7.1	10.4	9.8	12.5	54.6	9.9	10.7	21.3	12.8	15.5	12.9	39.6	20.3	74.1	5.0	0.0	8.0	11.3	11.8	23.8	24.8	19.2	12.0	102.2	4.7	10.2	21.2	7.1	10.1	41.2	20.7	20.3	10.6	8.8	28.6	95.1	7.5	8.2	12.3	19.4	13.7	20.2	14.9	5.4	54.4	14.9	26.1	18.6	88.4	115.8	6.8	4.5	21.1	13.5	10.2	8.4	5.5	18.0	38.1	0.0	32.3	22.0	17.7	22.6	9.5	5.5	5.6	18.1	19.6	6.2	5.5
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type palmitoyltransferase 20"	Q5W0Z9	13	21372571-21459370	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 434.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	10.9	9.2	15.2	17.6	52.9	30.0	11.5	51.8	23.3	16.2	0.0	16.9	19.3	13.8	9.6	30.2	10.9	17.1	7.9	12.0	27.0	6.7	9.8	17.0	18.0	70.8	40.7	9.7	9.0	8.9	4.4	18.8	60.3	15.1	16.1	5.6	8.5	12.2	4.0	22.1	19.0	15.2	35.1	16.1	39.5	31.7	40.7	22.6	16.4	9.4	19.5	22.9	9.3	95.0	32.9	16.4	27.7	18.1	24.5	26.7	68.3	35.6	36.3	23.3	20.6	33.8	102.5	34.8	19.3	44.7	23.8	52.7	30.5	26.5	44.8	40.0	20.4	61.8	11.7	19.6	14.1	43.3	25.8	24.2	19.4	23.6	16.2	30.0	37.6	45.9	17.3	14.9	35.3	27.2	62.0	17.2	22.9	87.3	18.0	49.8	49.1	12.7	28.9	59.7	25.2	11.4	46.0	28.7	19.3	28.6	27.0	21.8	62.6	25.0	24.0	41.7	27.4	15.6	19.9	37.7	18.2	23.6	73.1	12.6	16.2	3.8	10.1	14.9	9.3	4.6	8.7	8.7	8.4	3.4	8.1	8.4	3.0	11.2	13.8	4.1	10.4	13.5	15.2	52.9	51.8	23.3	12.0	27.0	70.8	40.7	60.3	35.1	40.7	95.0	27.6	51.3	31.5	29.0	19.9	1.0	7.8	1.4	18.2	7.4	21.9	13.7	7.4	14.3	20.7	11.0	8.4	20.7	34.7	35.5	0.0	8.5	91.3	23.4	25.2	25.7	24.0	8.4	69.1	12.2	20.9	13.6	53.0	34.5	14.0	16.1	20.0	20.8	21.7	18.5	80.0	29.1	2.0	92.5	3.2	81.2	15.5	49.0	1.8	46.9	48.4	3.7	30.9	54.8	434.3	22.8	25.5	10.9	18.1	14.5	30.3	6.3	11.7	9.5	19.7	12.7	11.6	10.4	14.1	28.1	1.6	44.6	28.4	9.7	25.1	25.6
ZDHHC9	"CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type palmitoyltransferase 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 66.0;Oligodendrocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	28.2	12.0	39.2	10.2	66.6	5.4	24.3	46.5	52.5	19.1	23.3	22.0	31.6	11.8	11.7	15.6	12.1	15.3	15.5	39.2	49.0	37.1	40.1	26.7	3.3	60.5	58.2	11.2	25.9	25.2	11.4	17.2	52.5	18.8	24.9	6.0	21.1	11.3	13.4	35.3	34.0	15.3	44.8	3.9	19.5	4.1	57.8	3.6	13.8	11.3	6.6	23.8	14.5	78.6	45.9	23.8	33.2	67.5	112.4	87.7	27.0	44.3	50.6	20.9	26.0	37.6	58.4	1.6	73.7	47.6	54.0	30.4	38.0	44.6	30.0	2.6	23.7	9.2	24.0	50.1	44.4	6.1	15.7	96.0	71.1	34.0	50.1	36.5	39.9	15.0	10.1	17.6	34.0	40.0	8.8	11.4	18.0	102.3	40.4	8.2	21.4	27.1	30.1	25.2	26.3	22.0	12.7	64.7	20.5	38.9	27.6	10.1	32.8	21.1	7.3	50.0	36.3	16.5	12.7	5.5	37.9	25.1	10.8	0.0	2.2	1.8	3.0	2.0	3.7	2.7	3.6	2.9	2.4	1.5	4.5	2.6	0.0	2.5	5.2	5.1	1.8	2.1	39.2	66.6	46.5	52.5	39.2	49.0	60.5	58.2	52.5	44.8	57.8	78.6	66.0	22.4	28.6	4.6	2.8	18.6	12.4	12.8	13.1	9.1	16.8	15.1	4.6	17.2	15.9	46.0	2.1	5.6	2.7	20.1	3.9	18.6	1.8	23.8	16.9	16.6	18.0	4.2	10.5	19.8	19.1	32.7	18.3	59.7	2.5	11.5	7.9	43.7	4.9	1.7	11.8	23.2	10.2	3.5	12.2	2.0	12.2	3.9	10.6	7.5	0.3	1.5	1.0	9.5	118.2	33.5	14.6	7.5	7.7	39.1	51.0	25.8	7.2	2.8	0.0	9.5	11.1	8.4	8.7	16.9	19.2	10.3	5.1	7.5	27.2	22.1